{
    "sodium bicarbonate": {
        "definition": "A systemic alkalizer and antacid used to relieve heartburn, acid indigestion, and to treat metabolic acidosis.",
        "mechanism": "Neutralizes gastric acid and increases plasma bicarbonate, buffering excess hydrogen ion concentration.",
        "indications": [
            "Metabolic acidosis",
            "Heartburn and acid indigestion",
            "Urinary alkalinization",
            "Hyperkalemia (emergency adjunct)"
        ],
        "dosage": {
            "adults": "325-2000 mg orally 1-4 times daily as antacid; 1 mEq/kg IV for metabolic acidosis.",
            "children": "Dose varies by indication; consult guidelines."
        },
        "side effects": [
            "Metabolic alkalosis",
            "Edema",
            "Hypernatremia",
            "Hypokalemia"
        ],
        "contraindications": [
            "Metabolic or respiratory alkalosis",
            "Hypocalcemia",
            "Sodium-restricted diet"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed (FDA category C).",
            "renal impairment": "Use with caution; monitor electrolytes."
        },
        "interactions": [
            "Tetracycline antibiotics",
            "Aspirin",
            "Lithium"
        ],
        "last updated": "2024-11-01",
        "official sources": [
            "FDA DailyMed",
            "MedlinePlus",
            "DrugBank"
        ]
    },
    "citric acid": {
        "definition": "An alkalinizing agent used to make urine less acidic and prevent kidney stones.",
        "mechanism": "Metabolized to bicarbonate, increases urinary pH.",
        "indications": [
            "Metabolic acidosis",
            "Prevention of kidney stones",
            "Urinary alkalinization"
        ],
        "dosage": {
            "adults": "10-30 mL oral solution after meals and at bedtime.",
            "children": "5-15 mL oral solution after meals and at bedtime."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Diarrhea",
            "Metabolic alkalosis"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Sodium-restricted diet"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Aluminum-containing antacids"
        ],
        "last updated": "2024-10-15",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium citrate": {
        "definition": "An alkalinizing agent used to treat metabolic acidosis and prevent kidney stones.",
        "mechanism": "Metabolized to bicarbonate, increases urinary and systemic pH.",
        "indications": [
            "Metabolic acidosis",
            "Prevention of kidney stones",
            "Urinary alkalinization"
        ],
        "dosage": {
            "adults": "10-30 mL oral solution after meals and at bedtime.",
            "children": "5-15 mL oral solution after meals and at bedtime."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Diarrhea",
            "Metabolic alkalosis"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Sodium-restricted diet"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Aluminum-containing antacids"
        ],
        "last updated": "2024-09-30",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bethanechol": {
        "definition": "A cholinergic agonist used to treat urinary retention by stimulating bladder contraction.",
        "mechanism": "Stimulates muscarinic receptors, increasing detrusor muscle tone.",
        "indications": [
            "Acute postoperative and postpartum urinary retention",
            "Neurogenic bladder atony"
        ],
        "dosage": {
            "adults": "10-50 mg orally 3-4 times daily.",
            "children": "Not routinely recommended; consult guidelines."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Diarrhea",
            "Bradycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Asthma",
            "Bradycardia",
            "Peptic ulcer",
            "Mechanical obstruction"
        ],
        "special populations": {
            "pregnancy": "Category C; use only if needed.",
            "elderly": "Use with caution."
        },
        "interactions": [
            "Anticholinergics",
            "Ganglion-blocking agents"
        ],
        "last updated": "2024-10-05",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pamabrom": {
        "definition": "A mild diuretic used to relieve bloating and water retention, often in combination with analgesics for menstrual symptoms.",
        "mechanism": "Increases renal excretion of water, reducing fluid retention.",
        "indications": [
            "Relief of bloating and water retention associated with menstruation"
        ],
        "dosage": {
            "adults": "50 mg orally up to 4 times daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Increased urination",
            "Nausea",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to pamabrom"
        ],
        "special populations": {
            "pregnancy": "Consult physician.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "No significant interactions reported."
        ],
        "last updated": "2024-08-20",
        "official sources": [
            "FDA DailyMed",
            "Drugs.com"
        ]
    },
    "vasopressin": {
        "definition": "A synthetic hormone used to treat diabetes insipidus, vasodilatory shock, and to control bleeding from esophageal varices.",
        "mechanism": "Acts on V1 and V2 receptors to increase water reabsorption in kidneys and constrict blood vessels.",
        "indications": [
            "Diabetes insipidus",
            "Vasodilatory shock",
            "Esophageal variceal bleeding"
        ],
        "dosage": {
            "adults": "0.01–0.07 units/min IV infusion for shock; 5–10 units IM or SC for diabetes insipidus.",
            "children": "Consult official guidelines."
        },
        "side effects": [
            "Abdominal cramps",
            "Headache",
            "Hyponatremia",
            "Vasoconstriction"
        ],
        "contraindications": [
            "Chronic nephritis with nitrogen retention",
            "Known hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Category C; use only if needed.",
            "elderly": "Monitor for cardiovascular effects."
        },
        "interactions": [
            "Carbamazepine",
            "Chlorpropamide",
            "Lithium"
        ],
        "last updated": "2024-09-10",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "medroxyprogesterone": {
        "definition": "A progestin used for contraception, abnormal uterine bleeding, and endometrial hyperplasia prevention.",
        "mechanism": "Binds progesterone receptors, altering endometrial lining and inhibiting gonadotropin release.",
        "indications": [
            "Contraception",
            "Abnormal uterine bleeding",
            "Endometrial hyperplasia prevention"
        ],
        "dosage": {
            "adults": "5–10 mg orally daily for 5–10 days (bleeding); 150 mg IM every 3 months (contraception).",
            "children": "Not recommended for premenarchal girls."
        },
        "side effects": [
            "Weight changes",
            "Headache",
            "Amenorrhea",
            "Bone loss (long-term)"
        ],
        "contraindications": [
            "Active thromboembolic disorder",
            "Liver dysfunction",
            "Known/suspected pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inducers (e.g., phenytoin)",
            "Aminoglutethimide"
        ],
        "last updated": "2024-10-12",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "norethindrone": {
        "definition": "A synthetic progestin used for contraception, endometriosis, and abnormal uterine bleeding.",
        "mechanism": "Inhibits ovulation, thickens cervical mucus, and alters endometrial lining.",
        "indications": [
            "Contraception",
            "Endometriosis",
            "Abnormal uterine bleeding"
        ],
        "dosage": {
            "adults": "0.35–1 mg orally daily (contraception); 5–15 mg daily (other indications).",
            "children": "Not recommended for premenarchal girls."
        },
        "side effects": [
            "Irregular bleeding",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Active thromboembolic disorder",
            "Liver dysfunction",
            "Known/suspected pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inducers",
            "Rifampin"
        ],
        "last updated": "2024-09-30",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "megestrol": {
        "definition": "A synthetic progestin used to treat anorexia, cachexia, and significant weight loss in AIDS and cancer patients.",
        "mechanism": "Stimulates appetite and weight gain, has anti-gonadotropic and anti-estrogenic effects.",
        "indications": [
            "Anorexia and cachexia in AIDS or cancer",
            "Endometrial carcinoma"
        ],
        "dosage": {
            "adults": "400–800 mg orally daily (appetite stimulation); 40–320 mg daily (carcinoma).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Weight gain",
            "Edema",
            "Hypertension",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Known hypersensitivity",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "elderly": "Monitor for thromboembolic events."
        },
        "interactions": [
            "Indinavir",
            "Warfarin"
        ],
        "last updated": "2024-09-22",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levonorgestrel": {
        "definition": "A synthetic progestin used for contraception, emergency contraception, and in hormonal IUDs.",
        "mechanism": "Inhibits ovulation, thickens cervical mucus, alters endometrial lining.",
        "indications": [
            "Contraception",
            "Emergency contraception"
        ],
        "dosage": {
            "adults": "1.5 mg orally as a single dose (emergency contraception); IUD: 52 mg device, replaced every 3–5 years.",
            "children": "Not recommended for premenarchal girls."
        },
        "side effects": [
            "Irregular bleeding",
            "Nausea",
            "Abdominal pain"
        ],
        "contraindications": [
            "Active thromboembolic disorder",
            "Liver dysfunction",
            "Known/suspected pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inducers",
            "Carbamazepine"
        ],
        "last updated": "2024-10-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ethinyl estradiol": {
        "definition": "A synthetic estrogen used in combination with progestins for hormonal contraception and to treat menopausal symptoms.",
        "mechanism": "Binds to estrogen receptors, regulating gene transcription and modulating the development and maintenance of the female reproductive system.",
        "indications": [
            "Hormonal contraception (in combination products)",
            "Treatment of menopausal symptoms",
            "Hypoestrogenism"
        ],
        "dosage": {
            "adults": "20–50 mcg orally daily in combination with a progestin for 21 days per cycle.",
            "children": "Not recommended for prepubertal children."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Breast tenderness",
            "Thromboembolic events"
        ],
        "contraindications": [
            "Active or history of thromboembolic disorders",
            "Estrogen-dependent neoplasia",
            "Undiagnosed abnormal genital bleeding",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "May reduce milk production; caution advised."
        },
        "interactions": [
            "CYP3A4 inducers (e.g., rifampin, phenytoin)",
            "Antibiotics (may reduce efficacy)"
        ],
        "last updated": "2024-10-11",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "norgestimate": {
        "definition": "A synthetic progestin used in combination with ethinyl estradiol for oral contraception.",
        "mechanism": "Inhibits ovulation, thickens cervical mucus, and alters endometrial lining to prevent pregnancy.",
        "indications": [
            "Hormonal contraception (in combination with ethinyl estradiol)"
        ],
        "dosage": {
            "adults": "0.18–0.25 mg orally daily (with 35 mcg ethinyl estradiol) for 21 days per cycle.",
            "children": "Not recommended for premenarchal girls."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Breast tenderness",
            "Breakthrough bleeding"
        ],
        "contraindications": [
            "Thromboembolic disorders",
            "Liver disease",
            "Known or suspected pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "May reduce milk production."
        },
        "interactions": [
            "CYP3A4 inducers",
            "Antibiotics"
        ],
        "last updated": "2024-09-28",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desogestrel": {
        "definition": "A synthetic progestin used for hormonal contraception, often combined with ethinyl estradiol.",
        "mechanism": "Inhibits ovulation and thickens cervical mucus, preventing fertilization.",
        "indications": [
            "Hormonal contraception (in combination with ethinyl estradiol)"
        ],
        "dosage": {
            "adults": "0.15 mg orally daily (with 30 mcg ethinyl estradiol) for 21 days per cycle.",
            "children": "Not recommended for premenarchal girls."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Breast tenderness",
            "Venous thromboembolism"
        ],
        "contraindications": [
            "Thromboembolic disorders",
            "Liver disease",
            "Known or suspected pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "breastfeeding": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inducers",
            "Antibiotics"
        ],
        "last updated": "2024-10-02",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "misoprostol": {
        "definition": "A synthetic prostaglandin E1 analog used for gastric ulcer prevention, labor induction, and medical abortion.",
        "mechanism": "Stimulates uterine contractions and inhibits gastric acid secretion by binding to prostaglandin receptors.",
        "indications": [
            "Prevention of NSAID-induced gastric ulcers",
            "Medical abortion (with mifepristone)",
            "Labor induction"
        ],
        "dosage": {
            "adults": "200 mcg orally 2–4 times daily for ulcer prevention; 800 mcg vaginally or buccally for abortion protocols.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Nausea",
            "Uterine cramping"
        ],
        "contraindications": [
            "Pregnancy (when used for ulcer prevention)",
            "Hypersensitivity to prostaglandins"
        ],
        "special populations": {
            "pregnancy": "Contraindicated for ulcer prevention; indicated for abortion/labor induction.",
            "breastfeeding": "Use with caution."
        },
        "interactions": [
            "Oxytocic agents (additive uterotonic effects)"
        ],
        "last updated": "2024-10-08",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mifepristone": {
        "definition": "An antiprogestin used for medical abortion and the treatment of Cushing's syndrome.",
        "mechanism": "Blocks progesterone receptors, leading to termination of pregnancy; also blocks glucocorticoid receptors at higher doses.",
        "indications": [
            "Medical abortion (with misoprostol)",
            "Cushing's syndrome (hyperglycemia management)"
        ],
        "dosage": {
            "adults": "200 mg orally as a single dose for abortion; up to 1200 mg daily for Cushing's syndrome.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Vaginal bleeding",
            "Abdominal pain",
            "Nausea",
            "Fatigue"
        ],
        "contraindications": [
            "Chronic adrenal failure",
            "Ectopic pregnancy",
            "Anticoagulant therapy"
        ],
        "special populations": {
            "pregnancy": "Indicated for abortion; contraindicated otherwise.",
            "breastfeeding": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Anticoagulants"
        ],
        "last updated": "2024-09-22",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxytocin": {
        "definition": "A synthetic hormone used to induce labor, control postpartum bleeding, and stimulate uterine contractions.",
        "mechanism": "Stimulates uterine smooth muscle contraction by binding to oxytocin receptors.",
        "indications": [
            "Induction or augmentation of labor",
            "Postpartum hemorrhage control"
        ],
        "dosage": {
            "adults": "0.5–1 mU/min IV infusion, titrated for labor; 10–40 units in 1 L IV for postpartum hemorrhage.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Uterine hyperstimulation",
            "Hyponatremia",
            "Hypotension",
            "Tachycardia"
        ],
        "contraindications": [
            "Cephalopelvic disproportion",
            "Fetal distress (when delivery is not imminent)",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Indicated for labor induction.",
            "breastfeeding": "Considered safe."
        },
        "interactions": [
            "Vasoconstrictors",
            "Prostaglandins"
        ],
        "last updated": "2024-10-10",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carboprost": {
        "definition": "A synthetic prostaglandin F2α analog used to treat postpartum hemorrhage and induce abortion.",
        "mechanism": "Stimulates uterine contractions by binding to prostaglandin receptors.",
        "indications": [
            "Postpartum hemorrhage due to uterine atony",
            "Second-trimester abortion"
        ],
        "dosage": {
            "adults": "250 mcg IM every 15–90 minutes as needed (max 2 mg).",
            "children": "Not recommended."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Diarrhea",
            "Fever",
            "Hypertension"
        ],
        "contraindications": [
            "Acute pelvic inflammatory disease",
            "Active cardiac, pulmonary, renal, or hepatic disease"
        ],
        "special populations": {
            "pregnancy": "Indicated for abortion/postpartum hemorrhage.",
            "asthma": "Use with extreme caution or avoid."
        },
        "interactions": [
            "Other uterotonic agents"
        ],
        "last updated": "2024-09-15",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dinoprostone": {
        "definition": "A synthetic prostaglandin E2 analog used for cervical ripening, labor induction, and abortion.",
        "mechanism": "Relaxes cervical smooth muscle and stimulates uterine contractions.",
        "indications": [
            "Cervical ripening prior to labor induction",
            "Termination of pregnancy"
        ],
        "dosage": {
            "adults": "10 mg vaginal insert for up to 12 hours; 20 mg vaginal suppository every 3–4 hours for abortion.",
            "children": "Not recommended."
        },
        "side effects": [
            "Uterine hyperstimulation",
            "Fever",
            "Nausea",
            "Vomiting"
        ],
        "contraindications": [
            "Acute pelvic inflammatory disease",
            "Unexplained vaginal bleeding",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Indicated for labor induction/abortion.",
            "asthma": "Use with caution."
        },
        "interactions": [
            "Other uterotonic agents"
        ],
        "last updated": "2024-09-18",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methotrexate": {
        "definition": "An antimetabolite and antifolate agent used to treat cancer, autoimmune diseases, and ectopic pregnancy.",
        "mechanism": "Inhibits dihydrofolate reductase, interfering with DNA synthesis and cell replication.",
        "indications": [
            "Rheumatoid arthritis",
            "Psoriasis",
            "Certain cancers (leukemia, lymphoma, breast cancer)",
            "Ectopic pregnancy"
        ],
        "dosage": {
            "adults": "7.5–25 mg orally or parenterally once weekly (RA/psoriasis); cancer dosing varies.",
            "children": "Dosing varies by indication and weight."
        },
        "side effects": [
            "Mucositis",
            "Myelosuppression",
            "Hepatotoxicity",
            "Pulmonary fibrosis"
        ],
        "contraindications": [
            "Pregnancy (except for ectopic pregnancy)",
            "Severe hepatic or renal impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated except for ectopic pregnancy.",
            "renal/hepatic impairment": "Use with caution; dose adjust."
        },
        "interactions": [
            "NSAIDs",
            "Trimethoprim",
            "Live vaccines"
        ],
        "last updated": "2024-10-03",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefotaxime": {
        "definition": "A third-generation cephalosporin antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Urinary tract infections",
            "Septicemia",
            "Meningitis"
        ],
        "dosage": {
            "adults": "1–2 g IV/IM every 8–12 hours.",
            "children": "50–180 mg/kg/day divided every 6–8 hours."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Eosinophilia",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe (Category B).",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Aminoglycosides",
            "Probenecid"
        ],
        "last updated": "2024-09-29",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levetiracetam": {
        "definition": "An anticonvulsant used to treat partial-onset, myoclonic, and generalized tonic-clonic seizures.",
        "mechanism": "Modulates synaptic neurotransmitter release by binding to synaptic vesicle protein SV2A in the brain.",
        "indications": [
            "Partial-onset seizures",
            "Myoclonic seizures",
            "Generalized tonic-clonic seizures"
        ],
        "dosage": {
            "adults": "500 mg twice daily, may increase gradually up to 1500 mg twice daily.",
            "children": "Dose based on weight and indication; refer to guidelines."
        },
        "side effects": [
            "Somnolence",
            "Asthenia",
            "Dizziness",
            "Irritability"
        ],
        "contraindications": [
            "Hypersensitivity to levetiracetam"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "No major drug interactions reported."
        ],
        "last updated": "2024-08-20",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenobarbital": {
        "definition": "A long-acting barbiturate used as an anticonvulsant and sedative.",
        "mechanism": "Enhances GABA-mediated chloride influx, leading to CNS depression.",
        "indications": [
            "Seizure disorders",
            "Sedation",
            "Status epilepticus"
        ],
        "dosage": {
            "adults": "50-100 mg orally or IM/IV once daily or divided doses.",
            "children": "3-6 mg/kg/day orally or IM/IV."
        },
        "side effects": [
            "Drowsiness",
            "Ataxia",
            "Cognitive impairment",
            "Respiratory depression"
        ],
        "contraindications": [
            "Severe respiratory disease",
            "Porphyria",
            "History of addiction"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed; may cause fetal harm.",
            "elderly": "Increased risk of sedation and falls."
        },
        "interactions": [
            "CYP450 inducers and substrates",
            "Warfarin",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-14",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenytoin": {
        "definition": "A hydantoin anticonvulsant used to control seizures.",
        "mechanism": "Stabilizes neuronal membranes and decreases seizure activity by increasing efflux or decreasing influx of sodium ions.",
        "indications": [
            "Tonic-clonic seizures",
            "Complex partial seizures",
            "Prevention of seizures during neurosurgery"
        ],
        "dosage": {
            "adults": "100 mg orally three times daily; adjust based on serum levels.",
            "children": "5 mg/kg/day in 2-3 divided doses."
        },
        "side effects": [
            "Gingival hyperplasia",
            "Nystagmus",
            "Ataxia",
            "Rash"
        ],
        "contraindications": [
            "Sinus bradycardia",
            "SA block",
            "Adams-Stokes syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed; risk of fetal hydantoin syndrome.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP450 inducers/inhibitors",
            "Warfarin",
            "Oral contraceptives"
        ],
        "last updated": "2024-08-05",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diazepam": {
        "definition": "A benzodiazepine used for anxiety, muscle spasms, seizures, and alcohol withdrawal.",
        "mechanism": "Enhances the effect of GABA at the GABA-A receptor, producing CNS depression.",
        "indications": [
            "Anxiety disorders",
            "Muscle spasms",
            "Seizure disorders",
            "Alcohol withdrawal"
        ],
        "dosage": {
            "adults": "2-10 mg orally 2-4 times daily; IV/IM dosing varies by indication.",
            "children": "0.12-0.8 mg/kg/day in divided doses."
        },
        "side effects": [
            "Drowsiness",
            "Fatigue",
            "Ataxia",
            "Respiratory depression"
        ],
        "contraindications": [
            "Myasthenia gravis",
            "Severe respiratory insufficiency",
            "Sleep apnea syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed; risk of fetal harm.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-09-10",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxcarbazepine": {
        "definition": "An anticonvulsant used to treat partial-onset seizures.",
        "mechanism": "Blocks voltage-sensitive sodium channels, stabilizing hyperexcited neural membranes.",
        "indications": [
            "Partial-onset seizures"
        ],
        "dosage": {
            "adults": "600 mg orally twice daily; titrate as needed.",
            "children": "8-10 mg/kg twice daily."
        },
        "side effects": [
            "Dizziness",
            "Somnolence",
            "Diplopia",
            "Hyponatremia"
        ],
        "contraindications": [
            "Hypersensitivity to oxcarbazepine or eslicarbazepine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Oral contraceptives",
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-08-18",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zonisamide": {
        "definition": "A sulfonamide anticonvulsant used for partial seizures.",
        "mechanism": "Blocks sodium and T-type calcium channels, stabilizing neuronal membranes.",
        "indications": [
            "Partial seizures"
        ],
        "dosage": {
            "adults": "100 mg once daily, may increase to 400 mg/day in divided doses.",
            "children": "6-8 mg/kg/day in divided doses."
        },
        "side effects": [
            "Somnolence",
            "Anorexia",
            "Dizziness",
            "Kidney stones"
        ],
        "contraindications": [
            "Hypersensitivity to zonisamide or sulfonamides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal/hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inducers",
            "Carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-20",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "topiramate": {
        "definition": "An anticonvulsant used for epilepsy and migraine prophylaxis.",
        "mechanism": "Blocks sodium channels, enhances GABA activity, antagonizes glutamate receptors.",
        "indications": [
            "Epilepsy",
            "Migraine prophylaxis"
        ],
        "dosage": {
            "adults": "25-50 mg once daily, titrate up to 200-400 mg/day.",
            "children": "5-9 mg/kg/day in divided doses."
        },
        "side effects": [
            "Paresthesia",
            "Anorexia",
            "Cognitive impairment",
            "Kidney stones"
        ],
        "contraindications": [
            "Recent alcohol use with extended-release form"
        ],
        "special populations": {
            "pregnancy": "Increased risk of fetal harm.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Oral contraceptives",
            "CNS depressants"
        ],
        "last updated": "2024-08-27",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valproic acid": {
        "definition": "A broad-spectrum anticonvulsant used for epilepsy, bipolar disorder, and migraine prophylaxis.",
        "mechanism": "Increases GABA levels and inhibits sodium and calcium channels.",
        "indications": [
            "Epilepsy",
            "Bipolar disorder",
            "Migraine prophylaxis"
        ],
        "dosage": {
            "adults": "10-15 mg/kg/day orally in divided doses, titrate as needed.",
            "children": "Same as adults, adjust based on weight."
        },
        "side effects": [
            "Hepatotoxicity",
            "Pancreatitis",
            "Weight gain",
            "Alopecia"
        ],
        "contraindications": [
            "Liver disease",
            "Urea cycle disorders"
        ],
        "special populations": {
            "pregnancy": "Contraindicated unless no alternatives.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CNS depressants",
            "Aspirin",
            "Carbapenem antibiotics"
        ],
        "last updated": "2024-09-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "primidone": {
        "definition": "A barbiturate anticonvulsant used to treat various seizure types.",
        "mechanism": "Metabolized to phenobarbital and PEMA, enhancing GABA activity.",
        "indications": [
            "Generalized tonic-clonic seizures",
            "Complex partial seizures",
            "Focal seizures"
        ],
        "dosage": {
            "adults": "100-125 mg at bedtime, increase gradually to 750-1500 mg/day in divided doses.",
            "children": "5-25 mg/kg/day in divided doses."
        },
        "side effects": [
            "Drowsiness",
            "Ataxia",
            "Nausea",
            "Blood dyscrasias"
        ],
        "contraindications": [
            "Porphyria",
            "Hypersensitivity to barbiturates"
        ],
        "special populations": {
            "pregnancy": "Use only if clearly needed.",
            "elderly": "Use with caution."
        },
        "interactions": [
            "CYP450 inducers",
            "Warfarin",
            "Oral contraceptives"
        ],
        "last updated": "2024-08-09",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aspirin": {
        "definition": "An NSAID and antiplatelet agent used for pain, fever, inflammation, and cardiovascular protection.",
        "mechanism": "Irreversibly inhibits COX-1 and COX-2, reducing prostaglandin and thromboxane synthesis.",
        "indications": [
            "Pain and fever",
            "Inflammation",
            "Prevention of cardiovascular events"
        ],
        "dosage": {
            "adults": "325-650 mg orally every 4-6 hours as needed; 81-325 mg daily for antiplatelet effect.",
            "children": "Avoid in viral infections due to risk of Reye's syndrome."
        },
        "side effects": [
            "GI bleeding",
            "Ulceration",
            "Tinnitus",
            "Allergic reactions"
        ],
        "contraindications": [
            "Active peptic ulcer disease",
            "Bleeding disorders",
            "Children with viral infections"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "NSAIDs",
            "Methotrexate"
        ],
        "last updated": "2024-08-15",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitroglycerin": {
        "definition": "A nitrate used to treat and prevent angina pectoris.",
        "mechanism": "Releases nitric oxide, causing vasodilation and reducing cardiac oxygen demand.",
        "indications": [
            "Acute angina",
            "Chronic angina prophylaxis",
            "Heart failure (adjunct)"
        ],
        "dosage": {
            "adults": "0.3-0.6 mg sublingually every 5 minutes as needed (max 3 doses in 15 minutes).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Headache",
            "Hypotension",
            "Flushing",
            "Dizziness"
        ],
        "contraindications": [
            "Hypotension",
            "Use with PDE5 inhibitors",
            "Severe anemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "PDE5 inhibitors",
            "Antihypertensives",
            "Alcohol"
        ],
        "last updated": "2024-09-05",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metoprolol": {
        "definition": "A beta-1 selective blocker used for hypertension, angina, and heart failure.",
        "mechanism": "Blocks beta-1 adrenergic receptors, reducing heart rate and cardiac output.",
        "indications": [
            "Hypertension",
            "Angina",
            "Heart failure",
            "Arrhythmias"
        ],
        "dosage": {
            "adults": "25-100 mg orally once or twice daily; IV dosing for acute arrhythmias.",
            "children": "1-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Fatigue",
            "Dizziness"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Heart block",
            "Decompensated heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "asthma": "Use with caution."
        },
        "interactions": [
            "Calcium channel blockers",
            "Digoxin",
            "Clonidine"
        ],
        "last updated": "2024-08-12",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amlodipine": {
        "definition": "A calcium channel blocker used to treat hypertension and angina.",
        "mechanism": "Inhibits calcium ion influx into vascular smooth muscle and myocardium, causing vasodilation.",
        "indications": [
            "Hypertension",
            "Angina"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily.",
            "children": "2.5-5 mg orally once daily."
        },
        "side effects": [
            "Peripheral edema",
            "Dizziness",
            "Flushing",
            "Fatigue"
        ],
        "contraindications": [
            "Severe hypotension",
            "Cardiogenic shock"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Simvastatin"
        ],
        "last updated": "2024-07-30",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isosorbide mononitrate": {
        "definition": "A long-acting nitrate used for the prevention of angina pectoris.",
        "mechanism": "Releases nitric oxide, causing vasodilation and reducing cardiac oxygen demand.",
        "indications": [
            "Prevention of angina pectoris"
        ],
        "dosage": {
            "adults": "30-60 mg orally once daily in the morning; may increase to 120 mg once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Headache",
            "Dizziness",
            "Hypotension",
            "Flushing"
        ],
        "contraindications": [
            "Hypersensitivity to nitrates",
            "Concurrent use with PDE5 inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "PDE5 inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-15",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isosorbide dinitrate": {
        "definition": "A nitrate used to prevent and treat angina pectoris.",
        "mechanism": "Releases nitric oxide, causing vasodilation and reducing cardiac oxygen demand.",
        "indications": [
            "Prevention and treatment of angina pectoris",
            "Heart failure (adjunct)"
        ],
        "dosage": {
            "adults": "10-40 mg orally 2-3 times daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Headache",
            "Dizziness",
            "Hypotension",
            "Flushing"
        ],
        "contraindications": [
            "Hypersensitivity to nitrates",
            "Concurrent use with PDE5 inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "PDE5 inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-15",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "enoxaparin": {
        "definition": "A low molecular weight heparin used for prophylaxis and treatment of thromboembolic disorders.",
        "mechanism": "Potentiates antithrombin III, inhibiting factor Xa and IIa.",
        "indications": [
            "Deep vein thrombosis prophylaxis and treatment",
            "Pulmonary embolism",
            "Unstable angina"
        ],
        "dosage": {
            "adults": "Prophylaxis: 40 mg SC once daily; Treatment: 1 mg/kg SC every 12 hours.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia",
            "Injection site reactions"
        ],
        "contraindications": [
            "Active major bleeding",
            "History of heparin-induced thrombocytopenia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be required."
        },
        "interactions": [
            "Antiplatelet agents",
            "Other anticoagulants"
        ],
        "last updated": "2024-07-21",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ranolazine": {
        "definition": "An antianginal agent used to treat chronic angina.",
        "mechanism": "Inhibits late phase of inward sodium current in cardiac cells, reducing ischemia.",
        "indications": [
            "Chronic angina"
        ],
        "dosage": {
            "adults": "500 mg orally twice daily; may increase to 1000 mg twice daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dizziness",
            "Headache",
            "Constipation",
            "QT prolongation"
        ],
        "contraindications": [
            "Liver cirrhosis",
            "Strong CYP3A inhibitors/inducers"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-08-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atenolol": {
        "definition": "A beta-1 selective blocker used for hypertension, angina, and arrhythmias.",
        "mechanism": "Blocks beta-1 adrenergic receptors, reducing heart rate and cardiac output.",
        "indications": [
            "Hypertension",
            "Angina",
            "Arrhythmias",
            "Myocardial infarction (secondary prevention)"
        ],
        "dosage": {
            "adults": "25-100 mg orally once daily.",
            "children": "0.5-1 mg/kg/day in 1-2 divided doses."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Fatigue",
            "Cold extremities"
        ],
        "contraindications": [
            "Sinus bradycardia",
            "Heart block",
            "Overt cardiac failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "asthma": "Use with caution."
        },
        "interactions": [
            "Calcium channel blockers",
            "Clonidine"
        ],
        "last updated": "2024-07-12",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carvedilol": {
        "definition": "A non-selective beta and alpha-1 blocker used for heart failure and hypertension.",
        "mechanism": "Blocks beta-1, beta-2, and alpha-1 adrenergic receptors, reducing heart rate and vasoconstriction.",
        "indications": [
            "Heart failure",
            "Hypertension",
            "Left ventricular dysfunction after MI"
        ],
        "dosage": {
            "adults": "6.25-25 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Dizziness",
            "Fatigue",
            "Bradycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Bronchial asthma",
            "Severe hepatic impairment",
            "Second or third-degree AV block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CYP2D6 inhibitors",
            "Digoxin",
            "Insulin"
        ],
        "last updated": "2024-08-02",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atorvastatin": {
        "definition": "A statin used to lower cholesterol and reduce risk of cardiovascular disease.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Prevention of cardiovascular events"
        ],
        "dosage": {
            "adults": "10-80 mg orally once daily.",
            "children": "10-20 mg orally once daily (age 10+)."
        },
        "side effects": [
            "Myalgia",
            "Liver enzyme elevation",
            "Diarrhea",
            "Muscle weakness"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy",
            "Breastfeeding"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Fibrates"
        ],
        "last updated": "2024-07-25",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dextranomer": {
        "definition": "A polysaccharide used as a wound dressing and to treat fecal incontinence (as dextranomer/hyaluronic acid gel).",
        "mechanism": "Absorbs wound exudate and promotes healing; acts as a bulking agent for incontinence.",
        "indications": [
            "Wound management",
            "Fecal incontinence (as gel implant)"
        ],
        "dosage": {
            "adults": "Apply to wound as needed; gel: 1 mL per injection site.",
            "children": "Consult specific product guidelines."
        },
        "side effects": [
            "Local irritation",
            "Pain at injection site"
        ],
        "contraindications": [
            "Active infection at application site"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safety depends on indication."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-06-15",
        "official sources": [
            "FDA DailyMed",
            "MedlinePlus"
        ]
    },
    "sodium hyaluronate": {
        "definition": "A viscosupplement used for osteoarthritis of the knee and as an ophthalmic surgical aid.",
        "mechanism": "Acts as a lubricant and shock absorber in joints; maintains eye shape during surgery.",
        "indications": [
            "Osteoarthritis of the knee",
            "Ophthalmic surgery"
        ],
        "dosage": {
            "adults": "20-48 mg intra-articular injection weekly for 3-5 weeks (knee OA).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Injection site pain",
            "Swelling",
            "Joint effusion"
        ],
        "contraindications": [
            "Infection at injection site"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not recommended."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-06-20",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acetylcysteine": {
        "definition": "A mucolytic agent and antidote for acetaminophen overdose.",
        "mechanism": "Breaks disulfide bonds in mucus, reducing viscosity; replenishes glutathione in acetaminophen toxicity.",
        "indications": [
            "Acetaminophen overdose",
            "Mucolytic therapy in respiratory conditions"
        ],
        "dosage": {
            "adults": "Acetaminophen overdose: 140 mg/kg orally, then 70 mg/kg every 4 hours for 17 doses; Mucolytic: 2-20% inhalation solution.",
            "children": "Same as adults, adjust by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Rash",
            "Bronchospasm"
        ],
        "contraindications": [
            "Hypersensitivity to acetylcysteine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "asthma": "Use with caution."
        },
        "interactions": [
            "Activated charcoal (may reduce absorption)"
        ],
        "last updated": "2024-07-14",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "meloxicam": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for osteoarthritis and rheumatoid arthritis.",
        "mechanism": "Inhibits cyclooxygenase (COX-2 > COX-1), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "7.5-15 mg orally once daily.",
            "children": "0.125 mg/kg once daily (juvenile RA, age ≥2 years)."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Hypertension"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-06-30",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naproxen": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain, fever, and inflammation.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Pain",
            "Fever",
            "Inflammation",
            "Arthritis"
        ],
        "dosage": {
            "adults": "250-500 mg orally twice daily.",
            "children": "10 mg/kg/day in 2 divided doses (juvenile arthritis)."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Headache"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-06-28",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "indomethacin": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for moderate to severe arthritis and gout.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis",
            "Gout",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "25-50 mg orally 2-3 times daily.",
            "children": "1-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Headache",
            "Dizziness"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-06-27",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trolamine salicylate": {
        "definition": "A topical analgesic and anti-inflammatory agent used for the temporary relief of minor aches and pains of muscles and joints.",
        "mechanism": "Salicylate inhibits prostaglandin synthesis; trolamine acts as a vehicle.",
        "indications": [
            "Minor aches and pains of muscles and joints"
        ],
        "dosage": {
            "adults": "Apply to affected area not more than 3-4 times daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to salicylates"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not recommended."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-06-15",
        "official sources": [
            "FDA DailyMed",
            "MedlinePlus"
        ]
    },
    "sulindac": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for arthritis and acute gouty arthritis.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis",
            "Ankylosing spondylitis",
            "Acute gouty arthritis"
        ],
        "dosage": {
            "adults": "150-200 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Headache",
            "Dizziness"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-06-25",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "omeprazole": {
        "definition": "A proton pump inhibitor used to treat GERD, ulcers, and Zollinger-Ellison syndrome.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Peptic ulcer disease",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "20-40 mg orally once daily.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to omeprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin",
            "Diazepam"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pantoprazole": {
        "definition": "A proton pump inhibitor used to treat GERD, erosive esophagitis, and Zollinger-Ellison syndrome.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Erosive esophagitis",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "40 mg orally or IV once daily.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to pantoprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ranitidine": {
        "definition": "A histamine-2 receptor antagonist used to treat ulcers, GERD, and conditions with excess stomach acid.",
        "mechanism": "Blocks H2 receptors on gastric parietal cells, reducing acid secretion.",
        "indications": [
            "Duodenal ulcer",
            "Gastric ulcer",
            "GERD",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily or 300 mg at bedtime.",
            "children": "2-4 mg/kg twice daily."
        },
        "side effects": [
            "Headache",
            "Constipation",
            "Diarrhea",
            "Confusion (elderly)"
        ],
        "contraindications": [
            "Hypersensitivity to ranitidine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Warfarin",
            "Ketoconazole",
            "Atazanavir"
        ],
        "last updated": "2024-06-29",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "famotidine": {
        "definition": "A histamine-2 receptor antagonist used to treat ulcers, GERD, and conditions with excess stomach acid.",
        "mechanism": "Blocks H2 receptors on gastric parietal cells, reducing acid secretion.",
        "indications": [
            "Duodenal ulcer",
            "Gastric ulcer",
            "GERD",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "20-40 mg orally once or twice daily.",
            "children": "0.5 mg/kg/dose twice daily."
        },
        "side effects": [
            "Headache",
            "Constipation",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to famotidine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Warfarin",
            "Ketoconazole"
        ],
        "last updated": "2024-06-29",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lansoprazole": {
        "definition": "A proton pump inhibitor used to treat GERD, ulcers, and Zollinger-Ellison syndrome.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Peptic ulcer disease",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "15-30 mg orally once daily.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to lansoprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "esomeprazole": {
        "definition": "A proton pump inhibitor used to treat GERD, erosive esophagitis, and Zollinger-Ellison syndrome.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Erosive esophagitis",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "20-40 mg orally once daily.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to esomeprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rabeprazole": {
        "definition": "A proton pump inhibitor used to treat GERD, ulcers, and Zollinger-Ellison syndrome.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Peptic ulcer disease",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "20 mg orally once daily.",
            "children": "Dose based on weight and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to rabeprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sucralfate": {
        "definition": "A gastrointestinal protectant used to treat and prevent ulcers.",
        "mechanism": "Forms a protective barrier over ulcers, shielding them from acid and pepsin.",
        "indications": [
            "Duodenal ulcer",
            "Gastric ulcer"
        ],
        "dosage": {
            "adults": "1 g orally 4 times daily before meals and at bedtime.",
            "children": "40-80 mg/kg/day divided every 6 hours."
        },
        "side effects": [
            "Constipation",
            "Dry mouth",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to sucralfate"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Tetracyclines",
            "Fluoroquinolones",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexlansoprazole": {
        "definition": "A proton pump inhibitor used to treat GERD and erosive esophagitis.",
        "mechanism": "Inhibits gastric parietal cell H+/K+ ATPase, suppressing gastric acid secretion.",
        "indications": [
            "GERD",
            "Erosive esophagitis"
        ],
        "dosage": {
            "adults": "30-60 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Nausea",
            "Flatulence"
        ],
        "contraindications": [
            "Hypersensitivity to dexlansoprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Clopidogrel",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ibuprofen": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain, fever, and inflammation.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Pain",
            "Fever",
            "Inflammation",
            "Arthritis"
        ],
        "dosage": {
            "adults": "200-400 mg orally every 4-6 hours as needed.",
            "children": "5-10 mg/kg orally every 6-8 hours as needed."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Headache"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acetaminophen": {
        "definition": "An analgesic and antipyretic used for pain and fever.",
        "mechanism": "Inhibits prostaglandin synthesis in the CNS and works peripherally to block pain impulse generation.",
        "indications": [
            "Pain",
            "Fever"
        ],
        "dosage": {
            "adults": "325-1000 mg orally every 4-6 hours as needed (max 4g/day).",
            "children": "10-15 mg/kg every 4-6 hours as needed."
        },
        "side effects": [
            "Liver toxicity (overdose)",
            "Rash",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "Alcohol",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diclofenac": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Pain",
            "Osteoarthritis",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "50 mg orally 2-3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nabumetone": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation in osteoarthritis and rheumatoid arthritis.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "1000 mg orally once daily; may increase to 1500-2000 mg/day in 1-2 divided doses.",
            "children": "Not recommended."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Dizziness"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxycycline": {
        "definition": "A tetracycline antibiotic used to treat a wide variety of bacterial infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Respiratory tract infections",
            "Acne",
            "Chlamydia",
            "Malaria prophylaxis"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "2 mg/kg twice daily (age ≥8 years)."
        },
        "side effects": [
            "Photosensitivity",
            "GI upset",
            "Tooth discoloration (children)",
            "Esophagitis"
        ],
        "contraindications": [
            "Hypersensitivity to tetracyclines",
            "Children under 8 years (except for serious infections)"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Avoid under age 8 unless necessary."
        },
        "interactions": [
            "Antacids",
            "Iron supplements",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "spironolactone": {
        "definition": "A potassium-sparing diuretic and aldosterone antagonist used for heart failure, hypertension, and hyperaldosteronism.",
        "mechanism": "Blocks aldosterone receptors in the distal nephron, increasing sodium and water excretion while retaining potassium.",
        "indications": [
            "Heart failure",
            "Hypertension",
            "Edema",
            "Primary hyperaldosteronism",
            "Hirsutism"
        ],
        "dosage": {
            "adults": "25-100 mg orally once daily.",
            "children": "1-3 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperkalemia",
            "Gynecomastia",
            "Menstrual irregularities",
            "GI upset"
        ],
        "contraindications": [
            "Anuria",
            "Acute renal insufficiency",
            "Hyperkalemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor potassium closely."
        },
        "interactions": [
            "ACE inhibitors",
            "ARBs",
            "Potassium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "minocycline": {
        "definition": "A tetracycline antibiotic used to treat various bacterial infections and acne.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Acne",
            "Respiratory tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "100 mg orally every 12 hours.",
            "children": "2 mg/kg initially, then 1 mg/kg every 12 hours (age ≥8 years)."
        },
        "side effects": [
            "Dizziness",
            "Vertigo",
            "Skin pigmentation",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to tetracyclines",
            "Children under 8 years (except for serious infections)"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Avoid under age 8 unless necessary."
        },
        "interactions": [
            "Antacids",
            "Iron supplements",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clindamycin": {
        "definition": "A lincosamide antibiotic used to treat serious bacterial infections and acne.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "Serious infections",
            "Acne",
            "Anaerobic infections"
        ],
        "dosage": {
            "adults": "150-450 mg orally every 6-8 hours.",
            "children": "8-20 mg/kg/day in 3-4 divided doses."
        },
        "side effects": [
            "Diarrhea",
            "C. difficile colitis",
            "Rash",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to clindamycin or lincomycin"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Erythromycin",
            "Neuromuscular blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tretinoin": {
        "definition": "A topical retinoid used to treat acne vulgaris and photoaging.",
        "mechanism": "Modulates epithelial cell growth and differentiation.",
        "indications": [
            "Acne vulgaris",
            "Photoaging (topical)",
            "Acute promyelocytic leukemia (oral)"
        ],
        "dosage": {
            "adults": "Apply a thin layer to affected area once daily at bedtime (topical).",
            "children": "Safety and efficacy not established for topical use under 12 years."
        },
        "side effects": [
            "Skin irritation",
            "Erythema",
            "Dryness",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to tretinoin",
            "Pregnancy (oral form)"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (oral); topical form: avoid if possible.",
            "children": "Use with caution."
        },
        "interactions": [
            "Photosensitizing agents",
            "Keratolytics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isotretinoin": {
        "definition": "An oral retinoid used for severe recalcitrant nodular acne.",
        "mechanism": "Reduces sebaceous gland size and sebum production; modulates cell differentiation.",
        "indications": [
            "Severe recalcitrant nodular acne"
        ],
        "dosage": {
            "adults": "0.5-1 mg/kg/day in two divided doses for 15-20 weeks.",
            "children": "Same as adults (age ≥12 years)."
        },
        "side effects": [
            "Dry skin",
            "Cheilitis",
            "Teratogenicity",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity to isotretinoin or vitamin A"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (iPLEDGE program).",
            "children": "Not for use under 12 years."
        },
        "interactions": [
            "Tetracyclines",
            "Vitamin A supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzoyl peroxide": {
        "definition": "A topical agent with antibacterial and keratolytic properties used to treat acne.",
        "mechanism": "Releases oxygen free radicals that oxidize bacterial proteins and decrease P. acnes.",
        "indications": [
            "Acne vulgaris"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Dryness",
            "Peeling",
            "Erythema"
        ],
        "contraindications": [
            "Hypersensitivity to benzoyl peroxide"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Safe for pediatric acne."
        },
        "interactions": [
            "Topical retinoids (may increase irritation)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "adapalene": {
        "definition": "A topical retinoid used to treat acne vulgaris.",
        "mechanism": "Modulates cell differentiation and keratinization, reducing comedone formation.",
        "indications": [
            "Acne vulgaris"
        ],
        "dosage": {
            "adults": "Apply a thin layer to affected area once daily.",
            "children": "Safe for ages 12 and up."
        },
        "side effects": [
            "Skin irritation",
            "Dryness",
            "Erythema",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to adapalene"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for pediatric acne (age ≥12)."
        },
        "interactions": [
            "Other topical acne products"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tetracycline": {
        "definition": "A tetracycline antibiotic used to treat a wide range of bacterial infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Respiratory tract infections",
            "Acne",
            "Chlamydia",
            "Rickettsial infections"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6 hours.",
            "children": "25-50 mg/kg/day in 4 divided doses (age ≥8 years)."
        },
        "side effects": [
            "Photosensitivity",
            "GI upset",
            "Tooth discoloration (children)",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to tetracyclines",
            "Children under 8 years (except for serious infections)"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Avoid under age 8 unless necessary."
        },
        "interactions": [
            "Antacids",
            "Iron supplements",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cephalexin": {
        "definition": "A first-generation cephalosporin antibiotic used to treat various bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Skin infections",
            "Respiratory tract infections",
            "Urinary tract infections"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6 hours.",
            "children": "25-50 mg/kg/day in divided doses."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Nausea",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Probenecid",
            "Metformin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulfamethoxazole": {
        "definition": "A sulfonamide antibiotic used in combination with trimethoprim to treat various bacterial infections.",
        "mechanism": "Inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid.",
        "indications": [
            "Urinary tract infections",
            "Respiratory tract infections",
            "Traveler's diarrhea"
        ],
        "dosage": {
            "adults": "Usually combined with trimethoprim (see TMP-SMX dosing).",
            "children": "See TMP-SMX dosing."
        },
        "side effects": [
            "Rash",
            "Photosensitivity",
            "Crystalluria",
            "Stevens-Johnson syndrome"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Severe renal or hepatic impairment",
            "Infants <2 months"
        ],
        "special populations": {
            "pregnancy": "Avoid in late pregnancy.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Warfarin",
            "Methotrexate",
            "Oral hypoglycemics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trimethoprim": {
        "definition": "An antibiotic often used in combination with sulfamethoxazole to treat various bacterial infections.",
        "mechanism": "Inhibits bacterial dihydrofolate reductase, blocking folic acid synthesis.",
        "indications": [
            "Urinary tract infections",
            "Respiratory tract infections",
            "Traveler's diarrhea"
        ],
        "dosage": {
            "adults": "Usually combined with sulfamethoxazole (see TMP-SMX dosing).",
            "children": "See TMP-SMX dosing."
        },
        "side effects": [
            "Rash",
            "Hyperkalemia",
            "Megaloblastic anemia"
        ],
        "contraindications": [
            "Megaloblastic anemia due to folate deficiency",
            "Severe renal or hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Avoid in first trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Phenytoin",
            "Methotrexate",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metronidazole": {
        "definition": "An antibiotic and antiprotozoal agent used to treat anaerobic bacterial and certain protozoal infections.",
        "mechanism": "Disrupts DNA synthesis in anaerobic bacteria and protozoa.",
        "indications": [
            "Anaerobic infections",
            "Trichomoniasis",
            "Bacterial vaginosis",
            "Giardiasis"
        ],
        "dosage": {
            "adults": "500 mg orally or IV every 8-12 hours.",
            "children": "7.5 mg/kg every 8 hours."
        },
        "side effects": [
            "Nausea",
            "Metallic taste",
            "Peripheral neuropathy",
            "Disulfiram-like reaction with alcohol"
        ],
        "contraindications": [
            "Hypersensitivity to metronidazole",
            "First trimester of pregnancy (trichomoniasis)"
        ],
        "special populations": {
            "pregnancy": "Avoid in first trimester.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Alcohol",
            "Warfarin",
            "Lithium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azelaic acid": {
        "definition": "A topical dicarboxylic acid used to treat acne and rosacea.",
        "mechanism": "Inhibits microbial protein synthesis and keratinization of follicular epidermis.",
        "indications": [
            "Acne vulgaris",
            "Rosacea"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to azelaic acid"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not established."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulfacetamide sodium": {
        "definition": "A sulfonamide antibiotic used topically for acne and seborrheic dermatitis.",
        "mechanism": "Inhibits bacterial synthesis of dihydrofolic acid.",
        "indications": [
            "Acne vulgaris",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for pediatric acne."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulfur": {
        "definition": "A topical keratolytic and antibacterial agent used to treat acne and seborrheic dermatitis.",
        "mechanism": "Promotes shedding of keratin and has mild antibacterial properties.",
        "indications": [
            "Acne vulgaris",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Dryness",
            "Redness"
        ],
        "contraindications": [
            "Hypersensitivity to sulfur"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Safe for pediatric acne."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ivermectin": {
        "definition": "An antiparasitic agent used orally for strongyloidiasis and onchocerciasis, and topically for rosacea and lice.",
        "mechanism": "Binds to glutamate-gated chloride channels in nerve and muscle cells of parasites, causing paralysis and death.",
        "indications": [
            "Strongyloidiasis",
            "Onchocerciasis",
            "Rosacea (topical)",
            "Head lice (topical)"
        ],
        "dosage": {
            "adults": "Oral: 150-200 mcg/kg as a single dose; Topical: apply once daily (rosacea) or once to scalp (lice).",
            "children": "Oral: same as adults for weight ≥15 kg."
        },
        "side effects": [
            "Pruritus",
            "Rash",
            "Fever",
            "Skin irritation (topical)"
        ],
        "contraindications": [
            "Hypersensitivity to ivermectin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Oral form not for children <15 kg."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brimonidine": {
        "definition": "An alpha-2 adrenergic agonist used to lower intraocular pressure in glaucoma and as a topical gel for rosacea.",
        "mechanism": "Reduces aqueous humor production and increases uveoscleral outflow (ocular); vasoconstricts cutaneous vessels (topical).",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension",
            "Rosacea (topical)"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1 drop in affected eye(s) 2-3 times daily; Topical: apply a pea-sized amount once daily.",
            "children": "Not recommended for children <2 years."
        },
        "side effects": [
            "Ocular hyperemia",
            "Allergic conjunctivitis",
            "Dry mouth",
            "Skin redness (topical)"
        ],
        "contraindications": [
            "Neonates and infants <2 years",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Ophthalmic not for <2 years."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lamivudine": {
        "definition": "A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV and chronic hepatitis B.",
        "mechanism": "Inhibits reverse transcriptase, terminating viral DNA chain elongation.",
        "indications": [
            "HIV infection",
            "Chronic hepatitis B"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily or 300 mg once daily.",
            "children": "4 mg/kg twice daily (max 150 mg/dose)."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Fatigue",
            "Lactic acidosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to lamivudine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Emtricitabine",
            "Trimethoprim/sulfamethoxazole"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "efavirenz": {
        "definition": "A non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection.",
        "mechanism": "Inhibits HIV-1 reverse transcriptase by binding non-competitively, blocking viral replication.",
        "indications": [
            "HIV-1 infection (in combination therapy)"
        ],
        "dosage": {
            "adults": "600 mg orally once daily.",
            "children": "Dose based on weight."
        },
        "side effects": [
            "Rash",
            "Dizziness",
            "Insomnia",
            "Vivid dreams",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to efavirenz",
            "Concurrent use with certain CYP3A4 substrates"
        ],
        "special populations": {
            "pregnancy": "Avoid in first trimester.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "St. John's wort"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "emtricitabine": {
        "definition": "A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV-1 infection and chronic hepatitis B.",
        "mechanism": "Inhibits reverse transcriptase, causing chain termination of viral DNA.",
        "indications": [
            "HIV-1 infection",
            "Chronic hepatitis B"
        ],
        "dosage": {
            "adults": "200 mg orally once daily.",
            "children": "Dose based on weight."
        },
        "side effects": [
            "Headache",
            "Diarrhea",
            "Rash",
            "Hyperpigmentation of palms/soles"
        ],
        "contraindications": [
            "Hypersensitivity to emtricitabine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Lamivudine",
            "Other HIV drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tenofovir": {
        "definition": "A nucleotide reverse transcriptase inhibitor (NRTI) used to treat HIV-1 infection and chronic hepatitis B.",
        "mechanism": "Inhibits reverse transcriptase, causing chain termination of viral DNA.",
        "indications": [
            "HIV-1 infection",
            "Chronic hepatitis B"
        ],
        "dosage": {
            "adults": "300 mg orally once daily.",
            "children": "Dose based on weight."
        },
        "side effects": [
            "Renal toxicity",
            "Decreased bone mineral density",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to tenofovir"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Didanosine",
            "Adefovir"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ritonavir": {
        "definition": "A protease inhibitor used as an antiretroviral agent and as a pharmacokinetic enhancer in HIV therapy.",
        "mechanism": "Inhibits HIV protease, preventing cleavage of viral polyproteins; strong CYP3A4 inhibitor.",
        "indications": [
            "HIV-1 infection (as booster or in combination)"
        ],
        "dosage": {
            "adults": "100-400 mg orally daily (as booster or in combination).",
            "children": "Dose based on weight."
        },
        "side effects": [
            "GI upset",
            "Hepatotoxicity",
            "Taste disturbance",
            "Hyperlipidemia"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Concomitant use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors/inducers",
            "Many drug-drug interactions"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "abacavir": {
        "definition": "A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV-1 infection.",
        "mechanism": "Inhibits reverse transcriptase, causing chain termination of viral DNA.",
        "indications": [
            "HIV-1 infection (in combination therapy)"
        ],
        "dosage": {
            "adults": "600 mg orally once daily or 300 mg twice daily.",
            "children": "Dose based on weight."
        },
        "side effects": [
            "Hypersensitivity reaction (HLA-B*5701)",
            "Rash",
            "Fever",
            "GI upset"
        ],
        "contraindications": [
            "HLA-B*5701 positive",
            "Previous hypersensitivity to abacavir"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Alcohol",
            "Methadone"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methylene blue": {
        "definition": "A dye and medication used to treat methemoglobinemia and as a diagnostic agent.",
        "mechanism": "Reduces methemoglobin to hemoglobin via NADPH-dependent pathway.",
        "indications": [
            "Methemoglobinemia",
            "Ifosfamide-induced encephalopathy",
            "Diagnostic staining"
        ],
        "dosage": {
            "adults": "1-2 mg/kg IV over 5 minutes (methemoglobinemia).",
            "children": "Same as adults, adjust by weight."
        },
        "side effects": [
            "Blue-green urine",
            "Nausea",
            "Headache",
            "Serotonin syndrome (with SSRIs)"
        ],
        "contraindications": [
            "G6PD deficiency",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Avoid unless life-threatening.",
            "children": "Use with caution."
        },
        "interactions": [
            "SSRIs",
            "Serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bromocriptine": {
        "definition": "A dopamine agonist used to treat Parkinson's disease, hyperprolactinemia, and acromegaly.",
        "mechanism": "Stimulates dopamine receptors, inhibiting prolactin secretion and affecting motor control.",
        "indications": [
            "Parkinson's disease",
            "Hyperprolactinemia",
            "Acromegaly",
            "Type 2 diabetes (adjunct)"
        ],
        "dosage": {
            "adults": "1.25-2.5 mg orally daily, titrate as needed.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Orthostatic hypotension",
            "Headache",
            "Hallucinations"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Hypersensitivity to ergot derivatives"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased sensitivity."
        },
        "interactions": [
            "Antipsychotics",
            "Ergot alkaloids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "octreotide": {
        "definition": "A somatostatin analog used to treat acromegaly, carcinoid tumors, and variceal bleeding.",
        "mechanism": "Inhibits secretion of growth hormone, insulin, glucagon, and various GI peptides.",
        "indications": [
            "Acromegaly",
            "Carcinoid tumors",
            "VIPomas",
            "Variceal bleeding"
        ],
        "dosage": {
            "adults": "50-100 mcg SC 2-3 times daily; long-acting: 20 mg IM every 4 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "Gallstones",
            "Bradycardia",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Hypersensitivity to octreotide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Limited data."
        },
        "interactions": [
            "Insulin",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegvisomant": {
        "definition": "A growth hormone receptor antagonist used to treat acromegaly.",
        "mechanism": "Blocks growth hormone receptors, reducing IGF-1 production.",
        "indications": [
            "Acromegaly (inadequate response to surgery/radiation/other medications)"
        ],
        "dosage": {
            "adults": "40 mg SC loading dose, then 10-30 mg SC once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Injection site reactions",
            "Liver enzyme elevation",
            "Flu-like symptoms"
        ],
        "contraindications": [
            "Hypersensitivity to pegvisomant"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Monitor liver function."
        },
        "interactions": [
            "Opioids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lanreotide": {
        "definition": "A somatostatin analog used to treat acromegaly and neuroendocrine tumors.",
        "mechanism": "Inhibits secretion of growth hormone and various GI peptides.",
        "indications": [
            "Acromegaly",
            "Neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "60-120 mg deep SC injection every 4 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "Gallstones",
            "Bradycardia",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Hypersensitivity to lanreotide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Limited data."
        },
        "interactions": [
            "Insulin",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pasireotide": {
        "definition": "A somatostatin analog used to treat Cushing's disease and acromegaly.",
        "mechanism": "Inhibits ACTH secretion, reducing cortisol production.",
        "indications": [
            "Cushing's disease",
            "Acromegaly"
        ],
        "dosage": {
            "adults": "0.6-0.9 mg SC twice daily (Cushing's); 40 mg IM every 4 weeks (acromegaly).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hyperglycemia",
            "Diarrhea",
            "Cholelithiasis",
            "Bradycardia"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "QT-prolonging drugs",
            "Antidiabetic agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gabapentin": {
        "definition": "An anticonvulsant and neuropathic pain agent.",
        "mechanism": "Binds to alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release.",
        "indications": [
            "Partial seizures",
            "Postherpetic neuralgia",
            "Neuropathic pain"
        ],
        "dosage": {
            "adults": "300 mg once daily, titrate to 1800-3600 mg/day in divided doses.",
            "children": "10-15 mg/kg/day in 3 divided doses."
        },
        "side effects": [
            "Dizziness",
            "Somnolence",
            "Peripheral edema",
            "Ataxia"
        ],
        "contraindications": [
            "Hypersensitivity to gabapentin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Antacids",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluorouracil": {
        "definition": "A pyrimidine analog antimetabolite used to treat various cancers (topical for actinic keratosis and superficial basal cell carcinoma).",
        "mechanism": "Inhibits thymidylate synthase, interfering with DNA synthesis.",
        "indications": [
            "Colorectal cancer",
            "Breast cancer",
            "Actinic keratosis (topical)",
            "Basal cell carcinoma (topical)"
        ],
        "dosage": {
            "adults": "IV: 500-1000 mg/m² weekly; Topical: apply 1-2 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "GI toxicity",
            "Hand-foot syndrome",
            "Photosensitivity (topical)"
        ],
        "contraindications": [
            "Dihydropyrimidine dehydrogenase deficiency",
            "Severe bone marrow suppression"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aminolevulinic acid": {
        "definition": "A photosensitizing agent used in photodynamic therapy for actinic keratosis.",
        "mechanism": "Converted to protoporphyrin IX, which produces reactive oxygen species upon light exposure, destroying abnormal cells.",
        "indications": [
            "Actinic keratosis (in combination with photodynamic therapy)"
        ],
        "dosage": {
            "adults": "Topical: apply to lesion, then illuminate with blue light after 14-18 hours.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Photosensitivity",
            "Erythema",
            "Edema",
            "Pain at site"
        ],
        "contraindications": [
            "Porphyria",
            "Hypersensitivity to aminolevulinic acid"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not established."
        },
        "interactions": [
            "Photosensitizing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ingenol": {
        "definition": "A topical agent (ingenol mebutate) used to treat actinic keratosis.",
        "mechanism": "Induces cell death and promotes inflammatory response to destroy abnormal skin cells.",
        "indications": [
            "Actinic keratosis"
        ],
        "dosage": {
            "adults": "Apply to affected area once daily for 2-3 consecutive days.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Erythema",
            "Crusting",
            "Erosion",
            "Pain at site"
        ],
        "contraindications": [
            "Hypersensitivity to ingenol mebutate"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not established."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amoxicillin": {
        "definition": "A penicillin antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Otitis media",
            "Urinary tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "500-875 mg orally every 8-12 hours.",
            "children": "20-40 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Nausea",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Allopurinol",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penicillin g sodium": {
        "definition": "A natural penicillin antibiotic used to treat serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Pneumonia",
            "Meningitis",
            "Syphilis",
            "Anthrax"
        ],
        "dosage": {
            "adults": "1-5 million units IV every 4-6 hours.",
            "children": "50,000-100,000 units/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Allergic reactions",
            "Seizures (high dose)",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Tetracyclines",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penicillin g potassium": {
        "definition": "A natural penicillin antibiotic used to treat serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Pneumonia",
            "Meningitis",
            "Syphilis",
            "Anthrax"
        ],
        "dosage": {
            "adults": "1-5 million units IV every 4-6 hours.",
            "children": "50,000-100,000 units/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Allergic reactions",
            "Seizures (high dose)",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Tetracyclines",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "albuterol": {
        "definition": "A short-acting beta-2 agonist used as a bronchodilator for asthma and COPD.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchial smooth muscle relaxation.",
        "indications": [
            "Asthma",
            "COPD",
            "Exercise-induced bronchospasm"
        ],
        "dosage": {
            "adults": "1-2 puffs (90-180 mcg) inhaled every 4-6 hours as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Tremor",
            "Tachycardia",
            "Nervousness",
            "Hypokalemia"
        ],
        "contraindications": [
            "Hypersensitivity to albuterol"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "cardiac disease": "Use with caution."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prednisolone": {
        "definition": "A glucocorticoid used to treat inflammation, allergies, and autoimmune diseases.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Asthma",
            "Allergic reactions",
            "Autoimmune diseases",
            "Inflammatory conditions"
        ],
        "dosage": {
            "adults": "5-60 mg orally daily (dose individualized).",
            "children": "0.14-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Live vaccines (high dose)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methylprednisolone": {
        "definition": "A glucocorticoid used to treat inflammatory and autoimmune conditions, severe allergies, and as immunosuppression.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Asthma",
            "Autoimmune diseases",
            "Allergic reactions",
            "Inflammatory conditions"
        ],
        "dosage": {
            "adults": "4-48 mg orally daily or IV/IM (dose individualized).",
            "children": "0.5-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Live vaccines (high dose)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epinephrine": {
        "definition": "A sympathomimetic catecholamine used for anaphylaxis, cardiac arrest, and severe asthma exacerbations.",
        "mechanism": "Stimulates alpha and beta adrenergic receptors, causing vasoconstriction, increased heart rate, and bronchodilation.",
        "indications": [
            "Anaphylaxis",
            "Cardiac arrest",
            "Severe asthma exacerbation"
        ],
        "dosage": {
            "adults": "0.3-0.5 mg IM (anaphylaxis); 1 mg IV every 3-5 min (cardiac arrest).",
            "children": "0.01 mg/kg IM (anaphylaxis); 0.01 mg/kg IV (cardiac arrest)."
        },
        "side effects": [
            "Tachycardia",
            "Hypertension",
            "Arrhythmias",
            "Anxiety"
        ],
        "contraindications": [
            "None in emergency use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased sensitivity."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors",
            "Tricyclic antidepressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydrocortisone": {
        "definition": "A glucocorticoid used for adrenal insufficiency, inflammation, and allergic conditions.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Adrenal insufficiency",
            "Inflammatory conditions",
            "Allergic reactions"
        ],
        "dosage": {
            "adults": "15-240 mg/day orally or IV/IM in divided doses.",
            "children": "0.5-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Live vaccines (high dose)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "theophylline": {
        "definition": "A methylxanthine bronchodilator used for asthma and COPD.",
        "mechanism": "Inhibits phosphodiesterase, increasing cAMP and causing bronchodilation.",
        "indications": [
            "Asthma",
            "COPD",
            "Apnea of prematurity"
        ],
        "dosage": {
            "adults": "300-600 mg/day in divided doses (dose individualized by serum levels).",
            "children": "10-16 mg/kg/day in divided doses."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Arrhythmias",
            "Seizures"
        ],
        "contraindications": [
            "Hypersensitivity to theophylline"
        ],
        "special populations": {
            "pregnancy": "Use with caution.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP1A2 inhibitors/inducers",
            "Macrolide antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexamethasone": {
        "definition": "A potent glucocorticoid used for inflammatory and autoimmune conditions, cerebral edema, and as antiemetic in chemotherapy.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Cerebral edema",
            "Inflammatory conditions",
            "Allergic reactions",
            "Antiemetic (chemo)"
        ],
        "dosage": {
            "adults": "0.5-10 mg orally/IV/IM daily (dose individualized).",
            "children": "0.02-0.3 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Live vaccines (high dose)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levalbuterol": {
        "definition": "A short-acting beta-2 agonist bronchodilator used for asthma and COPD.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchial smooth muscle relaxation.",
        "indications": [
            "Asthma",
            "COPD"
        ],
        "dosage": {
            "adults": "0.63-1.25 mg nebulized every 6-8 hours as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Tremor",
            "Tachycardia",
            "Nervousness",
            "Hypokalemia"
        ],
        "contraindications": [
            "Hypersensitivity to levalbuterol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Use with caution."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "terbutaline": {
        "definition": "A beta-2 adrenergic agonist used as a bronchodilator for asthma and as a tocolytic.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchial and uterine smooth muscle relaxation.",
        "indications": [
            "Asthma",
            "COPD",
            "Preterm labor (tocolysis)"
        ],
        "dosage": {
            "adults": "2.5-5 mg orally three times daily; 0.25 mg SC every 20 min (max 3 doses).",
            "children": "0.01 mg/kg SC every 20 min (max 3 doses)."
        },
        "side effects": [
            "Tremor",
            "Tachycardia",
            "Nervousness",
            "Hypokalemia"
        ],
        "contraindications": [
            "Hypersensitivity to terbutaline",
            "Prolonged use in pregnancy (tocolysis)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Use with caution."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ciprofloxacin": {
        "definition": "A fluoroquinolone antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.",
        "indications": [
            "Urinary tract infections",
            "Respiratory tract infections",
            "Gastrointestinal infections",
            "Anthrax"
        ],
        "dosage": {
            "adults": "250-750 mg orally every 12 hours.",
            "children": "10-20 mg/kg every 12 hours (specific indications only)."
        },
        "side effects": [
            "GI upset",
            "Tendinitis/tendon rupture",
            "QT prolongation",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to ciprofloxacin or other quinolones"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Use only for specific serious infections."
        },
        "interactions": [
            "Antacids",
            "Warfarin",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitrofurantoin": {
        "definition": "A nitrofuran antibiotic used primarily for urinary tract infections.",
        "mechanism": "Inhibits bacterial enzymes involved in carbohydrate metabolism and cell wall synthesis.",
        "indications": [
            "Uncomplicated urinary tract infections"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily for 5-7 days.",
            "children": "5-7 mg/kg/day in 2-4 divided doses."
        },
        "side effects": [
            "GI upset",
            "Pulmonary fibrosis (chronic)",
            "Peripheral neuropathy",
            "Urine discoloration"
        ],
        "contraindications": [
            "Renal impairment (CrCl <30 mL/min)",
            "Pregnancy at term",
            "Infants <1 month"
        ],
        "special populations": {
            "pregnancy": "Avoid at term.",
            "renal impairment": "Contraindicated if CrCl <30 mL/min."
        },
        "interactions": [
            "Antacids",
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levofloxacin": {
        "definition": "A fluoroquinolone antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.",
        "indications": [
            "Respiratory tract infections",
            "Urinary tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "250-750 mg orally or IV once daily.",
            "children": "10-20 mg/kg once daily (specific indications only)."
        },
        "side effects": [
            "GI upset",
            "Tendinitis/tendon rupture",
            "QT prolongation",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to levofloxacin or other quinolones"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Use only for specific serious infections."
        },
        "interactions": [
            "Antacids",
            "Warfarin",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ceftriaxone": {
        "definition": "A third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Meningitis",
            "Gonorrhea",
            "Septicemia"
        ],
        "dosage": {
            "adults": "1-2 g IV/IM once daily.",
            "children": "50-100 mg/kg/day in 1-2 divided doses."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Biliary sludging",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins",
            "Neonates with hyperbilirubinemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "neonates": "Avoid in hyperbilirubinemia."
        },
        "interactions": [
            "Calcium-containing IV solutions (neonates)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clavulanate": {
        "definition": "A beta-lactamase inhibitor used in combination with certain penicillins to extend their spectrum.",
        "mechanism": "Inhibits bacterial beta-lactamases, preventing antibiotic degradation.",
        "indications": [
            "Used in combination with amoxicillin or ticarcillin for various infections"
        ],
        "dosage": {
            "adults": "See combination product (e.g., amoxicillin-clavulanate: 500/125 mg orally every 8-12 hours).",
            "children": "See combination product."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "History of cholestatic jaundice with clavulanate-containing products"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Allopurinol",
            "Oral anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefuroxime": {
        "definition": "A second-generation cephalosporin antibiotic used to treat various bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Urinary tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "250-500 mg orally twice daily or 750-1500 mg IV/IM every 8 hours.",
            "children": "20-30 mg/kg/day in divided doses."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Nausea",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Probenecid",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methenamine": {
        "definition": "A urinary antiseptic used for prophylaxis and treatment of chronic urinary tract infections.",
        "mechanism": "Hydrolyzed to formaldehyde in acidic urine, exerting antibacterial effects.",
        "indications": [
            "Prophylaxis and treatment of chronic urinary tract infections"
        ],
        "dosage": {
            "adults": "1 g orally twice daily.",
            "children": "8-12 mg/kg orally twice daily."
        },
        "side effects": [
            "GI upset",
            "Bladder irritation",
            "Rash"
        ],
        "contraindications": [
            "Renal impairment",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Contraindicated."
        },
        "interactions": [
            "Sulfonamides",
            "Urinary alkalinizers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ampicillin": {
        "definition": "A penicillin antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Meningitis",
            "Urinary tract infections",
            "Endocarditis"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6 hours; 1-2 g IV/IM every 4-6 hours.",
            "children": "50-100 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Hypersensitivity reactions",
            "Seizures (high dose)"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Allopurinol",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prednisone": {
        "definition": "A glucocorticoid used to treat inflammation, allergies, and autoimmune diseases.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Asthma",
            "Allergic reactions",
            "Autoimmune diseases",
            "Inflammatory conditions"
        ],
        "dosage": {
            "adults": "5-60 mg orally daily (dose individualized).",
            "children": "0.14-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Live vaccines (high dose)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vincristine": {
        "definition": "A vinca alkaloid chemotherapy agent used to treat various cancers including leukemia and lymphoma.",
        "mechanism": "Inhibits microtubule formation in mitotic spindle, arresting cell division in metaphase.",
        "indications": [
            "Acute lymphoblastic leukemia",
            "Lymphomas",
            "Solid tumors"
        ],
        "dosage": {
            "adults": "1.4 mg/m² IV once weekly (max 2 mg/dose).",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Constipation",
            "Alopecia",
            "SIADH"
        ],
        "contraindications": [
            "Charcot-Marie-Tooth syndrome",
            "Intrathecal administration (fatal)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "Azole antifungals",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyclophosphamide": {
        "definition": "An alkylating agent used in chemotherapy and immunosuppression.",
        "mechanism": "Alkylates DNA, causing cross-links and inhibiting DNA replication.",
        "indications": [
            "Lymphomas",
            "Leukemias",
            "Solid tumors",
            "Autoimmune diseases"
        ],
        "dosage": {
            "adults": "1-5 mg/kg/day orally or 40-50 mg/kg IV every 2-4 weeks.",
            "children": "Dose individualized by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Hemorrhagic cystitis",
            "Alopecia",
            "Nausea"
        ],
        "contraindications": [
            "Severe bone marrow suppression",
            "Urinary outflow obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal/hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "Allopurinol",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "asparaginase escherichia coli": {
        "definition": "An enzyme used in chemotherapy for acute lymphoblastic leukemia (ALL).",
        "mechanism": "Depletes asparagine, an amino acid necessary for leukemia cell survival.",
        "indications": [
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "6,000-10,000 units/m² IM or IV every 3 days.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Hypersensitivity reactions",
            "Pancreatitis",
            "Coagulopathy",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "History of severe hypersensitivity to asparaginase"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "daunorubicin": {
        "definition": "An anthracycline antibiotic used as a chemotherapy agent for leukemia.",
        "mechanism": "Intercalates DNA and inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Acute myeloid leukemia (AML)",
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "30-60 mg/m² IV on days 1-3 of induction (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Alopecia",
            "Red urine"
        ],
        "contraindications": [
            "Severe cardiac impairment",
            "Hypersensitivity to daunorubicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor closely."
        },
        "interactions": [
            "Cyclophosphamide",
            "Other cardiotoxic agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "asparaginase erwinia chrysanthemi": {
        "definition": "An enzyme used in chemotherapy for acute lymphoblastic leukemia (ALL), derived from Erwinia chrysanthemi.",
        "mechanism": "Depletes asparagine, an amino acid necessary for leukemia cell survival.",
        "indications": [
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "25,000 units/m² IM or IV three times weekly.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Hypersensitivity reactions",
            "Pancreatitis",
            "Coagulopathy",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "History of severe hypersensitivity to asparaginase"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "teniposide": {
        "definition": "A podophyllotoxin derivative used in chemotherapy for acute lymphoblastic leukemia (ALL).",
        "mechanism": "Inhibits topoisomerase II, causing DNA strand breaks and inhibiting cell division.",
        "indications": [
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "165 mg/m² IV over 30-60 min once or twice weekly.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Myelosuppression",
            "Alopecia",
            "Nausea",
            "Hypotension"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity to teniposide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Live vaccines",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clopidogrel": {
        "definition": "An antiplatelet agent used to reduce the risk of cardiovascular events.",
        "mechanism": "Inhibits ADP-induced platelet aggregation by irreversibly binding to the P2Y12 receptor.",
        "indications": [
            "Acute coronary syndrome",
            "Myocardial infarction",
            "Stroke prevention",
            "Peripheral arterial disease"
        ],
        "dosage": {
            "adults": "75 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bleeding",
            "Bruising",
            "GI upset",
            "Rash"
        ],
        "contraindications": [
            "Active bleeding",
            "Hypersensitivity to clopidogrel"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Proton pump inhibitors",
            "Warfarin",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ticagrelor": {
        "definition": "A reversible P2Y12 receptor antagonist antiplatelet agent used to reduce the risk of cardiovascular events.",
        "mechanism": "Reversibly inhibits ADP-induced platelet aggregation by binding to the P2Y12 receptor.",
        "indications": [
            "Acute coronary syndrome",
            "Myocardial infarction"
        ],
        "dosage": {
            "adults": "180 mg loading dose, then 90 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bleeding",
            "Dyspnea",
            "Bradyarrhythmias"
        ],
        "contraindications": [
            "Active bleeding",
            "History of intracranial hemorrhage"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated in severe impairment."
        },
        "interactions": [
            "Strong CYP3A4 inhibitors/inducers",
            "Aspirin (high dose)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prasugrel": {
        "definition": "An irreversible P2Y12 receptor antagonist antiplatelet agent used to reduce the risk of cardiovascular events.",
        "mechanism": "Irreversibly inhibits ADP-induced platelet aggregation by binding to the P2Y12 receptor.",
        "indications": [
            "Acute coronary syndrome (with PCI)"
        ],
        "dosage": {
            "adults": "60 mg loading dose, then 10 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bleeding",
            "Hypertension",
            "Hyperlipidemia"
        ],
        "contraindications": [
            "Active bleeding",
            "History of stroke or TIA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of bleeding."
        },
        "interactions": [
            "Warfarin",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eptifibatide": {
        "definition": "A glycoprotein IIb/IIIa inhibitor antiplatelet agent used in acute coronary syndrome and PCI.",
        "mechanism": "Blocks glycoprotein IIb/IIIa receptor, inhibiting platelet aggregation.",
        "indications": [
            "Acute coronary syndrome",
            "Percutaneous coronary intervention (PCI)"
        ],
        "dosage": {
            "adults": "180 mcg/kg IV bolus, then 2 mcg/kg/min infusion.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia",
            "Hypotension"
        ],
        "contraindications": [
            "Active bleeding",
            "History of hemorrhagic stroke"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Anticoagulants",
            "Other antiplatelet agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tirofiban": {
        "definition": "A glycoprotein IIb/IIIa inhibitor antiplatelet agent used in acute coronary syndrome and PCI.",
        "mechanism": "Blocks glycoprotein IIb/IIIa receptor, inhibiting platelet aggregation.",
        "indications": [
            "Acute coronary syndrome",
            "Percutaneous coronary intervention (PCI)"
        ],
        "dosage": {
            "adults": "25 mcg/kg IV bolus, then 0.15 mcg/kg/min infusion.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia",
            "Bradycardia"
        ],
        "contraindications": [
            "Active bleeding",
            "History of hemorrhagic stroke"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Anticoagulants",
            "Other antiplatelet agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azathioprine": {
        "definition": "An immunosuppressant used to prevent organ rejection and treat autoimmune diseases.",
        "mechanism": "Inhibits purine synthesis, suppressing lymphocyte proliferation.",
        "indications": [
            "Organ transplantation",
            "Rheumatoid arthritis",
            "Inflammatory bowel disease"
        ],
        "dosage": {
            "adults": "1-3 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Myelosuppression",
            "Infection",
            "Hepatotoxicity",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to azathioprine",
            "Pregnancy (relative)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "TPMT deficiency": "Increased risk of toxicity."
        },
        "interactions": [
            "Allopurinol",
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penicillin g benzathine": {
        "definition": "A long-acting penicillin antibiotic used to treat syphilis and rheumatic fever prophylaxis.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Syphilis",
            "Rheumatic fever prophylaxis",
            "Streptococcal infections"
        ],
        "dosage": {
            "adults": "1.2-2.4 million units IM single dose (syphilis).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Allergic reactions",
            "Injection site reactions",
            "Jarisch-Herxheimer reaction"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Methotrexate",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cytarabine": {
        "definition": "A pyrimidine analog antimetabolite used in chemotherapy for leukemia and lymphoma.",
        "mechanism": "Inhibits DNA synthesis by acting as a cytosine analog.",
        "indications": [
            "Acute myeloid leukemia (AML)",
            "Acute lymphoblastic leukemia (ALL)",
            "Non-Hodgkin lymphoma"
        ],
        "dosage": {
            "adults": "100-200 mg/m²/day IV continuous infusion for 7 days (induction).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Cerebellar toxicity",
            "Conjunctivitis",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to cytarabine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Digoxin",
            "Gentamicin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "idarubicin": {
        "definition": "An anthracycline antibiotic used as a chemotherapy agent for leukemia.",
        "mechanism": "Intercalates DNA and inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Acute myeloid leukemia (AML)"
        ],
        "dosage": {
            "adults": "12 mg/m² IV daily for 3 days (induction).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Alopecia",
            "Red urine"
        ],
        "contraindications": [
            "Severe cardiac impairment",
            "Hypersensitivity to idarubicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor closely."
        },
        "interactions": [
            "Other cardiotoxic agents",
            "Cyclophosphamide"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "decitabine": {
        "definition": "A hypomethylating agent used to treat myelodysplastic syndromes and acute myeloid leukemia.",
        "mechanism": "Inhibits DNA methyltransferase, causing hypomethylation and reactivation of tumor suppressor genes.",
        "indications": [
            "Myelodysplastic syndromes",
            "Acute myeloid leukemia (AML)"
        ],
        "dosage": {
            "adults": "20 mg/m² IV daily for 5 days every 4 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Myelosuppression",
            "Infection",
            "Nausea",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to decitabine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Use with caution."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gemtuzumab": {
        "definition": "A monoclonal antibody-drug conjugate targeting CD33, used in acute myeloid leukemia.",
        "mechanism": "Binds to CD33 on leukemic cells, delivering cytotoxic agent calicheamicin.",
        "indications": [
            "Acute myeloid leukemia (AML)"
        ],
        "dosage": {
            "adults": "3 mg/m² IV on days 1, 4, and 7 (induction).",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Myelosuppression",
            "Hepatotoxicity",
            "Infusion reactions",
            "Hemorrhage"
        ],
        "contraindications": [
            "Hypersensitivity to gemtuzumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Monitor closely."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "midostaurin": {
        "definition": "A multi-kinase inhibitor used to treat FLT3-mutated acute myeloid leukemia and systemic mastocytosis.",
        "mechanism": "Inhibits multiple kinases including FLT3, KIT, and PDGFR.",
        "indications": [
            "FLT3-mutated acute myeloid leukemia (AML)",
            "Aggressive systemic mastocytosis"
        ],
        "dosage": {
            "adults": "50 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "QT prolongation",
            "Myelosuppression"
        ],
        "contraindications": [
            "Hypersensitivity to midostaurin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "venetoclax": {
        "definition": "A BCL-2 inhibitor used to treat chronic lymphocytic leukemia and acute myeloid leukemia.",
        "mechanism": "Inhibits BCL-2, promoting apoptosis in cancer cells.",
        "indications": [
            "Chronic lymphocytic leukemia (CLL)",
            "Acute myeloid leukemia (AML)"
        ],
        "dosage": {
            "adults": "Start at 100 mg orally daily, titrate to 400-600 mg daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Tumor lysis syndrome",
            "Neutropenia",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to venetoclax"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal/hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "enasidenib": {
        "definition": "An IDH2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with IDH2 mutation.",
        "mechanism": "Inhibits mutant IDH2 enzyme, reducing 2-hydroxyglutarate and promoting cell differentiation.",
        "indications": [
            "Relapsed or refractory acute myeloid leukemia (IDH2 mutation)"
        ],
        "dosage": {
            "adults": "100 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Differentiation syndrome",
            "Hyperbilirubinemia",
            "Leukocytosis"
        ],
        "contraindications": [
            "Hypersensitivity to enasidenib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cytarabine liposomal": {
        "definition": "A liposomal formulation of cytarabine for intrathecal use in meningeal leukemia and lymphoma.",
        "mechanism": "Inhibits DNA synthesis by acting as a cytosine analog.",
        "indications": [
            "Lymphomatous meningitis",
            "Leptomeningeal leukemia"
        ],
        "dosage": {
            "adults": "50 mg intrathecal every 2 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Arachnoiditis",
            "Nausea",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity to cytarabine or liposomal components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "CNS disease": "Monitor closely."
        },
        "interactions": [
            "Other intrathecal drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "daunorubicin liposomal": {
        "definition": "A liposomal formulation of daunorubicin used in combination with cytarabine for acute myeloid leukemia.",
        "mechanism": "Intercalates DNA and inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Acute myeloid leukemia (AML) (with cytarabine liposomal)"
        ],
        "dosage": {
            "adults": "44 mg/m² IV on days 1, 3, 5 (with cytarabine liposomal).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Alopecia",
            "Infusion reactions"
        ],
        "contraindications": [
            "Severe cardiac impairment",
            "Hypersensitivity to daunorubicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor closely."
        },
        "interactions": [
            "Other cardiotoxic agents",
            "Cyclophosphamide"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ivosidenib": {
        "definition": "An IDH1 inhibitor used to treat relapsed or refractory acute myeloid leukemia with IDH1 mutation.",
        "mechanism": "Inhibits mutant IDH1 enzyme, reducing 2-hydroxyglutarate and promoting cell differentiation.",
        "indications": [
            "Relapsed or refractory acute myeloid leukemia (IDH1 mutation)"
        ],
        "dosage": {
            "adults": "500 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Differentiation syndrome",
            "QT prolongation",
            "Leukocytosis"
        ],
        "contraindications": [
            "Hypersensitivity to ivosidenib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gilteritinib": {
        "definition": "A FLT3 inhibitor used to treat relapsed or refractory acute myeloid leukemia with FLT3 mutation.",
        "mechanism": "Inhibits FLT3 tyrosine kinase, blocking proliferation of leukemic cells.",
        "indications": [
            "Relapsed or refractory acute myeloid leukemia (FLT3 mutation)"
        ],
        "dosage": {
            "adults": "120 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Differentiation syndrome",
            "QT prolongation",
            "Myalgia"
        ],
        "contraindications": [
            "Hypersensitivity to gilteritinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glasdegib": {
        "definition": "A hedgehog pathway inhibitor used to treat newly diagnosed acute myeloid leukemia (AML) in adults who are not candidates for intensive chemotherapy.",
        "mechanism": "Inhibits the hedgehog signaling pathway by binding to Smoothened (SMO) receptor.",
        "indications": [
            "Acute myeloid leukemia (AML), newly diagnosed, ineligible for intensive chemotherapy"
        ],
        "dosage": {
            "adults": "100 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Anemia",
            "Fatigue",
            "Edema",
            "Dysgeusia",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity to glasdegib"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorpromazine": {
        "definition": "A typical antipsychotic used to treat psychotic disorders, nausea/vomiting, and intractable hiccups.",
        "mechanism": "Blocks dopamine D2 receptors in the brain; also has anticholinergic and antihistaminic effects.",
        "indications": [
            "Schizophrenia",
            "Nausea and vomiting",
            "Intractable hiccups",
            "Acute intermittent porphyria"
        ],
        "dosage": {
            "adults": "25-100 mg orally 2-4 times daily.",
            "children": "0.55 mg/kg every 4-6 hours."
        },
        "side effects": [
            "Sedation",
            "Hypotension",
            "Extrapyramidal symptoms",
            "Anticholinergic effects"
        ],
        "contraindications": [
            "Severe CNS depression",
            "Bone marrow suppression",
            "Pheochromocytoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of falls."
        },
        "interactions": [
            "CNS depressants",
            "Anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hemin": {
        "definition": "A heme derivative used to treat acute attacks of porphyria.",
        "mechanism": "Inhibits delta-aminolevulinic acid synthase, reducing porphyrin synthesis.",
        "indications": [
            "Acute intermittent porphyria",
            "Other acute porphyrias"
        ],
        "dosage": {
            "adults": "3-4 mg/kg IV once daily for 3-14 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Phlebitis",
            "Coagulopathy",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to hemin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "givosiran": {
        "definition": "A small interfering RNA (siRNA) used to treat acute hepatic porphyria.",
        "mechanism": "Silences ALAS1 mRNA, reducing production of neurotoxic heme intermediates.",
        "indications": [
            "Acute hepatic porphyria"
        ],
        "dosage": {
            "adults": "2.5 mg/kg SC once monthly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Fatigue",
            "Injection site reactions",
            "Renal dysfunction"
        ],
        "contraindications": [
            "Hypersensitivity to givosiran"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Monitor closely."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mercaptopurine": {
        "definition": "A purine antimetabolite used in the treatment of acute lymphoblastic leukemia (ALL).",
        "mechanism": "Inhibits purine synthesis, interfering with DNA and RNA synthesis.",
        "indications": [
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "1.5-2.5 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Myelosuppression",
            "Hepatotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to mercaptopurine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "TPMT deficiency": "Increased risk of toxicity."
        },
        "interactions": [
            "Allopurinol",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dasatinib": {
        "definition": "A tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome.",
        "mechanism": "Inhibits BCR-ABL and other tyrosine kinases.",
        "indications": [
            "Chronic myeloid leukemia (CML)",
            "Philadelphia chromosome-positive ALL"
        ],
        "dosage": {
            "adults": "100-140 mg orally once daily.",
            "children": "Dose by BSA."
        },
        "side effects": [
            "Myelosuppression",
            "Pleural effusion",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity to dasatinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegaspargase": {
        "definition": "A pegylated form of L-asparaginase used in the treatment of acute lymphoblastic leukemia (ALL).",
        "mechanism": "Depletes asparagine, an amino acid necessary for leukemia cell survival.",
        "indications": [
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "2,500 units/m² IM or IV every 2 weeks.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Hypersensitivity reactions",
            "Pancreatitis",
            "Coagulopathy",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "History of severe hypersensitivity to pegaspargase"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxorubicin": {
        "definition": "An anthracycline antibiotic used as a chemotherapy agent for various cancers.",
        "mechanism": "Intercalates DNA and inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Breast cancer",
            "Lymphomas",
            "Leukemias",
            "Solid tumors"
        ],
        "dosage": {
            "adults": "60-75 mg/m² IV every 21 days or 20-30 mg/m² weekly.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Alopecia",
            "Red urine"
        ],
        "contraindications": [
            "Severe cardiac impairment",
            "Hypersensitivity to doxorubicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor closely."
        },
        "interactions": [
            "Other cardiotoxic agents",
            "Cyclophosphamide"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "imatinib": {
        "definition": "A tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).",
        "mechanism": "Inhibits BCR-ABL, c-KIT, and PDGFR tyrosine kinases.",
        "indications": [
            "Chronic myeloid leukemia (CML)",
            "Gastrointestinal stromal tumors (GIST)"
        ],
        "dosage": {
            "adults": "400-600 mg orally once daily.",
            "children": "Dose by BSA."
        },
        "side effects": [
            "Edema",
            "Nausea",
            "Muscle cramps",
            "Myelosuppression"
        ],
        "contraindications": [
            "Hypersensitivity to imatinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ponatinib": {
        "definition": "A tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive ALL resistant to other therapies.",
        "mechanism": "Inhibits BCR-ABL and other kinases, including T315I mutant.",
        "indications": [
            "Chronic myeloid leukemia (CML)",
            "Philadelphia chromosome-positive ALL"
        ],
        "dosage": {
            "adults": "45 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Arterial thrombosis",
            "Myelosuppression",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to ponatinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vincristine liposome": {
        "definition": "A liposomal formulation of vincristine used for Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in adults.",
        "mechanism": "Inhibits microtubule formation in mitotic spindle, arresting cell division in metaphase.",
        "indications": [
            "Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "2.25 mg/m² IV over 60 min weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Myelosuppression",
            "Constipation"
        ],
        "contraindications": [
            "Hypersensitivity to vincristine or liposomal components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "Azole antifungals",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "blinatumomab": {
        "definition": "A bispecific T-cell engager antibody used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).",
        "mechanism": "Links CD19 on B cells to CD3 on T cells, promoting T-cell mediated cytotoxicity.",
        "indications": [
            "Relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "9 mcg/day IV continuous infusion for 7 days, then 28 mcg/day for 21 days (cycle-specific).",
            "children": "Dose by BSA."
        },
        "side effects": [
            "Cytokine release syndrome",
            "Neurotoxicity",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to blinatumomab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Use with caution."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thioguanine": {
        "definition": "A purine antimetabolite used to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).",
        "mechanism": "Inhibits purine synthesis, interfering with DNA and RNA synthesis.",
        "indications": [
            "Acute myeloid leukemia (AML)",
            "Acute lymphoblastic leukemia (ALL)"
        ],
        "dosage": {
            "adults": "2 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Myelosuppression",
            "Hepatotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to thioguanine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "TPMT deficiency": "Increased risk of toxicity."
        },
        "interactions": [
            "Allopurinol",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mitoxantrone": {
        "definition": "An anthracenedione antineoplastic agent used to treat certain cancers and multiple sclerosis.",
        "mechanism": "Intercalates DNA and inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Acute myeloid leukemia (AML)",
            "Prostate cancer",
            "Multiple sclerosis"
        ],
        "dosage": {
            "adults": "12 mg/m² IV every 21 days (cancer); 12 mg/m² IV every 3 months (MS).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Blue-green urine",
            "Nausea"
        ],
        "contraindications": [
            "Severe cardiac impairment",
            "Hypersensitivity to mitoxantrone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor closely."
        },
        "interactions": [
            "Other cardiotoxic agents",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ofloxacin": {
        "definition": "A fluoroquinolone antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.",
        "indications": [
            "Respiratory tract infections",
            "Urinary tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "200-400 mg orally every 12 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Tendinitis/tendon rupture",
            "QT prolongation",
            "Photosensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to ofloxacin or other quinolones"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Not routinely used."
        },
        "interactions": [
            "Antacids",
            "Warfarin",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "colistin sulfate": {
        "definition": "A polymyxin antibiotic used to treat infections caused by multidrug-resistant Gram-negative bacteria.",
        "mechanism": "Disrupts bacterial cell membrane by binding to phospholipids.",
        "indications": [
            "Serious Gram-negative infections (including Pseudomonas, Acinetobacter)"
        ],
        "dosage": {
            "adults": "2.5-5 mg/kg/day in 2-4 divided doses (IV/IM).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Neurotoxicity",
            "Respiratory arrest (high dose)"
        ],
        "contraindications": [
            "Hypersensitivity to colistin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Other nephrotoxic drugs",
            "Neuromuscular blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "neomycin": {
        "definition": "An aminoglycoside antibiotic used topically and orally for bowel decontamination and hepatic encephalopathy.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Bowel decontamination",
            "Hepatic encephalopathy",
            "Topical infections"
        ],
        "dosage": {
            "adults": "1 g orally every 6-8 hours (short-term); Topical: apply as directed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Ototoxicity",
            "Nephrotoxicity",
            "Diarrhea",
            "Contact dermatitis (topical)"
        ],
        "contraindications": [
            "Intestinal obstruction",
            "Hypersensitivity to neomycin or aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Other nephrotoxic or ototoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thonzonium bromide": {
        "definition": "A surfactant used in combination otic preparations to facilitate penetration and dispersion.",
        "mechanism": "Acts as a surfactant to enhance penetration of other otic medications.",
        "indications": [
            "Used in combination for otitis externa and otitis media"
        ],
        "dosage": {
            "adults": "As part of combination otic solutions, instill as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Local irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to thonzonium bromide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe as part of combination products."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "arsenic trioxide": {
        "definition": "An antineoplastic agent used to treat acute promyelocytic leukemia (APL).",
        "mechanism": "Induces apoptosis and promotes differentiation of leukemic cells.",
        "indications": [
            "Acute promyelocytic leukemia (APL)"
        ],
        "dosage": {
            "adults": "0.15 mg/kg IV daily until remission (up to 60 doses).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "QT prolongation",
            "Differentiation syndrome",
            "Leukocytosis"
        ],
        "contraindications": [
            "Hypersensitivity to arsenic trioxide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "cardiac disease": "Monitor ECG."
        },
        "interactions": [
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "beractant": {
        "definition": "A pulmonary surfactant used to prevent and treat respiratory distress syndrome (RDS) in premature infants.",
        "mechanism": "Reduces surface tension in the alveoli, improving lung compliance.",
        "indications": [
            "Prevention and treatment of respiratory distress syndrome (RDS) in premature infants"
        ],
        "dosage": {
            "neonates": "100 mg/kg (4 mL/kg) intratracheally, up to 4 doses in 48 hours."
        },
        "side effects": [
            "Bradycardia",
            "Oxygen desaturation",
            "Pulmonary hemorrhage"
        ],
        "contraindications": [
            "Active pulmonary hemorrhage",
            "Congenital anomalies incompatible with life"
        ],
        "special populations": {
            "pregnancy": "Not applicable (neonatal use).",
            "adults": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "poractant": {
        "definition": "A natural surfactant extracted from porcine lungs, used to treat or prevent respiratory distress syndrome (RDS) in premature infants.",
        "mechanism": "Reduces surface tension in the alveoli, improving lung compliance and oxygenation.",
        "indications": [
            "Prevention and treatment of respiratory distress syndrome (RDS) in premature infants"
        ],
        "dosage": {
            "neonates": "Initial: 200 mg/kg (2.5 mL/kg) intratracheally; up to 2 repeat doses of 100 mg/kg at 12-hour intervals."
        },
        "side effects": [
            "Bradycardia",
            "Oxygen desaturation",
            "Pulmonary hemorrhage"
        ],
        "contraindications": [
            "Active pulmonary hemorrhage",
            "Congenital anomalies incompatible with life"
        ],
        "special populations": {
            "pregnancy": "Not applicable (neonatal use).",
            "adults": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calfactant": {
        "definition": "A natural surfactant derived from calf lungs, used to treat or prevent respiratory distress syndrome (RDS) in premature infants.",
        "mechanism": "Reduces surface tension in the alveoli, improving lung compliance.",
        "indications": [
            "Prevention and treatment of respiratory distress syndrome (RDS) in premature infants"
        ],
        "dosage": {
            "neonates": "3 mL/kg intratracheally; may repeat every 12 hours up to 3 doses."
        },
        "side effects": [
            "Bradycardia",
            "Oxygen desaturation",
            "Pulmonary hemorrhage"
        ],
        "contraindications": [
            "Active pulmonary hemorrhage",
            "Congenital anomalies incompatible with life"
        ],
        "special populations": {
            "pregnancy": "Not applicable (neonatal use).",
            "adults": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefdinir": {
        "definition": "A third-generation cephalosporin antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Skin infections",
            "Otitis media"
        ],
        "dosage": {
            "adults": "300 mg orally every 12 hours for 5-10 days.",
            "children": "14 mg/kg/day divided every 12 or 24 hours."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Nausea",
            "Vaginal moniliasis"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Antacids",
            "Iron supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azithromycin": {
        "definition": "A macrolide antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "Respiratory tract infections",
            "Skin infections",
            "Chlamydia",
            "Otitis media"
        ],
        "dosage": {
            "adults": "500 mg orally on day 1, then 250 mg once daily on days 2-5.",
            "children": "10 mg/kg on day 1, then 5 mg/kg once daily on days 2-5."
        },
        "side effects": [
            "GI upset",
            "QT prolongation",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to macrolides"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Antacids",
            "Warfarin",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clarithromycin": {
        "definition": "A macrolide antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "Respiratory tract infections",
            "Skin infections",
            "Helicobacter pylori eradication"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 12 hours.",
            "children": "7.5 mg/kg every 12 hours."
        },
        "side effects": [
            "GI upset",
            "Taste disturbance",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity to macrolides",
            "Concomitant use with certain statins or ergot derivatives"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "moxifloxacin": {
        "definition": "A fluoroquinolone antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.",
        "indications": [
            "Respiratory tract infections",
            "Skin infections",
            "Intra-abdominal infections"
        ],
        "dosage": {
            "adults": "400 mg orally or IV once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "QT prolongation",
            "Tendinitis/tendon rupture"
        ],
        "contraindications": [
            "Hypersensitivity to moxifloxacin or other quinolones"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Not routinely used."
        },
        "interactions": [
            "Antacids",
            "Warfarin",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sertraline": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS, increasing serotonin levels.",
        "indications": [
            "Depression",
            "Obsessive-compulsive disorder",
            "Panic disorder",
            "PTSD"
        ],
        "dosage": {
            "adults": "50-200 mg orally once daily.",
            "children": "OCD: 25-200 mg once daily (age 6+)."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Sexual dysfunction",
            "Serotonin syndrome"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to sertraline"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "citalopram": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS, increasing serotonin levels.",
        "indications": [
            "Depression"
        ],
        "dosage": {
            "adults": "20-40 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Sexual dysfunction",
            "QT prolongation"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to citalopram"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluoxetine": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS, increasing serotonin levels.",
        "indications": [
            "Depression",
            "Obsessive-compulsive disorder",
            "Bulimia nervosa",
            "Panic disorder"
        ],
        "dosage": {
            "adults": "20-80 mg orally once daily.",
            "children": "OCD/depression: 10-60 mg once daily (age 7+)."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Sexual dysfunction",
            "Serotonin syndrome"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to fluoxetine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amitriptyline": {
        "definition": "A tricyclic antidepressant used for depression and certain types of chronic pain.",
        "mechanism": "Inhibits reuptake of norepinephrine and serotonin in the CNS.",
        "indications": [
            "Depression",
            "Neuropathic pain",
            "Migraine prophylaxis"
        ],
        "dosage": {
            "adults": "25-150 mg orally at bedtime.",
            "children": "Not routinely used for depression."
        },
        "side effects": [
            "Sedation",
            "Anticholinergic effects",
            "Orthostatic hypotension",
            "Weight gain"
        ],
        "contraindications": [
            "Recent MI",
            "Use with MAO inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Start at lower doses."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "venlafaxine": {
        "definition": "A serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin and norepinephrine in the CNS.",
        "indications": [
            "Depression",
            "Generalized anxiety disorder",
            "Panic disorder",
            "Social anxiety disorder"
        ],
        "dosage": {
            "adults": "75-225 mg orally once daily (extended-release).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Hypertension",
            "Sexual dysfunction"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to venlafaxine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paroxetine": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS, increasing serotonin levels.",
        "indications": [
            "Depression",
            "Anxiety disorders",
            "Panic disorder",
            "PTSD",
            "OCD"
        ],
        "dosage": {
            "adults": "20-50 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Sexual dysfunction",
            "Weight gain",
            "Drowsiness"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to paroxetine"
        ],
        "special populations": {
            "pregnancy": "Avoid if possible (risk of fetal effects).",
            "hepatic/renal impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prazosin": {
        "definition": "An alpha-1 adrenergic blocker used to treat hypertension and PTSD-related nightmares.",
        "mechanism": "Blocks alpha-1 adrenergic receptors, causing vasodilation.",
        "indications": [
            "Hypertension",
            "PTSD-related nightmares"
        ],
        "dosage": {
            "adults": "1-20 mg orally daily in divided doses.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Orthostatic hypotension",
            "Dizziness",
            "Headache",
            "Nasal congestion"
        ],
        "contraindications": [
            "Hypersensitivity to prazosin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "Other antihypertensives",
            "Phosphodiesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluvoxamine": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) used for obsessive-compulsive disorder and depression.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS, increasing serotonin levels.",
        "indications": [
            "Obsessive-compulsive disorder",
            "Depression"
        ],
        "dosage": {
            "adults": "50-300 mg orally daily in divided doses.",
            "children": "OCD: 25-200 mg/day (age 8+)."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Sexual dysfunction",
            "Serotonin syndrome"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity to fluvoxamine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegademase bovine": {
        "definition": "A pegylated bovine adenosine deaminase enzyme used to treat severe combined immunodeficiency disease (SCID) due to ADA deficiency.",
        "mechanism": "Replaces deficient adenosine deaminase, reducing toxic metabolites.",
        "indications": [
            "Adenosine deaminase deficiency SCID"
        ],
        "dosage": {
            "adults": "5 units/kg IM once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Immune reactions",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to pegademase or bovine proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "elapegademase": {
        "definition": "A recombinant pegylated adenosine deaminase enzyme used to treat ADA-SCID.",
        "mechanism": "Replaces deficient adenosine deaminase, reducing toxic metabolites.",
        "indications": [
            "Adenosine deaminase deficiency SCID (ADA-SCID)"
        ],
        "dosage": {
            "adults": "0.2 mg/kg IM once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Immune reactions",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to elapegademase"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ephedrine": {
        "definition": "A sympathomimetic agent used for hypotension during anesthesia and as a bronchodilator.",
        "mechanism": "Stimulates alpha and beta adrenergic receptors, increasing blood pressure and cardiac output.",
        "indications": [
            "Hypotension during anesthesia",
            "Bronchospasm"
        ],
        "dosage": {
            "adults": "5-25 mg IV/IM/SC as needed.",
            "children": "0.5-1 mg/kg/dose."
        },
        "side effects": [
            "Hypertension",
            "Tachycardia",
            "Anxiety",
            "Urinary retention"
        ],
        "contraindications": [
            "Severe hypertension",
            "Coronary artery disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased sensitivity."
        },
        "interactions": [
            "MAO inhibitors",
            "Other sympathomimetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isoproterenol": {
        "definition": "A non-selective beta-adrenergic agonist used for bradyarrhythmias and heart block.",
        "mechanism": "Stimulates beta-1 and beta-2 adrenergic receptors, increasing heart rate and causing bronchodilation.",
        "indications": [
            "Bradyarrhythmias",
            "Heart block",
            "Bronchospasm (rare)"
        ],
        "dosage": {
            "adults": "2-10 mcg/min IV infusion, titrate to response.",
            "children": "0.1-1 mcg/kg/min IV infusion."
        },
        "side effects": [
            "Tachycardia",
            "Arrhythmias",
            "Palpitations",
            "Headache"
        ],
        "contraindications": [
            "Tachyarrhythmias",
            "Digitalis intoxication"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased sensitivity."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methylphenidate": {
        "definition": "A CNS stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.",
        "mechanism": "Blocks reuptake of norepinephrine and dopamine in the brain.",
        "indications": [
            "ADHD",
            "Narcolepsy"
        ],
        "dosage": {
            "adults": "10-60 mg/day in divided doses.",
            "children": "0.3-2 mg/kg/day in divided doses."
        },
        "side effects": [
            "Insomnia",
            "Decreased appetite",
            "Tachycardia",
            "Anxiety"
        ],
        "contraindications": [
            "Glaucoma",
            "Tics or Tourette syndrome",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "MAO inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amphetamine": {
        "definition": "A CNS stimulant used to treat ADHD and narcolepsy.",
        "mechanism": "Promotes release of norepinephrine and dopamine from presynaptic neurons.",
        "indications": [
            "ADHD",
            "Narcolepsy"
        ],
        "dosage": {
            "adults": "5-40 mg/day in divided doses.",
            "children": "2.5-40 mg/day in divided doses."
        },
        "side effects": [
            "Insomnia",
            "Decreased appetite",
            "Tachycardia",
            "Anxiety"
        ],
        "contraindications": [
            "Advanced arteriosclerosis",
            "Cardiovascular disease",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "MAO inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dextroamphetamine": {
        "definition": "A CNS stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.",
        "mechanism": "Promotes release of norepinephrine and dopamine from presynaptic neurons.",
        "indications": [
            "ADHD",
            "Narcolepsy"
        ],
        "dosage": {
            "adults": "5-40 mg/day in divided doses.",
            "children": "2.5-40 mg/day in divided doses."
        },
        "side effects": [
            "Insomnia",
            "Decreased appetite",
            "Tachycardia",
            "Anxiety"
        ],
        "contraindications": [
            "Advanced arteriosclerosis",
            "Cardiovascular disease",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "MAO inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clonidine": {
        "definition": "An alpha-2 adrenergic agonist used to treat hypertension, ADHD, and withdrawal symptoms.",
        "mechanism": "Stimulates alpha-2 adrenergic receptors in the CNS, reducing sympathetic outflow.",
        "indications": [
            "Hypertension",
            "ADHD",
            "Opioid withdrawal",
            "Tourette syndrome (off-label)"
        ],
        "dosage": {
            "adults": "0.1-0.3 mg orally twice daily.",
            "children": "0.05-0.4 mg/day in divided doses."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Bradycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to clonidine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "Other antihypertensives",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bupropion": {
        "definition": "An atypical antidepressant used to treat depression, seasonal affective disorder, and for smoking cessation.",
        "mechanism": "Inhibits reuptake of norepinephrine and dopamine.",
        "indications": [
            "Depression",
            "Seasonal affective disorder",
            "Smoking cessation"
        ],
        "dosage": {
            "adults": "150-300 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Insomnia",
            "Dry mouth",
            "Seizures (dose-related)",
            "Weight loss"
        ],
        "contraindications": [
            "Seizure disorder",
            "Eating disorders",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "MAO inhibitors",
            "Drugs that lower seizure threshold"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "guanfacine": {
        "definition": "An alpha-2 adrenergic agonist used to treat hypertension and ADHD.",
        "mechanism": "Stimulates alpha-2 adrenergic receptors in the CNS, reducing sympathetic outflow.",
        "indications": [
            "Hypertension",
            "ADHD"
        ],
        "dosage": {
            "adults": "1-3 mg orally once daily (hypertension).",
            "children": "1-7 mg orally once daily (ADHD, age 6+)."
        },
        "side effects": [
            "Drowsiness",
            "Fatigue",
            "Bradycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to guanfacine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of hypotension."
        },
        "interactions": [
            "Other antihypertensives",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lisdexamfetamine": {
        "definition": "A CNS stimulant prodrug used to treat ADHD and binge eating disorder.",
        "mechanism": "Converted to dextroamphetamine, which increases norepinephrine and dopamine release.",
        "indications": [
            "ADHD",
            "Binge eating disorder"
        ],
        "dosage": {
            "adults": "30-70 mg orally once daily in the morning.",
            "children": "Same as adults (age 6+)."
        },
        "side effects": [
            "Insomnia",
            "Decreased appetite",
            "Tachycardia",
            "Irritability"
        ],
        "contraindications": [
            "Advanced arteriosclerosis",
            "Cardiovascular disease",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "MAO inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atomoxetine": {
        "definition": "A selective norepinephrine reuptake inhibitor used to treat ADHD.",
        "mechanism": "Inhibits norepinephrine reuptake in the CNS.",
        "indications": [
            "ADHD"
        ],
        "dosage": {
            "adults": "40-100 mg orally once daily or divided twice daily.",
            "children": "0.5-1.4 mg/kg/day (age 6+)."
        },
        "side effects": [
            "GI upset",
            "Insomnia",
            "Decreased appetite",
            "Increased heart rate"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fludrocortisone": {
        "definition": "A synthetic mineralocorticoid used to treat adrenocortical insufficiency and orthostatic hypotension.",
        "mechanism": "Increases sodium reabsorption and potassium excretion in the distal tubules.",
        "indications": [
            "Adrenocortical insufficiency (Addison's disease)",
            "Orthostatic hypotension"
        ],
        "dosage": {
            "adults": "0.05-0.2 mg orally once daily.",
            "children": "0.05-0.2 mg orally once daily."
        },
        "side effects": [
            "Hypertension",
            "Edema",
            "Hypokalemia",
            "Heart failure"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Hypersensitivity to fludrocortisone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth and electrolytes."
        },
        "interactions": [
            "Diuretics",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pazopanib": {
        "definition": "A multi-tyrosine kinase inhibitor used to treat advanced renal cell carcinoma and soft tissue sarcoma.",
        "mechanism": "Inhibits VEGFR, PDGFR, and c-KIT tyrosine kinases.",
        "indications": [
            "Advanced renal cell carcinoma",
            "Advanced soft tissue sarcoma"
        ],
        "dosage": {
            "adults": "800 mg orally once daily (empty stomach).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Diarrhea",
            "Hair color change",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity to pazopanib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sunitinib": {
        "definition": "A multi-tyrosine kinase inhibitor used to treat renal cell carcinoma and gastrointestinal stromal tumors (GIST).",
        "mechanism": "Inhibits VEGFR, PDGFR, and other kinases.",
        "indications": [
            "Renal cell carcinoma",
            "Gastrointestinal stromal tumors (GIST)",
            "Pancreatic neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "50 mg orally once daily for 4 weeks, then 2 weeks off (6-week cycle).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Fatigue",
            "Hypertension",
            "Hand-foot syndrome",
            "Hypothyroidism"
        ],
        "contraindications": [
            "Hypersensitivity to sunitinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "axitinib": {
        "definition": "A tyrosine kinase inhibitor used to treat advanced renal cell carcinoma.",
        "mechanism": "Inhibits VEGFR-1, -2, and -3 tyrosine kinases.",
        "indications": [
            "Advanced renal cell carcinoma (after failure of prior therapy)"
        ],
        "dosage": {
            "adults": "5 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Diarrhea",
            "Fatigue",
            "Hand-foot syndrome"
        ],
        "contraindications": [
            "Hypersensitivity to axitinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nivolumab": {
        "definition": "A PD-1 immune checkpoint inhibitor used to treat various cancers including melanoma, lung, and renal cell carcinoma.",
        "mechanism": "Blocks PD-1 receptor, enhancing T-cell mediated immune response against tumors.",
        "indications": [
            "Melanoma",
            "Non-small cell lung cancer",
            "Renal cell carcinoma",
            "Hodgkin lymphoma",
            "Others"
        ],
        "dosage": {
            "adults": "240 mg IV every 2 weeks or 480 mg IV every 4 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Fatigue",
            "Immune-mediated reactions",
            "Rash",
            "Colitis"
        ],
        "contraindications": [
            "Hypersensitivity to nivolumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "autoimmune disease": "Use with caution."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sorafenib": {
        "definition": "A multi-kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer.",
        "mechanism": "Inhibits multiple kinases including RAF, VEGFR, and PDGFR.",
        "indications": [
            "Advanced renal cell carcinoma",
            "Hepatocellular carcinoma",
            "Thyroid cancer"
        ],
        "dosage": {
            "adults": "400 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hand-foot syndrome",
            "Diarrhea",
            "Rash",
            "Hypertension"
        ],
        "contraindications": [
            "Hypersensitivity to sorafenib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "everolimus": {
        "definition": "An mTOR inhibitor used to treat various cancers and prevent organ transplant rejection.",
        "mechanism": "Inhibits mTOR, suppressing cell proliferation and angiogenesis.",
        "indications": [
            "Renal cell carcinoma",
            "Breast cancer",
            "Neuroendocrine tumors",
            "Transplant rejection prevention"
        ],
        "dosage": {
            "adults": "10 mg orally once daily (cancer); 0.75 mg twice daily (transplant).",
            "children": "Dose by indication and BSA."
        },
        "side effects": [
            "Mouth ulcers",
            "Infection",
            "Hyperglycemia",
            "Pneumonitis"
        ],
        "contraindications": [
            "Hypersensitivity to everolimus or sirolimus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bevacizumab": {
        "definition": "A monoclonal antibody against VEGF used to treat various cancers and some eye diseases.",
        "mechanism": "Binds to VEGF, inhibiting angiogenesis.",
        "indications": [
            "Colorectal cancer",
            "Non-small cell lung cancer",
            "Renal cell carcinoma",
            "Glioblastoma",
            "Others"
        ],
        "dosage": {
            "adults": "5-15 mg/kg IV every 2-3 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Bleeding",
            "Proteinuria",
            "Wound healing complications"
        ],
        "contraindications": [
            "Hypersensitivity to bevacizumab"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "surgery": "Delay use before/after major surgery."
        },
        "interactions": [
            "Other antiangiogenic agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cabozantinib": {
        "definition": "A multi-tyrosine kinase inhibitor used to treat renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.",
        "mechanism": "Inhibits MET, VEGFR2, and other kinases.",
        "indications": [
            "Renal cell carcinoma",
            "Hepatocellular carcinoma",
            "Medullary thyroid cancer"
        ],
        "dosage": {
            "adults": "60 mg orally once daily (RCC/HCC); 140 mg once daily (thyroid).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Diarrhea",
            "Hand-foot syndrome",
            "Fatigue",
            "Hypertension"
        ],
        "contraindications": [
            "Hypersensitivity to cabozantinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aldesleukin": {
        "definition": "A recombinant interleukin-2 (IL-2) used to treat metastatic renal cell carcinoma and metastatic melanoma.",
        "mechanism": "Stimulates proliferation and activation of lymphocytes.",
        "indications": [
            "Metastatic renal cell carcinoma",
            "Metastatic melanoma"
        ],
        "dosage": {
            "adults": "600,000 IU/kg IV every 8 hours for up to 14 doses per cycle.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Capillary leak syndrome",
            "Hypotension",
            "Fever",
            "Renal dysfunction"
        ],
        "contraindications": [
            "Organ transplant recipients",
            "Severe cardiac or pulmonary disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Monitor closely."
        },
        "interactions": [
            "Corticosteroids",
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "capecitabine": {
        "definition": "An oral prodrug of 5-fluorouracil used to treat breast and colorectal cancer.",
        "mechanism": "Converted to 5-FU, which inhibits thymidylate synthase and DNA synthesis.",
        "indications": [
            "Breast cancer",
            "Colorectal cancer"
        ],
        "dosage": {
            "adults": "1,250 mg/m² orally twice daily for 14 days, then 7 days off (21-day cycle).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hand-foot syndrome",
            "Diarrhea",
            "Nausea",
            "Myelosuppression"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Hypersensitivity to capecitabine or 5-FU"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Warfarin",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "temsirolimus": {
        "definition": "An mTOR inhibitor used to treat advanced renal cell carcinoma.",
        "mechanism": "Inhibits mTOR, suppressing cell proliferation and angiogenesis.",
        "indications": [
            "Advanced renal cell carcinoma"
        ],
        "dosage": {
            "adults": "25 mg IV once weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Rash",
            "Hyperglycemia",
            "Infection",
            "Interstitial lung disease"
        ],
        "contraindications": [
            "Hypersensitivity to temsirolimus or polysorbate 80"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lenvatinib": {
        "definition": "A multi-tyrosine kinase inhibitor used to treat thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.",
        "mechanism": "Inhibits VEGFR, FGFR, PDGFR, RET, and KIT kinases.",
        "indications": [
            "Thyroid cancer",
            "Renal cell carcinoma",
            "Hepatocellular carcinoma"
        ],
        "dosage": {
            "adults": "8-24 mg orally once daily, depending on indication.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Diarrhea",
            "Fatigue",
            "Proteinuria"
        ],
        "contraindications": [
            "Hypersensitivity to lenvatinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "adenovirus vaccine": {
        "definition": "A live, oral vaccine used to prevent febrile acute respiratory disease caused by adenovirus types 4 and 7, primarily in military populations.",
        "mechanism": "Induces immunity against adenovirus types 4 and 7.",
        "indications": [
            "Prevention of adenovirus types 4 and 7 infection (military personnel)"
        ],
        "dosage": {
            "adults": "One dose (two tablets: type 4 and type 7) orally, as a single dose.",
            "children": "Not recommended."
        },
        "side effects": [
            "Fever",
            "Headache",
            "Respiratory symptoms",
            "Abdominal pain"
        ],
        "contraindications": [
            "Pregnancy",
            "Immunocompromised individuals",
            "Hypersensitivity to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "immunocompromised": "Contraindicated."
        },
        "interactions": [
            "Immunosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "piroxicam": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation in osteoarthritis and rheumatoid arthritis.",
        "mechanism": "Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "20 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema",
            "Headache"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "triamcinolone": {
        "definition": "A glucocorticoid used to treat inflammation, allergies, and certain skin conditions.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Allergic disorders",
            "Inflammatory skin conditions",
            "Arthritis (intra-articular)"
        ],
        "dosage": {
            "adults": "Topical: apply as directed; IM: 40-80 mg as a single dose; intra-articular: 2.5-40 mg per joint.",
            "children": "Dose by indication and weight."
        },
        "side effects": [
            "Skin thinning (topical)",
            "Hyperglycemia",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fentanyl": {
        "definition": "A potent synthetic opioid analgesic used for severe pain and anesthesia.",
        "mechanism": "Binds to mu-opioid receptors in the CNS, altering pain perception.",
        "indications": [
            "Severe pain",
            "Anesthesia",
            "Chronic pain (transdermal patch)"
        ],
        "dosage": {
            "adults": "IV: 25-100 mcg/dose; transdermal: 12-100 mcg/hr patch every 72 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Respiratory depression",
            "Constipation",
            "Nausea",
            "Sedation"
        ],
        "contraindications": [
            "Acute respiratory depression",
            "Severe asthma",
            "Paralytic ileus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased sensitivity."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pregabalin": {
        "definition": "An anticonvulsant and neuropathic pain agent.",
        "mechanism": "Binds to alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release.",
        "indications": [
            "Neuropathic pain",
            "Fibromyalgia",
            "Partial seizures",
            "Generalized anxiety disorder (off-label)"
        ],
        "dosage": {
            "adults": "150-600 mg/day in divided doses.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Dizziness",
            "Somnolence",
            "Weight gain",
            "Peripheral edema"
        ],
        "contraindications": [
            "Hypersensitivity to pregabalin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "probenecid": {
        "definition": "A uricosuric agent used to treat gout and prolong the action of certain antibiotics.",
        "mechanism": "Inhibits renal tubular reabsorption of uric acid, increasing its excretion.",
        "indications": [
            "Gout",
            "Hyperuricemia",
            "Adjunct to penicillin therapy"
        ],
        "dosage": {
            "adults": "250 mg orally twice daily, may increase to 500-1000 mg twice daily.",
            "children": "25-40 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Kidney stones"
        ],
        "contraindications": [
            "Uric acid kidney stones",
            "Acute gout attack",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Contraindicated."
        },
        "interactions": [
            "Penicillins",
            "NSAIDs",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "enalapril": {
        "definition": "An angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Left ventricular dysfunction"
        ],
        "dosage": {
            "adults": "5-40 mg orally once or twice daily.",
            "children": "0.08-0.6 mg/kg/day in divided doses."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema",
            "Hypotension"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lisinopril": {
        "definition": "An ACE inhibitor used to treat hypertension, heart failure, and post-myocardial infarction.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Post-myocardial infarction"
        ],
        "dosage": {
            "adults": "10-40 mg orally once daily.",
            "children": "0.07 mg/kg once daily (age 6+)."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema",
            "Hypotension"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "captopril": {
        "definition": "An ACE inhibitor used to treat hypertension, heart failure, and diabetic nephropathy.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Diabetic nephropathy"
        ],
        "dosage": {
            "adults": "25-150 mg orally 2-3 times daily.",
            "children": "0.15-0.3 mg/kg/dose every 8-12 hours."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema",
            "Rash"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mitotane": {
        "definition": "An adrenolytic agent used to treat inoperable adrenocortical carcinoma.",
        "mechanism": "Destroys adrenocortical cells, reducing cortisol production.",
        "indications": [
            "Inoperable adrenocortical carcinoma"
        ],
        "dosage": {
            "adults": "2-6 g orally daily in divided doses.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "CNS depression",
            "Rash",
            "Adrenal insufficiency"
        ],
        "contraindications": [
            "Hypersensitivity to mitotane"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Use with caution."
        },
        "interactions": [
            "Warfarin",
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cortisone": {
        "definition": "A glucocorticoid used for adrenal insufficiency and inflammatory conditions.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Adrenal insufficiency",
            "Inflammatory conditions"
        ],
        "dosage": {
            "adults": "25-300 mg orally or IM daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hyperglycemia",
            "Osteoporosis",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cosyntropin": {
        "definition": "A synthetic ACTH analog used as a diagnostic agent for adrenal insufficiency.",
        "mechanism": "Stimulates the adrenal cortex to secrete cortisol, aldosterone, and androgens.",
        "indications": [
            "Diagnosis of adrenal insufficiency (ACTH stimulation test)"
        ],
        "dosage": {
            "adults": "250 mcg IV or IM as a single dose.",
            "children": "15 mcg/kg IV or IM (max 250 mcg)."
        },
        "side effects": [
            "Injection site reactions",
            "Allergic reactions",
            "Flushing"
        ],
        "contraindications": [
            "Hypersensitivity to cosyntropin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for diagnosis."
        },
        "interactions": [
            "Glucocorticoids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "somatropin": {
        "definition": "A recombinant human growth hormone used to treat growth hormone deficiency and certain growth disorders.",
        "mechanism": "Stimulates growth, cell reproduction, and regeneration.",
        "indications": [
            "Growth hormone deficiency",
            "Turner syndrome",
            "Chronic renal insufficiency",
            "Prader-Willi syndrome"
        ],
        "dosage": {
            "adults": "0.005-0.01 mg/kg/day SC.",
            "children": "0.025-0.035 mg/kg/day SC."
        },
        "side effects": [
            "Edema",
            "Arthralgia",
            "Hyperglycemia",
            "Intracranial hypertension"
        ],
        "contraindications": [
            "Active malignancy",
            "Acute critical illness"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric growth disorders."
        },
        "interactions": [
            "Glucocorticoids",
            "Insulin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anakinra": {
        "definition": "An interleukin-1 receptor antagonist used to treat rheumatoid arthritis and cryopyrin-associated periodic syndromes.",
        "mechanism": "Blocks interleukin-1, reducing inflammation.",
        "indications": [
            "Rheumatoid arthritis",
            "Cryopyrin-associated periodic syndromes (CAPS)"
        ],
        "dosage": {
            "adults": "100 mg SC once daily.",
            "children": "1-2 mg/kg SC once daily (CAPS)."
        },
        "side effects": [
            "Injection site reactions",
            "Infection",
            "Neutropenia"
        ],
        "contraindications": [
            "Hypersensitivity to anakinra",
            "Active infections"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "TNF inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tocilizumab": {
        "definition": "An interleukin-6 receptor antagonist used to treat rheumatoid arthritis and cytokine release syndrome.",
        "mechanism": "Blocks interleukin-6 receptors, reducing inflammation.",
        "indications": [
            "Rheumatoid arthritis",
            "Systemic juvenile idiopathic arthritis",
            "Cytokine release syndrome"
        ],
        "dosage": {
            "adults": "4-8 mg/kg IV every 4 weeks or 162 mg SC every week.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Elevated liver enzymes",
            "Neutropenia"
        ],
        "contraindications": [
            "Active infections",
            "Hypersensitivity to tocilizumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Monitor closely."
        },
        "interactions": [
            "CYP450 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "etanercept": {
        "definition": "A tumor necrosis factor (TNF) inhibitor used to treat autoimmune diseases.",
        "mechanism": "Binds TNF-alpha, preventing its interaction with cell surface receptors.",
        "indications": [
            "Rheumatoid arthritis",
            "Psoriatic arthritis",
            "Ankylosing spondylitis",
            "Plaque psoriasis"
        ],
        "dosage": {
            "adults": "50 mg SC once weekly.",
            "children": "0.8 mg/kg SC once weekly (max 50 mg)."
        },
        "side effects": [
            "Infection",
            "Injection site reactions",
            "Headache"
        ],
        "contraindications": [
            "Sepsis",
            "Hypersensitivity to etanercept"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for juvenile idiopathic arthritis."
        },
        "interactions": [
            "Other biologic immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "digoxin": {
        "definition": "A cardiac glycoside used to treat heart failure and atrial fibrillation.",
        "mechanism": "Inhibits Na+/K+-ATPase, increasing intracellular calcium and cardiac contractility.",
        "indications": [
            "Heart failure",
            "Atrial fibrillation"
        ],
        "dosage": {
            "adults": "0.125-0.25 mg orally daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Arrhythmias",
            "Visual disturbances",
            "Confusion"
        ],
        "contraindications": [
            "Ventricular fibrillation",
            "Hypersensitivity to digoxin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Amiodarone",
            "Verapamil",
            "Quinidine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diltiazem": {
        "definition": "A non-dihydropyridine calcium channel blocker used for hypertension, angina, and arrhythmias.",
        "mechanism": "Inhibits calcium influx into cardiac and vascular smooth muscle, reducing contractility and conduction.",
        "indications": [
            "Hypertension",
            "Angina",
            "Atrial fibrillation/flutter",
            "Paroxysmal supraventricular tachycardia"
        ],
        "dosage": {
            "adults": "120-360 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "Edema",
            "Constipation",
            "Hypotension"
        ],
        "contraindications": [
            "Severe hypotension",
            "Second/third-degree AV block",
            "Sick sinus syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Beta blockers",
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flecainide": {
        "definition": "A class Ic antiarrhythmic used to treat and prevent certain types of serious arrhythmias.",
        "mechanism": "Blocks sodium channels, slowing conduction in cardiac tissue.",
        "indications": [
            "Paroxysmal supraventricular tachycardia",
            "Atrial fibrillation/flutter",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "50-150 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Dizziness",
            "Visual disturbances",
            "Arrhythmias",
            "Heart failure"
        ],
        "contraindications": [
            "Structural heart disease",
            "AV block",
            "Cardiogenic shock"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal/hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Amiodarone",
            "Beta blockers",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sotalol": {
        "definition": "A non-selective beta blocker and class III antiarrhythmic used to treat and prevent arrhythmias.",
        "mechanism": "Blocks beta-adrenergic receptors and prolongs cardiac action potential.",
        "indications": [
            "Atrial fibrillation/flutter",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "80-160 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "QT prolongation",
            "Fatigue",
            "Dizziness"
        ],
        "contraindications": [
            "Bronchial asthma",
            "Second/third-degree AV block",
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "Other QT-prolonging drugs",
            "Calcium channel blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "propafenone": {
        "definition": "A class Ic antiarrhythmic used to treat and prevent certain types of serious arrhythmias.",
        "mechanism": "Blocks sodium channels, slowing conduction in cardiac tissue.",
        "indications": [
            "Paroxysmal supraventricular tachycardia",
            "Atrial fibrillation/flutter",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "150-300 mg orally every 8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Dizziness",
            "Taste disturbance",
            "Arrhythmias",
            "Bradycardia"
        ],
        "contraindications": [
            "Structural heart disease",
            "Bradycardia",
            "AV block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Beta blockers",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rivaroxaban": {
        "definition": "An oral direct factor Xa inhibitor anticoagulant.",
        "mechanism": "Inhibits factor Xa, preventing thrombin generation and clot formation.",
        "indications": [
            "Atrial fibrillation",
            "Deep vein thrombosis",
            "Pulmonary embolism",
            "Venous thromboembolism prophylaxis"
        ],
        "dosage": {
            "adults": "10-20 mg orally once daily (dose depends on indication).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Anemia",
            "GI upset"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dronedarone": {
        "definition": "A class III antiarrhythmic used to reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation.",
        "mechanism": "Blocks multiple cardiac ion channels, prolonging action potential and refractory period.",
        "indications": [
            "Paroxysmal or persistent atrial fibrillation"
        ],
        "dosage": {
            "adults": "400 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "QT prolongation",
            "Bradycardia",
            "Liver injury"
        ],
        "contraindications": [
            "Severe heart failure",
            "Permanent atrial fibrillation",
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "propranolol": {
        "definition": "A non-selective beta blocker used for hypertension, angina, arrhythmias, migraine prophylaxis, and anxiety.",
        "mechanism": "Blocks beta-1 and beta-2 adrenergic receptors, reducing heart rate and blood pressure.",
        "indications": [
            "Hypertension",
            "Angina",
            "Arrhythmias",
            "Migraine prophylaxis",
            "Anxiety"
        ],
        "dosage": {
            "adults": "40-320 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "Fatigue",
            "Dizziness",
            "Cold extremities"
        ],
        "contraindications": [
            "Bronchial asthma",
            "Bradycardia",
            "Heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "asthma": "Contraindicated."
        },
        "interactions": [
            "Calcium channel blockers",
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentamidine": {
        "definition": "An antiprotozoal and antifungal agent used to treat Pneumocystis jirovecii pneumonia and leishmaniasis.",
        "mechanism": "Inhibits DNA, RNA, and protein synthesis in susceptible organisms.",
        "indications": [
            "Pneumocystis jirovecii pneumonia",
            "Leishmaniasis",
            "Trypanosomiasis"
        ],
        "dosage": {
            "adults": "4 mg/kg IV or IM once daily for 14-21 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Hypoglycemia",
            "Hypotension",
            "Arrhythmias"
        ],
        "contraindications": [
            "Hypersensitivity to pentamidine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor closely."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benznidazole": {
        "definition": "An antiprotozoal agent used to treat Chagas disease (Trypanosoma cruzi infection).",
        "mechanism": "Produces free radicals that damage DNA and proteins in parasites.",
        "indications": [
            "Chagas disease (Trypanosoma cruzi infection)"
        ],
        "dosage": {
            "adults": "5-7 mg/kg/day orally in 2 divided doses for 60 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Rash",
            "Peripheral neuropathy",
            "GI upset",
            "Bone marrow suppression"
        ],
        "contraindications": [
            "Hypersensitivity to benznidazole"
        ],
        "special populations": {
            "pregnancy": "Avoid unless no alternatives.",
            "children": "Indicated for pediatric Chagas disease."
        },
        "interactions": [
            "Alcohol",
            "Other myelosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "haloperidol": {
        "definition": "A typical antipsychotic used to treat schizophrenia, acute psychosis, and Tourette syndrome.",
        "mechanism": "Blocks dopamine D2 receptors in the brain.",
        "indications": [
            "Schizophrenia",
            "Acute psychosis",
            "Tourette syndrome"
        ],
        "dosage": {
            "adults": "2-20 mg orally daily in divided doses; IM/IV for acute agitation.",
            "children": "0.05-0.15 mg/kg/day in divided doses."
        },
        "side effects": [
            "Extrapyramidal symptoms",
            "Sedation",
            "QT prolongation",
            "Neuroleptic malignant syndrome"
        ],
        "contraindications": [
            "Parkinson's disease",
            "Severe CNS depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aripiprazole": {
        "definition": "An atypical antipsychotic used to treat schizophrenia, bipolar disorder, and depression (adjunct).",
        "mechanism": "Partial agonist at dopamine D2 and serotonin 5-HT1A receptors; antagonist at 5-HT2A.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder",
            "Adjunct in depression",
            "Tourette syndrome"
        ],
        "dosage": {
            "adults": "10-30 mg orally once daily.",
            "children": "2-30 mg once daily (age 6+)."
        },
        "side effects": [
            "Akathisia",
            "Insomnia",
            "Weight gain",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to aripiprazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olanzapine": {
        "definition": "An atypical antipsychotic used to treat schizophrenia and bipolar disorder.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder",
            "Depression (with fluoxetine)"
        ],
        "dosage": {
            "adults": "5-20 mg orally once daily.",
            "children": "10-20 mg once daily (age 13+)."
        },
        "side effects": [
            "Weight gain",
            "Sedation",
            "Hyperglycemia",
            "Dyslipidemia"
        ],
        "contraindications": [
            "Hypersensitivity to olanzapine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CYP1A2 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "loxapine": {
        "definition": "A typical antipsychotic used to treat schizophrenia and acute agitation.",
        "mechanism": "Blocks dopamine D2 receptors in the brain.",
        "indications": [
            "Schizophrenia",
            "Acute agitation"
        ],
        "dosage": {
            "adults": "10-50 mg orally 2-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Sedation",
            "Extrapyramidal symptoms",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to loxapine",
            "Severe CNS depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CNS depressants",
            "Anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "risperidone": {
        "definition": "An atypical antipsychotic used to treat schizophrenia, bipolar disorder, and irritability in autism.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder",
            "Irritability in autism"
        ],
        "dosage": {
            "adults": "1-8 mg orally once or twice daily.",
            "children": "0.25-6 mg daily (age 5+)."
        },
        "side effects": [
            "Weight gain",
            "Hyperprolactinemia",
            "Sedation",
            "Extrapyramidal symptoms"
        ],
        "contraindications": [
            "Hypersensitivity to risperidone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "perphenazine": {
        "definition": "A typical antipsychotic used to treat schizophrenia and severe nausea/vomiting.",
        "mechanism": "Blocks dopamine D2 receptors in the brain.",
        "indications": [
            "Schizophrenia",
            "Severe nausea and vomiting"
        ],
        "dosage": {
            "adults": "4-16 mg orally 2-4 times daily.",
            "children": "0.25 mg/kg/day in divided doses."
        },
        "side effects": [
            "Extrapyramidal symptoms",
            "Sedation",
            "Anticholinergic effects",
            "QT prolongation"
        ],
        "contraindications": [
            "Comatose states",
            "Severe CNS depression",
            "Bone marrow suppression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CNS depressants",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ruxolitinib": {
        "definition": "A Janus kinase (JAK) inhibitor used to treat myelofibrosis, polycythemia vera, and graft-versus-host disease.",
        "mechanism": "Inhibits JAK1 and JAK2, reducing cytokine and growth factor signaling.",
        "indications": [
            "Myelofibrosis",
            "Polycythemia vera",
            "Graft-versus-host disease"
        ],
        "dosage": {
            "adults": "5-25 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Anemia",
            "Thrombocytopenia",
            "Infection",
            "Bruising"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity to ruxolitinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fedratinib": {
        "definition": "A Janus kinase 2 (JAK2) inhibitor used to treat myelofibrosis.",
        "mechanism": "Inhibits JAK2, reducing abnormal blood cell production.",
        "indications": [
            "Myelofibrosis"
        ],
        "dosage": {
            "adults": "400 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Anemia",
            "Thrombocytopenia",
            "Wernicke's encephalopathy",
            "GI upset"
        ],
        "contraindications": [
            "Thiamine deficiency",
            "Hypersensitivity to fedratinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic/renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "filgrastim": {
        "definition": "A granulocyte colony-stimulating factor (G-CSF) used to reduce the risk of infection in neutropenic patients.",
        "mechanism": "Stimulates production of neutrophils in the bone marrow.",
        "indications": [
            "Neutropenia",
            "Stem cell mobilization"
        ],
        "dosage": {
            "adults": "5 mcg/kg/day SC or IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Bone pain",
            "Splenomegaly",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to filgrastim or E. coli-derived proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric neutropenia."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dronabinol": {
        "definition": "A synthetic form of THC used to treat chemotherapy-induced nausea and vomiting and appetite loss in AIDS.",
        "mechanism": "Activates cannabinoid receptors in the CNS.",
        "indications": [
            "Chemotherapy-induced nausea and vomiting",
            "Anorexia in AIDS"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally 1-3 times daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Euphoria",
            "Drowsiness",
            "Dizziness",
            "Dry mouth"
        ],
        "contraindications": [
            "Hypersensitivity to sesame oil or cannabinoids"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "psychiatric illness": "Use with caution."
        },
        "interactions": [
            "CNS depressants",
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naltrexone": {
        "definition": "An opioid antagonist used to treat alcohol and opioid dependence.",
        "mechanism": "Blocks opioid receptors, reducing the effects of opioids and alcohol.",
        "indications": [
            "Alcohol dependence",
            "Opioid dependence"
        ],
        "dosage": {
            "adults": "50 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Insomnia",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Acute hepatitis",
            "Liver failure",
            "Current opioid use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Opioid analgesics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acamprosate": {
        "definition": "A medication used to maintain abstinence in alcohol-dependent patients.",
        "mechanism": "Modulates glutamatergic neurotransmission in the CNS.",
        "indications": [
            "Alcohol dependence (maintenance of abstinence)"
        ],
        "dosage": {
            "adults": "666 mg orally three times daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Diarrhea",
            "Insomnia",
            "Anxiety",
            "Depression"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Contraindicated if CrCl ≤30 mL/min."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "disulfiram": {
        "definition": "A medication used to support the treatment of chronic alcoholism by producing an acute sensitivity to ethanol.",
        "mechanism": "Inhibits aldehyde dehydrogenase, causing unpleasant effects when alcohol is consumed.",
        "indications": [
            "Alcohol dependence (deterrent therapy)"
        ],
        "dosage": {
            "adults": "250-500 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Drowsiness",
            "Metallic taste",
            "Hepatotoxicity",
            "Peripheral neuropathy"
        ],
        "contraindications": [
            "Severe myocardial disease",
            "Psychosis",
            "Concurrent use of alcohol or metronidazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Alcohol",
            "Metronidazole",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ondansetron": {
        "definition": "A selective 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting.",
        "mechanism": "Blocks serotonin (5-HT3) receptors in the CNS and GI tract.",
        "indications": [
            "Chemotherapy-induced nausea and vomiting",
            "Postoperative nausea and vomiting"
        ],
        "dosage": {
            "adults": "4-8 mg orally or IV every 8 hours as needed.",
            "children": "0.15 mg/kg IV every 8 hours."
        },
        "side effects": [
            "Headache",
            "Constipation",
            "QT prolongation",
            "Dizziness"
        ],
        "contraindications": [
            "Hypersensitivity to ondansetron"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "QT-prolonging drugs",
            "Apomorphine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gabapentin enacarbil": {
        "definition": "A prodrug of gabapentin used to treat restless legs syndrome and postherpetic neuralgia.",
        "mechanism": "Converted to gabapentin, which binds to alpha-2-delta subunit of voltage-gated calcium channels.",
        "indications": [
            "Restless legs syndrome",
            "Postherpetic neuralgia"
        ],
        "dosage": {
            "adults": "600 mg orally once or twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Dizziness",
            "Somnolence",
            "Peripheral edema",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to gabapentin enacarbil or gabapentin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment required."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "baclofen": {
        "definition": "A muscle relaxant used to treat spasticity from multiple sclerosis and spinal cord injuries.",
        "mechanism": "Activates GABA-B receptors, inhibiting synaptic transmission in the spinal cord.",
        "indications": [
            "Spasticity due to multiple sclerosis or spinal cord injury"
        ],
        "dosage": {
            "adults": "5-20 mg orally three times daily.",
            "children": "5-20 mg orally three times daily (age 2+)."
        },
        "side effects": [
            "Drowsiness",
            "Weakness",
            "Hypotonia",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to baclofen"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlordiazepoxide": {
        "definition": "A benzodiazepine used to treat anxiety, alcohol withdrawal, and preoperative sedation.",
        "mechanism": "Enhances the effect of GABA at the GABA-A receptor, producing CNS depression.",
        "indications": [
            "Anxiety",
            "Alcohol withdrawal",
            "Preoperative sedation"
        ],
        "dosage": {
            "adults": "5-25 mg orally 3-4 times daily.",
            "children": "5-10 mg orally 2-4 times daily."
        },
        "side effects": [
            "Drowsiness",
            "Confusion",
            "Ataxia",
            "Dependence"
        ],
        "contraindications": [
            "Severe respiratory insufficiency",
            "Sleep apnea syndrome",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxazepam": {
        "definition": "A benzodiazepine used to treat anxiety and alcohol withdrawal.",
        "mechanism": "Enhances the effect of GABA at the GABA-A receptor, producing CNS depression.",
        "indications": [
            "Anxiety",
            "Alcohol withdrawal"
        ],
        "dosage": {
            "adults": "10-30 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Fatigue",
            "Ataxia",
            "Dependence"
        ],
        "contraindications": [
            "Severe respiratory insufficiency",
            "Sleep apnea syndrome",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clorazepate": {
        "definition": "A benzodiazepine used to treat anxiety, alcohol withdrawal, and as adjunct in seizure disorders.",
        "mechanism": "Enhances the effect of GABA at the GABA-A receptor, producing CNS depression.",
        "indications": [
            "Anxiety",
            "Alcohol withdrawal",
            "Adjunct in seizure disorders"
        ],
        "dosage": {
            "adults": "15-60 mg orally daily in divided doses.",
            "children": "0.5-1 mg/kg/day in divided doses (seizures, age ≥9 years)."
        },
        "side effects": [
            "Drowsiness",
            "Confusion",
            "Ataxia",
            "Dependence"
        ],
        "contraindications": [
            "Severe respiratory insufficiency",
            "Sleep apnea syndrome",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "propylthiouracil": {
        "definition": "An antithyroid agent used to treat hyperthyroidism and Graves' disease.",
        "mechanism": "Inhibits thyroid hormone synthesis and peripheral conversion of T4 to T3.",
        "indications": [
            "Hyperthyroidism",
            "Graves' disease",
            "Thyroid storm"
        ],
        "dosage": {
            "adults": "100-150 mg orally every 8 hours.",
            "children": "5-7 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Agranulocytosis",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to propylthiouracil"
        ],
        "special populations": {
            "pregnancy": "Preferred in first trimester.",
            "hepatic impairment": "Monitor closely."
        },
        "interactions": [
            "Anticoagulants",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxandrolone": {
        "definition": "An anabolic steroid used to promote weight gain after weight loss and to offset protein catabolism.",
        "mechanism": "Promotes protein synthesis and muscle growth.",
        "indications": [
            "Weight gain after weight loss",
            "Offset protein catabolism",
            "Turner syndrome (off-label)"
        ],
        "dosage": {
            "adults": "2.5-20 mg orally daily in divided doses.",
            "children": "0.1 mg/kg every 12 hours."
        },
        "side effects": [
            "Liver toxicity",
            "Hyperlipidemia",
            "Virilization",
            "Edema"
        ],
        "contraindications": [
            "Prostate or breast cancer",
            "Pregnancy",
            "Nephrosis"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Monitor for premature epiphyseal closure."
        },
        "interactions": [
            "Anticoagulants",
            "Oral hypoglycemics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxyquinoline": {
        "definition": "A topical antiseptic and antifungal agent (also known as clioquinol).",
        "mechanism": "Chelates metal ions and disrupts microbial enzyme systems.",
        "indications": [
            "Dermatological infections",
            "Fungal skin infections"
        ],
        "dosage": {
            "adults": "Apply to affected area 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Discoloration",
            "Neurotoxicity (rare, with oral use)"
        ],
        "contraindications": [
            "Hypersensitivity to hydroxyquinoline"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for topical use."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ammonium chloride": {
        "definition": "An expectorant and systemic acidifying agent.",
        "mechanism": "Increases acidity of body fluids and stimulates respiratory tract secretions.",
        "indications": [
            "Metabolic alkalosis",
            "Expectorant in cough preparations"
        ],
        "dosage": {
            "adults": "1-2 g orally 3-4 times daily (alkalosis); as directed in cough syrups.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Metabolic acidosis",
            "GI upset",
            "Irritation"
        ],
        "contraindications": [
            "Severe hepatic or renal impairment",
            "Acidosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Urinary alkalinizers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "salmeterol": {
        "definition": "A long-acting beta-2 agonist bronchodilator used for asthma and COPD maintenance therapy.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchial smooth muscle relaxation.",
        "indications": [
            "Asthma (maintenance)",
            "COPD (maintenance)"
        ],
        "dosage": {
            "adults": "1 inhalation (50 mcg) twice daily.",
            "children": "Same as adults (age 4+)."
        },
        "side effects": [
            "Tremor",
            "Headache",
            "Tachycardia",
            "Paradoxical bronchospasm"
        ],
        "contraindications": [
            "Acute asthma attacks",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not for acute relief."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ketotifen": {
        "definition": "An antihistamine and mast cell stabilizer used for allergic conjunctivitis and asthma prophylaxis (non-U.S.).",
        "mechanism": "Blocks histamine H1 receptors and stabilizes mast cells.",
        "indications": [
            "Allergic conjunctivitis",
            "Asthma prophylaxis (non-U.S.)"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1 drop in affected eye(s) twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Headache",
            "Dry eyes"
        ],
        "contraindications": [
            "Hypersensitivity to ketotifen"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for allergic conjunctivitis."
        },
        "interactions": [
            "Other antihistamines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azelastine": {
        "definition": "A second-generation antihistamine used for allergic rhinitis and allergic conjunctivitis.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "Nasal: 1-2 sprays per nostril twice daily; Ophthalmic: 1 drop in each eye twice daily.",
            "children": "Same as adults (age 6+ for nasal, age 3+ for ophthalmic)."
        },
        "side effects": [
            "Bitter taste",
            "Drowsiness",
            "Nasal irritation"
        ],
        "contraindications": [
            "Hypersensitivity to azelastine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergic rhinitis/conjunctivitis."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cromolyn": {
        "definition": "A mast cell stabilizer used for asthma prophylaxis and allergic conditions.",
        "mechanism": "Prevents mast cell degranulation, inhibiting the release of histamine and other mediators.",
        "indications": [
            "Asthma prophylaxis",
            "Allergic rhinitis",
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "Inhaled: 20 mg 4 times daily; Nasal: 1 spray per nostril 3-4 times daily; Ophthalmic: 1-2 drops in each eye 4-6 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Cough",
            "Throat irritation",
            "Nasal irritation"
        ],
        "contraindications": [
            "Hypersensitivity to cromolyn"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Indicated for pediatric asthma/allergies."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epinastine": {
        "definition": "A second-generation antihistamine and mast cell stabilizer for allergic conjunctivitis.",
        "mechanism": "Blocks histamine H1 receptors and stabilizes mast cells.",
        "indications": [
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1 drop in each eye twice daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Eye irritation",
            "Burning",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to epinastine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergic conjunctivitis."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nedocromil": {
        "definition": "A mast cell stabilizer used for allergic conjunctivitis and formerly for asthma prophylaxis.",
        "mechanism": "Prevents mast cell degranulation, inhibiting the release of histamine and other mediators.",
        "indications": [
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1-2 drops in each eye twice daily.",
            "children": "Same as adults (age 3+)."
        },
        "side effects": [
            "Eye irritation",
            "Burning",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to nedocromil"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergic conjunctivitis."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bepotastine": {
        "definition": "A second-generation antihistamine used for allergic conjunctivitis.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1 drop in each eye twice daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Eye irritation",
            "Taste disturbance",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to bepotastine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergic conjunctivitis."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cetirizine": {
        "definition": "A second-generation antihistamine used to treat allergic rhinitis and urticaria.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily.",
            "children": "2.5-10 mg orally once daily (age 2+)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to cetirizine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Indicated for pediatric allergies."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alcaftadine": {
        "definition": "A second-generation antihistamine used for allergic conjunctivitis.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1 drop in each eye once daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Eye irritation",
            "Burning",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to alcaftadine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergic conjunctivitis."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carbinoxamine": {
        "definition": "A first-generation antihistamine used to treat allergic conditions and as a sedative.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria",
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "4-8 mg orally every 8-12 hours.",
            "children": "0.2 mg/kg/day in divided doses (age 2+)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Dizziness"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "MAO inhibitor use",
            "Newborns or premature infants"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergies (age 2+)."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxylamine": {
        "definition": "A first-generation antihistamine used as a short-term sleep aid and for allergy symptoms.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Insomnia (short-term)",
            "Allergic rhinitis",
            "Nausea and vomiting in pregnancy (with pyridoxine)"
        ],
        "dosage": {
            "adults": "25 mg orally 30 minutes before bedtime.",
            "children": "Not recommended for children <12 years."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Confusion"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "MAO inhibitor use",
            "Newborns or premature infants"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe for NVP.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clobetasol": {
        "definition": "A super-high potency topical corticosteroid used for inflammatory and pruritic skin disorders.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Psoriasis",
            "Eczema",
            "Lichen planus",
            "Other inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area twice daily for up to 2 weeks.",
            "children": "Use with caution; not recommended for children <12 years."
        },
        "side effects": [
            "Skin atrophy",
            "Striae",
            "Telangiectasia",
            "Systemic absorption (rare)"
        ],
        "contraindications": [
            "Viral, fungal, or tubercular skin infections",
            "Hypersensitivity to clobetasol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Use with caution and for short duration."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "betamethasone": {
        "definition": "A potent glucocorticoid used to treat inflammation, allergies, and certain skin conditions.",
        "mechanism": "Suppresses inflammation and immune responses by modulating gene expression.",
        "indications": [
            "Allergic disorders",
            "Inflammatory skin conditions",
            "Antenatal fetal lung maturity"
        ],
        "dosage": {
            "adults": "Topical: apply as directed; IM: 12 mg for 2 doses 24 hours apart (antenatal).",
            "children": "Dose by indication and weight."
        },
        "side effects": [
            "Skin thinning (topical)",
            "Hyperglycemia",
            "Weight gain",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Antenatal use for fetal lung maturity.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "NSAIDs",
            "Warfarin",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluocinonide": {
        "definition": "A high-potency topical corticosteroid used for inflammatory and pruritic skin disorders.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Psoriasis",
            "Eczema",
            "Other inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 2-4 times daily.",
            "children": "Use with caution; not recommended for children <12 years."
        },
        "side effects": [
            "Skin atrophy",
            "Striae",
            "Telangiectasia",
            "Systemic absorption (rare)"
        ],
        "contraindications": [
            "Viral, fungal, or tubercular skin infections",
            "Hypersensitivity to fluocinonide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Use with caution and for short duration."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tacrolimus": {
        "definition": "A calcineurin inhibitor immunosuppressant used for organ transplantation and as a topical agent for eczema.",
        "mechanism": "Inhibits calcineurin, reducing T-cell activation and cytokine production.",
        "indications": [
            "Organ transplantation (systemic)",
            "Atopic dermatitis (topical)"
        ],
        "dosage": {
            "adults": "Oral: 0.1-0.2 mg/kg/day in 2 divided doses; Topical: apply thin layer twice daily.",
            "children": "Topical: 0.03% ointment for age 2+."
        },
        "side effects": [
            "Nephrotoxicity",
            "Neurotoxicity",
            "Hypertension",
            "Skin burning (topical)"
        ],
        "contraindications": [
            "Hypersensitivity to tacrolimus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mometasone": {
        "definition": "A medium- to high-potency corticosteroid used for allergic rhinitis, asthma, and skin inflammation.",
        "mechanism": "Suppresses inflammation and immune responses.",
        "indications": [
            "Allergic rhinitis",
            "Asthma",
            "Inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Nasal: 2 sprays per nostril once daily; Inhaled: 220 mcg once daily; Topical: apply thin layer once daily.",
            "children": "Dosing varies by indication and age."
        },
        "side effects": [
            "Nasal irritation",
            "Oral candidiasis (inhaled)",
            "Skin atrophy (topical)"
        ],
        "contraindications": [
            "Hypersensitivity to mometasone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "Other corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desonide": {
        "definition": "A low-potency topical corticosteroid used for mild inflammatory skin conditions.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Mild inflammatory skin conditions",
            "Eczema",
            "Dermatitis"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 2-4 times daily.",
            "children": "Safe for use in children ≥3 months."
        },
        "side effects": [
            "Skin irritation",
            "Atrophy (rare)",
            "Contact dermatitis"
        ],
        "contraindications": [
            "Hypersensitivity to desonide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for mild pediatric eczema."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluocinolone": {
        "definition": "A low- to medium-potency topical corticosteroid used for inflammatory and pruritic skin disorders.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Eczema",
            "Psoriasis",
            "Other inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 2-4 times daily.",
            "children": "Use with caution; safe for pediatric eczema."
        },
        "side effects": [
            "Skin irritation",
            "Atrophy (rare)",
            "Contact dermatitis"
        ],
        "contraindications": [
            "Hypersensitivity to fluocinolone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for mild pediatric eczema."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desoximetasone": {
        "definition": "A high-potency topical corticosteroid used for inflammatory and pruritic skin disorders.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Psoriasis",
            "Eczema",
            "Other inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area twice daily.",
            "children": "Use with caution; not recommended for children <12 years."
        },
        "side effects": [
            "Skin atrophy",
            "Striae",
            "Telangiectasia",
            "Systemic absorption (rare)"
        ],
        "contraindications": [
            "Viral, fungal, or tubercular skin infections",
            "Hypersensitivity to desoximetasone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Use with caution and for short duration."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluticasone": {
        "definition": "A corticosteroid used for asthma, allergic rhinitis, and skin inflammation.",
        "mechanism": "Suppresses inflammation and immune responses.",
        "indications": [
            "Asthma",
            "Allergic rhinitis",
            "Inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Inhaled: 100-500 mcg twice daily; Nasal: 1-2 sprays per nostril once daily; Topical: apply thin layer once or twice daily.",
            "children": "Dosing varies by indication and age."
        },
        "side effects": [
            "Oral candidiasis (inhaled)",
            "Nasal irritation",
            "Skin atrophy (topical)"
        ],
        "contraindications": [
            "Hypersensitivity to fluticasone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "Other corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diphenhydramine": {
        "definition": "A first-generation antihistamine used for allergy symptoms, insomnia, and motion sickness.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria",
            "Insomnia",
            "Motion sickness"
        ],
        "dosage": {
            "adults": "25-50 mg orally every 4-6 hours as needed.",
            "children": "1 mg/kg/dose every 6 hours (age 2+)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Confusion",
            "Urinary retention"
        ],
        "contraindications": [
            "Neonates",
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "loratadine": {
        "definition": "A second-generation antihistamine used to treat allergy symptoms.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria"
        ],
        "dosage": {
            "adults": "10 mg orally once daily.",
            "children": "5-10 mg orally once daily (age 2+)."
        },
        "side effects": [
            "Headache",
            "Drowsiness (rare)",
            "Dry mouth"
        ],
        "contraindications": [
            "Hypersensitivity to loratadine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Indicated for pediatric allergies."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorpheniramine": {
        "definition": "A first-generation antihistamine used for allergy symptoms and cold relief.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria",
            "Common cold symptoms"
        ],
        "dosage": {
            "adults": "4 mg orally every 4-6 hours (max 24 mg/day).",
            "children": "2 mg every 4-6 hours (age 6-12)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Confusion"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "promethazine": {
        "definition": "A first-generation antihistamine with antiemetic and sedative properties.",
        "mechanism": "Blocks histamine H1 receptors and dopamine receptors.",
        "indications": [
            "Allergic conditions",
            "Nausea and vomiting",
            "Motion sickness",
            "Sedation"
        ],
        "dosage": {
            "adults": "12.5-25 mg orally or IM every 4-6 hours as needed.",
            "children": "0.1 mg/kg/dose every 6 hours (age 2+)."
        },
        "side effects": [
            "Sedation",
            "Confusion",
            "Extrapyramidal symptoms",
            "Respiratory depression (young children)"
        ],
        "contraindications": [
            "Children <2 years",
            "Comatose states",
            "Severe respiratory depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Avoid in <2 years due to respiratory depression risk."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyproheptadine": {
        "definition": "A first-generation antihistamine with antiserotonergic and appetite-stimulating properties.",
        "mechanism": "Blocks histamine H1 and serotonin receptors.",
        "indications": [
            "Allergic rhinitis",
            "Appetite stimulation",
            "Migraine prophylaxis"
        ],
        "dosage": {
            "adults": "4 mg orally 3 times daily.",
            "children": "2 mg 2-3 times daily (age 2+)."
        },
        "side effects": [
            "Drowsiness",
            "Increased appetite",
            "Dry mouth"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma",
            "Newborns"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergies (age 2+)."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "montelukast": {
        "definition": "A leukotriene receptor antagonist used for asthma maintenance and allergic rhinitis.",
        "mechanism": "Blocks leukotriene D4 receptors in the airways.",
        "indications": [
            "Asthma maintenance",
            "Allergic rhinitis",
            "Exercise-induced bronchospasm"
        ],
        "dosage": {
            "adults": "10 mg orally once daily in the evening.",
            "children": "4-5 mg once daily (age 2-14)."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Neuropsychiatric events"
        ],
        "contraindications": [
            "Hypersensitivity to montelukast"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric asthma/allergies."
        },
        "interactions": [
            "Phenobarbital",
            "Rifampin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fexofenadine": {
        "definition": "A second-generation antihistamine used to treat allergy symptoms.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria"
        ],
        "dosage": {
            "adults": "60 mg orally twice daily or 180 mg once daily.",
            "children": "30-60 mg twice daily (age 2+)."
        },
        "side effects": [
            "Headache",
            "Drowsiness (rare)",
            "Dry mouth"
        ],
        "contraindications": [
            "Hypersensitivity to fexofenadine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "children": "Indicated for pediatric allergies."
        },
        "interactions": [
            "Antacids",
            "Fruit juices (reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levocetirizine": {
        "definition": "A second-generation antihistamine used to treat allergy symptoms.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria"
        ],
        "dosage": {
            "adults": "5 mg orally once daily.",
            "children": "1.25-5 mg once daily (age 6+)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to levocetirizine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric allergies."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxyzine": {
        "definition": "A first-generation antihistamine used for anxiety, pruritus, and as a sedative.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Anxiety",
            "Pruritus",
            "Sedation"
        ],
        "dosage": {
            "adults": "25-100 mg orally 3-4 times daily.",
            "children": "0.5-1 mg/kg/dose every 6-8 hours."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "QT prolongation"
        ],
        "contraindications": [
            "Early pregnancy",
            "Prolonged QT interval"
        ],
        "special populations": {
            "pregnancy": "Avoid in early pregnancy.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "triprolidine": {
        "definition": "A first-generation antihistamine used for allergy symptoms and cold relief.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria",
            "Common cold symptoms"
        ],
        "dosage": {
            "adults": "2.5 mg orally every 4-6 hours (max 10 mg/day).",
            "children": "1.25 mg every 4-6 hours (age 6-12)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Confusion"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tetracaine": {
        "definition": "A local anesthetic used for topical anesthesia of the eye, skin, and mucous membranes.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Topical anesthesia (ophthalmic, dermal, mucosal)"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1-2 drops as needed; Topical: apply as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Burning",
            "Stinging",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to tetracaine or ester anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Safe for topical use."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "corticotropin": {
        "definition": "A polypeptide hormone used as a diagnostic agent and to treat certain inflammatory conditions.",
        "mechanism": "Stimulates the adrenal cortex to secrete cortisol, aldosterone, and androgens.",
        "indications": [
            "Diagnosis of adrenal insufficiency",
            "Infantile spasms",
            "Multiple sclerosis (acute exacerbations)"
        ],
        "dosage": {
            "adults": "80-120 units IM daily for 2-3 weeks (MS exacerbation).",
            "children": "Dose by indication and weight."
        },
        "side effects": [
            "Sodium retention",
            "Hypertension",
            "Infection",
            "Mood changes"
        ],
        "contraindications": [
            "Systemic fungal infections",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for infantile spasms."
        },
        "interactions": [
            "Live vaccines",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexbrompheniramine": {
        "definition": "A first-generation antihistamine used for allergy symptoms and cold relief.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria",
            "Common cold symptoms"
        ],
        "dosage": {
            "adults": "2 mg orally every 4-6 hours (max 12 mg/day).",
            "children": "1 mg every 4-6 hours (age 6-12)."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Confusion"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of confusion."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenylephrine": {
        "definition": "An alpha-1 adrenergic agonist used as a decongestant, vasopressor, and mydriatic.",
        "mechanism": "Stimulates alpha-1 adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Nasal congestion",
            "Hypotension",
            "Mydriasis (ophthalmic)"
        ],
        "dosage": {
            "adults": "10 mg orally every 4 hours (decongestant); IV: 0.1-0.5 mg as needed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hypertension",
            "Headache",
            "Reflex bradycardia"
        ],
        "contraindications": [
            "Severe hypertension",
            "Ventricular tachycardia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other sympathomimetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "minoxidil": {
        "definition": "A vasodilator used orally for severe hypertension and topically for androgenetic alopecia.",
        "mechanism": "Opens potassium channels in vascular smooth muscle, causing vasodilation.",
        "indications": [
            "Severe hypertension (oral)",
            "Androgenetic alopecia (topical)"
        ],
        "dosage": {
            "adults": "Oral: 2.5-80 mg daily in divided doses; Topical: apply 1 mL to scalp twice daily.",
            "children": "Oral: 0.2-1 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hypertrichosis",
            "Edema",
            "Tachycardia",
            "Dermatitis (topical)"
        ],
        "contraindications": [
            "Pheochromocytoma",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Oral use for severe hypertension only."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulfasalazine": {
        "definition": "A sulfonamide and salicylate derivative used to treat rheumatoid arthritis and inflammatory bowel disease.",
        "mechanism": "Inhibits prostaglandin synthesis and modulates immune response.",
        "indications": [
            "Rheumatoid arthritis",
            "Ulcerative colitis",
            "Crohn's disease"
        ],
        "dosage": {
            "adults": "500-1000 mg orally 2-4 times daily.",
            "children": "40-60 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Headache",
            "Reversible oligospermia"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Porphyria"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric IBD."
        },
        "interactions": [
            "Folic acid",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxyurea": {
        "definition": "An antimetabolite used to treat sickle cell disease, chronic myeloid leukemia, and other cancers.",
        "mechanism": "Inhibits ribonucleotide reductase, blocking DNA synthesis.",
        "indications": [
            "Sickle cell disease",
            "Chronic myeloid leukemia",
            "Polycythemia vera"
        ],
        "dosage": {
            "adults": "15-35 mg/kg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Myelosuppression",
            "GI upset",
            "Skin ulcers"
        ],
        "contraindications": [
            "Severe bone marrow suppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Indicated for pediatric sickle cell disease."
        },
        "interactions": [
            "Antiretrovirals",
            "Other myelosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deferasirox": {
        "definition": "An oral iron chelator used to treat chronic iron overload due to blood transfusions.",
        "mechanism": "Binds iron, allowing its excretion in the feces.",
        "indications": [
            "Chronic iron overload (transfusion-dependent anemias)"
        ],
        "dosage": {
            "adults": "20-40 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Renal impairment",
            "GI upset",
            "Hepatic toxicity"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal/hepatic impairment": "Contraindicated if severe."
        },
        "interactions": [
            "Aluminum-containing antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deferiprone": {
        "definition": "An oral iron chelator used to treat transfusional iron overload in thalassemia syndromes.",
        "mechanism": "Binds iron, allowing its excretion in the urine.",
        "indications": [
            "Transfusional iron overload (thalassemia syndromes)"
        ],
        "dosage": {
            "adults": "75 mg/kg/day in 3 divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Neutropenia",
            "Agranulocytosis",
            "GI upset"
        ],
        "contraindications": [
            "Severe neutropenia",
            "Hypersensitivity to deferiprone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric thalassemia."
        },
        "interactions": [
            "Other myelosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alpha 1-proteinase inhibitor": {
        "definition": "A plasma-derived protein used to treat alpha-1 antitrypsin deficiency.",
        "mechanism": "Inhibits neutrophil elastase, protecting lung tissue.",
        "indications": [
            "Alpha-1 antitrypsin deficiency (augmentation therapy)"
        ],
        "dosage": {
            "adults": "60 mg/kg IV once weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Headache",
            "Dizziness",
            "Fever",
            "Infusion reactions"
        ],
        "contraindications": [
            "Selective IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "losartan": {
        "definition": "An angiotensin II receptor blocker (ARB) used to treat hypertension, heart failure, and diabetic nephropathy.",
        "mechanism": "Blocks angiotensin II type 1 receptors, lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Diabetic nephropathy"
        ],
        "dosage": {
            "adults": "25-100 mg orally once daily.",
            "children": "0.7 mg/kg once daily (age 6+)."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity to losartan"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fosinopril": {
        "definition": "An ACE inhibitor used to treat hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "10-40 mg orally once daily.",
            "children": "0.1 mg/kg once daily (age 6+)."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema",
            "Hypotension"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "candesartan": {
        "definition": "An angiotensin II receptor blocker (ARB) used to treat hypertension and heart failure.",
        "mechanism": "Blocks angiotensin II type 1 receptors, lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "8-32 mg orally once daily.",
            "children": "4-16 mg once daily (age 1+; dose by weight)."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity to candesartan"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "quinapril": {
        "definition": "An ACE inhibitor used to treat hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "10-80 mg orally once or twice daily.",
            "children": "0.1-0.6 mg/kg once daily (age 6+)."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema",
            "Hypotension"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "riluzole": {
        "definition": "A glutamate antagonist used to slow disease progression in amyotrophic lateral sclerosis (ALS).",
        "mechanism": "Inhibits glutamate release, inactivates voltage-dependent sodium channels.",
        "indications": [
            "Amyotrophic lateral sclerosis (ALS)"
        ],
        "dosage": {
            "adults": "50 mg orally every 12 hours.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Weakness",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity to riluzole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "edaravone": {
        "definition": "A free radical scavenger used to slow functional decline in amyotrophic lateral sclerosis (ALS).",
        "mechanism": "Reduces oxidative stress by scavenging free radicals.",
        "indications": [
            "Amyotrophic lateral sclerosis (ALS)"
        ],
        "dosage": {
            "adults": "60 mg IV over 60 minutes daily for 14 days, then 14-day drug-free period (cycle repeats).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Contusion",
            "Gait disturbance",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to edaravone or sulfites"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trabectedin": {
        "definition": "An antineoplastic agent used to treat unresectable or metastatic liposarcoma or leiomyosarcoma.",
        "mechanism": "Binds to DNA minor groove, disrupting cell division.",
        "indications": [
            "Unresectable or metastatic liposarcoma/leiomyosarcoma"
        ],
        "dosage": {
            "adults": "1.5 mg/m² IV over 24 hours every 3 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Fatigue",
            "Myelosuppression",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated if severe."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olaratumab": {
        "definition": "A monoclonal antibody that targets PDGFR-alpha, previously used for soft tissue sarcoma.",
        "mechanism": "Blocks PDGFR-alpha, inhibiting tumor growth.",
        "indications": [
            "Soft tissue sarcoma (withdrawn from market in some regions)"
        ],
        "dosage": {
            "adults": "15 mg/kg IV on days 1 and 8 of a 21-day cycle.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Infusion reactions",
            "Neutropenia",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to olaratumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "donepezil": {
        "definition": "A cholinesterase inhibitor used to treat Alzheimer's disease.",
        "mechanism": "Inhibits acetylcholinesterase, increasing acetylcholine in the CNS.",
        "indications": [
            "Alzheimer's disease (mild, moderate, severe)"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily (max 23 mg/day for severe).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Diarrhea",
            "Insomnia",
            "Muscle cramps"
        ],
        "contraindications": [
            "Hypersensitivity to donepezil or piperidine derivatives"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticholinergics",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "memantine": {
        "definition": "An NMDA receptor antagonist used to treat moderate to severe Alzheimer's disease.",
        "mechanism": "Blocks NMDA glutamate receptors, reducing excitotoxicity.",
        "indications": [
            "Alzheimer's disease (moderate to severe)"
        ],
        "dosage": {
            "adults": "5-20 mg orally once daily or divided twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Dizziness",
            "Headache",
            "Constipation",
            "Confusion"
        ],
        "contraindications": [
            "Hypersensitivity to memantine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "NMDA antagonists",
            "Carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "galantamine": {
        "definition": "A cholinesterase inhibitor used to treat mild to moderate Alzheimer's disease.",
        "mechanism": "Inhibits acetylcholinesterase and modulates nicotinic receptors.",
        "indications": [
            "Alzheimer's disease (mild to moderate)"
        ],
        "dosage": {
            "adults": "16-24 mg orally once daily (extended-release) or divided twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Bradycardia",
            "Insomnia"
        ],
        "contraindications": [
            "Severe hepatic or renal impairment",
            "Hypersensitivity to galantamine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticholinergics",
            "CYP2D6/CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rivastigmine": {
        "definition": "A cholinesterase inhibitor used to treat mild to moderate Alzheimer's and Parkinson's dementia.",
        "mechanism": "Inhibits acetylcholinesterase and butyrylcholinesterase.",
        "indications": [
            "Alzheimer's disease",
            "Parkinson's disease dementia"
        ],
        "dosage": {
            "adults": "6-12 mg orally daily in divided doses or 4.6-13.3 mg/24h transdermal patch.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Weight loss",
            "Dizziness"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Hypersensitivity to rivastigmine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vitamin e": {
        "definition": "A fat-soluble vitamin with antioxidant properties.",
        "mechanism": "Protects cell membranes from oxidative damage.",
        "indications": [
            "Vitamin E deficiency",
            "Supportive therapy in various conditions"
        ],
        "dosage": {
            "adults": "15 mg (22.4 IU) orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "GI upset",
            "Fatigue",
            "Blurred vision (high doses)"
        ],
        "contraindications": [
            "Hypersensitivity to vitamin E"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Anticoagulants",
            "Cholestyramine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ergoloid mesylates": {
        "definition": "A mixture of ergot alkaloids used to treat cognitive impairment and dementia.",
        "mechanism": "Enhances cerebral metabolism and neurotransmitter activity.",
        "indications": [
            "Cognitive impairment",
            "Dementia (questionable efficacy)"
        ],
        "dosage": {
            "adults": "1 mg orally 3 times daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "GI upset",
            "Dizziness",
            "Flushing"
        ],
        "contraindications": [
            "Peripheral vascular disease",
            "Psychosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ergot alkaloids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tinidazole": {
        "definition": "A nitroimidazole antibiotic used to treat protozoal and anaerobic bacterial infections.",
        "mechanism": "Disrupts DNA synthesis in susceptible organisms.",
        "indications": [
            "Giardiasis",
            "Amebiasis",
            "Trichomoniasis",
            "Bacterial vaginosis"
        ],
        "dosage": {
            "adults": "2 g orally once daily for 1-3 days.",
            "children": "50 mg/kg once daily for 1-3 days."
        },
        "side effects": [
            "Metallic taste",
            "Nausea",
            "Headache"
        ],
        "contraindications": [
            "First trimester of pregnancy",
            "Hypersensitivity to tinidazole"
        ],
        "special populations": {
            "pregnancy": "Avoid in first trimester.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "Alcohol",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitazoxanide": {
        "definition": "An antiprotozoal and antiviral agent used to treat diarrhea caused by Giardia or Cryptosporidium.",
        "mechanism": "Interferes with anaerobic energy metabolism by inhibiting pyruvate:ferredoxin oxidoreductase.",
        "indications": [
            "Diarrhea caused by Giardia lamblia or Cryptosporidium parvum"
        ],
        "dosage": {
            "adults": "500 mg orally every 12 hours for 3 days.",
            "children": "100-200 mg every 12 hours for 3 days (age 1-11)."
        },
        "side effects": [
            "Nausea",
            "Abdominal pain",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to nitazoxanide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paromomycin": {
        "definition": "An aminoglycoside antibiotic used to treat intestinal amebiasis and tapeworm infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Intestinal amebiasis",
            "Tapeworm infections"
        ],
        "dosage": {
            "adults": "25-35 mg/kg/day orally in 3 divided doses for 5-10 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "GI upset",
            "Ototoxicity (rare)",
            "Nephrotoxicity (rare)"
        ],
        "contraindications": [
            "Intestinal obstruction",
            "Hypersensitivity to aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic or ototoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chloroquine": {
        "definition": "An antimalarial and anti-inflammatory agent used to treat malaria and autoimmune diseases.",
        "mechanism": "Inhibits heme polymerase in Plasmodium and modulates immune response.",
        "indications": [
            "Malaria",
            "Rheumatoid arthritis",
            "Lupus erythematosus"
        ],
        "dosage": {
            "adults": "1 g orally, then 500 mg at 6, 24, and 48 hours (malaria); 250-500 mg daily (RA/lupus).",
            "children": "10 mg/kg, then 5 mg/kg at 6, 24, and 48 hours."
        },
        "side effects": [
            "Retinopathy",
            "GI upset",
            "Pruritus"
        ],
        "contraindications": [
            "Retinal or visual field changes",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "CYP2D6 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "progesterone": {
        "definition": "A natural progestin hormone used in hormone replacement, contraception, and infertility.",
        "mechanism": "Binds to progesterone receptors, regulating gene expression.",
        "indications": [
            "Hormone replacement therapy",
            "Luteal support in infertility",
            "Amenorrhea"
        ],
        "dosage": {
            "adults": "100-200 mg orally or vaginally daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Bloating",
            "Mood changes"
        ],
        "contraindications": [
            "Active thromboembolic disorder",
            "Liver dysfunction"
        ],
        "special populations": {
            "pregnancy": "Indicated for luteal support.",
            "breastfeeding": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tafamidis": {
        "definition": "A transthyretin stabilizer used to treat transthyretin-mediated amyloidosis.",
        "mechanism": "Stabilizes transthyretin tetramer, preventing amyloid fibril formation.",
        "indications": [
            "Transthyretin-mediated amyloidosis (ATTR cardiomyopathy)"
        ],
        "dosage": {
            "adults": "61 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Urinary tract infection",
            "Muscle spasms",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity to tafamidis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "inotersen": {
        "definition": "An antisense oligonucleotide used to treat hereditary transthyretin-mediated amyloidosis.",
        "mechanism": "Inhibits hepatic production of transthyretin protein.",
        "indications": [
            "Hereditary transthyretin-mediated amyloidosis (hATTR)"
        ],
        "dosage": {
            "adults": "284 mg SC once weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Thrombocytopenia",
            "Glomerulonephritis",
            "Injection site reactions"
        ],
        "contraindications": [
            "Low platelet count",
            "Hypersensitivity to inotersen"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antiplatelet agents",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "patisiran": {
        "definition": "A small interfering RNA (siRNA) used to treat hereditary transthyretin-mediated amyloidosis.",
        "mechanism": "Silences transthyretin mRNA, reducing protein production.",
        "indications": [
            "Hereditary transthyretin-mediated amyloidosis (hATTR)"
        ],
        "dosage": {
            "adults": "0.3 mg/kg IV every 3 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Infusion reactions",
            "Peripheral edema",
            "Muscle spasms"
        ],
        "contraindications": [
            "Hypersensitivity to patisiran"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "colchicine": {
        "definition": "An anti-inflammatory agent used to treat and prevent gout flares and familial Mediterranean fever.",
        "mechanism": "Inhibits microtubule polymerization, reducing neutrophil activity.",
        "indications": [
            "Gout flares",
            "Familial Mediterranean fever"
        ],
        "dosage": {
            "adults": "1.2 mg orally at first sign of flare, then 0.6 mg 1 hour later (max 1.8 mg per flare).",
            "children": "0.3-1.8 mg/day in divided doses (FMF)."
        },
        "side effects": [
            "GI upset",
            "Myopathy",
            "Bone marrow suppression"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment",
            "Concomitant CYP3A4 inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "P-gp inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "piperacillin": {
        "definition": "An extended-spectrum penicillin antibiotic used to treat serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Serious Gram-negative and Gram-positive infections",
            "Pseudomonas infections"
        ],
        "dosage": {
            "adults": "3-4 g IV every 6-8 hours.",
            "children": "80-100 mg/kg IV every 6-8 hours."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Aminoglycosides",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tazobactam": {
        "definition": "A beta-lactamase inhibitor used in combination with piperacillin.",
        "mechanism": "Inhibits bacterial beta-lactamases, extending the spectrum of piperacillin.",
        "indications": [
            "Used in combination with piperacillin for serious infections"
        ],
        "dosage": {
            "adults": "Piperacillin/tazobactam: 3.375-4.5 g IV every 6-8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Hypersensitivity to beta-lactams"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Aminoglycosides",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulbactam": {
        "definition": "A beta-lactamase inhibitor used in combination with ampicillin and other beta-lactam antibiotics.",
        "mechanism": "Inhibits bacterial beta-lactamases, extending the spectrum of beta-lactam antibiotics.",
        "indications": [
            "Used in combination with ampicillin or other beta-lactams for serious infections"
        ],
        "dosage": {
            "adults": "Ampicillin/sulbactam: 1.5-3 g IV every 6 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Hypersensitivity to beta-lactams"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Aminoglycosides",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefoxitin": {
        "definition": "A second-generation cephalosporin antibiotic used to treat a variety of bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Intra-abdominal infections",
            "Gynecologic infections",
            "Prophylaxis in surgery"
        ],
        "dosage": {
            "adults": "1-2 g IV every 6-8 hours.",
            "children": "80-160 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Aminoglycosides",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cilastatin": {
        "definition": "A renal dehydropeptidase inhibitor used in combination with imipenem to prevent its degradation.",
        "mechanism": "Inhibits renal dehydropeptidase I, preventing imipenem breakdown.",
        "indications": [
            "Used in combination with imipenem for serious infections"
        ],
        "dosage": {
            "adults": "Imipenem/cilastatin: 250-1000 mg IV every 6-8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to cilastatin or imipenem"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Ganciclovir"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "imipenem": {
        "definition": "A broad-spectrum carbapenem antibiotic used to treat serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Serious Gram-negative and Gram-positive infections",
            "Pseudomonas infections"
        ],
        "dosage": {
            "adults": "250-1000 mg IV every 6-8 hours (with cilastatin).",
            "children": "15-25 mg/kg IV every 6 hours."
        },
        "side effects": [
            "Nausea",
            "Seizures",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to carbapenems"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Ganciclovir"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mitomycin": {
        "definition": "An antineoplastic antibiotic used to treat various cancers and as an intravesical agent for bladder cancer.",
        "mechanism": "Alkylates DNA, causing cross-links and inhibiting DNA synthesis.",
        "indications": [
            "Bladder cancer (intravesical)",
            "Gastric cancer",
            "Pancreatic cancer"
        ],
        "dosage": {
            "adults": "10-20 mg/m² IV every 6-8 weeks; intravesical: 20-40 mg once weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Myelosuppression",
            "Hemolytic-uremic syndrome",
            "GI toxicity"
        ],
        "contraindications": [
            "Thrombocytopenia",
            "Coagulopathy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cisplatin": {
        "definition": "A platinum-based chemotherapy agent used to treat various cancers.",
        "mechanism": "Forms DNA cross-links, inhibiting DNA synthesis and function.",
        "indications": [
            "Testicular cancer",
            "Ovarian cancer",
            "Bladder cancer",
            "Lung cancer"
        ],
        "dosage": {
            "adults": "50-100 mg/m² IV every 3-4 weeks (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Nephrotoxicity",
            "Ototoxicity",
            "Nausea",
            "Myelosuppression"
        ],
        "contraindications": [
            "Preexisting renal impairment",
            "Hearing impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Loop diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lidocaine": {
        "definition": "A local anesthetic and class Ib antiarrhythmic agent.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction and cardiac depolarization.",
        "indications": [
            "Local anesthesia",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "Arrhythmia: 1-1.5 mg/kg IV bolus, then infusion; Local: apply as directed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "CNS toxicity",
            "Hypotension",
            "Bradycardia"
        ],
        "contraindications": [
            "Severe SA, AV, or intraventricular block (arrhythmia use)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zinc oxide": {
        "definition": "A topical skin protectant and mild astringent.",
        "mechanism": "Forms a protective barrier on the skin.",
        "indications": [
            "Diaper rash",
            "Minor skin irritations",
            "Sunscreen"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to zinc oxide"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzocaine": {
        "definition": "A local anesthetic used topically for pain relief.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Oral pain",
            "Minor skin irritations",
            "Hemorrhoids"
        ],
        "dosage": {
            "adults": "Apply to affected area up to 4 times daily.",
            "children": "Use with caution; avoid in children <2 years."
        },
        "side effects": [
            "Methemoglobinemia",
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to benzocaine",
            "Children <2 years (risk of methemoglobinemia)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "temozolomide": {
        "definition": "An oral alkylating agent used to treat glioblastoma multiforme and anaplastic astrocytoma.",
        "mechanism": "Alkylates/methylates DNA, inhibiting replication.",
        "indications": [
            "Glioblastoma multiforme",
            "Anaplastic astrocytoma"
        ],
        "dosage": {
            "adults": "150-200 mg/m² orally once daily for 5 days every 28 days.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to temozolomide or dacarbazine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "procarbazine": {
        "definition": "An oral alkylating agent used to treat Hodgkin lymphoma and brain tumors.",
        "mechanism": "Inhibits DNA, RNA, and protein synthesis.",
        "indications": [
            "Hodgkin lymphoma",
            "Brain tumors"
        ],
        "dosage": {
            "adults": "100 mg/m² orally daily for 14 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Neurotoxicity"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lomustine": {
        "definition": "An oral alkylating agent used to treat brain tumors and Hodgkin lymphoma.",
        "mechanism": "Alkylates DNA and RNA, inhibiting synthesis.",
        "indications": [
            "Brain tumors",
            "Hodgkin lymphoma"
        ],
        "dosage": {
            "adults": "130 mg/m² orally every 6 weeks (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Pulmonary fibrosis"
        ],
        "contraindications": [
            "Hypersensitivity to lomustine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thyroid desiccated": {
        "definition": "A natural thyroid hormone product containing T3 and T4, used to treat hypothyroidism.",
        "mechanism": "Replaces deficient thyroid hormones.",
        "indications": [
            "Hypothyroidism"
        ],
        "dosage": {
            "adults": "30-120 mg orally once daily.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "Hyperthyroidism",
            "Arrhythmias",
            "Weight loss"
        ],
        "contraindications": [
            "Untreated thyrotoxicosis",
            "Acute MI"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe.",
            "elderly": "Start at lower doses."
        },
        "interactions": [
            "Antacids",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium iodide-i-131": {
        "definition": "A radioactive iodine isotope used to treat hyperthyroidism and thyroid cancer.",
        "mechanism": "Concentrates in thyroid tissue, emitting beta and gamma radiation to destroy cells.",
        "indications": [
            "Hyperthyroidism",
            "Thyroid cancer (ablation)"
        ],
        "dosage": {
            "adults": "Dose individualized by indication and uptake studies.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hypothyroidism",
            "Radiation thyroiditis",
            "Sialadenitis"
        ],
        "contraindications": [
            "Pregnancy",
            "Lactation"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Use with caution."
        },
        "interactions": [
            "Thyroid medications",
            "Iodine-containing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thyrotropin alpha": {
        "definition": "A recombinant human thyroid-stimulating hormone (TSH) used in diagnostic testing and thyroid cancer management.",
        "mechanism": "Stimulates thyroid tissue to uptake radioactive iodine.",
        "indications": [
            "Adjunct in thyroid cancer diagnostics and therapy"
        ],
        "dosage": {
            "adults": "0.9 mg IM once daily for 2 days.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to thyrotropin alpha"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vandetanib": {
        "definition": "A tyrosine kinase inhibitor used to treat medullary thyroid cancer.",
        "mechanism": "Inhibits VEGFR, EGFR, and RET tyrosine kinases.",
        "indications": [
            "Medullary thyroid cancer (advanced or metastatic)"
        ],
        "dosage": {
            "adults": "300 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "QT prolongation",
            "Diarrhea",
            "Rash",
            "Hypertension"
        ],
        "contraindications": [
            "QT prolongation",
            "Hypersensitivity to vandetanib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dabrafenib": {
        "definition": "A BRAF kinase inhibitor used to treat BRAF V600E mutation-positive cancers.",
        "mechanism": "Inhibits mutant BRAF kinase, blocking MAPK pathway activation.",
        "indications": [
            "Melanoma (BRAF V600E mutation)",
            "Non-small cell lung cancer (BRAF V600E mutation)",
            "Anaplastic thyroid cancer (BRAF V600E mutation)"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Fever",
            "Hyperglycemia",
            "Cutaneous squamous cell carcinoma"
        ],
        "contraindications": [
            "Hypersensitivity to dabrafenib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 and CYP2C8 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trametinib": {
        "definition": "A MEK inhibitor used to treat BRAF V600 mutation-positive cancers.",
        "mechanism": "Inhibits MEK1 and MEK2, blocking MAPK pathway activation.",
        "indications": [
            "Melanoma (BRAF V600 mutation)",
            "Non-small cell lung cancer (BRAF V600 mutation)",
            "Anaplastic thyroid cancer (BRAF V600 mutation)"
        ],
        "dosage": {
            "adults": "2 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Hypertension",
            "Cardiomyopathy"
        ],
        "contraindications": [
            "Hypersensitivity to trametinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mebendazole": {
        "definition": "A broad-spectrum antihelminthic agent used to treat intestinal worm infections.",
        "mechanism": "Inhibits microtubule synthesis in helminths.",
        "indications": [
            "Ascariasis",
            "Enterobiasis (pinworm)",
            "Trichuriasis",
            "Hookworm"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily for 3 days or 500 mg single dose (depending on infection).",
            "children": "Same as adults."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Alopecia (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to mebendazole"
        ],
        "special populations": {
            "pregnancy": "Avoid in first trimester.",
            "children": "Indicated for pediatric helminthiasis."
        },
        "interactions": [
            "Metronidazole"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "albendazole": {
        "definition": "A broad-spectrum antihelminthic agent used to treat various worm infections.",
        "mechanism": "Inhibits microtubule synthesis in helminths.",
        "indications": [
            "Neurocysticercosis",
            "Hydatid disease",
            "Ascariasis",
            "Enterobiasis",
            "Hookworm"
        ],
        "dosage": {
            "adults": "400 mg orally once or twice daily (duration depends on infection).",
            "children": "Same as adults."
        },
        "side effects": [
            "GI upset",
            "Liver enzyme elevation",
            "Alopecia (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to albendazole",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Indicated for pediatric helminthiasis."
        },
        "interactions": [
            "Dexamethasone",
            "Cimetidine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrantel": {
        "definition": "An antihelminthic agent used to treat intestinal worm infections.",
        "mechanism": "Depolarizes neuromuscular junctions in helminths, causing paralysis.",
        "indications": [
            "Ascariasis",
            "Enterobiasis (pinworm)",
            "Hookworm"
        ],
        "dosage": {
            "adults": "11 mg/kg orally as a single dose (max 1 g).",
            "children": "Same as adults."
        },
        "side effects": [
            "GI upset",
            "Headache",
            "Dizziness"
        ],
        "contraindications": [
            "Hypersensitivity to pyrantel"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Indicated for pediatric helminthiasis."
        },
        "interactions": [
            "Piperazine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "finasteride": {
        "definition": "A 5-alpha-reductase inhibitor used to treat benign prostatic hyperplasia and male pattern baldness.",
        "mechanism": "Inhibits conversion of testosterone to dihydrotestosterone (DHT).",
        "indications": [
            "Benign prostatic hyperplasia",
            "Male pattern baldness"
        ],
        "dosage": {
            "adults": "BPH: 5 mg orally once daily; Alopecia: 1 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Decreased libido",
            "Erectile dysfunction",
            "Gynecomastia"
        ],
        "contraindications": [
            "Pregnancy",
            "Women and children"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (teratogenic)."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ketoconazole": {
        "definition": "An imidazole antifungal agent used topically and orally for fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Fungal infections (topical, oral)",
            "Cushing's syndrome (off-label)"
        ],
        "dosage": {
            "adults": "Topical: apply once or twice daily; Oral: 200-400 mg once daily (serious infections only).",
            "children": "Topical: same as adults; Oral: dose by weight."
        },
        "side effects": [
            "Hepatotoxicity",
            "GI upset",
            "Adrenal insufficiency"
        ],
        "contraindications": [
            "Liver disease",
            "Concurrent use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors",
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epoetin alfa": {
        "definition": "A recombinant erythropoietin used to treat anemia due to chronic kidney disease, chemotherapy, or HIV.",
        "mechanism": "Stimulates erythropoiesis by acting on erythroid progenitor cells.",
        "indications": [
            "Anemia of chronic kidney disease",
            "Anemia due to chemotherapy or HIV"
        ],
        "dosage": {
            "adults": "50-100 units/kg IV or SC 3 times weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypertension",
            "Thromboembolism",
            "Pure red cell aplasia"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Pure red cell aplasia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cyclosporine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "multivitamin with iron": {
        "definition": "A combination supplement providing essential vitamins and iron for deficiency states.",
        "mechanism": "Replenishes essential vitamins and iron for hematopoiesis and metabolism.",
        "indications": [
            "Vitamin and iron deficiency",
            "Pregnancy supplementation"
        ],
        "dosage": {
            "adults": "1 tablet/capsule orally daily.",
            "children": "Pediatric formulations available."
        },
        "side effects": [
            "GI upset",
            "Constipation",
            "Dark stools"
        ],
        "contraindications": [
            "Hemochromatosis",
            "Iron overload"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Antacids",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyridoxine": {
        "definition": "Vitamin B6, used for deficiency, isoniazid-induced neuropathy, and as adjunct in some metabolic disorders.",
        "mechanism": "Cofactor in amino acid, glucose, and lipid metabolism.",
        "indications": [
            "Vitamin B6 deficiency",
            "Isoniazid-induced neuropathy",
            "Metabolic disorders"
        ],
        "dosage": {
            "adults": "10-50 mg orally once daily (deficiency); 25-100 mg once daily (neuropathy).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Peripheral neuropathy (high doses)",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to pyridoxine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Levodopa (without carbidopa)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxymetholone": {
        "definition": "An anabolic steroid used to treat anemia and promote weight gain.",
        "mechanism": "Stimulates erythropoiesis and protein synthesis.",
        "indications": [
            "Anemia",
            "Weight gain in chronic illness"
        ],
        "dosage": {
            "adults": "1-5 mg/kg orally daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Liver toxicity",
            "Edema",
            "Virilization",
            "Hyperlipidemia"
        ],
        "contraindications": [
            "Prostate or breast cancer",
            "Severe hepatic or renal impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Monitor for premature epiphyseal closure."
        },
        "interactions": [
            "Anticoagulants",
            "Oral hypoglycemics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lenalidomide": {
        "definition": "An immunomodulatory agent used to treat multiple myeloma, myelodysplastic syndromes, and lymphoma.",
        "mechanism": "Inhibits angiogenesis and modulates immune response.",
        "indications": [
            "Multiple myeloma",
            "Myelodysplastic syndromes",
            "Lymphoma"
        ],
        "dosage": {
            "adults": "5-25 mg orally once daily (cycle-specific).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Neutropenia",
            "Thrombocytopenia",
            "DVT",
            "Rash"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity to lenalidomide"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (REMS program)."
        },
        "interactions": [
            "Digoxin",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ferrous sulfate": {
        "definition": "An oral iron supplement used to treat and prevent iron deficiency anemia.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia"
        ],
        "dosage": {
            "adults": "325 mg orally 1-3 times daily.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "GI upset",
            "Constipation",
            "Dark stools"
        ],
        "contraindications": [
            "Hemochromatosis",
            "Iron overload"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Antacids",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ferrous fumarate": {
        "definition": "An oral iron supplement used to treat and prevent iron deficiency anemia.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia"
        ],
        "dosage": {
            "adults": "325 mg orally 1-2 times daily.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "GI upset",
            "Constipation",
            "Dark stools"
        ],
        "contraindications": [
            "Hemochromatosis",
            "Iron overload"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Antacids",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "darbepoetin alfa": {
        "definition": "A long-acting erythropoiesis-stimulating agent used to treat anemia due to chronic kidney disease or chemotherapy.",
        "mechanism": "Stimulates erythropoiesis by acting on erythroid progenitor cells.",
        "indications": [
            "Anemia of chronic kidney disease",
            "Anemia due to chemotherapy"
        ],
        "dosage": {
            "adults": "0.45 mcg/kg IV or SC once weekly or every 2-4 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypertension",
            "Thromboembolism",
            "Pure red cell aplasia"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Pure red cell aplasia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cyclosporine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ferrous gluconate": {
        "definition": "An oral iron supplement used to treat and prevent iron deficiency anemia.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia"
        ],
        "dosage": {
            "adults": "325 mg orally 1-3 times daily.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "GI upset",
            "Constipation",
            "Dark stools"
        ],
        "contraindications": [
            "Hemochromatosis",
            "Iron overload"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Antacids",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epoetin beta-methoxy polyethylene glycol": {
        "definition": "A long-acting erythropoiesis-stimulating agent used to treat anemia due to chronic kidney disease.",
        "mechanism": "Stimulates erythropoiesis by acting on erythroid progenitor cells.",
        "indications": [
            "Anemia of chronic kidney disease"
        ],
        "dosage": {
            "adults": "0.6 mcg/kg IV or SC every 2 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypertension",
            "Thromboembolism",
            "Pure red cell aplasia"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Pure red cell aplasia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cyclosporine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "folic acid": {
        "definition": "A B-vitamin used to treat and prevent folate deficiency and during pregnancy.",
        "mechanism": "Required for DNA synthesis and red blood cell formation.",
        "indications": [
            "Folate deficiency",
            "Pregnancy supplementation",
            "Megaloblastic anemia"
        ],
        "dosage": {
            "adults": "0.4-1 mg orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Rare; allergic reactions possible"
        ],
        "contraindications": [
            "Hypersensitivity to folic acid"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Phenytoin",
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iron polysaccharide": {
        "definition": "An oral iron supplement used to treat and prevent iron deficiency anemia.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia"
        ],
        "dosage": {
            "adults": "150 mg orally once daily.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "GI upset",
            "Constipation",
            "Dark stools"
        ],
        "contraindications": [
            "Hemochromatosis",
            "Iron overload"
        ],
        "special populations": {
            "pregnancy": "Indicated for supplementation."
        },
        "interactions": [
            "Antacids",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ferumoxytol": {
        "definition": "An intravenous iron replacement product for iron deficiency anemia in adults with chronic kidney disease.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia in chronic kidney disease"
        ],
        "dosage": {
            "adults": "510 mg IV injection, repeated in 3-8 days.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hypotension",
            "Allergic reactions",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to ferumoxytol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other IV iron products"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iron sucrose": {
        "definition": "An intravenous iron replacement product for iron deficiency anemia in adults with chronic kidney disease.",
        "mechanism": "Replaces iron stores needed for hemoglobin synthesis.",
        "indications": [
            "Iron deficiency anemia in chronic kidney disease"
        ],
        "dosage": {
            "adults": "100-200 mg IV per dose, total dose varies.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hypotension",
            "Allergic reactions",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to iron sucrose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other IV iron products"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "leucovorin": {
        "definition": "A reduced form of folic acid used to reduce toxicity of methotrexate and enhance effects of fluorouracil.",
        "mechanism": "Bypasses dihydrofolate reductase blockade, replenishing folate stores.",
        "indications": [
            "Methotrexate toxicity",
            "Colorectal cancer (with 5-FU)",
            "Megaloblastic anemia"
        ],
        "dosage": {
            "adults": "10-25 mg IV/IM every 6 hours (methotrexate rescue); 200-500 mg/m² IV (with 5-FU).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Allergic reactions",
            "Rash",
            "GI upset"
        ],
        "contraindications": [
            "Pernicious anemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Methotrexate",
            "Fluorouracil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glutamine": {
        "definition": "An amino acid supplement used for sickle cell disease and as a nutritional supplement.",
        "mechanism": "Improves redox potential in sickle cell disease; supports protein synthesis.",
        "indications": [
            "Sickle cell disease",
            "Nutritional support"
        ],
        "dosage": {
            "adults": "10-15 g orally twice daily (sickle cell).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Abdominal pain"
        ],
        "contraindications": [
            "Hypersensitivity to glutamine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "crizanlizumab": {
        "definition": "A monoclonal antibody used to reduce frequency of vaso-occlusive crises in sickle cell disease.",
        "mechanism": "Binds P-selectin, blocking interactions that lead to vaso-occlusion.",
        "indications": [
            "Sickle cell disease (to reduce vaso-occlusive crises)"
        ],
        "dosage": {
            "adults": "5 mg/kg IV at week 0, 2, then every 4 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Nausea",
            "Arthralgia",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity to crizanlizumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "propofol": {
        "definition": "A short-acting intravenous anesthetic agent used for induction and maintenance of anesthesia and sedation.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Induction and maintenance of anesthesia",
            "Sedation for procedures or ICU"
        ],
        "dosage": {
            "adults": "Induction: 1-2.5 mg/kg IV; Maintenance: 50-200 mcg/kg/min IV infusion.",
            "children": "Induction: 2.5-3.5 mg/kg IV."
        },
        "side effects": [
            "Hypotension",
            "Respiratory depression",
            "Pain at injection site"
        ],
        "contraindications": [
            "Hypersensitivity to propofol or egg/soy products"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prilocaine": {
        "definition": "An amide-type local anesthetic used for infiltration, nerve block, and topical anesthesia.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Local anesthesia (infiltration, nerve block, topical)"
        ],
        "dosage": {
            "adults": "Max 600 mg per procedure (infiltration/nerve block).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Methemoglobinemia",
            "CNS toxicity",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to prilocaine",
            "Congenital/idiopathic methemoglobinemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ketamine": {
        "definition": "A dissociative anesthetic used for induction and maintenance of anesthesia and procedural sedation.",
        "mechanism": "NMDA receptor antagonist; produces dissociative anesthesia.",
        "indications": [
            "Induction and maintenance of anesthesia",
            "Procedural sedation",
            "Pain management (off-label)"
        ],
        "dosage": {
            "adults": "1-2 mg/kg IV or 4-5 mg/kg IM.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Emergence reactions",
            "Increased intracranial pressure",
            "Hypertension",
            "Tachycardia"
        ],
        "contraindications": [
            "Conditions where increased BP is hazardous",
            "Schizophrenia (relative)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "succinylcholine": {
        "definition": "A depolarizing neuromuscular blocker used for rapid sequence intubation and short procedures.",
        "mechanism": "Mimics acetylcholine at neuromuscular junction, causing sustained depolarization and paralysis.",
        "indications": [
            "Rapid sequence intubation",
            "Short surgical procedures"
        ],
        "dosage": {
            "adults": "1-1.5 mg/kg IV.",
            "children": "2 mg/kg IV or IM."
        },
        "side effects": [
            "Hyperkalemia",
            "Malignant hyperthermia",
            "Bradycardia"
        ],
        "contraindications": [
            "Personal/family history of malignant hyperthermia",
            "Hyperkalemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glycopyrrolate": {
        "definition": "An anticholinergic agent used to reduce secretions and as an adjunct in anesthesia.",
        "mechanism": "Blocks acetylcholine at muscarinic receptors.",
        "indications": [
            "Reduction of secretions",
            "Adjunct in anesthesia",
            "Peptic ulcer (adjunct)"
        ],
        "dosage": {
            "adults": "0.1-0.2 mg IV/IM; oral: 1-2 mg 2-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Tachycardia",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rocuronium": {
        "definition": "A non-depolarizing neuromuscular blocker used for muscle relaxation during surgery and intubation.",
        "mechanism": "Blocks acetylcholine at nicotinic receptors at the neuromuscular junction.",
        "indications": [
            "Muscle relaxation during surgery",
            "Rapid sequence intubation"
        ],
        "dosage": {
            "adults": "0.6-1.2 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Prolonged paralysis",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to rocuronium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Magnesium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "etomidate": {
        "definition": "A short-acting intravenous anesthetic used for induction of general anesthesia and procedural sedation.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Induction of general anesthesia",
            "Procedural sedation"
        ],
        "dosage": {
            "adults": "0.2-0.6 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Adrenal suppression",
            "Myoclonus",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to etomidate"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vecuronium": {
        "definition": "A non-depolarizing neuromuscular blocker used for muscle relaxation during surgery and intubation.",
        "mechanism": "Blocks acetylcholine at nicotinic receptors at the neuromuscular junction.",
        "indications": [
            "Muscle relaxation during surgery",
            "Intubation"
        ],
        "dosage": {
            "adults": "0.08-0.1 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Prolonged paralysis",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to vecuronium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Magnesium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hyoscyamine": {
        "definition": "An anticholinergic agent used to treat GI disorders, bladder spasms, and as a pre-anesthetic.",
        "mechanism": "Blocks acetylcholine at muscarinic receptors.",
        "indications": [
            "GI disorders (IBS, spastic colon)",
            "Bladder spasms",
            "Pre-anesthetic"
        ],
        "dosage": {
            "adults": "0.125-0.25 mg orally or sublingually every 4 hours as needed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Tachycardia",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cisatracurium": {
        "definition": "A non-depolarizing neuromuscular blocker used for muscle relaxation during surgery and intubation.",
        "mechanism": "Blocks acetylcholine at nicotinic receptors at the neuromuscular junction.",
        "indications": [
            "Muscle relaxation during surgery",
            "Intubation",
            "Mechanical ventilation"
        ],
        "dosage": {
            "adults": "0.15-0.2 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Prolonged paralysis",
            "Hypersensitivity reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cisatracurium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Magnesium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydromorphone": {
        "definition": "A potent opioid analgesic used for moderate to severe pain.",
        "mechanism": "Binds to mu-opioid receptors in the CNS, altering pain perception.",
        "indications": [
            "Moderate to severe pain"
        ],
        "dosage": {
            "adults": "Oral: 2-8 mg every 4-6 hours; IV: 0.2-1 mg every 2-3 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Respiratory depression",
            "Constipation",
            "Nausea",
            "Sedation"
        ],
        "contraindications": [
            "Acute respiratory depression",
            "Severe asthma",
            "Paralytic ileus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atracurium": {
        "definition": "A non-depolarizing neuromuscular blocker used for muscle relaxation during surgery and intubation.",
        "mechanism": "Blocks acetylcholine at nicotinic receptors at the neuromuscular junction.",
        "indications": [
            "Muscle relaxation during surgery",
            "Intubation",
            "Mechanical ventilation"
        ],
        "dosage": {
            "adults": "0.4-0.5 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Histamine release",
            "Hypotension",
            "Prolonged paralysis"
        ],
        "contraindications": [
            "Hypersensitivity to atracurium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Magnesium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "butorphanol": {
        "definition": "A mixed agonist-antagonist opioid analgesic used for moderate to severe pain.",
        "mechanism": "Agonist at kappa and partial agonist/antagonist at mu opioid receptors.",
        "indications": [
            "Moderate to severe pain",
            "Migraine (nasal spray)"
        ],
        "dosage": {
            "adults": "1 mg IV/IM every 3-4 hours; Nasal: 1 mg (1 spray) in one nostril, may repeat in 60-90 min.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Sedation",
            "Nausea",
            "Dizziness",
            "Respiratory depression"
        ],
        "contraindications": [
            "Acute respiratory depression",
            "Severe asthma",
            "Paralytic ileus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methohexital": {
        "definition": "A barbiturate anesthetic used for induction of anesthesia and procedural sedation.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Induction of anesthesia",
            "Procedural sedation"
        ],
        "dosage": {
            "adults": "1-1.5 mg/kg IV bolus.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Respiratory depression",
            "Hypotension",
            "Laryngospasm"
        ],
        "contraindications": [
            "Porphyria",
            "Hypersensitivity to barbiturates"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bisoprolol": {
        "definition": "A beta-1 selective blocker used for hypertension and heart failure.",
        "mechanism": "Blocks beta-1 adrenergic receptors, reducing heart rate and cardiac output.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Heart block",
            "Decompensated heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Calcium channel blockers",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nifedipine": {
        "definition": "A dihydropyridine calcium channel blocker used for hypertension and angina.",
        "mechanism": "Inhibits calcium influx into vascular smooth muscle, causing vasodilation.",
        "indications": [
            "Hypertension",
            "Angina",
            "Preterm labor (off-label)"
        ],
        "dosage": {
            "adults": "30-90 mg extended-release orally once daily.",
            "children": "0.25-0.5 mg/kg/dose every 8 hours."
        },
        "side effects": [
            "Peripheral edema",
            "Flushing",
            "Headache"
        ],
        "contraindications": [
            "Severe hypotension",
            "Cardiogenic shock"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "interferon alfa-2b": {
        "definition": "A recombinant cytokine used to treat hepatitis B and C, certain cancers, and viral infections.",
        "mechanism": "Modulates immune response, inhibits viral replication and cell proliferation.",
        "indications": [
            "Chronic hepatitis B and C",
            "Malignant melanoma",
            "Hairy cell leukemia",
            "Condyloma acuminata"
        ],
        "dosage": {
            "adults": "3-10 million units SC or IM 3 times weekly (varies by indication).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Flu-like symptoms",
            "Depression",
            "Myelosuppression"
        ],
        "contraindications": [
            "Autoimmune hepatitis",
            "Severe psychiatric disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Theophylline",
            "Zidovudine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iohexol": {
        "definition": "A non-ionic, water-soluble radiographic contrast agent used in diagnostic imaging procedures.",
        "mechanism": "Enhances contrast of blood vessels and tissues during imaging by increasing X-ray absorption.",
        "indications": [
            "CT scans",
            "Angiography",
            "Urography",
            "Other radiographic studies"
        ],
        "dosage": {
            "adults": "Dose varies by procedure and concentration.",
            "children": "Dose by weight and procedure."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Allergic reactions",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to iohexol or iodinated contrast agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor renal function."
        },
        "interactions": [
            "Metformin (risk of lactic acidosis)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "danazol": {
        "definition": "A synthetic androgen used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema.",
        "mechanism": "Suppresses pituitary gonadotropins and increases C1 esterase inhibitor.",
        "indications": [
            "Endometriosis",
            "Fibrocystic breast disease",
            "Hereditary angioedema"
        ],
        "dosage": {
            "adults": "200-800 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Weight gain",
            "Acne",
            "Hirsutism",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Pregnancy",
            "Porphyria",
            "Severe hepatic, renal, or cardiac disease"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "Warfarin",
            "Statins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadobenate dimeglumine": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI of the CNS, liver, and vasculature"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "furosemide": {
        "definition": "A loop diuretic used to treat edema and hypertension.",
        "mechanism": "Inhibits Na-K-2Cl symporter in the thick ascending limb of Henle's loop.",
        "indications": [
            "Edema",
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "20-80 mg orally/IV once or twice daily.",
            "children": "1-2 mg/kg/dose."
        },
        "side effects": [
            "Hypokalemia",
            "Dehydration",
            "Ototoxicity",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to furosemide or sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydrochlorothiazide": {
        "definition": "A thiazide diuretic used to treat hypertension and edema.",
        "mechanism": "Inhibits Na-Cl symporter in the distal convoluted tubule.",
        "indications": [
            "Hypertension",
            "Edema"
        ],
        "dosage": {
            "adults": "12.5-50 mg orally once daily.",
            "children": "1-2 mg/kg/day."
        },
        "side effects": [
            "Hypokalemia",
            "Hyponatremia",
            "Hyperuricemia",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Lithium",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bumetanide": {
        "definition": "A potent loop diuretic used to treat edema.",
        "mechanism": "Inhibits Na-K-2Cl symporter in the thick ascending limb of Henle's loop.",
        "indications": [
            "Edema"
        ],
        "dosage": {
            "adults": "0.5-2 mg orally/IV once or twice daily.",
            "children": "0.015-0.1 mg/kg/dose."
        },
        "side effects": [
            "Hypokalemia",
            "Dehydration",
            "Ototoxicity"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to bumetanide or sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metolazone": {
        "definition": "A thiazide-like diuretic used to treat edema and hypertension.",
        "mechanism": "Inhibits Na-Cl symporter in the distal convoluted tubule.",
        "indications": [
            "Edema",
            "Hypertension"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally once daily.",
            "children": "0.2-0.4 mg/kg/day."
        },
        "side effects": [
            "Hypokalemia",
            "Hyponatremia",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to metolazone or sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Lithium",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "torsemide": {
        "definition": "A loop diuretic used to treat edema and hypertension.",
        "mechanism": "Inhibits Na-K-2Cl symporter in the thick ascending limb of Henle's loop.",
        "indications": [
            "Edema",
            "Hypertension"
        ],
        "dosage": {
            "adults": "10-20 mg orally/IV once daily.",
            "children": "0.1-0.2 mg/kg/dose."
        },
        "side effects": [
            "Hypokalemia",
            "Dehydration",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to torsemide or sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "triamterene": {
        "definition": "A potassium-sparing diuretic used to treat edema and hypertension (often in combination with thiazides).",
        "mechanism": "Inhibits sodium reabsorption in the distal tubule, reducing potassium excretion.",
        "indications": [
            "Edema",
            "Hypertension"
        ],
        "dosage": {
            "adults": "100-300 mg orally daily in 1-2 divided doses.",
            "children": "2-4 mg/kg/day."
        },
        "side effects": [
            "Hyperkalemia",
            "Kidney stones",
            "GI upset"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorthalidone": {
        "definition": "A thiazide-like diuretic used to treat hypertension and edema.",
        "mechanism": "Inhibits Na-Cl symporter in the distal convoluted tubule.",
        "indications": [
            "Hypertension",
            "Edema"
        ],
        "dosage": {
            "adults": "12.5-50 mg orally once daily.",
            "children": "0.3 mg/kg once daily."
        },
        "side effects": [
            "Hypokalemia",
            "Hyponatremia",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Anuria",
            "Hypersensitivity to sulfa drugs"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Lithium",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acetazolamide": {
        "definition": "A carbonic anhydrase inhibitor diuretic used for glaucoma, altitude sickness, and edema.",
        "mechanism": "Inhibits carbonic anhydrase, reducing bicarbonate reabsorption.",
        "indications": [
            "Glaucoma",
            "Altitude sickness",
            "Edema",
            "Epilepsy"
        ],
        "dosage": {
            "adults": "250-1000 mg orally daily in divided doses.",
            "children": "8-30 mg/kg/day in divided doses."
        },
        "side effects": [
            "Metabolic acidosis",
            "Hypokalemia",
            "Paresthesia",
            "Renal stones"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Severe hepatic or renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aspirin",
            "Other diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "celecoxib": {
        "definition": "A selective COX-2 inhibitor NSAID used for pain and inflammation.",
        "mechanism": "Inhibits COX-2, reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis",
            "Acute pain",
            "Dysmenorrhea"
        ],
        "dosage": {
            "adults": "100-200 mg orally once or twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI upset",
            "Hypertension",
            "Increased cardiovascular risk"
        ],
        "contraindications": [
            "Sulfa allergy",
            "History of MI or stroke"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Warfarin",
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "adalimumab": {
        "definition": "A monoclonal antibody TNF inhibitor used to treat autoimmune diseases.",
        "mechanism": "Binds TNF-alpha, blocking its inflammatory effects.",
        "indications": [
            "Rheumatoid arthritis",
            "Psoriatic arthritis",
            "Crohn's disease",
            "Ulcerative colitis",
            "Plaque psoriasis"
        ],
        "dosage": {
            "adults": "40 mg SC every 1-2 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Injection site reactions",
            "Headache"
        ],
        "contraindications": [
            "Active severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other biologics",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "infliximab": {
        "definition": "A monoclonal antibody TNF inhibitor used to treat autoimmune diseases.",
        "mechanism": "Binds TNF-alpha, blocking its inflammatory effects.",
        "indications": [
            "Rheumatoid arthritis",
            "Crohn's disease",
            "Ulcerative colitis",
            "Psoriatic arthritis",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "3-10 mg/kg IV at 0, 2, 6 weeks, then every 8 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Infusion reactions",
            "Headache"
        ],
        "contraindications": [
            "Active severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other biologics",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chloramphenicol": {
        "definition": "A broad-spectrum antibiotic used for serious infections when other agents are ineffective.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "Serious infections (meningitis, typhoid, rickettsial diseases)"
        ],
        "dosage": {
            "adults": "50-100 mg/kg/day IV or orally in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Aplastic anemia",
            "Gray baby syndrome",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to chloramphenicol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anthrax immune globulin intravenous": {
        "definition": "A human immune globulin used as adjunctive therapy for inhalational anthrax.",
        "mechanism": "Provides passive immunity by supplying anti-anthrax antibodies.",
        "indications": [
            "Inhalational anthrax (adjunctive therapy)"
        ],
        "dosage": {
            "adults": "Dose individualized based on weight and clinical response.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anthrax vaccine adsorbed": {
        "definition": "A vaccine used to prevent anthrax infection.",
        "mechanism": "Induces immunity against Bacillus anthracis protective antigen.",
        "indications": [
            "Pre-exposure and post-exposure prophylaxis of anthrax"
        ],
        "dosage": {
            "adults": "0.5 mL IM at 0, 1, 6, 12, and 18 months, then annual boosters.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Malaise"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "immune globulin intravenous": {
        "definition": "A preparation of pooled human immunoglobulin G (IgG) used for immune deficiencies and autoimmune conditions.",
        "mechanism": "Provides passive immunity and modulates immune response.",
        "indications": [
            "Primary immunodeficiency",
            "Immune thrombocytopenia",
            "Kawasaki disease",
            "Other autoimmune conditions"
        ],
        "dosage": {
            "adults": "0.4-2 g/kg IV, frequency varies by indication.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Thrombosis"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fomepizole": {
        "definition": "An antidote used to treat methanol and ethylene glycol poisoning.",
        "mechanism": "Inhibits alcohol dehydrogenase, preventing formation of toxic metabolites.",
        "indications": [
            "Methanol poisoning",
            "Ethylene glycol poisoning"
        ],
        "dosage": {
            "adults": "15 mg/kg IV loading, then 10 mg/kg every 12 hours.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Dizziness"
        ],
        "contraindications": [
            "Hypersensitivity to fomepizole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vancomycin": {
        "definition": "A glycopeptide antibiotic used to treat serious Gram-positive infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding D-Ala-D-Ala terminus.",
        "indications": [
            "MRSA infections",
            "Clostridioides difficile (oral)",
            "Serious Gram-positive infections"
        ],
        "dosage": {
            "adults": "15-20 mg/kg IV every 8-12 hours.",
            "children": "10-15 mg/kg IV every 6-12 hours."
        },
        "side effects": [
            "Nephrotoxicity",
            "Ototoxicity",
            "Red man syndrome"
        ],
        "contraindications": [
            "Hypersensitivity to vancomycin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "physostigmine": {
        "definition": "A reversible acetylcholinesterase inhibitor used as an antidote for anticholinergic toxicity.",
        "mechanism": "Inhibits acetylcholinesterase, increasing acetylcholine levels.",
        "indications": [
            "Anticholinergic toxicity (antidote)"
        ],
        "dosage": {
            "adults": "1-2 mg IV/IM slowly.",
            "children": "0.02 mg/kg IV/IM slowly."
        },
        "side effects": [
            "Bradycardia",
            "Seizures",
            "Bronchospasm"
        ],
        "contraindications": [
            "Asthma",
            "Mechanical intestinal/urinary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pralidoxime": {
        "definition": "An antidote for organophosphate and nerve agent poisoning.",
        "mechanism": "Reactivates acetylcholinesterase inhibited by organophosphates.",
        "indications": [
            "Organophosphate poisoning",
            "Nerve agent poisoning"
        ],
        "dosage": {
            "adults": "1-2 g IV over 15-30 min, repeat as needed.",
            "children": "20-50 mg/kg IV."
        },
        "side effects": [
            "Hypertension",
            "Tachycardia",
            "Blurred vision"
        ],
        "contraindications": [
            "Hypersensitivity to pralidoxime"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Atropine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atropine": {
        "definition": "An anticholinergic agent used for bradycardia, organophosphate poisoning, and as a pre-anesthetic.",
        "mechanism": "Blocks acetylcholine at muscarinic receptors.",
        "indications": [
            "Bradycardia",
            "Organophosphate poisoning",
            "Pre-anesthetic"
        ],
        "dosage": {
            "adults": "0.5-1 mg IV every 3-5 min (max 3 mg for bradycardia).",
            "children": "0.02 mg/kg IV/IM."
        },
        "side effects": [
            "Dry mouth",
            "Tachycardia",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "heparin": {
        "definition": "An anticoagulant used to prevent and treat thromboembolic disorders.",
        "mechanism": "Enhances antithrombin III activity, inhibiting thrombin and factor Xa.",
        "indications": [
            "Deep vein thrombosis",
            "Pulmonary embolism",
            "Acute coronary syndrome"
        ],
        "dosage": {
            "adults": "IV bolus 5,000 units, then infusion 12-18 units/kg/hr.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Heparin-induced thrombocytopenia",
            "Osteoporosis (long-term)"
        ],
        "contraindications": [
            "Active bleeding",
            "History of HIT"
        ],
        "special populations": {
            "pregnancy": "Preferred anticoagulant in pregnancy."
        },
        "interactions": [
            "Antiplatelet agents",
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "buspirone": {
        "definition": "An anxiolytic agent used to treat generalized anxiety disorder.",
        "mechanism": "Partial agonist at serotonin 5-HT1A receptors.",
        "indications": [
            "Generalized anxiety disorder"
        ],
        "dosage": {
            "adults": "10-30 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dizziness",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to buspirone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sildenafil": {
        "definition": "A phosphodiesterase-5 inhibitor used to treat erectile dysfunction and pulmonary arterial hypertension.",
        "mechanism": "Inhibits PDE-5, increasing cGMP and causing vasodilation.",
        "indications": [
            "Erectile dysfunction",
            "Pulmonary arterial hypertension"
        ],
        "dosage": {
            "adults": "ED: 25-100 mg orally as needed; PAH: 20 mg orally three times daily.",
            "children": "PAH: dose by weight (specialist use)."
        },
        "side effects": [
            "Headache",
            "Flushing",
            "Visual disturbances"
        ],
        "contraindications": [
            "Nitrate therapy",
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nitrates",
            "Alpha-blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amantadine": {
        "definition": "An antiviral and antiparkinsonian agent.",
        "mechanism": "Blocks viral uncoating (influenza A); increases dopamine release (Parkinson's).",
        "indications": [
            "Parkinson's disease",
            "Drug-induced extrapyramidal symptoms",
            "Influenza A (not recommended due to resistance)"
        ],
        "dosage": {
            "adults": "100 mg orally once or twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Livedo reticularis",
            "Edema",
            "Confusion",
            "Hallucinations"
        ],
        "contraindications": [
            "Untreated angle-closure glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticholinergics",
            "CNS stimulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "warfarin": {
        "definition": "An oral anticoagulant used to prevent and treat thromboembolic disorders.",
        "mechanism": "Inhibits vitamin K-dependent clotting factor synthesis.",
        "indications": [
            "Atrial fibrillation",
            "Venous thromboembolism",
            "Mechanical heart valves"
        ],
        "dosage": {
            "adults": "2-10 mg orally once daily (adjust to INR).",
            "children": "Dose by weight and INR target."
        },
        "side effects": [
            "Bleeding",
            "Skin necrosis",
            "Purple toe syndrome"
        ],
        "contraindications": [
            "Pregnancy",
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (except in some mechanical valves)."
        },
        "interactions": [
            "Many drugs (CYP2C9, 2C19, 1A2, 3A4 substrates)",
            "Vitamin K foods"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antithrombin iii": {
        "definition": "A plasma-derived anticoagulant used to treat hereditary antithrombin deficiency.",
        "mechanism": "Inhibits thrombin and factor Xa.",
        "indications": [
            "Hereditary antithrombin deficiency (prevention/treatment of thrombosis)"
        ],
        "dosage": {
            "adults": "Dose individualized by antithrombin activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe thrombocytopenia",
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Heparin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antithrombin (recombinant)": {
        "definition": "A recombinant form of human antithrombin used to treat hereditary antithrombin deficiency.",
        "mechanism": "Inhibits thrombin and factor Xa.",
        "indications": [
            "Hereditary antithrombin deficiency (prevention/treatment of thrombosis)"
        ],
        "dosage": {
            "adults": "Dose individualized by antithrombin activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe thrombocytopenia",
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Heparin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clonazepam": {
        "definition": "A benzodiazepine used to treat seizure disorders and panic disorder.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Seizure disorders",
            "Panic disorder"
        ],
        "dosage": {
            "adults": "0.5-2 mg orally 2-3 times daily.",
            "children": "0.01-0.03 mg/kg/day in divided doses."
        },
        "side effects": [
            "Drowsiness",
            "Ataxia",
            "Dependence",
            "Cognitive impairment"
        ],
        "contraindications": [
            "Severe liver disease",
            "Acute narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alprazolam": {
        "definition": "A benzodiazepine used to treat anxiety and panic disorders.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Anxiety disorders",
            "Panic disorder"
        ],
        "dosage": {
            "adults": "0.25-0.5 mg orally 2-3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dependence",
            "Cognitive impairment",
            "Ataxia"
        ],
        "contraindications": [
            "Acute narrow-angle glaucoma",
            "Concurrent ketoconazole/itraconazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lorazepam": {
        "definition": "A benzodiazepine used to treat anxiety, status epilepticus, and as a sedative.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Anxiety",
            "Status epilepticus",
            "Preoperative sedation"
        ],
        "dosage": {
            "adults": "1-4 mg orally 2-3 times daily; IV: 4 mg for status epilepticus.",
            "children": "0.05-0.1 mg/kg IV for status epilepticus."
        },
        "side effects": [
            "Drowsiness",
            "Dependence",
            "Ataxia",
            "Respiratory depression"
        ],
        "contraindications": [
            "Acute narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Use lowest effective dose."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "escitalopram": {
        "definition": "A selective serotonin reuptake inhibitor (SSRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin in the CNS.",
        "indications": [
            "Depression",
            "Generalized anxiety disorder"
        ],
        "dosage": {
            "adults": "10-20 mg orally once daily.",
            "children": "10-20 mg once daily (age 12+ for depression)."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Sexual dysfunction",
            "QT prolongation"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Use with caution."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trazodone": {
        "definition": "A serotonin antagonist and reuptake inhibitor (SARI) antidepressant, also used for insomnia.",
        "mechanism": "Inhibits serotonin reuptake and antagonizes 5-HT2 receptors.",
        "indications": [
            "Depression",
            "Insomnia (off-label)"
        ],
        "dosage": {
            "adults": "150-400 mg orally daily in divided doses (depression); 25-100 mg at bedtime (insomnia).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Orthostatic hypotension",
            "Priapism"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "duloxetine": {
        "definition": "A serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant.",
        "mechanism": "Inhibits reuptake of serotonin and norepinephrine in the CNS.",
        "indications": [
            "Depression",
            "Generalized anxiety disorder",
            "Neuropathic pain",
            "Fibromyalgia"
        ],
        "dosage": {
            "adults": "30-60 mg orally once daily.",
            "children": "30-60 mg once daily (age 7+ for GAD)."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Dry mouth",
            "Hypertension"
        ],
        "contraindications": [
            "Use with MAO inhibitors",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mirtazapine": {
        "definition": "A tetracyclic antidepressant with noradrenergic and specific serotonergic activity.",
        "mechanism": "Antagonizes central presynaptic alpha-2 adrenergic and certain serotonin receptors.",
        "indications": [
            "Depression"
        ],
        "dosage": {
            "adults": "15-45 mg orally once daily at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Weight gain",
            "Sedation",
            "Increased appetite"
        ],
        "contraindications": [
            "Hypersensitivity to mirtazapine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "quetiapine": {
        "definition": "An atypical antipsychotic used to treat schizophrenia, bipolar disorder, and depression (adjunct).",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2 receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder",
            "Adjunct in depression"
        ],
        "dosage": {
            "adults": "150-800 mg orally daily in divided doses.",
            "children": "Dose by age and indication (age 10+ for bipolar)."
        },
        "side effects": [
            "Sedation",
            "Weight gain",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to quetiapine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "elderly": "Increased risk of mortality in dementia-related psychosis."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dipyridamole": {
        "definition": "A platelet inhibitor and vasodilator used for stroke prevention and cardiac stress testing.",
        "mechanism": "Inhibits platelet aggregation by increasing cAMP; vasodilates coronary arteries.",
        "indications": [
            "Stroke prevention (with aspirin)",
            "Cardiac stress testing"
        ],
        "dosage": {
            "adults": "75-100 mg orally 4 times daily (stroke); IV dose for stress testing.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Dizziness",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to dipyridamole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Other antiplatelet agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iodixanol": {
        "definition": "A non-ionic, iso-osmolar iodinated contrast agent for intravascular imaging.",
        "mechanism": "Enhances X-ray contrast by increasing absorption in blood vessels/tissues.",
        "indications": [
            "CT scans",
            "Angiography",
            "Urography"
        ],
        "dosage": {
            "adults": "Dose varies by procedure and concentration.",
            "children": "Dose by weight and procedure."
        },
        "side effects": [
            "Nausea",
            "Allergic reactions",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to iodinated contrast agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor renal function."
        },
        "interactions": [
            "Metformin (risk of lactic acidosis)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexmethylphenidate": {
        "definition": "A CNS stimulant used to treat attention deficit hyperactivity disorder (ADHD).",
        "mechanism": "Blocks reuptake of norepinephrine and dopamine in the brain.",
        "indications": [
            "ADHD"
        ],
        "dosage": {
            "adults": "10-40 mg orally daily in divided doses.",
            "children": "2.5-20 mg daily (age 6+)."
        },
        "side effects": [
            "Insomnia",
            "Decreased appetite",
            "Tachycardia"
        ],
        "contraindications": [
            "Glaucoma",
            "Tics or Tourette syndrome",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "MAO inhibitors",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sargramostim": {
        "definition": "A recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate white blood cell production.",
        "mechanism": "Stimulates production of neutrophils, monocytes, and macrophages.",
        "indications": [
            "Neutropenia after bone marrow transplant",
            "Myeloid reconstitution",
            "AML induction therapy"
        ],
        "dosage": {
            "adults": "250 mcg/m²/day SC or IV.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Fever",
            "Bone pain",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to sargramostim or yeast-derived products"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Lithium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lymphocyte immune globulin, anti-thy (equine)": {
        "definition": "An immunosuppressive agent used to treat acute rejection in organ transplantation and aplastic anemia.",
        "mechanism": "Contains antibodies that deplete T lymphocytes.",
        "indications": [
            "Acute rejection in transplantation",
            "Aplastic anemia"
        ],
        "dosage": {
            "adults": "10-20 mg/kg/day IV for 8-14 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Infection",
            "Serum sickness"
        ],
        "contraindications": [
            "Hypersensitivity to equine proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eltrombopag": {
        "definition": "A thrombopoietin receptor agonist used to treat thrombocytopenia in chronic ITP, hepatitis C, and severe aplastic anemia.",
        "mechanism": "Stimulates thrombopoietin receptor, increasing platelet production.",
        "indications": [
            "Chronic immune thrombocytopenia (ITP)",
            "Hepatitis C-associated thrombocytopenia",
            "Severe aplastic anemia"
        ],
        "dosage": {
            "adults": "25-75 mg orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hepatotoxicity",
            "Thrombosis",
            "Cataracts"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Calcium, iron supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "caffeine": {
        "definition": "A CNS stimulant used to treat neonatal apnea and as a stimulant.",
        "mechanism": "Blocks adenosine receptors, increasing neuronal activity.",
        "indications": [
            "Neonatal apnea",
            "Fatigue",
            "Migraine (adjunct)"
        ],
        "dosage": {
            "adults": "100-200 mg orally every 3-4 hours as needed.",
            "children": "Neonates: 20 mg/kg IV/PO loading, then 5-10 mg/kg/day."
        },
        "side effects": [
            "Insomnia",
            "Tachycardia",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to caffeine"
        ],
        "special populations": {
            "pregnancy": "Limit intake."
        },
        "interactions": [
            "CYP1A2 inhibitors",
            "Other stimulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carbamazepine": {
        "definition": "An anticonvulsant and mood stabilizer used for epilepsy, trigeminal neuralgia, and bipolar disorder.",
        "mechanism": "Blocks voltage-gated sodium channels, reducing neuronal firing.",
        "indications": [
            "Epilepsy",
            "Trigeminal neuralgia",
            "Bipolar disorder"
        ],
        "dosage": {
            "adults": "400-1200 mg orally daily in divided doses.",
            "children": "10-30 mg/kg/day in divided doses."
        },
        "side effects": [
            "Hyponatremia",
            "Rash (SJS/TEN)",
            "Agranulocytosis",
            "Dizziness"
        ],
        "contraindications": [
            "Bone marrow suppression",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amiodarone": {
        "definition": "A class III antiarrhythmic agent used to treat and prevent serious arrhythmias.",
        "mechanism": "Blocks potassium channels, prolonging cardiac action potential.",
        "indications": [
            "Ventricular arrhythmias",
            "Atrial fibrillation"
        ],
        "dosage": {
            "adults": "Loading: 800-1600 mg/day; Maintenance: 200-400 mg/day.",
            "children": "5-15 mg/kg/day."
        },
        "side effects": [
            "Pulmonary fibrosis",
            "Thyroid dysfunction",
            "Corneal deposits",
            "QT prolongation"
        ],
        "contraindications": [
            "Severe sinus node dysfunction",
            "Heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin",
            "Digoxin",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "verapamil": {
        "definition": "A non-dihydropyridine calcium channel blocker used for hypertension, angina, and arrhythmias.",
        "mechanism": "Inhibits calcium influx into cardiac and vascular smooth muscle.",
        "indications": [
            "Hypertension",
            "Angina",
            "Atrial fibrillation/flutter",
            "SVT"
        ],
        "dosage": {
            "adults": "80-240 mg orally 2-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "Constipation",
            "Edema"
        ],
        "contraindications": [
            "Severe hypotension",
            "AV block",
            "Sick sinus syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dofetilide": {
        "definition": "A class III antiarrhythmic used to treat and maintain normal sinus rhythm in atrial fibrillation.",
        "mechanism": "Blocks potassium channels, prolonging cardiac action potential.",
        "indications": [
            "Atrial fibrillation/flutter"
        ],
        "dosage": {
            "adults": "500 mcg orally twice daily (adjust for renal function).",
            "children": "Not routinely used."
        },
        "side effects": [
            "QT prolongation",
            "Torsades de pointes",
            "Headache"
        ],
        "contraindications": [
            "QT prolongation",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mexiletine": {
        "definition": "A class Ib antiarrhythmic used to treat ventricular arrhythmias.",
        "mechanism": "Blocks sodium channels, shortening cardiac action potential.",
        "indications": [
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "200-300 mg orally every 8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Tremor"
        ],
        "contraindications": [
            "Cardiogenic shock",
            "Severe AV block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "disopyramide": {
        "definition": "A class Ia antiarrhythmic used to treat ventricular arrhythmias and atrial fibrillation.",
        "mechanism": "Blocks sodium channels, prolonging cardiac action potential.",
        "indications": [
            "Ventricular arrhythmias",
            "Atrial fibrillation"
        ],
        "dosage": {
            "adults": "100-200 mg orally every 6-8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Anticholinergic effects",
            "QT prolongation",
            "Heart failure"
        ],
        "contraindications": [
            "Cardiogenic shock",
            "AV block",
            "Glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "quinidine": {
        "definition": "A class Ia antiarrhythmic used to treat atrial and ventricular arrhythmias.",
        "mechanism": "Blocks sodium channels, prolonging cardiac action potential.",
        "indications": [
            "Atrial fibrillation/flutter",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "200-400 mg orally every 6 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Cinchonism",
            "QT prolongation",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Thrombocytopenia",
            "AV block",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "procainamide": {
        "definition": "A class Ia antiarrhythmic used to treat atrial and ventricular arrhythmias.",
        "mechanism": "Blocks sodium channels, prolonging cardiac action potential.",
        "indications": [
            "Atrial fibrillation/flutter",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "15-18 mg/kg IV over 30-60 min, then infusion.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Lupus-like syndrome",
            "QT prolongation",
            "Agranulocytosis"
        ],
        "contraindications": [
            "Complete heart block",
            "SLE (relative)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dimercaprol": {
        "definition": "A chelating agent used to treat arsenic, gold, and mercury poisoning.",
        "mechanism": "Binds heavy metals, forming complexes excreted in urine.",
        "indications": [
            "Arsenic poisoning",
            "Gold poisoning",
            "Mercury poisoning",
            "Lead poisoning (with EDTA)"
        ],
        "dosage": {
            "adults": "2.5-3 mg/kg IM every 4 hours.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypertension",
            "Tachycardia",
            "Nausea"
        ],
        "contraindications": [
            "Peanut allergy (contains peanut oil)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Iron supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rosuvastatin": {
        "definition": "A statin used to lower cholesterol and reduce risk of cardiovascular disease.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Prevention of cardiovascular events"
        ],
        "dosage": {
            "adults": "5-40 mg orally once daily.",
            "children": "5-20 mg once daily (age 8+)."
        },
        "side effects": [
            "Myalgia",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "Cyclosporine",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "perindopril": {
        "definition": "An ACE inhibitor used to treat hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production and lowering blood pressure.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "4-8 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "renal impairment": "Dose adjustment may be needed."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isoxsuprine": {
        "definition": "A vasodilator used to treat peripheral vascular disease and off-label for preterm labor.",
        "mechanism": "Beta-adrenergic agonist causing vasodilation of skeletal muscle.",
        "indications": [
            "Peripheral vascular disease",
            "Preterm labor (off-label)"
        ],
        "dosage": {
            "adults": "10-20 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Tachycardia",
            "Hypotension",
            "Flushing"
        ],
        "contraindications": [
            "Recent arterial bleeding",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxychloroquine": {
        "definition": "An antimalarial and immunomodulatory agent used for malaria and autoimmune diseases.",
        "mechanism": "Inhibits heme polymerase in Plasmodium; modulates immune response.",
        "indications": [
            "Malaria",
            "Rheumatoid arthritis",
            "Lupus erythematosus"
        ],
        "dosage": {
            "adults": "200-400 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Retinopathy",
            "GI upset",
            "Pruritus"
        ],
        "contraindications": [
            "Retinal or visual field changes",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "CYP2D6 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "leflunomide": {
        "definition": "A disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis.",
        "mechanism": "Inhibits pyrimidine synthesis, reducing lymphocyte proliferation.",
        "indications": [
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "10-20 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hepatotoxicity",
            "Diarrhea",
            "Hypertension"
        ],
        "contraindications": [
            "Pregnancy",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "hepatic impairment": "Contraindicated."
        },
        "interactions": [
            "Methotrexate",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydrocodone": {
        "definition": "An opioid analgesic used for moderate to severe pain and as an antitussive.",
        "mechanism": "Binds to mu-opioid receptors in the CNS, altering pain perception.",
        "indications": [
            "Moderate to severe pain",
            "Cough (antitussive)"
        ],
        "dosage": {
            "adults": "5-10 mg orally every 4-6 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Acute respiratory depression",
            "Severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chondroitin": {
        "definition": "A dietary supplement used for osteoarthritis and joint health.",
        "mechanism": "Component of cartilage; may reduce cartilage breakdown.",
        "indications": [
            "Osteoarthritis (supportive)"
        ],
        "dosage": {
            "adults": "800-1200 mg orally daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Nausea",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to chondroitin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glucosamine": {
        "definition": "A dietary supplement used for osteoarthritis and joint health.",
        "mechanism": "Component of cartilage; may promote cartilage repair.",
        "indications": [
            "Osteoarthritis (supportive)"
        ],
        "dosage": {
            "adults": "1500 mg orally daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Nausea",
            "Allergic reactions"
        ],
        "contraindications": [
            "Shellfish allergy (some formulations)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "etodolac": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.",
        "mechanism": "Inhibits cyclooxygenase (COX), reducing prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis",
            "Pain"
        ],
        "dosage": {
            "adults": "200-400 mg orally every 6-8 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Ulceration",
            "Edema"
        ],
        "contraindications": [
            "History of asthma, urticaria, or allergic-type reactions after NSAIDs",
            "Active GI bleeding"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Anticoagulants",
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mycophenolate mofetil": {
        "definition": "An immunosuppressant used to prevent organ transplant rejection.",
        "mechanism": "Inhibits inosine monophosphate dehydrogenase, suppressing lymphocyte proliferation.",
        "indications": [
            "Prevention of organ transplant rejection"
        ],
        "dosage": {
            "adults": "1-1.5 g orally twice daily.",
            "children": "600 mg/m² twice daily."
        },
        "side effects": [
            "GI upset",
            "Leukopenia",
            "Infection"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity to mycophenolate"
        ],
        "special populations": {
            "pregnancy": "Contraindicated.",
            "children": "Indicated for pediatric transplant."
        },
        "interactions": [
            "Antacids",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amiloride": {
        "definition": "A potassium-sparing diuretic used to treat hypertension and heart failure.",
        "mechanism": "Inhibits sodium reabsorption in the distal tubule, reducing potassium excretion.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "5-20 mg orally once daily.",
            "children": "0.625-1.25 mg/kg/day."
        },
        "side effects": [
            "Hyperkalemia",
            "Nausea",
            "Headache"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ethacrynic acid": {
        "definition": "A loop diuretic used to treat edema, especially in patients allergic to sulfa drugs.",
        "mechanism": "Inhibits Na-K-2Cl symporter in the thick ascending limb of Henle's loop.",
        "indications": [
            "Edema (especially in sulfa allergy)"
        ],
        "dosage": {
            "adults": "25-100 mg orally once or twice daily.",
            "children": "1 mg/kg/dose."
        },
        "side effects": [
            "Ototoxicity",
            "Hypokalemia",
            "Dehydration"
        ],
        "contraindications": [
            "Anuria",
            "Severe electrolyte imbalance"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides",
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alendronate": {
        "definition": "A bisphosphonate used to treat and prevent osteoporosis and Paget's disease.",
        "mechanism": "Inhibits osteoclast-mediated bone resorption.",
        "indications": [
            "Osteoporosis",
            "Paget's disease"
        ],
        "dosage": {
            "adults": "70 mg orally once weekly or 10 mg once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Esophagitis",
            "Osteonecrosis of jaw (rare)"
        ],
        "contraindications": [
            "Esophageal abnormalities",
            "Inability to stand/sit upright for 30 min"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Calcium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "itraconazole": {
        "definition": "A triazole antifungal used to treat systemic and superficial fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Aspergillosis",
            "Histoplasmosis",
            "Onychomycosis",
            "Other fungal infections"
        ],
        "dosage": {
            "adults": "100-400 mg orally daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hepatotoxicity",
            "GI upset",
            "Heart failure (rare)"
        ],
        "contraindications": [
            "Heart failure",
            "Concurrent use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Contraindicated except for life-threatening infections."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amphotericin b": {
        "definition": "A polyene antifungal used for serious systemic fungal infections.",
        "mechanism": "Binds ergosterol, forming pores in fungal cell membranes.",
        "indications": [
            "Systemic fungal infections",
            "Leishmaniasis"
        ],
        "dosage": {
            "adults": "0.3-1.5 mg/kg IV daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Infusion reactions",
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Hypersensitivity to amphotericin B"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amphotericin b lipid complex": {
        "definition": "A lipid formulation of amphotericin B with reduced nephrotoxicity.",
        "mechanism": "Binds ergosterol, forming pores in fungal cell membranes.",
        "indications": [
            "Systemic fungal infections"
        ],
        "dosage": {
            "adults": "5 mg/kg IV daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Electrolyte disturbances",
            "Nephrotoxicity (less than conventional)"
        ],
        "contraindications": [
            "Hypersensitivity to amphotericin B"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "voriconazole": {
        "definition": "A triazole antifungal used to treat serious fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Aspergillosis",
            "Candidemia",
            "Other serious fungal infections"
        ],
        "dosage": {
            "adults": "Loading: 6 mg/kg IV every 12h x2, then 4 mg/kg IV every 12h or 200-300 mg orally every 12h.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Visual disturbances",
            "Hepatotoxicity",
            "QT prolongation"
        ],
        "contraindications": [
            "Concurrent use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "posaconazole": {
        "definition": "A triazole antifungal used for prophylaxis and treatment of invasive fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Prophylaxis/treatment of invasive Aspergillus and Candida infections"
        ],
        "dosage": {
            "adults": "300 mg orally/IV twice daily on day 1, then 300 mg once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI upset",
            "Hepatotoxicity",
            "QT prolongation"
        ],
        "contraindications": [
            "Concurrent use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "caspofungin": {
        "definition": "An echinocandin antifungal used to treat invasive fungal infections.",
        "mechanism": "Inhibits synthesis of beta-(1,3)-D-glucan in fungal cell walls.",
        "indications": [
            "Invasive candidiasis",
            "Aspergillosis (refractory)"
        ],
        "dosage": {
            "adults": "Loading: 70 mg IV, then 50 mg IV daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to caspofungin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cyclosporine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amphotericin b liposomal": {
        "definition": "A liposomal formulation of amphotericin B with reduced nephrotoxicity.",
        "mechanism": "Binds ergosterol, forming pores in fungal cell membranes.",
        "indications": [
            "Systemic fungal infections",
            "Visceral leishmaniasis"
        ],
        "dosage": {
            "adults": "3-5 mg/kg IV daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Electrolyte disturbances",
            "Nephrotoxicity (less than conventional)"
        ],
        "contraindications": [
            "Hypersensitivity to amphotericin B"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isavuconazonium": {
        "definition": "A triazole antifungal prodrug used to treat invasive aspergillosis and mucormycosis.",
        "mechanism": "Converted to isavuconazole, which inhibits ergosterol synthesis.",
        "indications": [
            "Invasive aspergillosis",
            "Mucormycosis"
        ],
        "dosage": {
            "adults": "Loading: 372 mg IV/PO every 8h x6, then 372 mg once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "GI upset",
            "Hepatotoxicity",
            "Hypokalemia"
        ],
        "contraindications": [
            "Concurrent use with strong CYP3A4 inhibitors/inducers"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ipratropium": {
        "definition": "An anticholinergic bronchodilator used for COPD and asthma.",
        "mechanism": "Blocks muscarinic receptors in bronchial smooth muscle.",
        "indications": [
            "COPD",
            "Asthma (adjunct)"
        ],
        "dosage": {
            "adults": "2 inhalations (17 mcg each) 4 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Dry mouth",
            "Cough",
            "Blurred vision"
        ],
        "contraindications": [
            "Hypersensitivity to ipratropium or atropine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flunisolide": {
        "definition": "An inhaled corticosteroid used to treat asthma.",
        "mechanism": "Suppresses airway inflammation.",
        "indications": [
            "Asthma (maintenance therapy)"
        ],
        "dosage": {
            "adults": "160-320 mcg inhaled twice daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Oral candidiasis",
            "Hoarseness",
            "Throat irritation"
        ],
        "contraindications": [
            "Hypersensitivity to flunisolide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "formoterol": {
        "definition": "A long-acting beta-2 agonist bronchodilator used for asthma and COPD maintenance.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchodilation.",
        "indications": [
            "Asthma (with ICS)",
            "COPD"
        ],
        "dosage": {
            "adults": "12 mcg inhaled twice daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Tremor",
            "Palpitations",
            "Headache"
        ],
        "contraindications": [
            "Monotherapy in asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vilanterol": {
        "definition": "A long-acting beta-2 agonist bronchodilator used in combination inhalers for asthma and COPD.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchodilation.",
        "indications": [
            "Asthma (with ICS)",
            "COPD (with ICS/LAMA)"
        ],
        "dosage": {
            "adults": "25 mcg inhaled once daily (in combination).",
            "children": "Not recommended as monotherapy."
        },
        "side effects": [
            "Tremor",
            "Palpitations",
            "Headache"
        ],
        "contraindications": [
            "Monotherapy in asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ciclesonide": {
        "definition": "An inhaled corticosteroid used for asthma maintenance therapy.",
        "mechanism": "Suppresses airway inflammation.",
        "indications": [
            "Asthma (maintenance therapy)"
        ],
        "dosage": {
            "adults": "80-320 mcg inhaled once or twice daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Oral candidiasis",
            "Hoarseness",
            "Throat irritation"
        ],
        "contraindications": [
            "Hypersensitivity to ciclesonide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "budesonide": {
        "definition": "An inhaled corticosteroid used for asthma, COPD, and inflammatory bowel disease.",
        "mechanism": "Suppresses airway and mucosal inflammation.",
        "indications": [
            "Asthma",
            "COPD (with LABA)",
            "Crohn's disease",
            "Ulcerative colitis (rectal foam)"
        ],
        "dosage": {
            "adults": "Inhaled: 180-720 mcg twice daily; Oral: 9 mg once daily (IBD); Rectal: 2 mg once daily.",
            "children": "Inhaled: 90-360 mcg twice daily (age 6+)."
        },
        "side effects": [
            "Oral candidiasis",
            "Hoarseness",
            "Growth suppression (children)"
        ],
        "contraindications": [
            "Hypersensitivity to budesonide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "beclomethasone": {
        "definition": "An inhaled corticosteroid used for asthma and allergic rhinitis.",
        "mechanism": "Suppresses airway and mucosal inflammation.",
        "indications": [
            "Asthma",
            "Allergic rhinitis"
        ],
        "dosage": {
            "adults": "Inhaled: 40-320 mcg twice daily; Nasal: 1-2 sprays per nostril twice daily.",
            "children": "Inhaled: 40-80 mcg twice daily (age 5+)."
        },
        "side effects": [
            "Oral candidiasis",
            "Hoarseness",
            "Growth suppression (children)"
        ],
        "contraindications": [
            "Hypersensitivity to beclomethasone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "children": "Monitor growth with long-term use."
        },
        "interactions": [
            "Other corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium chloride": {
        "definition": "An electrolyte supplement used to treat hypocalcemia, cardiac arrest, and hyperkalemia.",
        "mechanism": "Provides calcium ions essential for muscle contraction, nerve transmission, and cardiac function.",
        "indications": [
            "Hypocalcemia",
            "Cardiac arrest",
            "Hyperkalemia",
            "Calcium channel blocker overdose"
        ],
        "dosage": {
            "adults": "500-1000 mg IV slowly.",
            "children": "20 mg/kg IV slowly."
        },
        "side effects": [
            "Vasodilation",
            "Bradycardia",
            "Tissue necrosis (extravasation)"
        ],
        "contraindications": [
            "Ventricular fibrillation",
            "Hypercalcemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clotrimazole": {
        "definition": "An imidazole antifungal used topically for skin and mucosal fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Dermatophytosis",
            "Candidiasis",
            "Tinea infections"
        ],
        "dosage": {
            "adults": "Topical: apply 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to clotrimazole"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant (topical)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "terbinafine": {
        "definition": "An allylamine antifungal used for dermatophyte and nail infections.",
        "mechanism": "Inhibits squalene epoxidase, blocking ergosterol synthesis.",
        "indications": [
            "Onychomycosis",
            "Tinea infections"
        ],
        "dosage": {
            "adults": "Oral: 250 mg once daily; Topical: apply once or twice daily.",
            "children": "Oral: 62.5-250 mg once daily (by weight)."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Chronic or active liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2D6 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "econazole": {
        "definition": "An imidazole antifungal used topically for skin and mucosal fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Dermatophytosis",
            "Candidiasis",
            "Tinea infections"
        ],
        "dosage": {
            "adults": "Topical: apply once or twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to econazole"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant (topical)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tolnaftate": {
        "definition": "A topical antifungal agent used for dermatophyte infections.",
        "mechanism": "Inhibits squalene epoxidase, blocking ergosterol synthesis.",
        "indications": [
            "Tinea pedis",
            "Tinea cruris",
            "Tinea corporis"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to tolnaftate"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ciclopirox": {
        "definition": "A topical antifungal and anti-inflammatory agent used for skin and nail infections.",
        "mechanism": "Disrupts fungal cell membrane transport.",
        "indications": [
            "Dermatophytosis",
            "Onychomycosis",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area once or twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to ciclopirox"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "miconazole": {
        "definition": "An imidazole antifungal used topically for skin and mucosal fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Dermatophytosis",
            "Candidiasis",
            "Tinea infections"
        ],
        "dosage": {
            "adults": "Apply 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity to miconazole"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Warfarin (rare, topical)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "griseofulvin": {
        "definition": "An oral antifungal used for dermatophyte infections of skin, hair, and nails.",
        "mechanism": "Disrupts fungal mitosis by binding to microtubules.",
        "indications": [
            "Tinea capitis",
            "Tinea corporis",
            "Tinea unguium"
        ],
        "dosage": {
            "adults": "500-1000 mg orally once daily.",
            "children": "10-20 mg/kg/day."
        },
        "side effects": [
            "Headache",
            "GI upset",
            "Photosensitivity"
        ],
        "contraindications": [
            "Liver failure",
            "Porphyria",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Warfarin",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "halobetasol": {
        "definition": "A super-high potency topical corticosteroid for inflammatory and pruritic skin disorders.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Psoriasis",
            "Eczema",
            "Other inflammatory skin conditions"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area once or twice daily for up to 2 weeks.",
            "children": "Not recommended for children <12 years."
        },
        "side effects": [
            "Skin atrophy",
            "Striae",
            "Systemic absorption (rare)"
        ],
        "contraindications": [
            "Viral, fungal, or tubercular skin infections",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pimecrolimus": {
        "definition": "A topical calcineurin inhibitor used for mild to moderate atopic dermatitis.",
        "mechanism": "Inhibits T-cell activation and cytokine release.",
        "indications": [
            "Atopic dermatitis (mild to moderate)"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area twice daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Application site burning",
            "Pruritus",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to pimecrolimus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants (topical/systemic)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alclometasone": {
        "definition": "A low- to medium-potency topical corticosteroid for mild inflammatory skin conditions.",
        "mechanism": "Suppresses inflammation and immune responses in the skin.",
        "indications": [
            "Mild inflammatory skin conditions",
            "Eczema",
            "Dermatitis"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 2-3 times daily.",
            "children": "Safe for use in children ≥1 year."
        },
        "side effects": [
            "Skin irritation",
            "Atrophy (rare)",
            "Contact dermatitis"
        ],
        "contraindications": [
            "Hypersensitivity to alclometasone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "esmolol": {
        "definition": "A short-acting beta-1 selective blocker used for rapid control of supraventricular tachycardia and hypertension.",
        "mechanism": "Blocks beta-1 adrenergic receptors, reducing heart rate and contractility.",
        "indications": [
            "Supraventricular tachycardia",
            "Intraoperative/postoperative tachycardia",
            "Hypertensive emergencies"
        ],
        "dosage": {
            "adults": "Loading: 500 mcg/kg IV over 1 min, then 50-200 mcg/kg/min infusion.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Heart block"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Heart block",
            "Decompensated heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Calcium channel blockers",
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ibutilide": {
        "definition": "A class III antiarrhythmic used for acute conversion of atrial fibrillation and flutter.",
        "mechanism": "Prolongs cardiac action potential by enhancing slow inward sodium current.",
        "indications": [
            "Acute conversion of atrial fibrillation/flutter"
        ],
        "dosage": {
            "adults": "1 mg IV over 10 min (repeat once if needed).",
            "children": "0.01 mg/kg IV over 10 min."
        },
        "side effects": [
            "QT prolongation",
            "Torsades de pointes",
            "Hypotension"
        ],
        "contraindications": [
            "QT prolongation",
            "Ventricular tachycardia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "adenosine": {
        "definition": "A purine nucleoside used to treat paroxysmal supraventricular tachycardia (PSVT).",
        "mechanism": "Slows AV node conduction via adenosine receptors.",
        "indications": [
            "Paroxysmal supraventricular tachycardia (PSVT)"
        ],
        "dosage": {
            "adults": "6 mg rapid IV push; may repeat with 12 mg if needed.",
            "children": "0.1-0.2 mg/kg rapid IV push."
        },
        "side effects": [
            "Flushing",
            "Chest discomfort",
            "Transient asystole"
        ],
        "contraindications": [
            "Second/third-degree AV block",
            "Sick sinus syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Dipyridamole",
            "Methylxanthines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "estradiol": {
        "definition": "A natural estrogen hormone used for hormone replacement therapy and contraception.",
        "mechanism": "Binds to estrogen receptors, regulating gene expression.",
        "indications": [
            "Menopausal symptoms",
            "Hypoestrogenism",
            "Contraception (in combination)"
        ],
        "dosage": {
            "adults": "Oral: 0.5-2 mg daily; Transdermal: 0.025-0.1 mg patch twice weekly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Breast tenderness",
            "Thromboembolism"
        ],
        "contraindications": [
            "Estrogen-dependent cancer",
            "Thromboembolic disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "conjugated estrogens": {
        "definition": "A mixture of natural estrogens used for hormone replacement therapy.",
        "mechanism": "Binds to estrogen receptors, regulating gene expression.",
        "indications": [
            "Menopausal symptoms",
            "Hypoestrogenism",
            "Osteoporosis prevention"
        ],
        "dosage": {
            "adults": "0.3-1.25 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Breast tenderness",
            "Thromboembolism"
        ],
        "contraindications": [
            "Estrogen-dependent cancer",
            "Thromboembolic disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ziprasidone": {
        "definition": "An atypical antipsychotic used for schizophrenia and bipolar disorder.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder"
        ],
        "dosage": {
            "adults": "20-80 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "QT prolongation",
            "Sedation",
            "Weight gain"
        ],
        "contraindications": [
            "QT prolongation",
            "Recent MI"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paliperidone": {
        "definition": "An atypical antipsychotic used for schizophrenia and schizoaffective disorder.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Schizoaffective disorder"
        ],
        "dosage": {
            "adults": "3-12 mg orally once daily.",
            "children": "3-12 mg once daily (age 12+)."
        },
        "side effects": [
            "Hyperprolactinemia",
            "QT prolongation",
            "Weight gain"
        ],
        "contraindications": [
            "Hypersensitivity to paliperidone or risperidone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oseltamivir": {
        "definition": "A neuraminidase inhibitor antiviral used to treat and prevent influenza A and B.",
        "mechanism": "Inhibits influenza virus neuraminidase, preventing viral release.",
        "indications": [
            "Influenza A and B (treatment and prophylaxis)"
        ],
        "dosage": {
            "adults": "75 mg orally twice daily for 5 days (treatment); once daily for prophylaxis.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Neuropsychiatric events"
        ],
        "contraindications": [
            "Hypersensitivity to oseltamivir"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live attenuated influenza vaccine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "influenza virus vaccine, h5n1": {
        "definition": "An inactivated vaccine for prevention of influenza A (H5N1) infection.",
        "mechanism": "Induces immunity against H5N1 influenza virus.",
        "indications": [
            "Prevention of influenza A (H5N1)"
        ],
        "dosage": {
            "adults": "1 mL IM, 2 doses 21 days apart.",
            "children": "Dose by age."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Myalgia"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "tisagenlecleucel": {
        "definition": "A CD19-directed CAR-T cell therapy for certain leukemias and lymphomas.",
        "mechanism": "Genetically modified T cells target and kill CD19+ cancer cells.",
        "indications": [
            "B-cell ALL (pediatric/young adult)",
            "Diffuse large B-cell lymphoma"
        ],
        "dosage": {
            "adults": "Single IV infusion (dose by weight).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Cytokine release syndrome",
            "Neurotoxicity",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to tisagenlecleucel"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyanocobalamin": {
        "definition": "Vitamin B12, used to treat and prevent B12 deficiency.",
        "mechanism": "Essential cofactor for DNA synthesis and neurologic function.",
        "indications": [
            "Vitamin B12 deficiency",
            "Pernicious anemia"
        ],
        "dosage": {
            "adults": "100-1000 mcg IM/SC monthly or orally daily.",
            "children": "Dose by age and deficiency severity."
        },
        "side effects": [
            "Injection site reactions",
            "Hypokalemia (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to cyanocobalamin"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Chloramphenicol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atovaquone": {
        "definition": "An antiprotozoal and antimalarial agent.",
        "mechanism": "Inhibits mitochondrial electron transport in parasites.",
        "indications": [
            "Pneumocystis jirovecii pneumonia (PCP)",
            "Babesiosis",
            "Malaria (with proguanil)"
        ],
        "dosage": {
            "adults": "750 mg orally twice daily (PCP); 1000 mg daily (babesiosis); 250 mg/100 mg with proguanil for malaria.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to atovaquone"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Rifampin",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tramadol": {
        "definition": "A centrally acting analgesic for moderate to moderately severe pain.",
        "mechanism": "Weak mu-opioid receptor agonist and inhibits reuptake of norepinephrine and serotonin.",
        "indications": [
            "Moderate to moderately severe pain"
        ],
        "dosage": {
            "adults": "50-100 mg orally every 4-6 hours (max 400 mg/day).",
            "children": "Not recommended."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Seizures",
            "Dependence"
        ],
        "contraindications": [
            "Acute intoxication",
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amikacin": {
        "definition": "An aminoglycoside antibiotic for serious Gram-negative infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Serious Gram-negative infections",
            "Mycobacterial infections"
        ],
        "dosage": {
            "adults": "15-20 mg/kg IV/IM daily in 1-2 divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Ototoxicity",
            "Neuromuscular blockade"
        ],
        "contraindications": [
            "Hypersensitivity to aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefepime": {
        "definition": "A fourth-generation cephalosporin antibiotic for serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Serious Gram-negative and Gram-positive infections",
            "Febrile neutropenia"
        ],
        "dosage": {
            "adults": "1-2 g IV every 8-12 hours.",
            "children": "50 mg/kg IV every 8-12 hours."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Neurotoxicity (high dose)"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ceftazidime": {
        "definition": "A third-generation cephalosporin antibiotic for serious Gram-negative infections, including Pseudomonas.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Serious Gram-negative infections",
            "Pseudomonas infections"
        ],
        "dosage": {
            "adults": "1-2 g IV every 8-12 hours.",
            "children": "50 mg/kg IV every 8-12 hours."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gentamicin": {
        "definition": "An aminoglycoside antibiotic for serious Gram-negative infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Serious Gram-negative infections",
            "Synergy for Gram-positive infections"
        ],
        "dosage": {
            "adults": "5-7 mg/kg IV/IM daily (once-daily or divided).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Ototoxicity",
            "Neuromuscular blockade"
        ],
        "contraindications": [
            "Hypersensitivity to aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "linezolid": {
        "definition": "An oxazolidinone antibiotic for resistant Gram-positive infections, including MRSA and VRE.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "MRSA infections",
            "VRE infections",
            "Pneumonia",
            "Skin infections"
        ],
        "dosage": {
            "adults": "600 mg orally/IV every 12 hours.",
            "children": "10 mg/kg every 8 hours."
        },
        "side effects": [
            "Myelosuppression",
            "Peripheral neuropathy",
            "Serotonin syndrome"
        ],
        "contraindications": [
            "MAO inhibitor use within 2 weeks"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "SSRIs",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "erythromycin": {
        "definition": "A macrolide antibiotic for respiratory, skin, and some GI infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.",
        "indications": [
            "Respiratory tract infections",
            "Skin infections",
            "Gastroparesis (off-label)"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6-12 hours.",
            "children": "30-50 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "QT prolongation",
            "Cholestatic hepatitis"
        ],
        "contraindications": [
            "Liver disease",
            "Concomitant use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tobramycin": {
        "definition": "An aminoglycoside antibiotic for serious Gram-negative infections and inhaled for cystic fibrosis.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Serious Gram-negative infections",
            "Inhaled for Pseudomonas in cystic fibrosis"
        ],
        "dosage": {
            "adults": "5-7 mg/kg IV/IM daily (once-daily or divided); Inhaled: 300 mg twice daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Ototoxicity",
            "Bronchospasm (inhaled)"
        ],
        "contraindications": [
            "Hypersensitivity to aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "polymyxin b": {
        "definition": "A polymyxin antibiotic for Gram-negative infections, often topical or ophthalmic.",
        "mechanism": "Disrupts bacterial cell membrane by binding to phospholipids.",
        "indications": [
            "Serious Gram-negative infections (topical, ophthalmic, rarely IV)"
        ],
        "dosage": {
            "adults": "IV: 1.5-2.5 mg/kg/day in divided doses; Topical: as directed.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Neurotoxicity",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to polymyxins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bacitracin": {
        "definition": "A topical polypeptide antibiotic for skin and eye infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Superficial skin infections",
            "Ophthalmic infections"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to bacitracin"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant (topical)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefadroxil": {
        "definition": "A first-generation cephalosporin antibiotic for skin, urinary, and respiratory infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Skin infections",
            "Urinary tract infections",
            "Pharyngitis"
        ],
        "dosage": {
            "adults": "500-1000 mg orally every 12-24 hours.",
            "children": "30 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefazolin": {
        "definition": "A first-generation cephalosporin antibiotic for surgical prophylaxis and various infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Surgical prophylaxis",
            "Skin infections",
            "Urinary tract infections"
        ],
        "dosage": {
            "adults": "1-2 g IV every 8 hours.",
            "children": "25-100 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzalkonium chloride": {
        "definition": "A quaternary ammonium compound used as a topical antiseptic and preservative.",
        "mechanism": "Disrupts microbial cell membranes.",
        "indications": [
            "Skin antisepsis",
            "Preservative in ophthalmic/nasal solutions"
        ],
        "dosage": {
            "adults": "Apply as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to benzalkonium chloride"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other topical antiseptics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pramoxine": {
        "definition": "A topical local anesthetic for minor skin irritation and hemorrhoids.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Minor skin irritation",
            "Hemorrhoids"
        ],
        "dosage": {
            "adults": "Apply to affected area up to 5 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to pramoxine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acetic acid": {
        "definition": "A topical solution used for otitis externa and as a urinary acidifier.",
        "mechanism": "Lowers pH, inhibiting bacterial and fungal growth.",
        "indications": [
            "Otitis externa",
            "Urinary acidification"
        ],
        "dosage": {
            "adults": "Otic: 3-5 drops in ear 3-4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Ear irritation",
            "Burning"
        ],
        "contraindications": [
            "Perforated tympanic membrane (otic use)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "secnidazole": {
        "definition": "A nitroimidazole antibiotic for bacterial vaginosis and protozoal infections.",
        "mechanism": "Disrupts DNA synthesis in susceptible organisms.",
        "indications": [
            "Bacterial vaginosis",
            "Trichomoniasis",
            "Giardiasis",
            "Amebiasis"
        ],
        "dosage": {
            "adults": "2 g orally as a single dose.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Vaginal yeast infection"
        ],
        "contraindications": [
            "Hypersensitivity to secnidazole or other nitroimidazoles"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "meclizine": {
        "definition": "A first-generation antihistamine used for motion sickness and vertigo.",
        "mechanism": "Blocks histamine H1 receptors in the CNS.",
        "indications": [
            "Motion sickness",
            "Vertigo"
        ],
        "dosage": {
            "adults": "25-50 mg orally 1 hour before travel, then every 24 hours as needed.",
            "children": "Not recommended for children <12 years."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Blurred vision"
        ],
        "contraindications": [
            "Hypersensitivity to meclizine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sincalide": {
        "definition": "A synthetic cholecystokinin (CCK) analog used as a diagnostic agent.",
        "mechanism": "Stimulates gallbladder contraction and pancreatic secretion.",
        "indications": [
            "Gallbladder and pancreatic function testing"
        ],
        "dosage": {
            "adults": "0.02 mcg/kg IV over 30-60 seconds.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Abdominal pain",
            "Nausea",
            "Flushing"
        ],
        "contraindications": [
            "Intestinal obstruction",
            "Hypersensitivity to sincalide"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium sulfate": {
        "definition": "An electrolyte supplement used for hypomagnesemia, eclampsia, and as a tocolytic.",
        "mechanism": "Provides magnesium ions, essential for neuromuscular and cardiac function.",
        "indications": [
            "Hypomagnesemia",
            "Eclampsia",
            "Tocolysis"
        ],
        "dosage": {
            "adults": "1-4 g IV/IM; eclampsia: 4-6 g IV loading, then 1-2 g/hr infusion.",
            "children": "25-50 mg/kg/dose."
        },
        "side effects": [
            "Flushing",
            "Hypotension",
            "Respiratory depression"
        ],
        "contraindications": [
            "Heart block",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Indicated for eclampsia/toxemia."
        },
        "interactions": [
            "Calcium channel blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nebivolol": {
        "definition": "A beta-1 selective blocker with vasodilatory properties for hypertension and heart failure.",
        "mechanism": "Blocks beta-1 adrenergic receptors and increases nitric oxide release.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "5-40 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Heart block",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nadolol": {
        "definition": "A non-selective beta blocker for hypertension, angina, and arrhythmias.",
        "mechanism": "Blocks beta-1 and beta-2 adrenergic receptors.",
        "indications": [
            "Hypertension",
            "Angina",
            "Arrhythmias"
        ],
        "dosage": {
            "adults": "40-320 mg orally once daily.",
            "children": "0.5-2 mg/kg once daily."
        },
        "side effects": [
            "Bradycardia",
            "Fatigue",
            "Dizziness"
        ],
        "contraindications": [
            "Bronchial asthma",
            "Bradycardia",
            "Heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Calcium channel blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "labetalol": {
        "definition": "A non-selective beta and alpha-1 blocker for hypertension and hypertensive emergencies.",
        "mechanism": "Blocks beta-1, beta-2, and alpha-1 adrenergic receptors.",
        "indications": [
            "Hypertension",
            "Hypertensive emergencies",
            "Preeclampsia"
        ],
        "dosage": {
            "adults": "100-400 mg orally twice daily; IV: 20-80 mg bolus or 1-2 mg/min infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bradycardia",
            "Orthostatic hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Bronchial asthma",
            "Heart block",
            "Severe bradycardia"
        ],
        "special populations": {
            "pregnancy": "Preferred for severe hypertension in pregnancy."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rifampin": {
        "definition": "A rifamycin antibiotic for tuberculosis and other bacterial infections.",
        "mechanism": "Inhibits bacterial RNA polymerase.",
        "indications": [
            "Tuberculosis",
            "Meningococcal prophylaxis",
            "Leprosy"
        ],
        "dosage": {
            "adults": "600 mg orally/IV once daily.",
            "children": "10-20 mg/kg once daily."
        },
        "side effects": [
            "Hepatotoxicity",
            "Orange discoloration of body fluids",
            "Drug interactions"
        ],
        "contraindications": [
            "Hypersensitivity to rifampin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP450 inducers (many drug interactions)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "imiquimod": {
        "definition": "A topical immune response modifier for skin conditions.",
        "mechanism": "Induces cytokine production, enhancing immune response.",
        "indications": [
            "Genital warts",
            "Actinic keratosis",
            "Superficial basal cell carcinoma"
        ],
        "dosage": {
            "adults": "Apply to affected area 2-3 times weekly.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Local skin reactions",
            "Erythema",
            "Flu-like symptoms"
        ],
        "contraindications": [
            "Hypersensitivity to imiquimod"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vismodegib": {
        "definition": "A hedgehog pathway inhibitor for advanced basal cell carcinoma.",
        "mechanism": "Inhibits Smoothened (SMO) receptor, blocking hedgehog signaling.",
        "indications": [
            "Metastatic or locally advanced basal cell carcinoma"
        ],
        "dosage": {
            "adults": "150 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Muscle spasms",
            "Alopecia",
            "Dysgeusia"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (teratogenic)."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sonidegib": {
        "definition": "A hedgehog pathway inhibitor used for advanced basal cell carcinoma.",
        "mechanism": "Inhibits Smoothened (SMO) receptor, blocking hedgehog signaling.",
        "indications": [
            "Locally advanced basal cell carcinoma"
        ],
        "dosage": {
            "adults": "200 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Muscle spasms",
            "Alopecia",
            "Dysgeusia"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (teratogenic)."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sumatriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine and cluster headache.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine",
            "Cluster headache"
        ],
        "dosage": {
            "adults": "25-100 mg orally as a single dose; may repeat after 2 hours (max 200 mg/day).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Tingling",
            "Flushing",
            "Chest discomfort"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rizatriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine"
        ],
        "dosage": {
            "adults": "5-10 mg orally at onset; may repeat after 2 hours (max 30 mg/day).",
            "children": "5-10 mg (age 6-17, by weight)."
        },
        "side effects": [
            "Dizziness",
            "Fatigue",
            "Chest discomfort"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "butalbital": {
        "definition": "A barbiturate used in combination for tension headaches and migraine.",
        "mechanism": "Depresses sensory cortex, producing sedation and muscle relaxation.",
        "indications": [
            "Tension headaches (in combination)"
        ],
        "dosage": {
            "adults": "Usually 50 mg per dose in combination products.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Dependence"
        ],
        "contraindications": [
            "Porphyria",
            "Severe respiratory depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyclobenzaprine": {
        "definition": "A skeletal muscle relaxant used for muscle spasm.",
        "mechanism": "Reduces tonic somatic motor activity via brainstem.",
        "indications": [
            "Muscle spasm (short-term)"
        ],
        "dosage": {
            "adults": "5-10 mg orally 3 times daily.",
            "children": "Not recommended for children <15 years."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Dizziness"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Hyperthyroidism",
            "Heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naratriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine"
        ],
        "dosage": {
            "adults": "1-2.5 mg orally at onset; may repeat after 4 hours (max 5 mg/day).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dizziness",
            "Fatigue",
            "Chest discomfort"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "almotriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine"
        ],
        "dosage": {
            "adults": "6.25-12.5 mg orally at onset; may repeat after 2 hours (max 25 mg/day).",
            "children": "6.25-12.5 mg (age 12-17)."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Fatigue"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zolmitriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine"
        ],
        "dosage": {
            "adults": "1.25-5 mg orally at onset; may repeat after 2 hours (max 10 mg/day).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Chest discomfort"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eletriptan": {
        "definition": "A selective serotonin (5-HT1B/1D) agonist for acute migraine.",
        "mechanism": "Vasoconstricts cranial blood vessels and inhibits neuropeptide release.",
        "indications": [
            "Acute migraine"
        ],
        "dosage": {
            "adults": "20-40 mg orally at onset; may repeat after 2 hours (max 80 mg/day).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dizziness",
            "Nausea",
            "Chest discomfort"
        ],
        "contraindications": [
            "Ischemic heart disease",
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other triptans",
            "SSRIs/SNRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "collagenase": {
        "definition": "An enzyme used for enzymatic debridement of chronic dermal ulcers and severe burns.",
        "mechanism": "Breaks down collagen in necrotic tissue.",
        "indications": [
            "Debridement of chronic dermal ulcers",
            "Burns"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area once daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Local irritation",
            "Pain",
            "Erythema"
        ],
        "contraindications": [
            "Allergy to collagenase or excipients"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Detergents, heavy metal ions (inactivate enzyme)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "becaplermin": {
        "definition": "A recombinant human platelet-derived growth factor for diabetic foot ulcers.",
        "mechanism": "Stimulates cell proliferation and wound healing.",
        "indications": [
            "Diabetic foot ulcers"
        ],
        "dosage": {
            "adults": "Apply thin layer to ulcer once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Erythema",
            "Rash",
            "Increased cancer risk (long-term use)"
        ],
        "contraindications": [
            "Malignancy at site of application"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cadexomer iodine": {
        "definition": "A topical antimicrobial used for chronic wounds and ulcers.",
        "mechanism": "Releases iodine slowly, providing sustained antimicrobial activity.",
        "indications": [
            "Chronic wounds",
            "Ulcers"
        ],
        "dosage": {
            "adults": "Apply to wound bed every 1-3 days.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Local irritation",
            "Iodine absorption (thyroid dysfunction)"
        ],
        "contraindications": [
            "Iodine sensitivity",
            "Thyroid disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other iodine-containing products"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "imipramine": {
        "definition": "A tricyclic antidepressant used for depression and enuresis.",
        "mechanism": "Inhibits reuptake of norepinephrine and serotonin.",
        "indications": [
            "Depression",
            "Nocturnal enuresis (children)"
        ],
        "dosage": {
            "adults": "75-200 mg orally daily in divided doses.",
            "children": "10-75 mg at bedtime (enuresis, age 6+)."
        },
        "side effects": [
            "Anticholinergic effects",
            "Orthostatic hypotension",
            "Arrhythmias"
        ],
        "contraindications": [
            "Recent MI",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "belladonna": {
        "definition": "A plant-derived anticholinergic alkaloid used in GI disorders and as an antispasmodic.",
        "mechanism": "Blocks muscarinic acetylcholine receptors.",
        "indications": [
            "GI spasms",
            "Irritable bowel syndrome (historical use)"
        ],
        "dosage": {
            "adults": "Varies by preparation.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Tachycardia"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "praziquantel": {
        "definition": "An antihelminthic agent for schistosomiasis and other fluke/tapeworm infections.",
        "mechanism": "Increases parasite cell membrane permeability to calcium.",
        "indications": [
            "Schistosomiasis",
            "Clonorchiasis",
            "Tapeworm infections"
        ],
        "dosage": {
            "adults": "20 mg/kg orally 3 times in one day.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Abdominal pain",
            "Dizziness",
            "Headache"
        ],
        "contraindications": [
            "Ocular cysticercosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "apremilast": {
        "definition": "A phosphodiesterase-4 inhibitor for psoriatic arthritis and plaque psoriasis.",
        "mechanism": "Inhibits PDE4, increasing cAMP and reducing inflammation.",
        "indications": [
            "Psoriatic arthritis",
            "Plaque psoriasis"
        ],
        "dosage": {
            "adults": "30 mg orally twice daily (titrated up).",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Diarrhea",
            "Nausea",
            "Weight loss"
        ],
        "contraindications": [
            "Hypersensitivity to apremilast"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "simethicone": {
        "definition": "An anti-foaming agent for relief of bloating and gas.",
        "mechanism": "Reduces surface tension of gas bubbles in the GI tract.",
        "indications": [
            "Gas relief",
            "Bloating"
        ],
        "dosage": {
            "adults": "40-125 mg orally after meals and at bedtime.",
            "children": "20-40 mg orally after meals and at bedtime."
        },
        "side effects": [
            "Rare; GI upset possible"
        ],
        "contraindications": [
            "Hypersensitivity to simethicone"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aluminum hydroxide": {
        "definition": "An antacid and phosphate binder.",
        "mechanism": "Neutralizes gastric acid; binds dietary phosphate in the gut.",
        "indications": [
            "Hyperacidity",
            "Hyperphosphatemia (CKD)"
        ],
        "dosage": {
            "adults": "500-1500 mg orally as needed.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Constipation",
            "Hypophosphatemia"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Fluoroquinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium hydroxide": {
        "definition": "An antacid and osmotic laxative.",
        "mechanism": "Neutralizes gastric acid; draws water into intestines.",
        "indications": [
            "Hyperacidity",
            "Constipation"
        ],
        "dosage": {
            "adults": "400-1200 mg orally as antacid; 15-60 mL (milk of magnesia) as laxative.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia (renal impairment)"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Fluoroquinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "modafinil": {
        "definition": "A CNS stimulant for narcolepsy, sleep apnea, and shift work sleep disorder.",
        "mechanism": "Unclear; increases dopamine in the brain.",
        "indications": [
            "Narcolepsy",
            "Obstructive sleep apnea",
            "Shift work sleep disorder"
        ],
        "dosage": {
            "adults": "200 mg orally once daily (morning).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Insomnia"
        ],
        "contraindications": [
            "Hypersensitivity to modafinil"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "armodafinil": {
        "definition": "A CNS stimulant for narcolepsy, sleep apnea, and shift work sleep disorder.",
        "mechanism": "R-enantiomer of modafinil; increases dopamine in the brain.",
        "indications": [
            "Narcolepsy",
            "Obstructive sleep apnea",
            "Shift work sleep disorder"
        ],
        "dosage": {
            "adults": "150-250 mg orally once daily (morning).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Insomnia"
        ],
        "contraindications": [
            "Hypersensitivity to armodafinil"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tamsulosin": {
        "definition": "An alpha-1A adrenergic blocker for benign prostatic hyperplasia (BPH).",
        "mechanism": "Relaxes smooth muscle in the prostate and bladder neck.",
        "indications": [
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "0.4 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dizziness",
            "Orthostatic hypotension",
            "Ejaculation disorders"
        ],
        "contraindications": [
            "Hypersensitivity to tamsulosin"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other alpha blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxazosin": {
        "definition": "An alpha-1 adrenergic blocker for hypertension and BPH.",
        "mechanism": "Relaxes vascular and prostate smooth muscle.",
        "indications": [
            "Hypertension",
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "1-8 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dizziness",
            "Orthostatic hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to doxazosin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "terazosin": {
        "definition": "An alpha-1 adrenergic blocker for hypertension and BPH.",
        "mechanism": "Relaxes vascular and prostate smooth muscle.",
        "indications": [
            "Hypertension",
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "1-20 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dizziness",
            "Orthostatic hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity to terazosin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alfuzosin": {
        "definition": "An alpha-1 adrenergic blocker for benign prostatic hyperplasia (BPH).",
        "mechanism": "Relaxes smooth muscle in the prostate and bladder neck.",
        "indications": [
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "10 mg orally once daily (extended-release).",
            "children": "Not recommended."
        },
        "side effects": [
            "Dizziness",
            "Orthostatic hypotension",
            "Fatigue"
        ],
        "contraindications": [
            "Moderate to severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other alpha blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tadalafil": {
        "definition": "A phosphodiesterase-5 inhibitor for erectile dysfunction, BPH, and pulmonary hypertension.",
        "mechanism": "Inhibits PDE-5, increasing cGMP and causing vasodilation.",
        "indications": [
            "Erectile dysfunction",
            "Benign prostatic hyperplasia (BPH)",
            "Pulmonary arterial hypertension"
        ],
        "dosage": {
            "adults": "ED/BPH: 5-20 mg orally once daily or as needed; PAH: 40 mg once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Flushing",
            "Back pain"
        ],
        "contraindications": [
            "Nitrate therapy",
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Nitrates",
            "Alpha-blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dutasteride": {
        "definition": "A 5-alpha-reductase inhibitor for benign prostatic hyperplasia (BPH).",
        "mechanism": "Inhibits conversion of testosterone to dihydrotestosterone (DHT).",
        "indications": [
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "0.5 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Decreased libido",
            "Erectile dysfunction",
            "Gynecomastia"
        ],
        "contraindications": [
            "Pregnancy",
            "Women and children"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (teratogenic)."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "silodosin": {
        "definition": "An alpha-1A adrenergic blocker for benign prostatic hyperplasia (BPH).",
        "mechanism": "Relaxes smooth muscle in the prostate and bladder neck.",
        "indications": [
            "Benign prostatic hyperplasia (BPH)"
        ],
        "dosage": {
            "adults": "8 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Retrograde ejaculation",
            "Dizziness",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Severe hepatic impairment",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flumazenil": {
        "definition": "A benzodiazepine antagonist used to reverse benzodiazepine sedation/overdose.",
        "mechanism": "Competitively inhibits benzodiazepine binding at the GABA-A receptor.",
        "indications": [
            "Benzodiazepine overdose",
            "Reversal of sedation"
        ],
        "dosage": {
            "adults": "0.2 mg IV over 15 sec, repeat as needed (max 3 mg).",
            "children": "0.01 mg/kg IV."
        },
        "side effects": [
            "Seizures",
            "Agitation",
            "Dizziness"
        ],
        "contraindications": [
            "Cyclic antidepressant overdose",
            "Benzodiazepine dependence"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thiamine": {
        "definition": "Vitamin B1, used to treat deficiency and Wernicke-Korsakoff syndrome.",
        "mechanism": "Cofactor in carbohydrate metabolism.",
        "indications": [
            "Thiamine deficiency",
            "Wernicke-Korsakoff syndrome",
            "Beriberi"
        ],
        "dosage": {
            "adults": "100 mg IV/IM/orally daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Injection site reactions",
            "Hypersensitivity"
        ],
        "contraindications": [
            "Hypersensitivity to thiamine"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "luspatercept": {
        "definition": "An erythroid maturation agent for anemia in beta thalassemia and myelodysplastic syndromes.",
        "mechanism": "Binds TGF-beta superfamily ligands, enhancing erythroid maturation.",
        "indications": [
            "Beta thalassemia anemia",
            "Myelodysplastic syndromes"
        ],
        "dosage": {
            "adults": "1-1.75 mg/kg SC every 3 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Fatigue",
            "Hypertension",
            "Bone pain"
        ],
        "contraindications": [
            "Hypersensitivity to luspatercept"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cholic acid": {
        "definition": "A bile acid for bile acid synthesis disorders due to single enzyme defects.",
        "mechanism": "Replaces deficient primary bile acids.",
        "indications": [
            "Bile acid synthesis disorders"
        ],
        "dosage": {
            "adults": "10-15 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Diarrhea",
            "Hepatic impairment"
        ],
        "contraindications": [
            "Cirrhosis",
            "Complete biliary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Bile acid sequestrants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ursodiol": {
        "definition": "A bile acid for primary biliary cholangitis and gallstone dissolution.",
        "mechanism": "Reduces cholesterol absorption and secretion into bile.",
        "indications": [
            "Primary biliary cholangitis",
            "Gallstone dissolution"
        ],
        "dosage": {
            "adults": "13-15 mg/kg/day in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Diarrhea",
            "Nausea",
            "Headache"
        ],
        "contraindications": [
            "Acute cholecystitis",
            "Biliary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Bile acid sequestrants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "obeticholic acid": {
        "definition": "A farnesoid X receptor agonist for primary biliary cholangitis.",
        "mechanism": "Reduces bile acid synthesis and increases clearance.",
        "indications": [
            "Primary biliary cholangitis"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Pruritus",
            "Fatigue",
            "Abdominal pain"
        ],
        "contraindications": [
            "Complete biliary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Bile acid sequestrants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lamotrigine": {
        "definition": "An anticonvulsant and mood stabilizer for epilepsy and bipolar disorder.",
        "mechanism": "Blocks voltage-gated sodium channels, reducing neuronal firing.",
        "indications": [
            "Epilepsy",
            "Bipolar disorder"
        ],
        "dosage": {
            "adults": "25-400 mg orally daily (titrated).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Rash (SJS/TEN)",
            "Dizziness",
            "Diplopia"
        ],
        "contraindications": [
            "Hypersensitivity to lamotrigine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Valproate",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lithium": {
        "definition": "A mood stabilizer for bipolar disorder.",
        "mechanism": "Alters sodium transport and affects neurotransmitter signaling.",
        "indications": [
            "Bipolar disorder (mania, maintenance)"
        ],
        "dosage": {
            "adults": "900-1800 mg orally daily in divided doses (titrate to serum level).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Tremor",
            "Polyuria",
            "Hypothyroidism",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Severe renal or cardiac disease",
            "Pregnancy (risk of Ebstein anomaly)"
        ],
        "special populations": {
            "pregnancy": "Avoid if possible."
        },
        "interactions": [
            "Thiazide diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "divalproex sodium": {
        "definition": "An anticonvulsant and mood stabilizer for epilepsy, migraine, and bipolar disorder.",
        "mechanism": "Increases GABA, blocks sodium channels.",
        "indications": [
            "Epilepsy",
            "Migraine prophylaxis",
            "Bipolar disorder"
        ],
        "dosage": {
            "adults": "10-60 mg/kg/day orally in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hepatotoxicity",
            "Pancreatitis",
            "Tremor",
            "Weight gain"
        ],
        "contraindications": [
            "Liver disease",
            "Pregnancy (migraine prophylaxis)"
        ],
        "special populations": {
            "pregnancy": "Contraindicated for migraine; avoid if possible in others."
        },
        "interactions": [
            "Lamotrigine",
            "Aspirin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "allopurinol": {
        "definition": "A xanthine oxidase inhibitor for gout and hyperuricemia.",
        "mechanism": "Inhibits xanthine oxidase, reducing uric acid production.",
        "indications": [
            "Gout",
            "Hyperuricemia (tumor lysis syndrome)"
        ],
        "dosage": {
            "adults": "100-800 mg orally daily.",
            "children": "10 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash (SJS/TEN)",
            "GI upset",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Hypersensitivity to allopurinol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Azathioprine",
            "Mercaptopurine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium oxide": {
        "definition": "A magnesium supplement and antacid/laxative.",
        "mechanism": "Provides magnesium ions; neutralizes gastric acid; draws water into intestines.",
        "indications": [
            "Hypomagnesemia",
            "Constipation",
            "Antacid"
        ],
        "dosage": {
            "adults": "250-400 mg orally 1-4 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia (renal impairment)"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Fluoroquinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium citrate": {
        "definition": "An alkalinizing agent for nephrolithiasis and metabolic acidosis.",
        "mechanism": "Alkalinizes urine, increases urinary citrate.",
        "indications": [
            "Nephrolithiasis (uric acid/calcium stones)",
            "Metabolic acidosis"
        ],
        "dosage": {
            "adults": "10-30 mEq orally 2-4 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI upset",
            "Hyperkalemia"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atezolizumab": {
        "definition": "A PD-L1 inhibitor immunotherapy for various cancers.",
        "mechanism": "Blocks PD-L1, enhancing T-cell mediated immune response.",
        "indications": [
            "Urothelial carcinoma",
            "Non-small cell lung cancer",
            "Triple-negative breast cancer"
        ],
        "dosage": {
            "adults": "1200 mg IV every 3 weeks.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Fatigue",
            "Immune-mediated reactions",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to atezolizumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thiotepa": {
        "definition": "An alkylating agent for various cancers and as conditioning for bone marrow transplant.",
        "mechanism": "Alkylates DNA, causing cross-links and inhibiting DNA synthesis.",
        "indications": [
            "Ovarian cancer",
            "Breast cancer",
            "Bladder cancer",
            "Bone marrow transplant conditioning"
        ],
        "dosage": {
            "adults": "Dose by protocol and indication.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Mucositis",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to thiotepa"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "erdafitinib": {
        "definition": "A FGFR kinase inhibitor for urothelial carcinoma with FGFR genetic alterations.",
        "mechanism": "Inhibits FGFR1-4 kinases, blocking tumor growth.",
        "indications": [
            "Locally advanced/metastatic urothelial carcinoma (FGFR alteration)"
        ],
        "dosage": {
            "adults": "8-9 mg orally once daily.",
            "children": "Safety and efficacy not established."
        },
        "side effects": [
            "Hyperphosphatemia",
            "Stomatitis",
            "Nail disorders"
        ],
        "contraindications": [
            "Hypersensitivity to erdafitinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2C9/CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "darifenacin": {
        "definition": "A muscarinic antagonist for overactive bladder.",
        "mechanism": "Blocks M3 muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder (urge incontinence, urgency, frequency)"
        ],
        "dosage": {
            "adults": "7.5-15 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "onabotulinumtoxinA": {
        "definition": "A neurotoxin used for muscle spasticity, chronic migraine, and overactive bladder.",
        "mechanism": "Blocks acetylcholine release at neuromuscular junction.",
        "indications": [
            "Chronic migraine",
            "Cervical dystonia",
            "Overactive bladder",
            "Cosmetic use"
        ],
        "dosage": {
            "adults": "Dose varies by indication and site.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Muscle weakness",
            "Dysphagia",
            "Injection site pain"
        ],
        "contraindications": [
            "Infection at injection site",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefpodoxime": {
        "definition": "A third-generation cephalosporin antibiotic for respiratory and urinary infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Respiratory tract infections",
            "Urinary tract infections",
            "Skin infections"
        ],
        "dosage": {
            "adults": "100-400 mg orally every 12 hours.",
            "children": "10 mg/kg/day in divided doses."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fosfomycin": {
        "definition": "A broad-spectrum antibiotic for uncomplicated urinary tract infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis (enolpyruvyl transferase inhibitor).",
        "indications": [
            "Uncomplicated urinary tract infections"
        ],
        "dosage": {
            "adults": "3 g orally as a single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Headache",
            "Vaginitis"
        ],
        "contraindications": [
            "Hypersensitivity to fosfomycin"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Metoclopramide (reduces absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenazopyridine": {
        "definition": "A urinary analgesic for relief of dysuria.",
        "mechanism": "Exerts local analgesic effect on urinary tract mucosa.",
        "indications": [
            "Dysuria (urinary tract irritation)"
        ],
        "dosage": {
            "adults": "100-200 mg orally 3 times daily after meals.",
            "children": "12 mg/kg/day in divided doses."
        },
        "side effects": [
            "Orange/red urine",
            "GI upset",
            "Hemolytic anemia (rare)"
        ],
        "contraindications": [
            "Renal insufficiency",
            "Glucose-6-phosphate dehydrogenase deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentosan polysulfate sodium": {
        "definition": "A urinary analgesic for interstitial cystitis.",
        "mechanism": "Adheres to bladder mucosa, providing a protective layer.",
        "indications": [
            "Interstitial cystitis (bladder pain syndrome)"
        ],
        "dosage": {
            "adults": "100 mg orally 3 times daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Nausea",
            "Diarrhea",
            "Alopecia"
        ],
        "contraindications": [
            "Bleeding disorders",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trospium": {
        "definition": "A muscarinic antagonist for overactive bladder.",
        "mechanism": "Blocks muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder (urge incontinence, urgency, frequency)"
        ],
        "dosage": {
            "adults": "20 mg orally twice daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dimethyl sulfoxide": {
        "definition": "An intravesical anti-inflammatory for interstitial cystitis.",
        "mechanism": "Reduces inflammation and pain in the bladder.",
        "indications": [
            "Interstitial cystitis"
        ],
        "dosage": {
            "adults": "50 mL of 50% solution instilled into bladder once every 1-2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Garlic-like breath odor",
            "Bladder irritation",
            "Dysuria"
        ],
        "contraindications": [
            "Bladder malignancy",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxybutynin": {
        "definition": "A muscarinic antagonist for overactive bladder and neurogenic bladder.",
        "mechanism": "Blocks muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder",
            "Neurogenic bladder"
        ],
        "dosage": {
            "adults": "5-10 mg orally 2-3 times daily; ER: 5-30 mg once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tolterodine": {
        "definition": "A muscarinic antagonist for overactive bladder.",
        "mechanism": "Blocks muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder (urge incontinence, urgency, frequency)"
        ],
        "dosage": {
            "adults": "1-2 mg orally twice daily; ER: 2-4 mg once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mirabegron": {
        "definition": "A beta-3 adrenergic agonist for overactive bladder.",
        "mechanism": "Relaxes detrusor smooth muscle via beta-3 adrenergic receptor stimulation.",
        "indications": [
            "Overactive bladder"
        ],
        "dosage": {
            "adults": "25-50 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Hypertension",
            "Nasopharyngitis",
            "UTI"
        ],
        "contraindications": [
            "Severe uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2D6 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "solifenacin": {
        "definition": "A muscarinic antagonist for overactive bladder.",
        "mechanism": "Blocks muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder (urge incontinence, urgency, frequency)"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fesoterodine": {
        "definition": "A muscarinic antagonist for overactive bladder.",
        "mechanism": "Blocks muscarinic receptors in the bladder.",
        "indications": [
            "Overactive bladder (urge incontinence, urgency, frequency)"
        ],
        "dosage": {
            "adults": "4-8 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Blurred vision"
        ],
        "contraindications": [
            "Urinary retention",
            "Gastric retention",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluconazole": {
        "definition": "A triazole antifungal for candidiasis, cryptococcal meningitis, and other fungal infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Candidiasis",
            "Cryptococcal meningitis",
            "Other fungal infections"
        ],
        "dosage": {
            "adults": "100-400 mg orally/IV daily.",
            "children": "3-12 mg/kg/day."
        },
        "side effects": [
            "Hepatotoxicity",
            "GI upset",
            "QT prolongation"
        ],
        "contraindications": [
            "Concurrent use with certain drugs (see label)"
        ],
        "special populations": {
            "pregnancy": "Avoid high doses."
        },
        "interactions": [
            "CYP2C9, CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tranexamic acid": {
        "definition": "An antifibrinolytic agent for bleeding control in surgery, trauma, and heavy menstrual bleeding.",
        "mechanism": "Inhibits plasminogen activation, reducing fibrinolysis.",
        "indications": [
            "Heavy menstrual bleeding",
            "Surgical bleeding",
            "Trauma"
        ],
        "dosage": {
            "adults": "1-1.5 g orally/IV 2-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Thromboembolism (rare)",
            "Visual disturbances"
        ],
        "contraindications": [
            "Active intravascular clotting",
            "Subarachnoid hemorrhage"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other procoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "goserelin": {
        "definition": "A GnRH agonist for prostate cancer, breast cancer, and endometriosis.",
        "mechanism": "Suppresses gonadotropin secretion, reducing sex hormone levels.",
        "indications": [
            "Prostate cancer",
            "Breast cancer",
            "Endometriosis"
        ],
        "dosage": {
            "adults": "3.6 mg SC every 28 days or 10.8 mg every 12 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Decreased libido",
            "Osteoporosis"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dextran, high molecular weight": {
        "definition": "A plasma volume expander for hypovolemia and shock.",
        "mechanism": "Increases plasma oncotic pressure, expanding intravascular volume.",
        "indications": [
            "Hypovolemia",
            "Shock"
        ],
        "dosage": {
            "adults": "500-1000 mL IV (concentration varies).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Anaphylaxis",
            "Volume overload",
            "Bleeding"
        ],
        "contraindications": [
            "Severe heart failure",
            "Renal failure",
            "Bleeding disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "incobotulinumtoxinA": {
        "definition": "A botulinum toxin type A for muscle spasticity, dystonia, and blepharospasm.",
        "mechanism": "Blocks acetylcholine release at neuromuscular junction.",
        "indications": [
            "Cervical dystonia",
            "Blepharospasm",
            "Upper limb spasticity"
        ],
        "dosage": {
            "adults": "Dose varies by indication and site.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Muscle weakness",
            "Dysphagia",
            "Injection site pain"
        ],
        "contraindications": [
            "Infection at injection site",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pseudoephedrine": {
        "definition": "A sympathomimetic decongestant for nasal congestion.",
        "mechanism": "Stimulates alpha-adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Nasal congestion"
        ],
        "dosage": {
            "adults": "60 mg orally every 4-6 hours (max 240 mg/day).",
            "children": "Dose by age."
        },
        "side effects": [
            "Insomnia",
            "Nervousness",
            "Hypertension"
        ],
        "contraindications": [
            "Severe hypertension",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other sympathomimetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxymetazoline": {
        "definition": "A topical nasal decongestant.",
        "mechanism": "Stimulates alpha-adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Nasal congestion"
        ],
        "dosage": {
            "adults": "2-3 sprays per nostril twice daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Rebound congestion",
            "Nasal irritation"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium chloride": {
        "definition": "An electrolyte supplement and irrigation solution.",
        "mechanism": "Provides sodium and chloride ions for fluid/electrolyte balance.",
        "indications": [
            "Hyponatremia",
            "Fluid replacement",
            "Irrigation"
        ],
        "dosage": {
            "adults": "IV: 0.9% (normal saline) as needed; oral/irrigation: as directed.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Fluid overload",
            "Hypernatremia"
        ],
        "contraindications": [
            "Hypernatremia",
            "Fluid retention states"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "xylometazoline": {
        "definition": "A topical nasal decongestant.",
        "mechanism": "Stimulates alpha-adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Nasal congestion"
        ],
        "dosage": {
            "adults": "2-3 sprays per nostril twice daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Rebound congestion",
            "Nasal irritation"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "apixaban": {
        "definition": "An oral direct factor Xa inhibitor anticoagulant.",
        "mechanism": "Inhibits factor Xa, preventing thrombin generation and clot formation.",
        "indications": [
            "Atrial fibrillation",
            "DVT",
            "PE",
            "VTE prophylaxis"
        ],
        "dosage": {
            "adults": "2.5-5 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Anemia",
            "GI upset"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4/P-gp inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dabigatran": {
        "definition": "An oral direct thrombin inhibitor anticoagulant.",
        "mechanism": "Inhibits thrombin (factor IIa), preventing clot formation.",
        "indications": [
            "Atrial fibrillation",
            "DVT",
            "PE",
            "VTE prophylaxis"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "GI upset",
            "Dyspepsia"
        ],
        "contraindications": [
            "Active bleeding",
            "Mechanical heart valves"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fondaparinux": {
        "definition": "A synthetic pentasaccharide anticoagulant (factor Xa inhibitor).",
        "mechanism": "Binds antithrombin III, selectively inhibiting factor Xa.",
        "indications": [
            "DVT",
            "PE",
            "VTE prophylaxis"
        ],
        "dosage": {
            "adults": "2.5-10 mg SC once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Anemia",
            "Injection site reactions"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "edoxaban": {
        "definition": "An oral direct factor Xa inhibitor anticoagulant.",
        "mechanism": "Inhibits factor Xa, preventing thrombin generation and clot formation.",
        "indications": [
            "Atrial fibrillation",
            "DVT",
            "PE"
        ],
        "dosage": {
            "adults": "30-60 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Anemia",
            "GI upset"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "urokinase": {
        "definition": "A thrombolytic agent for lysis of pulmonary emboli and catheter clearance.",
        "mechanism": "Converts plasminogen to plasmin, dissolving fibrin clots.",
        "indications": [
            "Pulmonary embolism",
            "Catheter clearance"
        ],
        "dosage": {
            "adults": "4400 units/kg IV bolus, then 4400 units/kg/hr infusion.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Allergic reactions"
        ],
        "contraindications": [
            "Active bleeding",
            "Recent major surgery"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hetastarch": {
        "definition": "A synthetic colloid plasma volume expander.",
        "mechanism": "Increases plasma oncotic pressure, expanding intravascular volume.",
        "indications": [
            "Hypovolemia",
            "Shock"
        ],
        "dosage": {
            "adults": "500-1000 mL IV (concentration varies).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Anaphylaxis",
            "Volume overload",
            "Coagulopathy"
        ],
        "contraindications": [
            "Severe heart failure",
            "Renal failure",
            "Bleeding disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nortriptyline": {
        "definition": "A tricyclic antidepressant for depression and neuropathic pain.",
        "mechanism": "Inhibits reuptake of norepinephrine and serotonin.",
        "indications": [
            "Depression",
            "Neuropathic pain"
        ],
        "dosage": {
            "adults": "25-150 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Anticholinergic effects",
            "Orthostatic hypotension",
            "Arrhythmias"
        ],
        "contraindications": [
            "Recent MI",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "capsaicin": {
        "definition": "A topical analgesic for neuropathic and musculoskeletal pain.",
        "mechanism": "Desensitizes sensory neurons by depleting substance P.",
        "indications": [
            "Neuropathic pain",
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "Apply to affected area 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Burning",
            "Stinging",
            "Erythema"
        ],
        "contraindications": [
            "Hypersensitivity to capsaicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ioversol": {
        "definition": "A non-ionic, low-osmolar iodinated contrast agent for intravascular imaging.",
        "mechanism": "Enhances X-ray contrast by increasing absorption in blood vessels/tissues.",
        "indications": [
            "CT scans",
            "Angiography"
        ],
        "dosage": {
            "adults": "Dose varies by procedure and concentration.",
            "children": "Dose by weight and procedure."
        },
        "side effects": [
            "Nausea",
            "Allergic reactions",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to iodinated contrast agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor renal function."
        },
        "interactions": [
            "Metformin (risk of lactic acidosis)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "permethrin": {
        "definition": "A topical insecticide for scabies and lice.",
        "mechanism": "Disrupts sodium channels in parasite nerve cell membranes.",
        "indications": [
            "Scabies",
            "Lice"
        ],
        "dosage": {
            "adults": "Apply cream/lotion to affected area, leave on 8-14 hours, then rinse.",
            "children": "Same as adults (age 2+ months)."
        },
        "side effects": [
            "Itching",
            "Burning",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to permethrin or pyrethroids"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lindane": {
        "definition": "A topical insecticide for scabies and lice (use limited due to neurotoxicity).",
        "mechanism": "Disrupts GABA neurotransmission in parasite nervous system.",
        "indications": [
            "Scabies",
            "Lice (second-line)"
        ],
        "dosage": {
            "adults": "Apply thin layer, leave on 8-12 hours, then rinse.",
            "children": "Not recommended for infants and young children."
        },
        "side effects": [
            "Neurotoxicity",
            "Seizures",
            "Skin irritation"
        ],
        "contraindications": [
            "Seizure disorders",
            "Premature infants",
            "Skin inflammation"
        ],
        "special populations": {
            "pregnancy": "Avoid if possible."
        },
        "interactions": [
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "piperonyl butoxide": {
        "definition": "A synergist in topical insecticide formulations for lice.",
        "mechanism": "Inhibits insect detoxification enzymes, enhancing insecticide efficacy.",
        "indications": [
            "Lice (in combination with pyrethrins)"
        ],
        "dosage": {
            "adults": "Apply as directed in combination products.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrethrins": {
        "definition": "Natural insecticides for lice (used with piperonyl butoxide).",
        "mechanism": "Disrupt sodium channels in parasite nerve cell membranes.",
        "indications": [
            "Lice"
        ],
        "dosage": {
            "adults": "Apply to dry hair, leave on 10 minutes, then rinse.",
            "children": "Same as adults (age 2+ years)."
        },
        "side effects": [
            "Itching",
            "Burning",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to pyrethrins or chrysanthemums"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "spinosad": {
        "definition": "A topical insecticide for head lice.",
        "mechanism": "Activates nicotinic acetylcholine receptors in lice, causing paralysis.",
        "indications": [
            "Head lice"
        ],
        "dosage": {
            "adults": "Apply to dry scalp/hair, leave on 10 minutes, then rinse.",
            "children": "Same as adults (age 6+ months)."
        },
        "side effects": [
            "Eye irritation",
            "Redness",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to spinosad"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dactinomycin": {
        "definition": "An antineoplastic antibiotic for Wilms tumor, rhabdomyosarcoma, and other cancers.",
        "mechanism": "Intercalates DNA, inhibiting RNA synthesis.",
        "indications": [
            "Wilms tumor",
            "Rhabdomyosarcoma",
            "Ewing sarcoma",
            "Gestational trophoblastic neoplasia"
        ],
        "dosage": {
            "adults": "10-15 mcg/kg IV daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "GI toxicity",
            "Alopecia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dicloxacillin": {
        "definition": "A penicillinase-resistant penicillin antibiotic used for staphylococcal infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.",
        "indications": [
            "Staphylococcal infections (MSSA)",
            "Skin and soft tissue infections"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6 hours.",
            "children": "12.5-25 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Methotrexate",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "busulfan": {
        "definition": "An alkylating agent used for chronic myeloid leukemia and bone marrow transplant conditioning.",
        "mechanism": "Alkylates DNA, causing cross-links and inhibiting DNA synthesis.",
        "indications": [
            "Chronic myeloid leukemia",
            "Bone marrow transplant conditioning"
        ],
        "dosage": {
            "adults": "0.06-2 mg/kg orally/IV per protocol.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Pulmonary fibrosis",
            "Seizures"
        ],
        "contraindications": [
            "Hypersensitivity to busulfan"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Phenytoin",
            "Itraconazole"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "denosumab": {
        "definition": "A monoclonal antibody for osteoporosis and bone metastases.",
        "mechanism": "Inhibits RANKL, reducing osteoclast activity and bone resorption.",
        "indications": [
            "Osteoporosis",
            "Bone metastases",
            "Giant cell tumor of bone"
        ],
        "dosage": {
            "adults": "60 mg SC every 6 months (osteoporosis); 120 mg SC every 4 weeks (cancer).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypocalcemia",
            "Infection",
            "Osteonecrosis of the jaw"
        ],
        "contraindications": [
            "Hypocalcemia"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zoledronic acid": {
        "definition": "A bisphosphonate for osteoporosis, Paget's disease, and hypercalcemia of malignancy.",
        "mechanism": "Inhibits osteoclast-mediated bone resorption.",
        "indications": [
            "Osteoporosis",
            "Paget's disease",
            "Hypercalcemia of malignancy"
        ],
        "dosage": {
            "adults": "5 mg IV once yearly (osteoporosis); 4 mg IV single dose (hypercalcemia).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fever",
            "Hypocalcemia",
            "Osteonecrosis of the jaw"
        ],
        "contraindications": [
            "Hypocalcemia",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pamidronate": {
        "definition": "A bisphosphonate for hypercalcemia of malignancy, Paget's disease, and bone metastases.",
        "mechanism": "Inhibits osteoclast-mediated bone resorption.",
        "indications": [
            "Hypercalcemia of malignancy",
            "Paget's disease",
            "Bone metastases"
        ],
        "dosage": {
            "adults": "30-90 mg IV over 2-24 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fever",
            "Hypocalcemia",
            "Osteonecrosis of the jaw"
        ],
        "contraindications": [
            "Hypocalcemia",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium": {
        "definition": "An essential mineral for bone health, muscle function, and nerve transmission.",
        "mechanism": "Provides calcium ions for physiological processes.",
        "indications": [
            "Hypocalcemia",
            "Osteoporosis prevention",
            "Dietary supplementation"
        ],
        "dosage": {
            "adults": "1000-1300 mg elemental calcium daily (diet + supplements).",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Hypercalcemia (high doses)"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Ventricular fibrillation"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vitamin d": {
        "definition": "A fat-soluble vitamin for bone health and calcium absorption.",
        "mechanism": "Promotes intestinal absorption of calcium and phosphate.",
        "indications": [
            "Vitamin D deficiency",
            "Osteoporosis prevention",
            "Rickets"
        ],
        "dosage": {
            "adults": "600-2000 IU daily (maintenance); higher for deficiency.",
            "children": "400-1000 IU daily."
        },
        "side effects": [
            "Hypercalcemia (high doses)",
            "GI upset"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Thiazide diuretics",
            "Corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium carbonate": {
        "definition": "A calcium supplement and antacid.",
        "mechanism": "Provides calcium ions; neutralizes gastric acid.",
        "indications": [
            "Hypocalcemia",
            "Osteoporosis prevention",
            "Antacid"
        ],
        "dosage": {
            "adults": "500-1000 mg orally 1-3 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Hypercalcemia (high doses)"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Ventricular fibrillation"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "risedronate": {
        "definition": "A bisphosphonate for osteoporosis and Paget's disease.",
        "mechanism": "Inhibits osteoclast-mediated bone resorption.",
        "indications": [
            "Osteoporosis",
            "Paget's disease"
        ],
        "dosage": {
            "adults": "35 mg orally once weekly or 150 mg once monthly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Esophagitis",
            "Osteonecrosis of the jaw (rare)"
        ],
        "contraindications": [
            "Hypocalcemia",
            "Inability to sit/stand upright for 30 min"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Calcium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ibandronate": {
        "definition": "A bisphosphonate for osteoporosis treatment and prevention.",
        "mechanism": "Inhibits osteoclast-mediated bone resorption.",
        "indications": [
            "Osteoporosis"
        ],
        "dosage": {
            "adults": "150 mg orally once monthly or 3 mg IV every 3 months.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Esophagitis",
            "Osteonecrosis of the jaw (rare)"
        ],
        "contraindications": [
            "Hypocalcemia",
            "Inability to sit/stand upright for 60 min"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Calcium supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "raloxifene": {
        "definition": "A selective estrogen receptor modulator (SERM) for osteoporosis and breast cancer risk reduction.",
        "mechanism": "Estrogen agonist in bone, antagonist in breast/uterus.",
        "indications": [
            "Osteoporosis prevention/treatment",
            "Breast cancer risk reduction"
        ],
        "dosage": {
            "adults": "60 mg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Hot flashes",
            "Leg cramps",
            "Venous thromboembolism"
        ],
        "contraindications": [
            "Active or past VTE",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Cholestyramine",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcitonin": {
        "definition": "A hormone for osteoporosis, Paget's disease, and hypercalcemia.",
        "mechanism": "Inhibits osteoclast activity, reducing bone resorption.",
        "indications": [
            "Osteoporosis",
            "Paget's disease",
            "Hypercalcemia"
        ],
        "dosage": {
            "adults": "Nasal: 200 IU once daily; IM/SC: 100 IU daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nasal irritation",
            "Flushing",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to salmon calcitonin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Lithium"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "teriparatide": {
        "definition": "A recombinant parathyroid hormone analog for osteoporosis.",
        "mechanism": "Stimulates osteoblast activity, increasing bone formation.",
        "indications": [
            "Osteoporosis (high risk)"
        ],
        "dosage": {
            "adults": "20 mcg SC once daily (max 2 years).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypercalcemia",
            "Leg cramps",
            "Nausea"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Bone metastases",
            "Paget's disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clozapine": {
        "definition": "An atypical antipsychotic for treatment-resistant schizophrenia.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Treatment-resistant schizophrenia",
            "Suicidal behavior in schizophrenia"
        ],
        "dosage": {
            "adults": "12.5-900 mg orally daily (titrated).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Agranulocytosis",
            "Seizures",
            "Weight gain",
            "Myocarditis"
        ],
        "contraindications": [
            "History of agranulocytosis",
            "Uncontrolled epilepsy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors",
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lurasidone": {
        "definition": "An atypical antipsychotic for schizophrenia and bipolar depression.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar depression"
        ],
        "dosage": {
            "adults": "20-160 mg orally once daily with food.",
            "children": "20-80 mg once daily (age 13+)."
        },
        "side effects": [
            "Somnolence",
            "Akathisia",
            "Nausea"
        ],
        "contraindications": [
            "Strong CYP3A4 inhibitors/inducers"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "l-methylfolate": {
        "definition": "A biologically active form of folate used as a medical food for depression and folate deficiency.",
        "mechanism": "Provides active folate for neurotransmitter synthesis and methylation.",
        "indications": [
            "Folate deficiency",
            "Adjunct in depression (medical food)"
        ],
        "dosage": {
            "adults": "7.5-15 mg orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Rare; GI upset possible"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "asenapine": {
        "definition": "An atypical antipsychotic for schizophrenia and bipolar disorder.",
        "mechanism": "Antagonist at dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia",
            "Bipolar disorder"
        ],
        "dosage": {
            "adults": "5-10 mg sublingually twice daily.",
            "children": "2.5-10 mg twice daily (age 10+ for bipolar)."
        },
        "side effects": [
            "Somnolence",
            "Weight gain",
            "Oral hypoesthesia"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "botulism immune globulin": {
        "definition": "A human immune globulin for treatment of infant botulism.",
        "mechanism": "Provides passive immunity by neutralizing botulinum toxin.",
        "indications": [
            "Infant botulism"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "50 mg/kg IV as a single dose (infants <1 year)."
        },
        "side effects": [
            "Infusion reactions",
            "Rash",
            "Fever"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "botulism antitoxin": {
        "definition": "A polyclonal antibody preparation for treatment of botulism in adults and children.",
        "mechanism": "Neutralizes circulating botulinum toxin.",
        "indications": [
            "Botulism (all ages)"
        ],
        "dosage": {
            "adults": "One vial IV (dose by product).",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Serum sickness",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity to antitoxin components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "polyethylene glycol 3350": {
        "definition": "An osmotic laxative for occasional constipation and bowel preparation.",
        "mechanism": "Retains water in the stool, increasing stool frequency and softness.",
        "indications": [
            "Occasional constipation",
            "Bowel preparation (higher doses)"
        ],
        "dosage": {
            "adults": "17 g powder in 4-8 oz liquid once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Bloating",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Bowel obstruction",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bisacodyl": {
        "definition": "A stimulant laxative used for constipation and bowel preparation.",
        "mechanism": "Stimulates enteric nerves to cause colonic contractions.",
        "indications": [
            "Constipation",
            "Bowel preparation"
        ],
        "dosage": {
            "adults": "5-15 mg orally once daily or 10 mg rectally.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Abdominal cramps",
            "Diarrhea",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Bowel obstruction",
            "Acute surgical abdomen"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Milk (may dissolve enteric coating)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "polyethylene glycol 3350 with electrolytes": {
        "definition": "An osmotic laxative with electrolytes for bowel cleansing before colonoscopy.",
        "mechanism": "Retains water in stool and balances electrolytes.",
        "indications": [
            "Bowel preparation for colonoscopy"
        ],
        "dosage": {
            "adults": "240 mL every 10 minutes until 4 L consumed or rectal effluent is clear.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Nausea",
            "Bloating",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Bowel obstruction",
            "GI perforation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium sulfate": {
        "definition": "An electrolyte used in oral bowel preparations and to treat hypokalemia.",
        "mechanism": "Provides potassium ions for physiological functions.",
        "indications": [
            "Bowel preparation",
            "Hypokalemia (rare)"
        ],
        "dosage": {
            "adults": "As part of bowel prep, per product instructions.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperkalemia",
            "GI upset"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium-sparing diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium sulfate": {
        "definition": "An osmotic laxative and electrolyte used in bowel preparation.",
        "mechanism": "Draws water into the colon, promoting evacuation.",
        "indications": [
            "Bowel preparation for colonoscopy"
        ],
        "dosage": {
            "adults": "As part of bowel prep, per product instructions.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dehydration",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "GI obstruction",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium picosulfate": {
        "definition": "A stimulant laxative for bowel preparation.",
        "mechanism": "Stimulates colonic peristalsis via enteric nerve activation.",
        "indications": [
            "Bowel preparation for colonoscopy"
        ],
        "dosage": {
            "adults": "10 mg orally as part of combination bowel prep.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "GI obstruction",
            "Acute surgical abdomen"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carmustine": {
        "definition": "An alkylating agent used for brain tumors, multiple myeloma, and lymphoma.",
        "mechanism": "Alkylates DNA and RNA, inhibiting replication and transcription.",
        "indications": [
            "Brain tumors",
            "Multiple myeloma",
            "Lymphoma"
        ],
        "dosage": {
            "adults": "150-200 mg/m² IV every 6 weeks (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Pulmonary fibrosis",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to carmustine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tamoxifen": {
        "definition": "A selective estrogen receptor modulator (SERM) for breast cancer.",
        "mechanism": "Estrogen antagonist in breast tissue, agonist in bone/uterus.",
        "indications": [
            "Breast cancer treatment and prevention"
        ],
        "dosage": {
            "adults": "20-40 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Thromboembolism",
            "Endometrial cancer"
        ],
        "contraindications": [
            "History of DVT/PE",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Warfarin",
            "CYP2D6 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anastrozole": {
        "definition": "An aromatase inhibitor for hormone receptor-positive breast cancer.",
        "mechanism": "Inhibits aromatase, reducing estrogen synthesis.",
        "indications": [
            "Hormone receptor-positive breast cancer (postmenopausal women)"
        ],
        "dosage": {
            "adults": "1 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Arthralgia",
            "Osteoporosis"
        ],
        "contraindications": [
            "Premenopausal women",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Estrogens",
            "Tamoxifen"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "letrozole": {
        "definition": "An aromatase inhibitor for hormone receptor-positive breast cancer.",
        "mechanism": "Inhibits aromatase, reducing estrogen synthesis.",
        "indications": [
            "Hormone receptor-positive breast cancer (postmenopausal women)"
        ],
        "dosage": {
            "adults": "2.5 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Arthralgia",
            "Osteoporosis"
        ],
        "contraindications": [
            "Premenopausal women",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Estrogens",
            "Tamoxifen"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "exemestane": {
        "definition": "An aromatase inhibitor for hormone receptor-positive breast cancer.",
        "mechanism": "Irreversibly inhibits aromatase, reducing estrogen synthesis.",
        "indications": [
            "Hormone receptor-positive breast cancer (postmenopausal women)"
        ],
        "dosage": {
            "adults": "25 mg orally once daily after a meal.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Arthralgia",
            "Osteoporosis"
        ],
        "contraindications": [
            "Premenopausal women",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Estrogens",
            "Tamoxifen"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paclitaxel": {
        "definition": "A taxane antineoplastic for breast, ovarian, and lung cancer.",
        "mechanism": "Stabilizes microtubules, inhibiting cell division.",
        "indications": [
            "Breast cancer",
            "Ovarian cancer",
            "Non-small cell lung cancer"
        ],
        "dosage": {
            "adults": "Dose by protocol (e.g., 175 mg/m² IV every 3 weeks).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Alopecia",
            "Peripheral neuropathy"
        ],
        "contraindications": [
            "Severe hypersensitivity to paclitaxel or polyoxyethylated castor oil"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trastuzumab": {
        "definition": "A monoclonal antibody for HER2-positive breast and gastric cancers.",
        "mechanism": "Binds HER2 receptor, inhibiting cell proliferation.",
        "indications": [
            "HER2-positive breast cancer",
            "HER2-positive gastric cancer"
        ],
        "dosage": {
            "adults": "Loading: 8 mg/kg IV, then 6 mg/kg IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cardiotoxicity",
            "Infusion reactions",
            "Pulmonary toxicity"
        ],
        "contraindications": [
            "Hypersensitivity to trastuzumab"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anthracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epirubicin": {
        "definition": "An anthracycline antineoplastic for breast cancer.",
        "mechanism": "Intercalates DNA, inhibits topoisomerase II, generates free radicals.",
        "indications": [
            "Breast cancer"
        ],
        "dosage": {
            "adults": "60-120 mg/m² IV every 3-4 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Cardiotoxicity",
            "Alopecia"
        ],
        "contraindications": [
            "Severe cardiac disease",
            "Hypersensitivity to anthracyclines"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Trastuzumab",
            "Other cardiotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "leuprolide": {
        "definition": "A GnRH agonist for prostate cancer, endometriosis, and precocious puberty.",
        "mechanism": "Suppresses gonadotropin secretion, reducing sex hormone levels.",
        "indications": [
            "Prostate cancer",
            "Endometriosis",
            "Precocious puberty"
        ],
        "dosage": {
            "adults": "3.75-22.5 mg IM/SC monthly or every 3 months.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hot flashes",
            "Decreased libido",
            "Osteoporosis"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "neratinib": {
        "definition": "A tyrosine kinase inhibitor for HER2-positive breast cancer.",
        "mechanism": "Irreversibly inhibits HER2, EGFR, and HER4 kinases.",
        "indications": [
            "HER2-positive breast cancer (extended adjuvant)"
        ],
        "dosage": {
            "adults": "240 mg orally once daily with food.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Hepatotoxicity",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity to neratinib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "palbociclib": {
        "definition": "A CDK4/6 inhibitor for HR-positive, HER2-negative breast cancer.",
        "mechanism": "Inhibits cyclin-dependent kinases 4 and 6, blocking cell cycle progression.",
        "indications": [
            "HR-positive, HER2-negative breast cancer (with endocrine therapy)"
        ],
        "dosage": {
            "adults": "125 mg orally once daily for 21 days, then 7 days off.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Fatigue",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to palbociclib"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alpelisib": {
        "definition": "A PI3K inhibitor for HR-positive, HER2-negative, PIK3CA-mutated breast cancer.",
        "mechanism": "Inhibits PI3K-alpha, blocking cell proliferation.",
        "indications": [
            "HR-positive, HER2-negative, PIK3CA-mutated breast cancer"
        ],
        "dosage": {
            "adults": "300 mg orally once daily with food.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperglycemia",
            "Rash",
            "Diarrhea"
        ],
        "contraindications": [
            "Severe hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fulvestrant": {
        "definition": "An estrogen receptor antagonist for HR-positive metastatic breast cancer.",
        "mechanism": "Binds and degrades estrogen receptors.",
        "indications": [
            "HR-positive metastatic breast cancer (postmenopausal women)"
        ],
        "dosage": {
            "adults": "500 mg IM on days 1, 15, 29, then monthly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site pain",
            "Nausea",
            "Hot flashes"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "docetaxel": {
        "definition": "A taxane antineoplastic for breast, prostate, and other cancers.",
        "mechanism": "Stabilizes microtubules, inhibiting cell division.",
        "indications": [
            "Breast cancer",
            "Prostate cancer",
            "Non-small cell lung cancer"
        ],
        "dosage": {
            "adults": "60-100 mg/m² IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Fluid retention",
            "Alopecia"
        ],
        "contraindications": [
            "Severe hypersensitivity to docetaxel or polysorbate 80"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eribulin": {
        "definition": "A microtubule inhibitor for metastatic breast cancer and liposarcoma.",
        "mechanism": "Inhibits microtubule growth, blocking cell division.",
        "indications": [
            "Metastatic breast cancer",
            "Liposarcoma"
        ],
        "dosage": {
            "adults": "1.4 mg/m² IV on days 1 and 8 of a 21-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Fatigue",
            "Peripheral neuropathy"
        ],
        "contraindications": [
            "Hypersensitivity to eribulin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "testosterone": {
        "definition": "An androgen hormone for hypogonadism and certain anemias.",
        "mechanism": "Binds androgen receptors, promoting male secondary sexual characteristics.",
        "indications": [
            "Male hypogonadism",
            "Delayed puberty",
            "Certain anemias"
        ],
        "dosage": {
            "adults": "50-400 mg IM every 2-4 weeks; topical/patch as directed.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Acne",
            "Gynecomastia",
            "Polycythemia"
        ],
        "contraindications": [
            "Prostate or breast cancer",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methyltestosterone": {
        "definition": "An oral androgen for hypogonadism and certain anemias.",
        "mechanism": "Binds androgen receptors, promoting male secondary sexual characteristics.",
        "indications": [
            "Male hypogonadism",
            "Delayed puberty",
            "Certain anemias"
        ],
        "dosage": {
            "adults": "10-50 mg orally daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Liver toxicity",
            "Acne",
            "Gynecomastia"
        ],
        "contraindications": [
            "Prostate or breast cancer",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluoxymesterone": {
        "definition": "An oral androgen for hypogonadism and certain anemias.",
        "mechanism": "Binds androgen receptors, promoting male secondary sexual characteristics.",
        "indications": [
            "Male hypogonadism",
            "Delayed puberty",
            "Certain anemias"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally 1-3 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Liver toxicity",
            "Acne",
            "Gynecomastia"
        ],
        "contraindications": [
            "Prostate or breast cancer",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "esterified estrogens": {
        "definition": "A mixture of estrogenic substances for hormone replacement therapy.",
        "mechanism": "Binds to estrogen receptors, regulating gene expression.",
        "indications": [
            "Menopausal symptoms",
            "Hypoestrogenism"
        ],
        "dosage": {
            "adults": "0.3-1.25 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Breast tenderness",
            "Thromboembolism"
        ],
        "contraindications": [
            "Estrogen-dependent cancer",
            "Thromboembolic disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metoclopramide": {
        "definition": "A dopamine antagonist for gastroparesis, GERD, and antiemesis.",
        "mechanism": "Blocks dopamine D2 receptors, enhances GI motility.",
        "indications": [
            "Gastroparesis",
            "GERD",
            "Nausea and vomiting"
        ],
        "dosage": {
            "adults": "10 mg orally/IV/IM 3-4 times daily.",
            "children": "0.1-0.2 mg/kg/dose."
        },
        "side effects": [
            "Drowsiness",
            "Extrapyramidal symptoms",
            "Tardive dyskinesia"
        ],
        "contraindications": [
            "GI obstruction",
            "Pheochromocytoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antipsychotics",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "guaifenesin": {
        "definition": "An expectorant for cough and chest congestion.",
        "mechanism": "Increases respiratory tract fluid, thinning mucus.",
        "indications": [
            "Cough",
            "Chest congestion"
        ],
        "dosage": {
            "adults": "200-400 mg orally every 4 hours (max 2.4 g/day).",
            "children": "Dose by age."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to guaifenesin"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ribavirin": {
        "definition": "An antiviral for hepatitis C (in combination) and RSV infection (inhaled).",
        "mechanism": "Inhibits viral RNA synthesis.",
        "indications": [
            "Hepatitis C (with other antivirals)",
            "RSV infection (inhaled)"
        ],
        "dosage": {
            "adults": "800-1200 mg orally daily in divided doses.",
            "children": "Inhaled: 20 mg/mL for 12-18 hours/day."
        },
        "side effects": [
            "Hemolytic anemia",
            "Teratogenicity",
            "Fatigue"
        ],
        "contraindications": [
            "Pregnancy",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Didanosine",
            "Zidovudine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "palivizumab": {
        "definition": "A monoclonal antibody for prevention of RSV infection in high-risk infants.",
        "mechanism": "Binds RSV F protein, preventing viral entry.",
        "indications": [
            "Prevention of RSV infection in high-risk infants"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "15 mg/kg IM monthly during RSV season."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity to palivizumab"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aclidinium": {
        "definition": "A long-acting anticholinergic bronchodilator for COPD.",
        "mechanism": "Blocks muscarinic receptors in bronchial smooth muscle.",
        "indications": [
            "COPD maintenance therapy"
        ],
        "dosage": {
            "adults": "400 mcg inhaled twice daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Cough",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity to aclidinium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "roflumilast": {
        "definition": "A phosphodiesterase-4 inhibitor for severe COPD with chronic bronchitis.",
        "mechanism": "Inhibits PDE4, reducing inflammation in the lungs.",
        "indications": [
            "Severe COPD with chronic bronchitis"
        ],
        "dosage": {
            "adults": "500 mcg orally once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Weight loss",
            "Diarrhea",
            "Depression"
        ],
        "contraindications": [
            "Moderate to severe liver impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "umeclidinium": {
        "definition": "A long-acting anticholinergic bronchodilator for COPD.",
        "mechanism": "Blocks muscarinic receptors in bronchial smooth muscle.",
        "indications": [
            "COPD maintenance therapy"
        ],
        "dosage": {
            "adults": "62.5 mcg inhaled once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Dry mouth",
            "Cough",
            "Pharyngitis"
        ],
        "contraindications": [
            "Hypersensitivity to umeclidinium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olodaterol": {
        "definition": "A long-acting beta-2 agonist bronchodilator for COPD.",
        "mechanism": "Stimulates beta-2 adrenergic receptors, causing bronchodilation.",
        "indications": [
            "COPD maintenance therapy"
        ],
        "dosage": {
            "adults": "5 mcg inhaled once daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Cough",
            "Nasopharyngitis",
            "Dizziness"
        ],
        "contraindications": [
            "Asthma (monotherapy)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tiotropium": {
        "definition": "A long-acting anticholinergic bronchodilator for COPD and asthma.",
        "mechanism": "Blocks muscarinic receptors in bronchial smooth muscle.",
        "indications": [
            "COPD maintenance therapy",
            "Asthma (adjunct)"
        ],
        "dosage": {
            "adults": "18 mcg inhaled once daily (HandiHaler); 2.5-5 mcg (Respimat).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention"
        ],
        "contraindications": [
            "Hypersensitivity to tiotropium"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dyphylline": {
        "definition": "A xanthine bronchodilator for asthma and COPD.",
        "mechanism": "Inhibits phosphodiesterase, increasing cAMP and causing bronchodilation.",
        "indications": [
            "Asthma",
            "COPD"
        ],
        "dosage": {
            "adults": "200-400 mg orally 3-4 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Nausea",
            "Tremor",
            "Insomnia"
        ],
        "contraindications": [
            "Seizure disorders",
            "Active peptic ulcer"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other xanthines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cimetidine": {
        "definition": "A histamine H2 receptor antagonist for peptic ulcer and GERD.",
        "mechanism": "Blocks H2 receptors, reducing gastric acid secretion.",
        "indications": [
            "Peptic ulcer",
            "GERD",
            "Zollinger-Ellison syndrome"
        ],
        "dosage": {
            "adults": "400-800 mg orally 1-2 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Gynecomastia",
            "Confusion",
            "CYP450 inhibition"
        ],
        "contraindications": [
            "Hypersensitivity to cimetidine"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin",
            "Phenytoin",
            "Theophylline"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "streptomycin": {
        "definition": "An aminoglycoside antibiotic for tuberculosis and other serious infections.",
        "mechanism": "Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.",
        "indications": [
            "Tuberculosis",
            "Plague",
            "Tularemia"
        ],
        "dosage": {
            "adults": "15 mg/kg IM once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Ototoxicity",
            "Nephrotoxicity",
            "Vestibular toxicity"
        ],
        "contraindications": [
            "Hypersensitivity to aminoglycosides"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "argatroban": {
        "definition": "A direct thrombin inhibitor anticoagulant for heparin-induced thrombocytopenia (HIT).",
        "mechanism": "Directly inhibits thrombin (factor IIa).",
        "indications": [
            "Heparin-induced thrombocytopenia",
            "Percutaneous coronary intervention (PCI)"
        ],
        "dosage": {
            "adults": "2 mcg/kg/min IV infusion (adjust to aPTT).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bleeding",
            "Hypotension"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alteplase": {
        "definition": "A recombinant tissue plasminogen activator (tPA) for thrombolysis.",
        "mechanism": "Converts plasminogen to plasmin, dissolving fibrin clots.",
        "indications": [
            "Acute ischemic stroke",
            "Myocardial infarction",
            "Pulmonary embolism"
        ],
        "dosage": {
            "adults": "0.9 mg/kg IV (stroke, max 90 mg); other indications by protocol.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Bleeding",
            "Angioedema"
        ],
        "contraindications": [
            "Active bleeding",
            "Recent major surgery"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dapsone": {
        "definition": "A sulfone antibiotic for leprosy, dermatitis herpetiformis, and Pneumocystis pneumonia prophylaxis.",
        "mechanism": "Inhibits bacterial folic acid synthesis.",
        "indications": [
            "Leprosy",
            "Dermatitis herpetiformis",
            "Pneumocystis pneumonia prophylaxis"
        ],
        "dosage": {
            "adults": "50-100 mg orally once daily.",
            "children": "1 mg/kg/day."
        },
        "side effects": [
            "Hemolysis",
            "Methemoglobinemia",
            "Rash"
        ],
        "contraindications": [
            "Severe anemia",
            "G6PD deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Rifampin",
            "Trimethoprim"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rituximab": {
        "definition": "A monoclonal antibody for CD20-positive cancers and autoimmune diseases.",
        "mechanism": "Binds CD20 on B lymphocytes, causing cell lysis.",
        "indications": [
            "Non-Hodgkin lymphoma",
            "Chronic lymphocytic leukemia",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "375 mg/m² IV once weekly (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Infusion reactions",
            "Infection",
            "Progressive multifocal leukoencephalopathy"
        ],
        "contraindications": [
            "Severe active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "silver sulfadiazine": {
        "definition": "A topical sulfonamide antibiotic for burn wounds.",
        "mechanism": "Inhibits bacterial DNA synthesis.",
        "indications": [
            "Burn wound infection prevention/treatment"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Rash",
            "Leukopenia",
            "Argyria (rare)"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Pregnancy (near term), infants <2 months"
        ],
        "special populations": {
            "pregnancy": "Avoid near term."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vitamin a & d": {
        "definition": "A combination of fat-soluble vitamins for deficiency states and skin health.",
        "mechanism": "Supports vision, immunity, bone health, and skin integrity.",
        "indications": [
            "Vitamin A and D deficiency",
            "Skin health (topical)"
        ],
        "dosage": {
            "adults": "As directed by product.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypervitaminosis A or D (high doses)"
        ],
        "contraindications": [
            "Hypercalcemia (vitamin D)"
        ],
        "special populations": {
            "pregnancy": "Avoid high doses."
        },
        "interactions": [
            "Retinoids",
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desvenlafaxine": {
        "definition": "A serotonin-norepinephrine reuptake inhibitor (SNRI) for depression.",
        "mechanism": "Inhibits reuptake of serotonin and norepinephrine.",
        "indications": [
            "Major depressive disorder"
        ],
        "dosage": {
            "adults": "50 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Hypertension",
            "Sexual dysfunction"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fidaxomicin": {
        "definition": "A macrolide antibiotic for Clostridioides difficile infection.",
        "mechanism": "Inhibits RNA polymerase in C. difficile.",
        "indications": [
            "Clostridioides difficile infection"
        ],
        "dosage": {
            "adults": "200 mg orally twice daily for 10 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "GI upset",
            "Anemia"
        ],
        "contraindications": [
            "Hypersensitivity to fidaxomicin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penicillin v potassium": {
        "definition": "A narrow-spectrum penicillin antibiotic for streptococcal and other susceptible infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Streptococcal pharyngitis",
            "Skin infections",
            "Rheumatic fever prophylaxis"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 6-8 hours.",
            "children": "25-50 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to penicillins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "daptomycin": {
        "definition": "A lipopeptide antibiotic for resistant Gram-positive infections.",
        "mechanism": "Disrupts bacterial cell membrane potential.",
        "indications": [
            "MRSA bacteremia",
            "Complicated skin infections"
        ],
        "dosage": {
            "adults": "4-6 mg/kg IV once daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Myopathy",
            "Eosinophilic pneumonia",
            "GI upset"
        ],
        "contraindications": [
            "Pneumonia (inactivated by surfactant)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dalfopristin": {
        "definition": "A streptogramin antibiotic (with quinupristin) for resistant Gram-positive infections.",
        "mechanism": "Inhibits bacterial protein synthesis (50S ribosomal subunit).",
        "indications": [
            "VRE (E. faecium) infections",
            "Complicated skin infections"
        ],
        "dosage": {
            "adults": "7.5 mg/kg IV every 8-12 hours (with quinupristin).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Arthralgia",
            "Myalgia",
            "Phlebitis"
        ],
        "contraindications": [
            "Hypersensitivity to streptogramins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "quinupristin": {
        "definition": "A streptogramin antibiotic (with dalfopristin) for resistant Gram-positive infections.",
        "mechanism": "Inhibits bacterial protein synthesis (50S ribosomal subunit).",
        "indications": [
            "VRE (E. faecium) infections",
            "Complicated skin infections"
        ],
        "dosage": {
            "adults": "7.5 mg/kg IV every 8-12 hours (with dalfopristin).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Arthralgia",
            "Myalgia",
            "Phlebitis"
        ],
        "contraindications": [
            "Hypersensitivity to streptogramins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carboplatin": {
        "definition": "A platinum-based chemotherapy for various cancers.",
        "mechanism": "Forms DNA cross-links, inhibiting DNA synthesis.",
        "indications": [
            "Ovarian cancer",
            "Lung cancer",
            "Other solid tumors"
        ],
        "dosage": {
            "adults": "Dose by protocol (AUC-based dosing).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to platinum compounds"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "etoposide": {
        "definition": "A topoisomerase II inhibitor for various cancers.",
        "mechanism": "Inhibits topoisomerase II, causing DNA strand breaks.",
        "indications": [
            "Testicular cancer",
            "Small cell lung cancer",
            "Lymphoma"
        ],
        "dosage": {
            "adults": "50-100 mg/m² IV/oral daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Alopecia",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorambucil": {
        "definition": "An alkylating agent for chronic lymphocytic leukemia and lymphoma.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Lymphoma"
        ],
        "dosage": {
            "adults": "0.1-0.2 mg/kg orally daily.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Infertility"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ifosfamide": {
        "definition": "An alkylating agent for various cancers.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Testicular cancer",
            "Sarcoma",
            "Lymphoma"
        ],
        "dosage": {
            "adults": "1.2-2.4 g/m² IV daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Hemorrhagic cystitis",
            "Myelosuppression",
            "Neurotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Mesna (protects bladder)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vinblastine": {
        "definition": "A vinca alkaloid for Hodgkin lymphoma, testicular cancer, and other tumors.",
        "mechanism": "Inhibits microtubule formation, blocking mitosis.",
        "indications": [
            "Hodgkin lymphoma",
            "Testicular cancer",
            "Kaposi sarcoma"
        ],
        "dosage": {
            "adults": "6 mg/m² IV every 1-2 weeks.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Alopecia",
            "Neurotoxicity"
        ],
        "contraindications": [
            "Severe leukopenia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "topotecan": {
        "definition": "A topoisomerase I inhibitor for ovarian, lung, and cervical cancer.",
        "mechanism": "Inhibits topoisomerase I, causing DNA strand breaks.",
        "indications": [
            "Ovarian cancer",
            "Small cell lung cancer",
            "Cervical cancer"
        ],
        "dosage": {
            "adults": "1.5 mg/m² IV daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Diarrhea"
        ],
        "contraindications": [
            "Severe neutropenia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fludarabine": {
        "definition": "A purine analog antimetabolite for hematologic malignancies.",
        "mechanism": "Inhibits DNA synthesis by interfering with DNA polymerase.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Non-Hodgkin lymphoma"
        ],
        "dosage": {
            "adults": "25-30 mg/m² IV daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Immunosuppression",
            "Neurotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pembrolizumab": {
        "definition": "A PD-1 inhibitor immunotherapy for various cancers.",
        "mechanism": "Blocks PD-1, enhancing T-cell mediated immune response.",
        "indications": [
            "Melanoma",
            "Non-small cell lung cancer",
            "Head and neck cancer",
            "Others"
        ],
        "dosage": {
            "adults": "200 mg IV every 3 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Immune-mediated reactions",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ibrutinib": {
        "definition": "A Bruton's tyrosine kinase inhibitor for B-cell malignancies.",
        "mechanism": "Inhibits BTK, blocking B-cell receptor signaling.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Mantle cell lymphoma",
            "Waldenström's macroglobulinemia"
        ],
        "dosage": {
            "adults": "420-560 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bleeding",
            "Atrial fibrillation",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bendamustine": {
        "definition": "An alkylating agent for chronic lymphocytic leukemia and lymphoma.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Non-Hodgkin lymphoma"
        ],
        "dosage": {
            "adults": "100-120 mg/m² IV on days 1 and 2 every 21-28 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Rash",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "idelalisib": {
        "definition": "A PI3K delta inhibitor for certain B-cell malignancies.",
        "mechanism": "Inhibits PI3K delta, blocking B-cell proliferation.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Follicular lymphoma"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Hepatotoxicity",
            "Pneumonitis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "obinutuzumab": {
        "definition": "A monoclonal antibody for chronic lymphocytic leukemia and follicular lymphoma.",
        "mechanism": "Binds CD20 on B lymphocytes, causing cell lysis.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Follicular lymphoma"
        ],
        "dosage": {
            "adults": "1000 mg IV on days 1, 8, 15, then every 21 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Neutropenia",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alemtuzumab": {
        "definition": "A monoclonal antibody for chronic lymphocytic leukemia and multiple sclerosis.",
        "mechanism": "Binds CD52 on lymphocytes, causing cell lysis.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Multiple sclerosis"
        ],
        "dosage": {
            "adults": "30 mg IV 3 times weekly (leukemia); 12 mg IV daily for 5 days (MS).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Infection",
            "Autoimmune disorders"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ofatumumab": {
        "definition": "A monoclonal antibody for chronic lymphocytic leukemia and multiple sclerosis.",
        "mechanism": "Binds CD20 on B lymphocytes, causing cell lysis.",
        "indications": [
            "Chronic lymphocytic leukemia",
            "Multiple sclerosis"
        ],
        "dosage": {
            "adults": "300-2000 mg IV per protocol (leukemia); 20 mg SC monthly (MS).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Infection",
            "Hypogammaglobulinemia"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nilotinib": {
        "definition": "A tyrosine kinase inhibitor for chronic myeloid leukemia.",
        "mechanism": "Inhibits BCR-ABL tyrosine kinase.",
        "indications": [
            "Chronic myeloid leukemia"
        ],
        "dosage": {
            "adults": "300-400 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "QT prolongation",
            "Rash",
            "Myelosuppression"
        ],
        "contraindications": [
            "QT prolongation",
            "Hypokalemia",
            "Hypomagnesemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anagrelide": {
        "definition": "A platelet-reducing agent for essential thrombocythemia.",
        "mechanism": "Inhibits megakaryocyte maturation, reducing platelet production.",
        "indications": [
            "Essential thrombocythemia"
        ],
        "dosage": {
            "adults": "0.5-2.5 mg orally 2-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Edema",
            "Tachycardia"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bosutinib": {
        "definition": "A tyrosine kinase inhibitor for chronic myeloid leukemia.",
        "mechanism": "Inhibits BCR-ABL and Src-family kinases.",
        "indications": [
            "Chronic myeloid leukemia"
        ],
        "dosage": {
            "adults": "400-500 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "omacetaxine": {
        "definition": "A protein synthesis inhibitor for chronic myeloid leukemia.",
        "mechanism": "Inhibits protein synthesis by binding to the ribosomal A-site.",
        "indications": [
            "Chronic myeloid leukemia (resistant/intolerant to TKIs)"
        ],
        "dosage": {
            "adults": "1.25 mg/m² SC twice daily for 14 days (cycle-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Infection",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "peginterferon alfa-2b": {
        "definition": "A pegylated interferon for hepatitis C and melanoma.",
        "mechanism": "Modulates immune response, inhibits viral replication.",
        "indications": [
            "Chronic hepatitis C",
            "Melanoma (adjuvant)"
        ],
        "dosage": {
            "adults": "1.5 mcg/kg SC once weekly.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Flu-like symptoms",
            "Depression",
            "Myelosuppression"
        ],
        "contraindications": [
            "Autoimmune hepatitis",
            "Severe psychiatric disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Theophylline",
            "Zidovudine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxaliplatin": {
        "definition": "A platinum-based chemotherapy for colorectal cancer.",
        "mechanism": "Forms DNA cross-links, inhibiting DNA synthesis.",
        "indications": [
            "Colorectal cancer"
        ],
        "dosage": {
            "adults": "85 mg/m² IV every 2 weeks (with 5-FU/leucovorin).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Myelosuppression",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity to platinum compounds"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "irinotecan": {
        "definition": "A topoisomerase I inhibitor for colorectal and other cancers.",
        "mechanism": "Inhibits topoisomerase I, causing DNA strand breaks.",
        "indications": [
            "Colorectal cancer",
            "Other solid tumors"
        ],
        "dosage": {
            "adults": "125 mg/m² IV weekly or 180 mg/m² every 2 weeks.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Diarrhea",
            "Myelosuppression",
            "Nausea"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cetuximab": {
        "definition": "An EGFR inhibitor monoclonal antibody for colorectal and head/neck cancer.",
        "mechanism": "Binds EGFR, inhibiting cell proliferation.",
        "indications": [
            "KRAS wild-type colorectal cancer",
            "Head and neck cancer"
        ],
        "dosage": {
            "adults": "400 mg/m² IV loading, then 250 mg/m² weekly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Rash",
            "Hypomagnesemia"
        ],
        "contraindications": [
            "Severe hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "panitumumab": {
        "definition": "An EGFR inhibitor monoclonal antibody for colorectal cancer.",
        "mechanism": "Binds EGFR, inhibiting cell proliferation.",
        "indications": [
            "KRAS wild-type colorectal cancer"
        ],
        "dosage": {
            "adults": "6 mg/kg IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Rash",
            "Hypomagnesemia"
        ],
        "contraindications": [
            "Severe hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "regorafenib": {
        "definition": "A multikinase inhibitor for metastatic colorectal, GIST, and liver cancer.",
        "mechanism": "Inhibits multiple kinases involved in tumor growth and angiogenesis.",
        "indications": [
            "Metastatic colorectal cancer",
            "GIST",
            "Hepatocellular carcinoma"
        ],
        "dosage": {
            "adults": "160 mg orally once daily for 21 days of a 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hand-foot syndrome",
            "Hypertension",
            "Fatigue"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "romidepsin": {
        "definition": "A histone deacetylase inhibitor for cutaneous and peripheral T-cell lymphoma.",
        "mechanism": "Inhibits histone deacetylase, altering gene expression.",
        "indications": [
            "Cutaneous T-cell lymphoma",
            "Peripheral T-cell lymphoma"
        ],
        "dosage": {
            "adults": "14 mg/m² IV on days 1, 8, 15 of a 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "QT prolongation",
            "Myelosuppression",
            "Infection"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vorinostat": {
        "definition": "A histone deacetylase inhibitor for cutaneous T-cell lymphoma.",
        "mechanism": "Inhibits histone deacetylase, altering gene expression.",
        "indications": [
            "Cutaneous T-cell lymphoma"
        ],
        "dosage": {
            "adults": "400 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "GI upset",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bexarotene": {
        "definition": "A retinoid for cutaneous T-cell lymphoma.",
        "mechanism": "Binds retinoid X receptors, altering gene expression.",
        "indications": [
            "Cutaneous T-cell lymphoma"
        ],
        "dosage": {
            "adults": "300 mg/m² orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperlipidemia",
            "Hypothyroidism",
            "Leukopenia"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Gemfibrozil",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methoxsalen": {
        "definition": "A psoralen used with UVA light for psoriasis, vitiligo, and cutaneous T-cell lymphoma.",
        "mechanism": "Intercalates DNA, activated by UVA, causing DNA cross-links.",
        "indications": [
            "Psoriasis",
            "Vitiligo",
            "Cutaneous T-cell lymphoma"
        ],
        "dosage": {
            "adults": "20 mg orally 1.5-2 hours before UVA exposure.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Photosensitivity",
            "Nausea",
            "Skin aging"
        ],
        "contraindications": [
            "Liver disease",
            "Photosensitivity disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other photosensitizing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "interferon gamma-1b": {
        "definition": "A recombinant cytokine for chronic granulomatous disease and osteopetrosis.",
        "mechanism": "Enhances phagocyte oxidative metabolism and immune response.",
        "indications": [
            "Chronic granulomatous disease",
            "Osteopetrosis"
        ],
        "dosage": {
            "adults": "50 mcg/m² SC 3 times weekly.",
            "children": "Same as adults, dose by BSA."
        },
        "side effects": [
            "Flu-like symptoms",
            "Fever",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "niraparib": {
        "definition": "A PARP inhibitor for ovarian, fallopian tube, and peritoneal cancer.",
        "mechanism": "Inhibits PARP enzymes, impairing DNA repair.",
        "indications": [
            "Ovarian, fallopian tube, peritoneal cancer (maintenance)"
        ],
        "dosage": {
            "adults": "200-300 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Thrombocytopenia",
            "Anemia",
            "Hypertension"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ramucirumab": {
        "definition": "A VEGFR-2 inhibitor monoclonal antibody for gastric, colorectal, and lung cancer.",
        "mechanism": "Blocks VEGFR-2, inhibiting angiogenesis.",
        "indications": [
            "Gastric cancer",
            "Colorectal cancer",
            "Non-small cell lung cancer"
        ],
        "dosage": {
            "adults": "8 mg/kg IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypertension",
            "Bleeding",
            "Proteinuria"
        ],
        "contraindications": [
            "Severe bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cladribine": {
        "definition": "A purine analog for hairy cell leukemia and multiple sclerosis.",
        "mechanism": "Inhibits DNA synthesis, causing cell death.",
        "indications": [
            "Hairy cell leukemia",
            "Multiple sclerosis"
        ],
        "dosage": {
            "adults": "0.09-0.14 mg/kg IV daily for 5-7 days (leukemia); oral dosing for MS.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Infection",
            "Fever"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentostatin": {
        "definition": "A purine analog antimetabolite for hairy cell leukemia.",
        "mechanism": "Inhibits adenosine deaminase, causing accumulation of toxic metabolites in lymphocytes.",
        "indications": [
            "Hairy cell leukemia"
        ],
        "dosage": {
            "adults": "4 mg/m² IV every other week.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Infection",
            "Nausea"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "moxetumomab pasudotox": {
        "definition": "A CD22-directed cytotoxin for relapsed/refractory hairy cell leukemia.",
        "mechanism": "Binds CD22 and delivers a bacterial toxin to kill B cells.",
        "indications": [
            "Relapsed/refractory hairy cell leukemia"
        ],
        "dosage": {
            "adults": "0.04 mg/kg IV on days 1, 3, and 5 of a 28-day cycle (up to 6 cycles).",
            "children": "Not established."
        },
        "side effects": [
            "Edema",
            "Nausea",
            "Hemolytic uremic syndrome"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bleomycin": {
        "definition": "An antineoplastic antibiotic for Hodgkin lymphoma, testicular cancer, and others.",
        "mechanism": "Induces DNA strand breaks via free radical formation.",
        "indications": [
            "Hodgkin lymphoma",
            "Testicular cancer",
            "Squamous cell cancers"
        ],
        "dosage": {
            "adults": "10-20 units/m² IV/IM/SQ weekly or biweekly (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Pulmonary fibrosis",
            "Skin changes",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity to bleomycin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other pulmonary toxic agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dacarbazine": {
        "definition": "An alkylating agent for Hodgkin lymphoma and melanoma.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Hodgkin lymphoma",
            "Melanoma"
        ],
        "dosage": {
            "adults": "150-375 mg/m² IV daily for 5 days (protocol-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brentuximab": {
        "definition": "An anti-CD30 antibody-drug conjugate for Hodgkin lymphoma and anaplastic large cell lymphoma.",
        "mechanism": "Delivers cytotoxic agent to CD30-positive cells.",
        "indications": [
            "Hodgkin lymphoma",
            "Anaplastic large cell lymphoma"
        ],
        "dosage": {
            "adults": "1.8 mg/kg IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Neutropenia",
            "Infusion reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Bleomycin (increased pulmonary toxicity)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxorubicin liposomal": {
        "definition": "A liposomal anthracycline for ovarian cancer, Kaposi sarcoma, and multiple myeloma.",
        "mechanism": "Intercalates DNA, inhibits topoisomerase II, generates free radicals.",
        "indications": [
            "Ovarian cancer",
            "Kaposi sarcoma",
            "Multiple myeloma"
        ],
        "dosage": {
            "adults": "30-50 mg/m² IV every 3-4 weeks (protocol-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Hand-foot syndrome",
            "Cardiotoxicity"
        ],
        "contraindications": [
            "Severe cardiac disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cardiotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alitretinoin": {
        "definition": "A retinoid for cutaneous lesions of Kaposi sarcoma and severe chronic hand eczema.",
        "mechanism": "Binds retinoid receptors, altering gene expression.",
        "indications": [
            "Kaposi sarcoma (topical)",
            "Severe chronic hand eczema (oral, not US-approved)"
        ],
        "dosage": {
            "adults": "Topical gel: apply twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Skin irritation",
            "Erythema",
            "Photosensitivity"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other retinoids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "erlotinib": {
        "definition": "A tyrosine kinase inhibitor for non-small cell lung cancer and pancreatic cancer.",
        "mechanism": "Inhibits EGFR tyrosine kinase.",
        "indications": [
            "Non-small cell lung cancer",
            "Pancreatic cancer"
        ],
        "dosage": {
            "adults": "150 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Interstitial lung disease"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pemetrexed": {
        "definition": "An antifolate antimetabolite for non-small cell lung cancer and mesothelioma.",
        "mechanism": "Inhibits folate-dependent enzymes in DNA synthesis.",
        "indications": [
            "Non-small cell lung cancer",
            "Malignant pleural mesothelioma"
        ],
        "dosage": {
            "adults": "500 mg/m² IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Rash",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "NSAIDs",
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gefitinib": {
        "definition": "A tyrosine kinase inhibitor for EGFR-mutant non-small cell lung cancer.",
        "mechanism": "Inhibits EGFR tyrosine kinase.",
        "indications": [
            "EGFR-mutant non-small cell lung cancer"
        ],
        "dosage": {
            "adults": "250 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Interstitial lung disease"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "crizotinib": {
        "definition": "A tyrosine kinase inhibitor for ALK- or ROS1-positive non-small cell lung cancer.",
        "mechanism": "Inhibits ALK, ROS1, and MET kinases.",
        "indications": [
            "ALK-positive or ROS1-positive non-small cell lung cancer"
        ],
        "dosage": {
            "adults": "250 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Vision disorders",
            "Nausea",
            "Edema"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nelarabine": {
        "definition": "A purine nucleoside analog for T-cell acute lymphoblastic leukemia/lymphoma.",
        "mechanism": "Inhibits DNA synthesis in T-lymphoblasts.",
        "indications": [
            "T-cell acute lymphoblastic leukemia/lymphoma"
        ],
        "dosage": {
            "adults": "1500 mg/m² IV on days 1, 3, 5 (repeat every 21 days).",
            "children": "650 mg/m² IV daily for 5 days."
        },
        "side effects": [
            "Neurotoxicity",
            "Myelosuppression",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other neurotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bortezomib": {
        "definition": "A proteasome inhibitor for multiple myeloma and mantle cell lymphoma.",
        "mechanism": "Inhibits 26S proteasome, disrupting protein degradation.",
        "indications": [
            "Multiple myeloma",
            "Mantle cell lymphoma"
        ],
        "dosage": {
            "adults": "1.3 mg/m² IV or SC twice weekly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Thrombocytopenia",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity to boron or mannitol"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pralatrexate": {
        "definition": "A folate analog antimetabolite for peripheral T-cell lymphoma.",
        "mechanism": "Inhibits dihydrofolate reductase, blocking DNA synthesis.",
        "indications": [
            "Peripheral T-cell lymphoma"
        ],
        "dosage": {
            "adults": "30 mg/m² IV weekly for 6 weeks of a 7-week cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Mucositis",
            "Thrombocytopenia",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thalidomide": {
        "definition": "An immunomodulatory drug for multiple myeloma and erythema nodosum leprosum.",
        "mechanism": "Inhibits TNF-alpha and modulates immune response.",
        "indications": [
            "Multiple myeloma",
            "Erythema nodosum leprosum"
        ],
        "dosage": {
            "adults": "100-400 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Teratogenicity",
            "Peripheral neuropathy",
            "Constipation"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other sedatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carfilzomib": {
        "definition": "A proteasome inhibitor for relapsed/refractory multiple myeloma.",
        "mechanism": "Irreversibly inhibits 20S proteasome.",
        "indications": [
            "Multiple myeloma (relapsed/refractory)"
        ],
        "dosage": {
            "adults": "20-56 mg/m² IV on days 1, 2, 8, 9, 15, 16 of 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cardiotoxicity",
            "Hypertension",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pomalidomide": {
        "definition": "An immunomodulatory drug for multiple myeloma.",
        "mechanism": "Inhibits TNF-alpha and modulates immune response.",
        "indications": [
            "Multiple myeloma (relapsed/refractory)"
        ],
        "dosage": {
            "adults": "4 mg orally once daily for 21 days of a 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Fatigue",
            "Teratogenicity"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "daratumumab": {
        "definition": "A monoclonal antibody for multiple myeloma.",
        "mechanism": "Targets CD38 on plasma cells, causing cell lysis.",
        "indications": [
            "Multiple myeloma"
        ],
        "dosage": {
            "adults": "16 mg/kg IV weekly (cycle-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Cytopenias",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "melphalan": {
        "definition": "An alkylating agent for multiple myeloma and ovarian cancer.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Multiple myeloma",
            "Ovarian cancer"
        ],
        "dosage": {
            "adults": "8-10 mg orally daily (myeloma); IV dosing for transplant.",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Infertility"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ipilimumab": {
        "definition": "A CTLA-4 inhibitor immunotherapy for melanoma and other cancers.",
        "mechanism": "Blocks CTLA-4, enhancing T-cell activation.",
        "indications": [
            "Melanoma",
            "Renal cell carcinoma",
            "Colorectal cancer (with MSI-H/dMMR)"
        ],
        "dosage": {
            "adults": "3 mg/kg IV every 3 weeks (cycle-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Immune-mediated reactions",
            "Rash",
            "Colitis"
        ],
        "contraindications": [
            "Severe immune-mediated reactions"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "talimogene laherparepvec": {
        "definition": "An oncolytic virus therapy for unresectable melanoma.",
        "mechanism": "Genetically modified HSV-1 replicates in tumors and stimulates immune response.",
        "indications": [
            "Unresectable cutaneous, subcutaneous, and nodal melanoma"
        ],
        "dosage": {
            "adults": "Up to 4 mL intratumoral injection (concentration varies).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Chills",
            "Fever"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Acyclovir (may reduce efficacy)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ibritumomab": {
        "definition": "A radiolabeled anti-CD20 monoclonal antibody for non-Hodgkin lymphoma.",
        "mechanism": "Delivers radioisotope to CD20-positive B cells, causing cell death.",
        "indications": [
            "Non-Hodgkin lymphoma"
        ],
        "dosage": {
            "adults": "0.4 mCi/kg IV (max 32 mCi).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cytopenias",
            "Infusion reactions",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olaparib": {
        "definition": "A PARP inhibitor for BRCA-mutated ovarian, breast, pancreatic, and prostate cancer.",
        "mechanism": "Inhibits PARP enzymes, impairing DNA repair.",
        "indications": [
            "BRCA-mutated ovarian, breast, pancreatic, prostate cancer"
        ],
        "dosage": {
            "adults": "300 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Anemia",
            "Nausea",
            "Fatigue"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gemcitabine": {
        "definition": "A nucleoside analog antimetabolite for various solid tumors.",
        "mechanism": "Inhibits DNA synthesis.",
        "indications": [
            "Pancreatic cancer",
            "Non-small cell lung cancer",
            "Breast, ovarian, bladder cancer"
        ],
        "dosage": {
            "adults": "1000 mg/m² IV weekly (cycle-specific).",
            "children": "Dose by protocol."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paclitaxel protein-bound": {
        "definition": "An albumin-bound formulation of paclitaxel for breast, lung, and pancreatic cancer.",
        "mechanism": "Stabilizes microtubules, inhibiting cell division.",
        "indications": [
            "Breast cancer",
            "Non-small cell lung cancer",
            "Pancreatic cancer"
        ],
        "dosage": {
            "adults": "100-260 mg/m² IV (cycle-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Peripheral neuropathy",
            "Alopecia"
        ],
        "contraindications": [
            "Severe hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pancreatin": {
        "definition": "A mixture of pancreatic enzymes for exocrine pancreatic insufficiency.",
        "mechanism": "Provides lipase, protease, and amylase for digestion.",
        "indications": [
            "Exocrine pancreatic insufficiency (cystic fibrosis, chronic pancreatitis, etc.)"
        ],
        "dosage": {
            "adults": "500-2500 lipase units/kg/meal.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Hypersensitivity to pork proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "irinotecan liposomal": {
        "definition": "A liposomal topoisomerase I inhibitor for pancreatic cancer.",
        "mechanism": "Inhibits topoisomerase I, causing DNA strand breaks.",
        "indications": [
            "Metastatic pancreatic cancer (with 5-FU/leucovorin)"
        ],
        "dosage": {
            "adults": "70 mg/m² IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Neutropenia",
            "Fatigue"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "streptozocin": {
        "definition": "An alkylating agent for pancreatic neuroendocrine tumors.",
        "mechanism": "Alkylates DNA, inhibiting replication.",
        "indications": [
            "Pancreatic neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "500 mg/m² IV daily for 5 days (cycle-specific).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nephrotoxicity",
            "Nausea",
            "Myelosuppression"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bicalutamide": {
        "definition": "A nonsteroidal antiandrogen for prostate cancer.",
        "mechanism": "Blocks androgen receptors.",
        "indications": [
            "Prostate cancer (in combination with GnRH analog)"
        ],
        "dosage": {
            "adults": "50 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Gynecomastia",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "abiraterone": {
        "definition": "A CYP17 inhibitor for metastatic castration-resistant prostate cancer.",
        "mechanism": "Inhibits androgen synthesis.",
        "indications": [
            "Metastatic castration-resistant prostate cancer"
        ],
        "dosage": {
            "adults": "1000 mg orally once daily (with prednisone).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypertension",
            "Hypokalemia",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "enzalutamide": {
        "definition": "An androgen receptor inhibitor for metastatic castration-resistant prostate cancer.",
        "mechanism": "Inhibits androgen receptor signaling.",
        "indications": [
            "Metastatic castration-resistant prostate cancer"
        ],
        "dosage": {
            "adults": "160 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Hypertension",
            "Seizures"
        ],
        "contraindications": [
            "Seizure disorder (relative)"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "CYP2C8/3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "degarelix": {
        "definition": "A GnRH antagonist for advanced prostate cancer.",
        "mechanism": "Blocks GnRH receptors, reducing testosterone production.",
        "indications": [
            "Advanced prostate cancer"
        ],
        "dosage": {
            "adults": "240 mg SC loading, then 80 mg SC monthly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hot flashes",
            "Injection site reactions",
            "Increased liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flutamide": {
        "definition": "A nonsteroidal antiandrogen for prostate cancer.",
        "mechanism": "Blocks androgen receptors.",
        "indications": [
            "Prostate cancer (in combination with GnRH analog)"
        ],
        "dosage": {
            "adults": "250 mg orally 3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Gynecomastia",
            "Hepatotoxicity",
            "Hot flashes"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "triptorelin": {
        "definition": "A GnRH agonist for prostate cancer and precocious puberty.",
        "mechanism": "Suppresses gonadotropin secretion, reducing sex hormone levels.",
        "indications": [
            "Prostate cancer",
            "Precocious puberty"
        ],
        "dosage": {
            "adults": "3.75 mg IM monthly or 11.25 mg every 3 months.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hot flashes",
            "Decreased libido",
            "Osteoporosis"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cemiplimab": {
        "definition": "A PD-1 inhibitor immunotherapy for cutaneous squamous cell carcinoma and other cancers.",
        "mechanism": "Blocks PD-1, enhancing T-cell mediated immune response.",
        "indications": [
            "Cutaneous squamous cell carcinoma",
            "Non-small cell lung cancer",
            "Basal cell carcinoma"
        ],
        "dosage": {
            "adults": "350 mg IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Immune-mediated reactions",
            "Fatigue",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anidulafungin": {
        "definition": "An echinocandin antifungal for candidemia and invasive candidiasis.",
        "mechanism": "Inhibits beta-(1,3)-D-glucan synthesis in fungal cell walls.",
        "indications": [
            "Candidemia",
            "Invasive candidiasis"
        ],
        "dosage": {
            "adults": "200 mg IV loading, then 100 mg IV daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Hepatotoxicity",
            "Hypokalemia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "micafungin": {
        "definition": "An echinocandin antifungal for candidemia and esophageal candidiasis.",
        "mechanism": "Inhibits beta-(1,3)-D-glucan synthesis in fungal cell walls.",
        "indications": [
            "Candidemia",
            "Esophageal candidiasis"
        ],
        "dosage": {
            "adults": "100-150 mg IV daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Hepatotoxicity",
            "Hypokalemia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flucytosine": {
        "definition": "An antimetabolite antifungal for cryptococcal meningitis and severe candidiasis (with amphotericin B).",
        "mechanism": "Inhibits fungal DNA and RNA synthesis.",
        "indications": [
            "Cryptococcal meningitis",
            "Severe candidiasis"
        ],
        "dosage": {
            "adults": "100-150 mg/kg/day orally in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Myelosuppression",
            "Hepatotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Amphotericin B"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nystatin": {
        "definition": "A polyene antifungal for oral, cutaneous, and vaginal candidiasis.",
        "mechanism": "Binds ergosterol, forming pores in fungal cell membranes.",
        "indications": [
            "Oral candidiasis",
            "Cutaneous candidiasis",
            "Vaginal candidiasis"
        ],
        "dosage": {
            "adults": "Oral: 400,000-600,000 units 4 times daily; Topical: apply 2-3 times daily.",
            "children": "Oral: 100,000-200,000 units 4 times daily."
        },
        "side effects": [
            "GI upset (oral)",
            "Skin irritation (topical)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gentian violet": {
        "definition": "A topical antiseptic and antifungal for skin and mucosal infections.",
        "mechanism": "Disrupts microbial cell walls and inhibits growth.",
        "indications": [
            "Oral thrush",
            "Minor skin infections"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin/mucosal staining",
            "Ulceration (rare)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "terconazole": {
        "definition": "An imidazole antifungal for vulvovaginal candidiasis.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Vulvovaginal candidiasis"
        ],
        "dosage": {
            "adults": "Suppository: 80 mg vaginally once daily for 3 days; Cream: 0.4-0.8% once daily for 3-7 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Vaginal irritation",
            "Headache",
            "Abdominal pain"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tioconazole": {
        "definition": "An imidazole antifungal for vaginal yeast infections.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Vaginal candidiasis"
        ],
        "dosage": {
            "adults": "300 mg ointment intravaginally as a single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Vaginal irritation",
            "Burning",
            "Itching"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "boric acid": {
        "definition": "A topical antiseptic and antifungal for vaginal yeast infections and minor wounds.",
        "mechanism": "Disrupts microbial cell walls and inhibits growth.",
        "indications": [
            "Recurrent vaginal candidiasis",
            "Minor wounds (topical)"
        ],
        "dosage": {
            "adults": "600 mg vaginal suppository once daily for 7-14 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Vaginal irritation",
            "Toxicity if ingested"
        ],
        "contraindications": [
            "Pregnancy",
            "Open wounds (systemic absorption)"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tazarotene": {
        "definition": "A topical retinoid for psoriasis and acne.",
        "mechanism": "Modulates gene expression, reducing keratinocyte proliferation.",
        "indications": [
            "Psoriasis",
            "Acne"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Skin irritation",
            "Photosensitivity",
            "Dryness"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other topical irritants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "abobotulinumtoxinA": {
        "definition": "A botulinum toxin type A for muscle spasticity, cervical dystonia, and cosmetic use.",
        "mechanism": "Blocks acetylcholine release at neuromuscular junction.",
        "indications": [
            "Cervical dystonia",
            "Upper limb spasticity",
            "Glabellar lines (cosmetic)"
        ],
        "dosage": {
            "adults": "Dose varies by indication and site.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Muscle weakness",
            "Dysphagia",
            "Injection site pain"
        ],
        "contraindications": [
            "Infection at injection site",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azficel-t": {
        "definition": "An autologous fibroblast cellular therapy for nasolabial fold wrinkles.",
        "mechanism": "Injects cultured fibroblasts to improve skin structure.",
        "indications": [
            "Nasolabial fold wrinkles (cosmetic)"
        ],
        "dosage": {
            "adults": "1.5 mL intradermal injections at 3-6 week intervals for 3 sessions.",
            "children": "Not indicated."
        },
        "side effects": [
            "Injection site reactions",
            "Bruising",
            "Swelling"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "uridine": {
        "definition": "A pyrimidine nucleoside for hereditary orotic aciduria and as an antidote for fluorouracil toxicity.",
        "mechanism": "Replenishes pyrimidine pools and counteracts fluorouracil toxicity.",
        "indications": [
            "Hereditary orotic aciduria",
            "Fluorouracil toxicity (as uridine triacetate)"
        ],
        "dosage": {
            "adults": "10 g orally every 6 hours for 20 doses (fluorouracil toxicity).",
            "children": "Same as adults."
        },
        "side effects": [
            "Vomiting",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rilonacept": {
        "definition": "An interleukin-1 inhibitor for cryopyrin-associated periodic syndromes (CAPS) and recurrent pericarditis.",
        "mechanism": "Binds IL-1, preventing its inflammatory effects.",
        "indications": [
            "CAPS",
            "Recurrent pericarditis"
        ],
        "dosage": {
            "adults": "320 mg SC loading, then 160 mg weekly.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Infection",
            "Upper respiratory tract infection"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "canakinumab": {
        "definition": "An interleukin-1 beta inhibitor for autoinflammatory diseases.",
        "mechanism": "Binds IL-1β, preventing its inflammatory effects.",
        "indications": [
            "CAPS",
            "Systemic juvenile idiopathic arthritis",
            "Still's disease",
            "Gout flares"
        ],
        "dosage": {
            "adults": "150 mg SC every 4-8 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Abdominal pain",
            "Headache"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "telotristat": {
        "definition": "A tryptophan hydroxylase inhibitor for carcinoid syndrome diarrhea.",
        "mechanism": "Reduces serotonin production in neuroendocrine tumors.",
        "indications": [
            "Carcinoid syndrome diarrhea (with somatostatin analog)"
        ],
        "dosage": {
            "adults": "250 mg orally three times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Depression",
            "Abdominal pain"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Somatostatin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "perflutren": {
        "definition": "An ultrasound contrast agent for echocardiography.",
        "mechanism": "Microbubbles enhance ultrasound reflection.",
        "indications": [
            "Contrast enhancement in echocardiography"
        ],
        "dosage": {
            "adults": "0.5-1.3 mL IV bolus or infusion.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Back pain",
            "Hypersensitivity"
        ],
        "contraindications": [
            "Known cardiac shunts",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexrazoxane": {
        "definition": "A cardioprotective agent for doxorubicin-induced cardiotoxicity and anthracycline extravasation.",
        "mechanism": "Chelates iron, reducing free radical formation.",
        "indications": [
            "Prevention of doxorubicin cardiotoxicity",
            "Anthracycline extravasation"
        ],
        "dosage": {
            "adults": "500-1000 mg/m² IV (cycle-specific).",
            "children": "Dose by BSA."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Doxorubicin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "simvastatin": {
        "definition": "A statin for hypercholesterolemia and cardiovascular risk reduction.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "10-40 mg orally once daily.",
            "children": "10-40 mg once daily (age 10+)."
        },
        "side effects": [
            "Myopathy",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ramipril": {
        "definition": "An ACE inhibitor for hypertension, heart failure, and cardiovascular risk reduction.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally once or twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "telmisartan": {
        "definition": "An angiotensin II receptor blocker (ARB) for hypertension and cardiovascular risk reduction.",
        "mechanism": "Blocks angiotensin II type 1 receptors.",
        "indications": [
            "Hypertension",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "20-80 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "empagliflozin": {
        "definition": "A sodium-glucose co-transporter 2 (SGLT2) inhibitor for type 2 diabetes and heart failure.",
        "mechanism": "Inhibits SGLT2 in the kidney, increasing urinary glucose excretion.",
        "indications": [
            "Type 2 diabetes",
            "Heart failure",
            "Chronic kidney disease"
        ],
        "dosage": {
            "adults": "10-25 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Genital infections",
            "UTI",
            "Hypotension"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Diabetic ketoacidosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "liraglutide": {
        "definition": "A GLP-1 receptor agonist for type 2 diabetes and obesity.",
        "mechanism": "Increases insulin secretion, decreases glucagon, slows gastric emptying.",
        "indications": [
            "Type 2 diabetes",
            "Obesity"
        ],
        "dosage": {
            "adults": "0.6-1.8 mg SC once daily (diabetes); up to 3 mg (obesity).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Pancreatitis"
        ],
        "contraindications": [
            "Medullary thyroid carcinoma",
            "MEN2 syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin",
            "Sulfonylureas"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alirocumab": {
        "definition": "A PCSK9 inhibitor for hypercholesterolemia.",
        "mechanism": "Inhibits PCSK9, increasing LDL receptor availability.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "75-150 mg SC every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Myalgia",
            "Flu-like symptoms"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "evolocumab": {
        "definition": "A PCSK9 inhibitor for hypercholesterolemia.",
        "mechanism": "Inhibits PCSK9, increasing LDL receptor availability.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "140 mg SC every 2 weeks or 420 mg monthly.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Injection site reactions",
            "Myalgia",
            "Flu-like symptoms"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "canagliflozin": {
        "definition": "A sodium-glucose co-transporter 2 (SGLT2) inhibitor for type 2 diabetes.",
        "mechanism": "Inhibits SGLT2 in the kidney, increasing urinary glucose excretion.",
        "indications": [
            "Type 2 diabetes",
            "Chronic kidney disease"
        ],
        "dosage": {
            "adults": "100-300 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Genital infections",
            "UTI",
            "Hyperkalemia"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Diabetic ketoacidosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metformin": {
        "definition": "A biguanide oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Decreases hepatic glucose production and increases insulin sensitivity.",
        "indications": [
            "Type 2 diabetes",
            "Polycystic ovary syndrome (off-label)"
        ],
        "dosage": {
            "adults": "500-2000 mg orally daily in divided doses.",
            "children": "500-2000 mg daily (age 10+)."
        },
        "side effects": [
            "GI upset",
            "Lactic acidosis (rare)",
            "B12 deficiency"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Metabolic acidosis"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Contrast agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "icosapent": {
        "definition": "A purified eicosapentaenoic acid (EPA) for hypertriglyceridemia and cardiovascular risk reduction.",
        "mechanism": "Reduces hepatic VLDL-TG synthesis/secretion.",
        "indications": [
            "Hypertriglyceridemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "2 g orally twice daily with food.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Arthralgia",
            "Atrial fibrillation",
            "Bleeding"
        ],
        "contraindications": [
            "Fish/shellfish allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "semaglutide": {
        "definition": "A GLP-1 receptor agonist for type 2 diabetes and obesity.",
        "mechanism": "Increases insulin secretion, decreases glucagon, slows gastric emptying.",
        "indications": [
            "Type 2 diabetes",
            "Obesity"
        ],
        "dosage": {
            "adults": "0.25-2 mg SC once weekly (diabetes); up to 2.4 mg (obesity).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Pancreatitis"
        ],
        "contraindications": [
            "Medullary thyroid carcinoma",
            "MEN2 syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin",
            "Sulfonylureas"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levocarnitine": {
        "definition": "A nutritional supplement for carnitine deficiency.",
        "mechanism": "Facilitates transport of fatty acids into mitochondria for energy production.",
        "indications": [
            "Primary and secondary carnitine deficiency"
        ],
        "dosage": {
            "adults": "990 mg orally 2-3 times daily.",
            "children": "50-100 mg/kg/day in divided doses."
        },
        "side effects": [
            "Fishy body odor",
            "GI upset",
            "Seizures (rare)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "siltuximab": {
        "definition": "An anti-IL-6 monoclonal antibody for multicentric Castleman disease.",
        "mechanism": "Binds IL-6, preventing its inflammatory effects.",
        "indications": [
            "Multicentric Castleman disease (HHV-8 negative, HIV negative)"
        ],
        "dosage": {
            "adults": "11 mg/kg IV every 3 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infection",
            "Rash",
            "Edema"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP450 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium oxybate": {
        "definition": "A CNS depressant for cataplexy and excessive daytime sleepiness in narcolepsy.",
        "mechanism": "Acts as a GABA-B agonist and CNS depressant.",
        "indications": [
            "Cataplexy",
            "Excessive daytime sleepiness in narcolepsy"
        ],
        "dosage": {
            "adults": "4.5-9 g orally nightly in 2 divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Respiratory depression"
        ],
        "contraindications": [
            "Succinic semialdehyde dehydrogenase deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "milnacipran": {
        "definition": "A serotonin-norepinephrine reuptake inhibitor (SNRI) for fibromyalgia.",
        "mechanism": "Inhibits reuptake of serotonin and norepinephrine.",
        "indications": [
            "Fibromyalgia"
        ],
        "dosage": {
            "adults": "50 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Hypertension"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Uncontrolled narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxepin": {
        "definition": "A tricyclic antidepressant for depression, anxiety, and insomnia.",
        "mechanism": "Inhibits reuptake of norepinephrine and serotonin.",
        "indications": [
            "Depression",
            "Anxiety",
            "Insomnia (low dose)"
        ],
        "dosage": {
            "adults": "75-300 mg orally daily (depression); 3-6 mg at bedtime (insomnia).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Anticholinergic effects",
            "Weight gain"
        ],
        "contraindications": [
            "Glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desmopressin": {
        "definition": "A synthetic vasopressin analog for diabetes insipidus, hemophilia A, and nocturnal enuresis.",
        "mechanism": "Increases water reabsorption in kidneys; increases factor VIII and vWF release.",
        "indications": [
            "Central diabetes insipidus",
            "Hemophilia A",
            "Nocturnal enuresis"
        ],
        "dosage": {
            "adults": "0.1-0.4 mg orally 2-3 times daily; intranasal/injection by indication.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hyponatremia",
            "Headache",
            "Nasal irritation (intranasal)"
        ],
        "contraindications": [
            "Hyponatremia",
            "Moderate/severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iopromide": {
        "definition": "A non-ionic, low-osmolar iodinated contrast agent for intravascular imaging.",
        "mechanism": "Enhances X-ray contrast by increasing absorption in blood vessels/tissues.",
        "indications": [
            "CT scans",
            "Angiography"
        ],
        "dosage": {
            "adults": "Dose varies by procedure and concentration.",
            "children": "Dose by weight and procedure."
        },
        "side effects": [
            "Nausea",
            "Allergic reactions",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to iodinated contrast agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor renal function."
        },
        "interactions": [
            "Metformin (risk of lactic acidosis)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mannitol": {
        "definition": "An osmotic diuretic for increased intracranial/intraocular pressure and acute renal failure.",
        "mechanism": "Increases osmotic pressure of plasma, drawing water out of tissues.",
        "indications": [
            "Cerebral edema",
            "Acute glaucoma",
            "Oliguric renal failure"
        ],
        "dosage": {
            "adults": "0.25-2 g/kg IV over 30-60 minutes.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Electrolyte imbalance",
            "Dehydration",
            "Pulmonary edema"
        ],
        "contraindications": [
            "Anuria",
            "Severe pulmonary edema",
            "Active intracranial bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trihexyphenidyl": {
        "definition": "An anticholinergic for Parkinson's disease and drug-induced extrapyramidal symptoms.",
        "mechanism": "Blocks central muscarinic receptors.",
        "indications": [
            "Parkinson's disease",
            "Extrapyramidal symptoms"
        ],
        "dosage": {
            "adults": "1-15 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Constipation"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ticlopidine": {
        "definition": "An oral antiplatelet agent for stroke prevention (rarely used due to toxicity).",
        "mechanism": "Inhibits ADP-induced platelet aggregation.",
        "indications": [
            "Stroke prevention",
            "Coronary stent thrombosis prevention"
        ],
        "dosage": {
            "adults": "250 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Thrombotic thrombocytopenic purpura",
            "Diarrhea"
        ],
        "contraindications": [
            "Blood disorders",
            "Severe liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Other antiplatelets"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nimodipine": {
        "definition": "A dihydropyridine calcium channel blocker for subarachnoid hemorrhage.",
        "mechanism": "Inhibits calcium influx into vascular smooth muscle, causing vasodilation.",
        "indications": [
            "Prevention of cerebral vasospasm after subarachnoid hemorrhage"
        ],
        "dosage": {
            "adults": "60 mg orally every 4 hours for 21 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypotension",
            "Headache",
            "Bradycardia"
        ],
        "contraindications": [
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carbamide peroxide": {
        "definition": "A topical agent for earwax removal and oral hygiene.",
        "mechanism": "Releases oxygen, softening and loosening earwax/debris.",
        "indications": [
            "Earwax removal",
            "Oral debriding agent"
        ],
        "dosage": {
            "adults": "5-10 drops in ear canal twice daily for up to 4 days.",
            "children": "Same as adults."
        },
        "side effects": [
            "Ear discomfort",
            "Rash"
        ],
        "contraindications": [
            "Perforated tympanic membrane"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rimabotulinumtoxinB": {
        "definition": "A botulinum toxin type B for cervical dystonia and sialorrhea.",
        "mechanism": "Blocks acetylcholine release at neuromuscular junction.",
        "indications": [
            "Cervical dystonia",
            "Chronic sialorrhea"
        ],
        "dosage": {
            "adults": "2500-5000 units IM (cervical dystonia); 1500-3500 units IM (sialorrhea).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Dysphagia",
            "Muscle weakness"
        ],
        "contraindications": [
            "Infection at injection site",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bupivacaine": {
        "definition": "An amide-type local anesthetic for regional, epidural, and nerve block anesthesia.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Local, regional, epidural, and nerve block anesthesia"
        ],
        "dosage": {
            "adults": "Max 175 mg per dose (plain); 225 mg with epinephrine.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "CNS toxicity",
            "Cardiotoxicity",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to amide-type anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ropivacaine": {
        "definition": "An amide-type local anesthetic for regional, epidural, and nerve block anesthesia.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Local, regional, epidural, and nerve block anesthesia"
        ],
        "dosage": {
            "adults": "Max 200-250 mg per dose (varies by block).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "CNS toxicity",
            "Cardiotoxicity",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity to amide-type anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefotetan": {
        "definition": "A second-generation cephalosporin antibiotic for surgical prophylaxis and infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Surgical prophylaxis",
            "Intra-abdominal, pelvic, and gynecologic infections"
        ],
        "dosage": {
            "adults": "1-2 g IV every 12 hours.",
            "children": "40-100 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Disulfiram-like reaction (with alcohol)"
        ],
        "contraindications": [
            "Hypersensitivity to cephalosporins"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Alcohol",
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tizanidine": {
        "definition": "A centrally acting alpha-2 agonist muscle relaxant for spasticity.",
        "mechanism": "Inhibits presynaptic motor neurons, reducing muscle tone.",
        "indications": [
            "Spasticity"
        ],
        "dosage": {
            "adults": "2-36 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Hypotension",
            "Dry mouth"
        ],
        "contraindications": [
            "CYP1A2 inhibitor use",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors",
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methocarbamol": {
        "definition": "A centrally acting muscle relaxant for musculoskeletal pain and spasm.",
        "mechanism": "Depresses CNS activity, causing muscle relaxation.",
        "indications": [
            "Muscle spasm",
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "1500 mg orally 4 times daily (initial); maintenance: 4000-4500 mg/day in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "GI upset"
        ],
        "contraindications": [
            "Renal impairment (IV form)",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carisoprodol": {
        "definition": "A centrally acting muscle relaxant for acute musculoskeletal pain.",
        "mechanism": "Interrupts neuronal communication in the reticular formation and spinal cord.",
        "indications": [
            "Acute musculoskeletal pain"
        ],
        "dosage": {
            "adults": "250-350 mg orally 3 times daily and at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Dependence"
        ],
        "contraindications": [
            "Acute intermittent porphyria",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metaxalone": {
        "definition": "A centrally acting muscle relaxant for musculoskeletal pain.",
        "mechanism": "Exact mechanism unknown; CNS depression.",
        "indications": [
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "800 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "GI upset"
        ],
        "contraindications": [
            "Severe hepatic or renal impairment",
            "Anemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorzoxazone": {
        "definition": "A centrally acting muscle relaxant for musculoskeletal pain.",
        "mechanism": "Acts at the spinal cord and subcortical brain levels to inhibit polysynaptic reflexes.",
        "indications": [
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "250-750 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "GI upset"
        ],
        "contraindications": [
            "Liver impairment",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "orphenadrine": {
        "definition": "A centrally acting muscle relaxant and anticholinergic for musculoskeletal pain.",
        "mechanism": "Anticholinergic and analgesic effects; CNS depression.",
        "indications": [
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Blurred vision"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis",
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "codeine": {
        "definition": "An opioid analgesic and antitussive.",
        "mechanism": "Binds mu-opioid receptors; suppresses cough reflex in CNS.",
        "indications": [
            "Mild to moderate pain",
            "Cough"
        ],
        "dosage": {
            "adults": "15-60 mg orally every 4-6 hours as needed.",
            "children": "Use with caution; avoid in <12 years."
        },
        "side effects": [
            "Drowsiness",
            "Constipation",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Children <12 years",
            "Post-tonsillectomy/adenoidectomy in children"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amifostine": {
        "definition": "A cytoprotective agent to reduce toxicity of chemotherapy and radiation.",
        "mechanism": "Free radical scavenger; protects normal tissues.",
        "indications": [
            "Prevention of cisplatin nephrotoxicity",
            "Xerostomia from radiation"
        ],
        "dosage": {
            "adults": "910 mg/m² IV 15-30 min before chemotherapy/radiation.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypotension",
            "Nausea",
            "Vomiting"
        ],
        "contraindications": [
            "Hypersensitivity to aminothiol compounds"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydralazine": {
        "definition": "A direct-acting vasodilator for hypertension and heart failure.",
        "mechanism": "Relaxes arteriolar smooth muscle.",
        "indications": [
            "Hypertension",
            "Heart failure (with nitrates)"
        ],
        "dosage": {
            "adults": "10-50 mg orally 2-4 times daily.",
            "children": "0.75-1 mg/kg/day in divided doses."
        },
        "side effects": [
            "Headache",
            "Tachycardia",
            "Lupus-like syndrome"
        ],
        "contraindications": [
            "Coronary artery disease",
            "Mitral valve rheumatic heart disease"
        ],
        "special populations": {
            "pregnancy": "Preferred for severe hypertension in pregnancy."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acyclovir": {
        "definition": "An antiviral for herpes simplex, varicella-zoster, and herpes zoster infections.",
        "mechanism": "Inhibits viral DNA polymerase.",
        "indications": [
            "Herpes simplex",
            "Varicella-zoster",
            "Herpes zoster"
        ],
        "dosage": {
            "adults": "200-800 mg orally 3-5 times daily; IV: 5-10 mg/kg every 8 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Renal toxicity",
            "Neurotoxicity (IV)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valacyclovir": {
        "definition": "A prodrug of acyclovir for herpes simplex and varicella-zoster infections.",
        "mechanism": "Converted to acyclovir; inhibits viral DNA polymerase.",
        "indications": [
            "Herpes simplex",
            "Varicella-zoster",
            "Herpes zoster"
        ],
        "dosage": {
            "adults": "500-1000 mg orally 1-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Renal toxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "varicella zoster immune globulin": {
        "definition": "A human immune globulin for post-exposure prophylaxis of varicella (chickenpox).",
        "mechanism": "Provides passive immunity against varicella-zoster virus.",
        "indications": [
            "Post-exposure prophylaxis of varicella in high-risk individuals"
        ],
        "dosage": {
            "adults": "125 units/10 kg IM (max 625 units) within 10 days of exposure.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Anaphylaxis (rare)"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "immune globulin intramuscular": {
        "definition": "A human immune globulin for passive immunization against hepatitis A, measles, and other infections.",
        "mechanism": "Provides passive immunity via pooled antibodies.",
        "indications": [
            "Hepatitis A post-exposure prophylaxis",
            "Measles post-exposure prophylaxis",
            "Immunodeficiency"
        ],
        "dosage": {
            "adults": "0.02-0.06 mL/kg IM (varies by indication).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "foscarnet": {
        "definition": "A pyrophosphate analog antiviral for CMV and acyclovir-resistant HSV infections.",
        "mechanism": "Inhibits viral DNA polymerase and reverse transcriptase.",
        "indications": [
            "CMV retinitis",
            "Acyclovir-resistant HSV"
        ],
        "dosage": {
            "adults": "60 mg/kg IV every 8 hours or 90 mg/kg every 12 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nephrotoxicity",
            "Electrolyte disturbances",
            "Seizures"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cholera vaccine, live": {
        "definition": "An oral live attenuated vaccine for prevention of cholera.",
        "mechanism": "Induces immunity to Vibrio cholerae O1.",
        "indications": [
            "Prevention of cholera (travelers to endemic areas)"
        ],
        "dosage": {
            "adults": "1 oral dose (buffered suspension).",
            "children": "2-5 years: 3 doses; 6-17 years: 2 doses."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Fever"
        ],
        "contraindications": [
            "Immunodeficiency",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Avoid if possible."
        },
        "interactions": [
            "Antibiotics",
            "Antimalarials"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "pravastatin": {
        "definition": "A statin for hypercholesterolemia and cardiovascular risk reduction.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "10-80 mg orally once daily.",
            "children": "10-40 mg once daily (age 8+)."
        },
        "side effects": [
            "Myopathy",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Cyclosporine",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lovastatin": {
        "definition": "A statin for hypercholesterolemia and cardiovascular risk reduction.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "10-80 mg orally once daily with evening meal.",
            "children": "10-40 mg once daily (age 10+)."
        },
        "side effects": [
            "Myopathy",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ezetimibe": {
        "definition": "A cholesterol absorption inhibitor for hypercholesterolemia.",
        "mechanism": "Inhibits intestinal absorption of cholesterol.",
        "indications": [
            "Hypercholesterolemia (alone or with statin)"
        ],
        "dosage": {
            "adults": "10 mg orally once daily.",
            "children": "10 mg once daily (age 10+)."
        },
        "side effects": [
            "GI upset",
            "Myalgia",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins",
            "Bile acid sequestrants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gemfibrozil": {
        "definition": "A fibric acid derivative for hypertriglyceridemia.",
        "mechanism": "Activates PPAR-alpha, increasing lipolysis of triglycerides.",
        "indications": [
            "Hypertriglyceridemia",
            "Hyperlipidemia"
        ],
        "dosage": {
            "adults": "600 mg orally twice daily 30 min before meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dyspepsia",
            "Gallstones",
            "Myopathy (with statins)"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment",
            "Gallbladder disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "niacin": {
        "definition": "A B vitamin (B3) used to treat dyslipidemia.",
        "mechanism": "Inhibits hepatic VLDL synthesis, lowering LDL and TG, raising HDL.",
        "indications": [
            "Dyslipidemia",
            "Pellagra"
        ],
        "dosage": {
            "adults": "500-2000 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flushing",
            "Hepatotoxicity",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Active liver disease",
            "Peptic ulcer"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fenofibric acid": {
        "definition": "A fibric acid derivative for hypertriglyceridemia.",
        "mechanism": "Activates PPAR-alpha, increasing lipolysis of triglycerides.",
        "indications": [
            "Hypertriglyceridemia",
            "Hyperlipidemia"
        ],
        "dosage": {
            "adults": "35-135 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dyspepsia",
            "Gallstones",
            "Myopathy (with statins)"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment",
            "Gallbladder disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "coagulation factor ix": {
        "definition": "A clotting factor for hemophilia B.",
        "mechanism": "Replaces deficient factor IX, enabling normal coagulation.",
        "indications": [
            "Hemophilia B (factor IX deficiency)"
        ],
        "dosage": {
            "adults": "Dose individualized by factor IX activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Allergic reactions",
            "Thrombosis"
        ],
        "contraindications": [
            "Disseminated intravascular coagulation (DIC)",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "factor ix complex": {
        "definition": "A plasma-derived concentrate of vitamin K-dependent clotting factors for hemophilia B and warfarin reversal.",
        "mechanism": "Replaces factors II, VII, IX, and X.",
        "indications": [
            "Hemophilia B",
            "Warfarin reversal"
        ],
        "dosage": {
            "adults": "Dose individualized by factor activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzonatate": {
        "definition": "A non-narcotic antitussive for cough.",
        "mechanism": "Anesthetizes stretch receptors in the respiratory tract.",
        "indications": [
            "Cough"
        ],
        "dosage": {
            "adults": "100-200 mg orally 3 times daily as needed.",
            "children": "Not recommended <10 years."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dextromethorphan": {
        "definition": "A non-opioid antitussive for cough.",
        "mechanism": "Suppresses cough center in the medulla.",
        "indications": [
            "Cough"
        ],
        "dosage": {
            "adults": "10-20 mg orally every 4 hours as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "GI upset"
        ],
        "contraindications": [
            "MAO inhibitor use within 14 days"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Other serotonergic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "homatropine": {
        "definition": "An anticholinergic used as a mydriatic/cycloplegic and antitussive (in combination).",
        "mechanism": "Blocks muscarinic receptors.",
        "indications": [
            "Mydriasis/cycloplegia",
            "Cough (with hydrocodone)"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1-2 drops per eye; antitussive: per combination product.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Blurred vision",
            "Dry mouth",
            "Tachycardia"
        ],
        "contraindications": [
            "Glaucoma",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "loperamide": {
        "definition": "A peripheral opioid agonist antidiarrheal.",
        "mechanism": "Slows intestinal motility by acting on opioid receptors in the gut.",
        "indications": [
            "Acute and chronic diarrhea"
        ],
        "dosage": {
            "adults": "4 mg orally, then 2 mg after each loose stool (max 16 mg/day).",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Abdominal pain",
            "QT prolongation (high doses)"
        ],
        "contraindications": [
            "Children <2 years",
            "Acute dysentery",
            "C. difficile infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "colesevelam": {
        "definition": "A bile acid sequestrant for hyperlipidemia and type 2 diabetes.",
        "mechanism": "Binds bile acids in the intestine, reducing cholesterol absorption.",
        "indications": [
            "Hyperlipidemia",
            "Type 2 diabetes (adjunct)"
        ],
        "dosage": {
            "adults": "3.75 g orally once daily or in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Dyspepsia",
            "Increased triglycerides"
        ],
        "contraindications": [
            "Bowel obstruction",
            "Hypertriglyceridemia (>500 mg/dL)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oral drugs (may reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bismuth subsalicylate": {
        "definition": "An antidiarrheal and antiulcer agent for diarrhea, dyspepsia, and H. pylori.",
        "mechanism": "Antimicrobial, anti-inflammatory, and antisecretory effects in the GI tract.",
        "indications": [
            "Diarrhea",
            "Dyspepsia",
            "H. pylori eradication (with antibiotics)"
        ],
        "dosage": {
            "adults": "524 mg orally every 30-60 min as needed (max 8 doses/day).",
            "children": "Use with caution; avoid in children with viral illness."
        },
        "side effects": [
            "Black tongue/stool",
            "Tinnitus",
            "Salicylate toxicity"
        ],
        "contraindications": [
            "Aspirin allergy",
            "Children/teens with viral illness (risk of Reye syndrome)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "difenoxin": {
        "definition": "A potent opioid antidiarrheal, usually combined with atropine.",
        "mechanism": "Slows intestinal motility by acting on opioid receptors in the gut.",
        "indications": [
            "Acute diarrhea (with atropine)"
        ],
        "dosage": {
            "adults": "2 mg orally, then 1 mg after each loose stool (max 8 mg/day).",
            "children": "Not recommended <12 years."
        },
        "side effects": [
            "Drowsiness",
            "Constipation",
            "Anticholinergic effects (from atropine)"
        ],
        "contraindications": [
            "Jaundice",
            "Children <12 years",
            "C. difficile infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "entecavir": {
        "definition": "A nucleoside analog antiviral for chronic hepatitis B.",
        "mechanism": "Inhibits HBV DNA polymerase.",
        "indications": [
            "Chronic hepatitis B"
        ],
        "dosage": {
            "adults": "0.5-1 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Lactic acidosis",
            "Hepatomegaly",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "adefovir": {
        "definition": "A nucleotide analog antiviral for chronic hepatitis B.",
        "mechanism": "Inhibits HBV DNA polymerase.",
        "indications": [
            "Chronic hepatitis B"
        ],
        "dosage": {
            "adults": "10 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nephrotoxicity",
            "Lactic acidosis",
            "Asthenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tenofovir alafenamide": {
        "definition": "A nucleotide reverse transcriptase inhibitor for hepatitis B and HIV.",
        "mechanism": "Inhibits HBV and HIV reverse transcriptase.",
        "indications": [
            "Chronic hepatitis B",
            "HIV (in combination)"
        ],
        "dosage": {
            "adults": "25 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Renal toxicity",
            "Decreased bone mineral density",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "peginterferon alfa-2a": {
        "definition": "A pegylated interferon for hepatitis B and C.",
        "mechanism": "Modulates immune response, inhibits viral replication.",
        "indications": [
            "Chronic hepatitis B",
            "Chronic hepatitis C"
        ],
        "dosage": {
            "adults": "180 mcg SC once weekly.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Flu-like symptoms",
            "Depression",
            "Myelosuppression"
        ],
        "contraindications": [
            "Autoimmune hepatitis",
            "Severe psychiatric disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Theophylline",
            "Zidovudine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ledipasvir": {
        "definition": "A direct-acting antiviral for hepatitis C (with sofosbuvir).",
        "mechanism": "Inhibits HCV NS5A protein.",
        "indications": [
            "Chronic hepatitis C (with sofosbuvir)"
        ],
        "dosage": {
            "adults": "90 mg (with sofosbuvir 400 mg) orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sofosbuvir": {
        "definition": "A nucleotide analog NS5B polymerase inhibitor for hepatitis C.",
        "mechanism": "Inhibits HCV NS5B RNA-dependent RNA polymerase.",
        "indications": [
            "Chronic hepatitis C (in combination therapy)"
        ],
        "dosage": {
            "adults": "400 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "velpatasvir": {
        "definition": "A direct-acting antiviral for hepatitis C (with sofosbuvir).",
        "mechanism": "Inhibits HCV NS5A protein.",
        "indications": [
            "Chronic hepatitis C (with sofosbuvir)"
        ],
        "dosage": {
            "adults": "100 mg (with sofosbuvir 400 mg) orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dasabuvir": {
        "definition": "A non-nucleoside NS5B polymerase inhibitor for hepatitis C (in combination).",
        "mechanism": "Inhibits HCV NS5B RNA-dependent RNA polymerase.",
        "indications": [
            "Chronic hepatitis C (with ombitasvir, paritaprevir, ritonavir)"
        ],
        "dosage": {
            "adults": "250 mg orally twice daily (with other antivirals).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Fatigue",
            "Pruritus"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2C8 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ombitasvir": {
        "definition": "A direct-acting antiviral for hepatitis C (in combination).",
        "mechanism": "Inhibits HCV NS5A protein.",
        "indications": [
            "Chronic hepatitis C (with paritaprevir, ritonavir, dasabuvir)"
        ],
        "dosage": {
            "adults": "12.5 mg orally once daily (in combination).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "Pruritus"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paritaprevir": {
        "definition": "A protease inhibitor for hepatitis C (in combination).",
        "mechanism": "Inhibits HCV NS3/4A protease.",
        "indications": [
            "Chronic hepatitis C (with ombitasvir, ritonavir, dasabuvir)"
        ],
        "dosage": {
            "adults": "150 mg orally once daily (in combination).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "Pruritus"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "elbasvir": {
        "definition": "A direct-acting antiviral for hepatitis C (with grazoprevir).",
        "mechanism": "Inhibits HCV NS5A protein.",
        "indications": [
            "Chronic hepatitis C (with grazoprevir)"
        ],
        "dosage": {
            "adults": "50 mg (with grazoprevir 100 mg) orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "ALT elevation"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "grazoprevir": {
        "definition": "A protease inhibitor for hepatitis C (with elbasvir).",
        "mechanism": "Inhibits HCV NS3/4A protease.",
        "indications": [
            "Chronic hepatitis C (with elbasvir)"
        ],
        "dosage": {
            "adults": "100 mg (with elbasvir 50 mg) orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "ALT elevation"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glecaprevir": {
        "definition": "A protease inhibitor for hepatitis C (with pibrentasvir).",
        "mechanism": "Inhibits HCV NS3/4A protease.",
        "indications": [
            "Chronic hepatitis C (with pibrentasvir)"
        ],
        "dosage": {
            "adults": "300 mg (with pibrentasvir 120 mg) orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "ALT elevation"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pibrentasvir": {
        "definition": "A direct-acting antiviral for hepatitis C (with glecaprevir).",
        "mechanism": "Inhibits HCV NS5A protein.",
        "indications": [
            "Chronic hepatitis C (with glecaprevir)"
        ],
        "dosage": {
            "adults": "120 mg (with glecaprevir 300 mg) orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "ALT elevation"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "voxilaprevir": {
        "definition": "A protease inhibitor for hepatitis C (with sofosbuvir and velpatasvir).",
        "mechanism": "Inhibits HCV NS3/4A protease.",
        "indications": [
            "Chronic hepatitis C (with sofosbuvir and velpatasvir)"
        ],
        "dosage": {
            "adults": "100 mg (with sofosbuvir 400 mg and velpatasvir 100 mg) orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "ALT elevation"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "plecanatide": {
        "definition": "A guanylate cyclase-C agonist for chronic idiopathic constipation and IBS-C.",
        "mechanism": "Increases intestinal fluid secretion and motility.",
        "indications": [
            "Chronic idiopathic constipation",
            "Irritable bowel syndrome with constipation (IBS-C)"
        ],
        "dosage": {
            "adults": "3 mg orally once daily.",
            "children": "Contraindicated <6 years."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Flatulence"
        ],
        "contraindications": [
            "Children <6 years",
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prucalopride": {
        "definition": "A selective 5-HT4 agonist for chronic idiopathic constipation.",
        "mechanism": "Stimulates colonic peristalsis.",
        "indications": [
            "Chronic idiopathic constipation"
        ],
        "dosage": {
            "adults": "2 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Nausea"
        ],
        "contraindications": [
            "Intestinal perforation/obstruction",
            "Inflammatory bowel disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "immune globulin intravenous and subcutaneous": {
        "definition": "A preparation of pooled human immunoglobulin G (IgG) for immune deficiencies and autoimmune conditions.",
        "mechanism": "Provides passive immunity and modulates immune response.",
        "indications": [
            "Primary immunodeficiency",
            "Immune thrombocytopenia",
            "Kawasaki disease",
            "Other autoimmune conditions"
        ],
        "dosage": {
            "adults": "0.4-2 g/kg IV or SC, frequency varies by indication.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Thrombosis"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "interferon beta-1b": {
        "definition": "A recombinant interferon for relapsing forms of multiple sclerosis.",
        "mechanism": "Modulates immune response, reduces inflammation in CNS.",
        "indications": [
            "Relapsing multiple sclerosis"
        ],
        "dosage": {
            "adults": "250 mcg SC every other day.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flu-like symptoms",
            "Injection site reactions",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunomodulators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "immune globulin subcutaneous": {
        "definition": "A preparation of pooled human immunoglobulin G (IgG) for immune deficiencies.",
        "mechanism": "Provides passive immunity.",
        "indications": [
            "Primary immunodeficiency"
        ],
        "dosage": {
            "adults": "100-200 mg/kg SC weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion site reactions",
            "Headache",
            "Fatigue"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levothyroxine": {
        "definition": "A synthetic thyroid hormone for hypothyroidism.",
        "mechanism": "Replaces deficient thyroxine (T4).",
        "indications": [
            "Hypothyroidism",
            "Thyroid hormone suppression therapy"
        ],
        "dosage": {
            "adults": "1.6 mcg/kg orally once daily (adjust to TSH).",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "Hyperthyroidism (overdose)",
            "Palpitations",
            "Weight loss"
        ],
        "contraindications": [
            "Untreated adrenal insufficiency",
            "Acute MI"
        ],
        "special populations": {
            "pregnancy": "Safe and recommended."
        },
        "interactions": [
            "Calcium, iron, antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "midodrine": {
        "definition": "An alpha-1 agonist for symptomatic orthostatic hypotension.",
        "mechanism": "Vasoconstricts arterioles and veins, increasing blood pressure.",
        "indications": [
            "Symptomatic orthostatic hypotension"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally 3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Piloerection",
            "Supine hypertension",
            "Urinary retention"
        ],
        "contraindications": [
            "Severe heart disease",
            "Acute renal disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other vasopressors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxycodone": {
        "definition": "A semi-synthetic opioid analgesic for moderate to severe pain.",
        "mechanism": "Binds mu-opioid receptors in the CNS.",
        "indications": [
            "Moderate to severe pain"
        ],
        "dosage": {
            "adults": "5-15 mg orally every 4-6 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Acute/severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "morphine": {
        "definition": "A natural opioid analgesic for moderate to severe pain.",
        "mechanism": "Binds mu-opioid receptors in the CNS.",
        "indications": [
            "Moderate to severe pain"
        ],
        "dosage": {
            "adults": "10-30 mg orally every 4 hours as needed; IV: 2-10 mg every 2-6 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Acute/severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methadone": {
        "definition": "A synthetic opioid analgesic for pain and opioid dependence.",
        "mechanism": "Binds mu-opioid receptors; also NMDA antagonist.",
        "indications": [
            "Pain",
            "Opioid dependence"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally every 8-12 hours (pain); 20-30 mg initial (dependence).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Respiratory depression",
            "QT prolongation"
        ],
        "contraindications": [
            "Respiratory depression",
            "Acute/severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "buprenorphine": {
        "definition": "A partial opioid agonist for opioid dependence and pain.",
        "mechanism": "Partial mu-opioid agonist, kappa antagonist.",
        "indications": [
            "Opioid dependence",
            "Pain"
        ],
        "dosage": {
            "adults": "2-24 mg SL daily (dependence); transdermal/IV for pain.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pancrelipase": {
        "definition": "A mixture of pancreatic enzymes for exocrine pancreatic insufficiency.",
        "mechanism": "Provides lipase, protease, and amylase for digestion.",
        "indications": [
            "Exocrine pancreatic insufficiency (cystic fibrosis, chronic pancreatitis, etc.)"
        ],
        "dosage": {
            "adults": "500-2500 lipase units/kg/meal.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Hyperuricemia"
        ],
        "contraindications": [
            "Hypersensitivity to pork proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dupilumab": {
        "definition": "A monoclonal antibody for atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis.",
        "mechanism": "Inhibits IL-4 and IL-13 signaling.",
        "indications": [
            "Atopic dermatitis",
            "Asthma",
            "Chronic rhinosinusitis with nasal polyposis"
        ],
        "dosage": {
            "adults": "600 mg SC loading, then 300 mg every 2 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Injection site reactions",
            "Conjunctivitis",
            "Herpes viral infections"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dantrolene": {
        "definition": "A direct-acting muscle relaxant for malignant hyperthermia and spasticity.",
        "mechanism": "Inhibits calcium release from sarcoplasmic reticulum.",
        "indications": [
            "Malignant hyperthermia",
            "Spasticity"
        ],
        "dosage": {
            "adults": "2.5 mg/kg IV (MH crisis); oral: 25-100 mg 1-4 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Muscle weakness",
            "Hepatotoxicity",
            "Drowsiness"
        ],
        "contraindications": [
            "Active liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mepolizumab": {
        "definition": "An anti-IL-5 monoclonal antibody for severe eosinophilic asthma.",
        "mechanism": "Inhibits IL-5, reducing eosinophil levels.",
        "indications": [
            "Severe eosinophilic asthma"
        ],
        "dosage": {
            "adults": "100 mg SC every 4 weeks.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Headache",
            "Injection site reactions",
            "Back pain"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cerliponase alfa": {
        "definition": "A recombinant enzyme for neuronal ceroid lipofuscinosis type 2 (CLN2 disease).",
        "mechanism": "Replaces deficient TPP1 enzyme in lysosomes.",
        "indications": [
            "Neuronal ceroid lipofuscinosis type 2 (CLN2 disease)"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "300 mg intraventricular infusion every 2 weeks."
        },
        "side effects": [
            "Fever",
            "Seizures",
            "Device-related complications"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bezlotoxumab": {
        "definition": "A monoclonal antibody for prevention of recurrent Clostridioides difficile infection.",
        "mechanism": "Binds C. difficile toxin B.",
        "indications": [
            "Prevention of recurrent C. difficile infection"
        ],
        "dosage": {
            "adults": "10 mg/kg IV as a single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Fever",
            "Heart failure (exacerbation)"
        ],
        "contraindications": [
            "History of heart failure (caution)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fibrin sealant": {
        "definition": "A topical hemostatic agent for surgical bleeding.",
        "mechanism": "Contains fibrinogen and thrombin to promote clot formation.",
        "indications": [
            "Surgical hemostasis"
        ],
        "dosage": {
            "adults": "Apply topically as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Infection (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dihydroergotamine": {
        "definition": "An ergot alkaloid for acute migraine and cluster headache.",
        "mechanism": "Vasoconstricts cranial blood vessels via serotonin receptors.",
        "indications": [
            "Acute migraine",
            "Cluster headache"
        ],
        "dosage": {
            "adults": "1 mg IV/IM/SC at onset; may repeat every hour (max 2 mg/24h).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Vasoconstriction",
            "Hypertension"
        ],
        "contraindications": [
            "Coronary artery disease",
            "Uncontrolled hypertension",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Triptans"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ergotamine": {
        "definition": "An ergot alkaloid for acute migraine and cluster headache.",
        "mechanism": "Vasoconstricts cranial blood vessels via serotonin receptors.",
        "indications": [
            "Acute migraine",
            "Cluster headache"
        ],
        "dosage": {
            "adults": "1-2 mg orally at onset; may repeat every 30 min (max 6 mg/24h).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Vasoconstriction",
            "Hypertension"
        ],
        "contraindications": [
            "Coronary artery disease",
            "Uncontrolled hypertension",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Triptans"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ganciclovir": {
        "definition": "An antiviral for cytomegalovirus (CMV) infections.",
        "mechanism": "Inhibits viral DNA polymerase.",
        "indications": [
            "CMV retinitis",
            "CMV prophylaxis in transplant recipients"
        ],
        "dosage": {
            "adults": "5 mg/kg IV every 12 hours (induction); 5 mg/kg IV daily (maintenance).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Myelosuppression",
            "Nephrotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valganciclovir": {
        "definition": "An oral prodrug of ganciclovir for CMV infections.",
        "mechanism": "Converted to ganciclovir; inhibits viral DNA polymerase.",
        "indications": [
            "CMV retinitis",
            "CMV prophylaxis in transplant recipients"
        ],
        "dosage": {
            "adults": "900 mg orally twice daily (induction); 900 mg daily (maintenance).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Myelosuppression",
            "Nephrotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cytomegalovirus immune globulin": {
        "definition": "A human immune globulin for prevention of CMV disease in transplant recipients.",
        "mechanism": "Provides passive immunity against CMV.",
        "indications": [
            "CMV prophylaxis in transplant recipients"
        ],
        "dosage": {
            "adults": "150 mg/kg IV within 72 hours of transplant, then per protocol.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Chills"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "letermovir": {
        "definition": "A CMV DNA terminase complex inhibitor for CMV prophylaxis in transplant recipients.",
        "mechanism": "Inhibits CMV DNA terminase complex.",
        "indications": [
            "CMV prophylaxis in hematopoietic stem cell transplant recipients"
        ],
        "dosage": {
            "adults": "480 mg orally/IV once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Diarrhea",
            "Edema"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cidofovir": {
        "definition": "A nucleotide analog antiviral for CMV retinitis in AIDS patients.",
        "mechanism": "Inhibits viral DNA polymerase.",
        "indications": [
            "CMV retinitis (AIDS)"
        ],
        "dosage": {
            "adults": "5 mg/kg IV once weekly for 2 weeks, then every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nephrotoxicity",
            "Neutropenia",
            "Ocular toxicity"
        ],
        "contraindications": [
            "Renal impairment",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs",
            "Probenecid (protects kidneys)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadopentetate dimeglumine": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadobutrol": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadoteridol": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadodiamide": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadoterate meglumine": {
        "definition": "A gadolinium-based MRI contrast agent.",
        "mechanism": "Shortens T1 and T2 relaxation times, enhancing MRI images.",
        "indications": [
            "MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.1 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyclosporine": {
        "definition": "A calcineurin inhibitor immunosuppressant for organ transplant and autoimmune diseases.",
        "mechanism": "Inhibits calcineurin, suppressing T-cell activation.",
        "indications": [
            "Organ transplant rejection prevention",
            "Rheumatoid arthritis",
            "Psoriasis"
        ],
        "dosage": {
            "adults": "2.5-15 mg/kg/day orally in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nephrotoxicity",
            "Hypertension",
            "Gingival hyperplasia"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Malignancy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers",
            "Nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "famciclovir": {
        "definition": "An oral prodrug of penciclovir for herpesvirus infections.",
        "mechanism": "Converted to penciclovir; inhibits viral DNA polymerase.",
        "indications": [
            "Herpes zoster",
            "Herpes simplex (genital, labial)"
        ],
        "dosage": {
            "adults": "250-500 mg orally 2-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penciclovir": {
        "definition": "A topical antiviral for herpes labialis (cold sores).",
        "mechanism": "Inhibits viral DNA polymerase.",
        "indications": [
            "Herpes labialis (cold sores)"
        ],
        "dosage": {
            "adults": "Apply cream every 2 hours while awake for 4 days.",
            "children": "Same as adults."
        },
        "side effects": [
            "Application site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzyl alcohol": {
        "definition": "A topical antiparasitic and preservative for head lice and medication formulations.",
        "mechanism": "Inhibits lice respiration; preservative effect in medications.",
        "indications": [
            "Head lice (topical)",
            "Preservative in medications"
        ],
        "dosage": {
            "adults": "Apply to dry hair/scalp for 10 min, repeat in 7 days.",
            "children": "Same as adults (age 6 months+)."
        },
        "side effects": [
            "Application site irritation",
            "Contact dermatitis"
        ],
        "contraindications": [
            "Neonates (risk of gasping syndrome)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dicyclomine": {
        "definition": "An anticholinergic for irritable bowel syndrome (IBS).",
        "mechanism": "Blocks muscarinic receptors, reducing GI motility and spasm.",
        "indications": [
            "Irritable bowel syndrome (IBS)"
        ],
        "dosage": {
            "adults": "20 mg orally 4 times daily.",
            "children": "Not recommended <6 months."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Urinary retention"
        ],
        "contraindications": [
            "GI obstruction",
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mesalamine": {
        "definition": "An aminosalicylate anti-inflammatory for ulcerative colitis and Crohn's disease.",
        "mechanism": "Inhibits prostaglandin and leukotriene synthesis in the colon.",
        "indications": [
            "Ulcerative colitis",
            "Crohn's disease"
        ],
        "dosage": {
            "adults": "2-4.8 g orally daily in divided doses.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Abdominal pain"
        ],
        "contraindications": [
            "Salicylate allergy",
            "Severe renal/hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "balsalazide": {
        "definition": "A prodrug of mesalamine (5-ASA) for ulcerative colitis.",
        "mechanism": "Converted to mesalamine in the colon, reducing inflammation.",
        "indications": [
            "Ulcerative colitis"
        ],
        "dosage": {
            "adults": "2.25 g orally 3 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Diarrhea"
        ],
        "contraindications": [
            "Salicylate allergy",
            "Severe hepatic/renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ammonium lactate": {
        "definition": "A topical moisturizer and keratolytic for dry, scaly skin.",
        "mechanism": "Increases hydration and promotes shedding of dead skin cells.",
        "indications": [
            "Xerosis",
            "Ichthyosis",
            "Lichen simplex chronicus"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Skin irritation",
            "Burning",
            "Erythema"
        ],
        "contraindications": [
            "Open wounds",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical irritants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "salicylic acid": {
        "definition": "A topical keratolytic and comedolytic for acne, warts, and psoriasis.",
        "mechanism": "Promotes exfoliation of the stratum corneum.",
        "indications": [
            "Acne",
            "Warts",
            "Psoriasis",
            "Dandruff"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-3 times daily.",
            "children": "Use with caution."
        },
        "side effects": [
            "Skin irritation",
            "Dryness",
            "Salicylate toxicity (large areas)"
        ],
        "contraindications": [
            "Salicylate allergy",
            "Children <2 years (large areas)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical irritants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "silver nitrate": {
        "definition": "A topical caustic agent for wound care, cauterization, and removal of granulation tissue.",
        "mechanism": "Releases silver ions, causing protein coagulation and tissue destruction.",
        "indications": [
            "Wound cauterization",
            "Removal of granulation tissue",
            "Epistaxis"
        ],
        "dosage": {
            "adults": "Apply stick or solution to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin staining",
            "Local irritation",
            "Argyria (chronic use)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cantharidin": {
        "definition": "A topical vesicant for the treatment of warts and molluscum contagiosum.",
        "mechanism": "Induces blister formation and destruction of infected tissue.",
        "indications": [
            "Warts",
            "Molluscum contagiosum"
        ],
        "dosage": {
            "adults": "Apply to lesion, wash off after specified time.",
            "children": "Same as adults."
        },
        "side effects": [
            "Blistering",
            "Pain",
            "Erythema"
        ],
        "contraindications": [
            "Inflamed or infected skin",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical irritants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mupirocin": {
        "definition": "A topical antibiotic for impetigo and skin infections.",
        "mechanism": "Inhibits bacterial isoleucyl-tRNA synthetase.",
        "indications": [
            "Impetigo",
            "Minor skin infections",
            "MRSA decolonization (nasal)"
        ],
        "dosage": {
            "adults": "Apply to affected area 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Burning",
            "Itching",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "meropenem": {
        "definition": "A broad-spectrum carbapenem antibiotic for serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Serious Gram-negative and Gram-positive infections",
            "Meningitis",
            "Intra-abdominal infections"
        ],
        "dosage": {
            "adults": "500 mg-2 g IV every 8 hours.",
            "children": "20-40 mg/kg IV every 8 hours."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Seizures (high dose)"
        ],
        "contraindications": [
            "Hypersensitivity to carbapenems"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Valproic acid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "barium sulfate": {
        "definition": "A radiopaque contrast agent for GI imaging studies.",
        "mechanism": "Absorbs X-rays, providing contrast for radiographic imaging.",
        "indications": [
            "Barium swallow",
            "Upper GI series",
            "Barium enema"
        ],
        "dosage": {
            "adults": "Dose per procedure.",
            "children": "Dose per procedure."
        },
        "side effects": [
            "Constipation",
            "Bowel obstruction (rare)"
        ],
        "contraindications": [
            "GI perforation",
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "podofilox": {
        "definition": "A topical antimitotic for external genital and perianal warts.",
        "mechanism": "Inhibits cell mitosis, causing wart necrosis.",
        "indications": [
            "External genital warts",
            "Perianal warts"
        ],
        "dosage": {
            "adults": "Apply to warts twice daily for 3 days, then 4 days off; repeat up to 4 cycles.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Local irritation",
            "Erythema",
            "Erosion"
        ],
        "contraindications": [
            "Open wounds",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sinecatechins": {
        "definition": "A topical botanical extract for external genital and perianal warts.",
        "mechanism": "Exact mechanism unknown; antioxidant and immunomodulatory effects.",
        "indications": [
            "External genital warts",
            "Perianal warts"
        ],
        "dosage": {
            "adults": "Apply ointment 3 times daily for up to 16 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Local irritation",
            "Erythema",
            "Pruritus"
        ],
        "contraindications": [
            "Immunocompromised patients",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "interferon alfa-n3": {
        "definition": "A recombinant interferon for condyloma acuminata (genital warts).",
        "mechanism": "Modulates immune response, inhibits viral replication.",
        "indications": [
            "Condyloma acuminata (genital warts)"
        ],
        "dosage": {
            "adults": "250,000 IU injected into wart 3 times weekly for up to 8 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flu-like symptoms",
            "Injection site reactions",
            "Depression"
        ],
        "contraindications": [
            "Autoimmune hepatitis",
            "Severe psychiatric disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunomodulators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fibrinogen": {
        "definition": "A plasma-derived clotting factor for congenital fibrinogen deficiency.",
        "mechanism": "Replaces deficient fibrinogen, enabling normal clot formation.",
        "indications": [
            "Congenital fibrinogen deficiency"
        ],
        "dosage": {
            "adults": "Dose individualized by fibrinogen level and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "procaine penicillin": {
        "definition": "A long-acting injectable penicillin for bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Syphilis",
            "Streptococcal infections",
            "Anthrax"
        ],
        "dosage": {
            "adults": "600,000-2.4 million units IM daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Allergic reactions",
            "Injection site pain",
            "Neurotoxicity (high dose)"
        ],
        "contraindications": [
            "Penicillin allergy"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "loteprednol": {
        "definition": "A topical corticosteroid for eye inflammation and allergic conjunctivitis.",
        "mechanism": "Suppresses ocular inflammation.",
        "indications": [
            "Ocular inflammation",
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) 4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Increased intraocular pressure",
            "Blurred vision",
            "Burning"
        ],
        "contraindications": [
            "Viral/fungal eye infections"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gatifloxacin": {
        "definition": "A fluoroquinolone antibiotic for bacterial conjunctivitis.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV.",
        "indications": [
            "Bacterial conjunctivitis (ophthalmic)"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) every 2 hours while awake for 2 days, then 4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Blurred vision",
            "Dysgeusia"
        ],
        "contraindications": [
            "Hypersensitivity to fluoroquinolones"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lodoxamide": {
        "definition": "A mast cell stabilizer for allergic conjunctivitis.",
        "mechanism": "Inhibits release of inflammatory mediators from mast cells.",
        "indications": [
            "Allergic conjunctivitis",
            "Vernal keratoconjunctivitis"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) 4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Burning",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "docusate": {
        "definition": "A stool softener for constipation.",
        "mechanism": "Reduces surface tension of stool, increasing water penetration.",
        "indications": [
            "Constipation"
        ],
        "dosage": {
            "adults": "50-400 mg orally daily in divided doses.",
            "children": "Dose by age."
        },
        "side effects": [
            "Abdominal cramping",
            "Diarrhea",
            "Throat irritation"
        ],
        "contraindications": [
            "Intestinal obstruction",
            "Abdominal pain of unknown cause"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Mineral oil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium citrate": {
        "definition": "An osmotic laxative for constipation and bowel preparation.",
        "mechanism": "Draws water into the intestines, stimulating peristalsis.",
        "indications": [
            "Constipation",
            "Bowel preparation"
        ],
        "dosage": {
            "adults": "150-300 mL orally as a single dose.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal cramping",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Renal failure",
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Fluoroquinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "psyllium": {
        "definition": "A bulk-forming fiber laxative for constipation.",
        "mechanism": "Absorbs water in the intestine, increasing stool bulk and promoting peristalsis.",
        "indications": [
            "Constipation",
            "Irritable bowel syndrome"
        ],
        "dosage": {
            "adults": "1 tsp or packet (3-6 g) in 8 oz water 1-3 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Bloating",
            "Flatulence",
            "Abdominal discomfort"
        ],
        "contraindications": [
            "GI obstruction",
            "Difficulty swallowing"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other oral medications (may delay absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "linaclotide": {
        "definition": "A guanylate cyclase-C agonist for chronic idiopathic constipation and IBS-C.",
        "mechanism": "Increases intestinal fluid secretion and motility.",
        "indications": [
            "Chronic idiopathic constipation",
            "Irritable bowel syndrome with constipation (IBS-C)"
        ],
        "dosage": {
            "adults": "145-290 mcg orally once daily on empty stomach.",
            "children": "Contraindicated <6 years."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Flatulence"
        ],
        "contraindications": [
            "Children <6 years",
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lactulose": {
        "definition": "A synthetic disaccharide laxative for constipation and hepatic encephalopathy.",
        "mechanism": "Increases osmotic pressure in colon; acidifies colonic contents, reducing ammonia absorption.",
        "indications": [
            "Constipation",
            "Hepatic encephalopathy"
        ],
        "dosage": {
            "adults": "15-30 mL orally 1-2 times daily (constipation); 30-45 mL 3-4 times daily (encephalopathy).",
            "children": "Dose by age."
        },
        "side effects": [
            "Flatulence",
            "Diarrhea",
            "Abdominal cramping"
        ],
        "contraindications": [
            "Galactosemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "senna": {
        "definition": "A stimulant laxative for constipation.",
        "mechanism": "Stimulates colonic peristalsis via enteric nerve activation.",
        "indications": [
            "Constipation"
        ],
        "dosage": {
            "adults": "17.2-34.4 mg orally once or twice daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Abdominal cramping",
            "Diarrhea",
            "Urine discoloration"
        ],
        "contraindications": [
            "GI obstruction",
            "Undiagnosed abdominal pain"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lubiprostone": {
        "definition": "A chloride channel activator for chronic idiopathic constipation and IBS-C.",
        "mechanism": "Increases intestinal fluid secretion and motility.",
        "indications": [
            "Chronic idiopathic constipation",
            "Irritable bowel syndrome with constipation (IBS-C)",
            "Opioid-induced constipation"
        ],
        "dosage": {
            "adults": "8-24 mcg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Diarrhea",
            "Headache"
        ],
        "contraindications": [
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methylnaltrexone": {
        "definition": "A peripherally acting opioid antagonist for opioid-induced constipation.",
        "mechanism": "Blocks opioid receptors in the GI tract without affecting analgesia.",
        "indications": [
            "Opioid-induced constipation (palliative care, chronic non-cancer pain)"
        ],
        "dosage": {
            "adults": "12 mg SC once daily or every other day.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Flatulence"
        ],
        "contraindications": [
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tegaserod": {
        "definition": "A selective 5-HT4 agonist for IBS-C and chronic idiopathic constipation (restricted use).",
        "mechanism": "Stimulates colonic peristalsis.",
        "indications": [
            "Irritable bowel syndrome with constipation (IBS-C, women <65)",
            "Chronic idiopathic constipation"
        ],
        "dosage": {
            "adults": "6 mg orally twice daily before meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Ischemic colitis (rare)"
        ],
        "contraindications": [
            "History of MI, stroke, unstable angina, bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2D6 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naloxegol": {
        "definition": "A peripherally acting opioid antagonist for opioid-induced constipation.",
        "mechanism": "Blocks opioid receptors in the GI tract without affecting analgesia.",
        "indications": [
            "Opioid-induced constipation (non-cancer pain)"
        ],
        "dosage": {
            "adults": "25 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Nausea"
        ],
        "contraindications": [
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naldemedine": {
        "definition": "A peripherally acting opioid antagonist for opioid-induced constipation.",
        "mechanism": "Blocks opioid receptors in the GI tract without affecting analgesia.",
        "indications": [
            "Opioid-induced constipation (chronic non-cancer pain)"
        ],
        "dosage": {
            "adults": "0.2 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Abdominal pain",
            "Diarrhea",
            "Nausea"
        ],
        "contraindications": [
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitroprusside": {
        "definition": "A potent vasodilator for hypertensive emergencies and acute heart failure.",
        "mechanism": "Releases nitric oxide, causing arterial and venous dilation.",
        "indications": [
            "Hypertensive emergency",
            "Acute heart failure"
        ],
        "dosage": {
            "adults": "0.3-10 mcg/kg/min IV infusion.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Cyanide toxicity",
            "Methemoglobinemia"
        ],
        "contraindications": [
            "Compensatory hypertension",
            "Leber's optic atrophy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cysteamine": {
        "definition": "A cystine-depleting agent for nephropathic cystinosis.",
        "mechanism": "Reduces lysosomal cystine accumulation.",
        "indications": [
            "Nephropathic cystinosis"
        ],
        "dosage": {
            "adults": "Dose by weight and cystine levels.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "GI upset",
            "Halitosis",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ketorolac": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for short-term pain management.",
        "mechanism": "Inhibits prostaglandin synthesis via COX-1 and COX-2 inhibition.",
        "indications": [
            "Moderate to severe pain (short-term)"
        ],
        "dosage": {
            "adults": "10 mg orally every 4-6 hours (max 5 days); IM/IV: 15-30 mg every 6 hours.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI bleeding",
            "Renal toxicity",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment",
            "Peptic ulcer disease"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Other NSAIDs",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "riboflavin": {
        "definition": "Vitamin B2, used for deficiency and migraine prophylaxis.",
        "mechanism": "Essential cofactor in energy metabolism.",
        "indications": [
            "Riboflavin deficiency",
            "Migraine prophylaxis"
        ],
        "dosage": {
            "adults": "5-100 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Yellow-orange urine",
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brompheniramine": {
        "definition": "A first-generation antihistamine for allergy symptoms.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Urticaria"
        ],
        "dosage": {
            "adults": "4 mg orally every 4-6 hours.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Dizziness"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cholestyramine": {
        "definition": "A bile acid sequestrant for hypercholesterolemia and pruritus due to bile acid accumulation.",
        "mechanism": "Binds bile acids in the intestine, reducing cholesterol absorption.",
        "indications": [
            "Hypercholesterolemia",
            "Pruritus from cholestasis",
            "Diarrhea due to bile acid malabsorption"
        ],
        "dosage": {
            "adults": "4-16 g orally daily in divided doses.",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Bloating",
            "Increased triglycerides"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oral drugs (may reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vedolizumab": {
        "definition": "A monoclonal antibody for ulcerative colitis and Crohn's disease.",
        "mechanism": "Blocks α4β7 integrin, preventing leukocyte migration to the gut.",
        "indications": [
            "Ulcerative colitis",
            "Crohn's disease"
        ],
        "dosage": {
            "adults": "300 mg IV at 0, 2, 6 weeks, then every 8 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Headache",
            "Arthralgia"
        ],
        "contraindications": [
            "Severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rifaximin": {
        "definition": "A non-absorbable antibiotic for traveler's diarrhea, IBS-D, and hepatic encephalopathy.",
        "mechanism": "Inhibits bacterial RNA synthesis.",
        "indications": [
            "Traveler's diarrhea",
            "IBS with diarrhea (IBS-D)",
            "Hepatic encephalopathy"
        ],
        "dosage": {
            "adults": "200 mg orally 3 times daily (diarrhea); 550 mg twice daily (encephalopathy/IBS-D).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Nausea",
            "Flatulence",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "certolizumab": {
        "definition": "A TNF-alpha inhibitor for Crohn's disease, rheumatoid arthritis, and psoriatic arthritis.",
        "mechanism": "Binds TNF-alpha, reducing inflammation.",
        "indications": [
            "Crohn's disease",
            "Rheumatoid arthritis",
            "Psoriatic arthritis",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "400 mg SC at 0, 2, 4 weeks, then 200 mg every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infection",
            "Injection site reactions",
            "Headache"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "May be considered (does not cross placenta well)."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ustekinumab": {
        "definition": "An IL-12/23 inhibitor for Crohn's disease, ulcerative colitis, and psoriasis.",
        "mechanism": "Binds IL-12 and IL-23, reducing inflammation.",
        "indications": [
            "Crohn's disease",
            "Ulcerative colitis",
            "Psoriasis",
            "Psoriatic arthritis"
        ],
        "dosage": {
            "adults": "IV induction, then 90 mg SC every 8 weeks.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Headache",
            "Fatigue"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "natalizumab": {
        "definition": "An α4-integrin inhibitor for multiple sclerosis and Crohn's disease.",
        "mechanism": "Blocks leukocyte migration across the blood-brain barrier and gut endothelium.",
        "indications": [
            "Multiple sclerosis",
            "Crohn's disease"
        ],
        "dosage": {
            "adults": "300 mg IV every 4 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "PML (progressive multifocal leukoencephalopathy)",
            "Infection",
            "Fatigue"
        ],
        "contraindications": [
            "History of PML",
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "corticorelin": {
        "definition": "A synthetic corticotropin-releasing factor for diagnostic testing of pituitary-adrenal function.",
        "mechanism": "Stimulates ACTH release from the pituitary.",
        "indications": [
            "Differentiation of pituitary vs. ectopic ACTH syndrome"
        ],
        "dosage": {
            "adults": "1 mcg/kg IV over 30 seconds.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Flushing",
            "Tachycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Glucocorticoids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "avelumab": {
        "definition": "A PD-L1 inhibitor immunotherapy for Merkel cell carcinoma and other cancers.",
        "mechanism": "Blocks PD-L1, enhancing T-cell mediated immune response.",
        "indications": [
            "Merkel cell carcinoma",
            "Urothelial carcinoma",
            "Renal cell carcinoma"
        ],
        "dosage": {
            "adults": "800 mg IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Fatigue",
            "Immune-mediated reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "miltefosine": {
        "definition": "An oral antileishmanial agent.",
        "mechanism": "Disrupts cell membrane function in Leishmania parasites.",
        "indications": [
            "Visceral, cutaneous, and mucosal leishmaniasis"
        ],
        "dosage": {
            "adults": "2.5 mg/kg orally daily for 28 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Teratogenicity"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium iodide": {
        "definition": "A thyroid blocking agent for radiation emergencies and expectorant.",
        "mechanism": "Blocks thyroid uptake of radioactive iodine; increases respiratory secretions.",
        "indications": [
            "Radiation emergency",
            "Thyroid storm",
            "Expectorant"
        ],
        "dosage": {
            "adults": "130 mg orally daily (radiation); expectorant: 300 mg daily in divided doses.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Hypothyroidism"
        ],
        "contraindications": [
            "Hypersensitivity to iodine",
            "Dermatitis herpetiformis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antithyroid drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zinc acetate": {
        "definition": "A zinc salt for Wilson's disease and dietary supplementation.",
        "mechanism": "Blocks copper absorption in the intestine.",
        "indications": [
            "Wilson's disease",
            "Zinc deficiency"
        ],
        "dosage": {
            "adults": "25-50 mg elemental zinc orally 1-3 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "GI upset",
            "Metallic taste"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzethonium chloride": {
        "definition": "A topical antiseptic and disinfectant.",
        "mechanism": "Disrupts microbial cell membranes.",
        "indications": [
            "Skin antisepsis",
            "Minor wound cleansing"
        ],
        "dosage": {
            "adults": "Apply as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical antiseptics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxocobalamin": {
        "definition": "A form of vitamin B12 for B12 deficiency and cyanide poisoning.",
        "mechanism": "Cofactor in DNA synthesis; binds cyanide to form non-toxic cyanocobalamin.",
        "indications": [
            "Vitamin B12 deficiency",
            "Cyanide poisoning"
        ],
        "dosage": {
            "adults": "1-10 g IV for cyanide poisoning; 1 mg IM/IV for deficiency.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Red urine",
            "Hypertension",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium nitrite": {
        "definition": "An antidote for cyanide poisoning.",
        "mechanism": "Induces methemoglobinemia, which binds cyanide.",
        "indications": [
            "Cyanide poisoning"
        ],
        "dosage": {
            "adults": "300 mg IV over 5-20 min.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Methemoglobinemia"
        ],
        "contraindications": [
            "Severe anemia",
            "Hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oxidizing agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium thiosulfate": {
        "definition": "An antidote for cyanide poisoning and cisplatin toxicity.",
        "mechanism": "Converts cyanide to thiocyanate, which is excreted.",
        "indications": [
            "Cyanide poisoning",
            "Cisplatin toxicity"
        ],
        "dosage": {
            "adults": "12.5 g IV over 10 min.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amyl nitrite": {
        "definition": "An inhaled antidote for cyanide poisoning.",
        "mechanism": "Induces methemoglobinemia, which binds cyanide.",
        "indications": [
            "Cyanide poisoning"
        ],
        "dosage": {
            "adults": "Inhale ampule for 30 sec every minute until IV antidote available.",
            "children": "Same as adults."
        },
        "side effects": [
            "Headache",
            "Hypotension",
            "Flushing"
        ],
        "contraindications": [
            "Severe anemia",
            "Hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oxidizing agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dornase alfa": {
        "definition": "A recombinant DNase for cystic fibrosis airway clearance.",
        "mechanism": "Breaks down DNA in respiratory secretions, reducing viscosity.",
        "indications": [
            "Cystic fibrosis (airway clearance)"
        ],
        "dosage": {
            "adults": "2.5 mg nebulized once daily.",
            "children": "Same as adults (age 5+)."
        },
        "side effects": [
            "Voice alteration",
            "Pharyngitis",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ivacaftor": {
        "definition": "A CFTR potentiator for cystic fibrosis with specific mutations.",
        "mechanism": "Increases activity of defective CFTR protein.",
        "indications": [
            "Cystic fibrosis (specific CFTR mutations)"
        ],
        "dosage": {
            "adults": "150 mg orally every 12 hours with fat-containing food.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "Headache",
            "Upper respiratory infection",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aztreonam": {
        "definition": "A monobactam antibiotic for Gram-negative bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Serious Gram-negative infections",
            "Cystic fibrosis (inhaled)"
        ],
        "dosage": {
            "adults": "1-2 g IV/IM every 8-12 hours; inhaled: 75 mg 3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Rash",
            "GI upset",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lumacaftor": {
        "definition": "A CFTR corrector for cystic fibrosis (combined with ivacaftor).",
        "mechanism": "Improves processing and trafficking of CFTR protein.",
        "indications": [
            "Cystic fibrosis (homozygous F508del mutation, with ivacaftor)"
        ],
        "dosage": {
            "adults": "400 mg (with ivacaftor 250 mg) orally every 12 hours.",
            "children": "Dose by age and weight."
        },
        "side effects": [
            "Dyspnea",
            "Nausea",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tiopronin": {
        "definition": "A thiol drug for cystinuria and cystine kidney stones.",
        "mechanism": "Binds cystine, forming a more soluble complex.",
        "indications": [
            "Cystinuria (prevention of kidney stones)"
        ],
        "dosage": {
            "adults": "800-1200 mg orally daily in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Rash",
            "Proteinuria",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Gold compounds"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "penicillamine": {
        "definition": "A chelating agent for Wilson's disease, cystinuria, and rheumatoid arthritis.",
        "mechanism": "Binds metals (copper, cystine), promoting excretion.",
        "indications": [
            "Wilson's disease",
            "Cystinuria",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "250-1000 mg orally daily in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Proteinuria",
            "Rash",
            "Bone marrow suppression"
        ],
        "contraindications": [
            "Renal impairment",
            "Pregnancy (RA)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Iron"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrithione zinc": {
        "definition": "A topical antifungal and antibacterial for dandruff and seborrheic dermatitis.",
        "mechanism": "Disrupts fungal and bacterial cell membranes.",
        "indications": [
            "Dandruff",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply shampoo to scalp 2-3 times weekly.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Dryness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "selenium sulfide": {
        "definition": "A topical antifungal for dandruff, seborrheic dermatitis, and tinea versicolor.",
        "mechanism": "Reduces epidermal cell turnover and fungal growth.",
        "indications": [
            "Dandruff",
            "Seborrheic dermatitis",
            "Tinea versicolor"
        ],
        "dosage": {
            "adults": "Apply shampoo/lotion to affected area 2-3 times weekly.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Hair discoloration"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "solriamfetol": {
        "definition": "A dopamine/norepinephrine reuptake inhibitor for excessive sleepiness in narcolepsy and OSA.",
        "mechanism": "Inhibits dopamine and norepinephrine reuptake.",
        "indications": [
            "Excessive sleepiness in narcolepsy",
            "Obstructive sleep apnea"
        ],
        "dosage": {
            "adults": "75-150 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Insomnia",
            "Increased blood pressure"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dalteparin": {
        "definition": "A low molecular weight heparin for VTE prophylaxis and treatment.",
        "mechanism": "Inhibits factor Xa and IIa (thrombin).",
        "indications": [
            "VTE prophylaxis",
            "VTE treatment",
            "Unstable angina"
        ],
        "dosage": {
            "adults": "2500-5000 units SC once daily (prophylaxis); 100 IU/kg SC every 12 hours (treatment).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia",
            "Injection site reactions"
        ],
        "contraindications": [
            "Active bleeding",
            "History of HIT"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desirudin": {
        "definition": "A direct thrombin inhibitor for DVT prophylaxis after hip replacement.",
        "mechanism": "Inhibits thrombin (factor IIa).",
        "indications": [
            "DVT prophylaxis after hip replacement"
        ],
        "dosage": {
            "adults": "15 mg SC every 12 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bleeding",
            "Injection site reactions"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lvp solution": {
        "definition": "Large volume parenteral solution for IV fluid and electrolyte replacement.",
        "mechanism": "Provides water and electrolytes for hydration and volume expansion.",
        "indications": [
            "Dehydration",
            "Electrolyte imbalance",
            "IV medication dilution"
        ],
        "dosage": {
            "adults": "Volume and rate per clinical need.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fluid overload",
            "Electrolyte imbalance"
        ],
        "contraindications": [
            "Fluid overload states",
            "Electrolyte abnormalities (specific to solution)"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trifluridine": {
        "definition": "A topical antiviral for herpes simplex keratitis.",
        "mechanism": "Inhibits viral DNA synthesis.",
        "indications": [
            "Herpes simplex keratitis (ocular)"
        ],
        "dosage": {
            "adults": "1 drop in affected eye every 2 hours while awake (max 9 drops/day).",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Eyelid edema",
            "Blurred vision"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydrogen peroxide": {
        "definition": "A topical antiseptic and oral debriding agent.",
        "mechanism": "Releases oxygen, destroying microorganisms and cleaning wounds.",
        "indications": [
            "Wound cleansing",
            "Oral debridement"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Delayed healing (prolonged use)"
        ],
        "contraindications": [
            "Deep wounds",
            "Serious burns"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brexanolone": {
        "definition": "A neuroactive steroid for postpartum depression.",
        "mechanism": "Positive allosteric modulator of GABA-A receptors.",
        "indications": [
            "Postpartum depression"
        ],
        "dosage": {
            "adults": "IV infusion over 60 hours (protocol-specific).",
            "children": "Not indicated."
        },
        "side effects": [
            "Sedation",
            "Loss of consciousness",
            "Dry mouth"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phentolamine": {
        "definition": "A non-selective alpha blocker for hypertensive emergencies and extravasation of vasoconstrictors.",
        "mechanism": "Blocks alpha-adrenergic receptors, causing vasodilation.",
        "indications": [
            "Hypertensive emergencies",
            "Vasopressor extravasation"
        ],
        "dosage": {
            "adults": "5-15 mg IV bolus or 5-10 mg SC locally.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Tachycardia",
            "Arrhythmias"
        ],
        "contraindications": [
            "Coronary artery disease",
            "MI"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lanolin": {
        "definition": "A topical emollient for dry or cracked skin and nipples.",
        "mechanism": "Moisturizes and protects skin.",
        "indications": [
            "Dry skin",
            "Nipple care (breastfeeding)"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Lanolin allergy"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "menthol": {
        "definition": "A topical counterirritant and flavoring agent.",
        "mechanism": "Activates cold-sensitive TRPM8 receptors, producing cooling sensation.",
        "indications": [
            "Minor pain relief",
            "Cough/cold preparations",
            "Pruritus"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vitamins a, d, and e": {
        "definition": "A combination of fat-soluble vitamins for deficiency states and skin health.",
        "mechanism": "Supports vision, immunity, bone health, and skin integrity.",
        "indications": [
            "Vitamin deficiency",
            "Skin health (topical)"
        ],
        "dosage": {
            "adults": "As directed by product.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypervitaminosis (high doses)"
        ],
        "contraindications": [
            "Hypercalcemia (vitamin D)"
        ],
        "special populations": {
            "pregnancy": "Avoid high doses."
        },
        "interactions": [
            "Retinoids",
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "balsam peru": {
        "definition": "A topical wound healing agent and protectant.",
        "mechanism": "Promotes tissue regeneration and has mild antiseptic properties.",
        "indications": [
            "Minor wounds",
            "Burns",
            "Hemorrhoids (with other agents)"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "castor oil": {
        "definition": "A stimulant laxative and topical emollient.",
        "mechanism": "Increases intestinal motility; moisturizes skin.",
        "indications": [
            "Constipation",
            "Dry skin"
        ],
        "dosage": {
            "adults": "15-60 mL orally as a single dose (laxative); topical as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "Abdominal cramps",
            "Diarrhea",
            "Skin irritation (topical)"
        ],
        "contraindications": [
            "GI obstruction",
            "Pregnancy (oral use)"
        ],
        "special populations": {
            "pregnancy": "Avoid oral use."
        },
        "interactions": [
            "Other laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trypsin": {
        "definition": "A topical enzymatic debriding agent for wounds and ulcers.",
        "mechanism": "Breaks down necrotic tissue and proteins.",
        "indications": [
            "Wound debridement"
        ],
        "dosage": {
            "adults": "Apply to wound as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Local irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Open wounds with active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroquinone": {
        "definition": "A topical depigmenting agent for hyperpigmentation disorders.",
        "mechanism": "Inhibits melanin production.",
        "indications": [
            "Melasma",
            "Lentigines",
            "Post-inflammatory hyperpigmentation"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area once or twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions",
            "Ochronosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "urea": {
        "definition": "A topical keratolytic and moisturizer for dry, scaly skin.",
        "mechanism": "Increases water content of the stratum corneum; promotes desquamation.",
        "indications": [
            "Xerosis",
            "Ichthyosis",
            "Hyperkeratotic skin conditions"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning"
        ],
        "contraindications": [
            "Open wounds"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "silver": {
        "definition": "A topical antimicrobial (often as silver sulfadiazine or silver nitrate) for wound care.",
        "mechanism": "Releases silver ions, disrupting microbial cell membranes.",
        "indications": [
            "Burns",
            "Wound care"
        ],
        "dosage": {
            "adults": "Apply as directed (formulation-specific).",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin discoloration",
            "Argyria (chronic use)",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mycophenolic acid": {
        "definition": "An immunosuppressant for organ transplant rejection prophylaxis.",
        "mechanism": "Inhibits inosine monophosphate dehydrogenase, suppressing lymphocyte proliferation.",
        "indications": [
            "Organ transplant rejection prophylaxis"
        ],
        "dosage": {
            "adults": "720 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "GI upset",
            "Leukopenia",
            "Infection"
        ],
        "contraindications": [
            "Pregnancy",
            "Active serious infection"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Antacids",
            "Cholestyramine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flavoxate": {
        "definition": "A urinary antispasmodic for symptoms of overactive bladder.",
        "mechanism": "Relaxes smooth muscle in the urinary tract.",
        "indications": [
            "Dysuria",
            "Urgency",
            "Nocturia",
            "Cystitis"
        ],
        "dosage": {
            "adults": "100-200 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Nausea"
        ],
        "contraindications": [
            "GI obstruction",
            "Glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glipizide": {
        "definition": "A sulfonylurea oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Stimulates pancreatic insulin secretion.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "2.5-40 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "GI upset"
        ],
        "contraindications": [
            "Type 1 diabetes",
            "DKA",
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glimepiride": {
        "definition": "A sulfonylurea oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Stimulates pancreatic insulin secretion.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "1-8 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "GI upset"
        ],
        "contraindications": [
            "Type 1 diabetes",
            "DKA",
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pioglitazone": {
        "definition": "A thiazolidinedione oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Increases insulin sensitivity via PPAR-gamma activation.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "15-45 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Weight gain",
            "Edema",
            "Heart failure exacerbation"
        ],
        "contraindications": [
            "Heart failure (NYHA III/IV)",
            "Bladder cancer"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sitagliptin": {
        "definition": "A DPP-4 inhibitor oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Inhibits DPP-4, increasing incretin levels and insulin secretion.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "100 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nasopharyngitis",
            "Pancreatitis",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hypoglycemics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin degludec": {
        "definition": "An ultra-long-acting basal insulin for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Start at 10 units SC once daily, adjust to blood glucose.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin aspart": {
        "definition": "A rapid-acting insulin analog for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Individualized; inject SC 5-10 min before meals.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin glargine": {
        "definition": "A long-acting insulin analog for diabetes mellitus.",
        "mechanism": "Provides basal insulin coverage over 24 hours.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Individualized; inject SC once daily at same time.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin lispro": {
        "definition": "A rapid-acting insulin analog for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Individualized; inject SC within 15 min before or after meals.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin regular": {
        "definition": "A short-acting human insulin for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes",
            "Diabetic ketoacidosis (IV)"
        ],
        "dosage": {
            "adults": "Individualized; inject SC 30 min before meals; IV for DKA.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin glulisine": {
        "definition": "A rapid-acting insulin analog for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Individualized; inject SC within 15 min before or after meals.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "irbesartan": {
        "definition": "An angiotensin II receptor blocker (ARB) for hypertension and diabetic nephropathy.",
        "mechanism": "Blocks angiotensin II type 1 receptors.",
        "indications": [
            "Hypertension",
            "Diabetic nephropathy"
        ],
        "dosage": {
            "adults": "150-300 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benazepril": {
        "definition": "An ACE inhibitor for hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production.",
        "indications": [
            "Hypertension",
            "Heart failure"
        ],
        "dosage": {
            "adults": "10-40 mg orally once or twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "moexipril": {
        "definition": "An ACE inhibitor for hypertension.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production.",
        "indications": [
            "Hypertension"
        ],
        "dosage": {
            "adults": "7.5-30 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trandolapril": {
        "definition": "An ACE inhibitor for hypertension and heart failure.",
        "mechanism": "Inhibits ACE, decreasing angiotensin II production.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Post-MI LV dysfunction"
        ],
        "dosage": {
            "adults": "1-4 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cough",
            "Hyperkalemia",
            "Angioedema"
        ],
        "contraindications": [
            "History of angioedema with ACE inhibitors",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ranibizumab": {
        "definition": "A VEGF inhibitor for neovascular (wet) age-related macular degeneration and other retinal diseases.",
        "mechanism": "Binds and inhibits VEGF-A, reducing neovascularization.",
        "indications": [
            "Wet age-related macular degeneration",
            "Diabetic macular edema",
            "Retinal vein occlusion"
        ],
        "dosage": {
            "adults": "0.5 mg intravitreal injection monthly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye pain",
            "Increased intraocular pressure",
            "Retinal detachment"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravitreal agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aflibercept": {
        "definition": "A VEGF inhibitor for retinal diseases and metastatic colorectal cancer.",
        "mechanism": "Binds VEGF-A, VEGF-B, and PlGF, inhibiting angiogenesis.",
        "indications": [
            "Wet age-related macular degeneration",
            "Diabetic macular edema",
            "Retinal vein occlusion",
            "Metastatic colorectal cancer (with chemo)"
        ],
        "dosage": {
            "adults": "2 mg intravitreal injection every 4-8 weeks (eye); 4 mg/kg IV every 2 weeks (cancer).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye pain",
            "Increased intraocular pressure",
            "Hemorrhage"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravitreal agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tapentadol": {
        "definition": "An opioid analgesic with norepinephrine reuptake inhibition for moderate to severe pain.",
        "mechanism": "Mu-opioid receptor agonist and norepinephrine reuptake inhibitor.",
        "indications": [
            "Moderate to severe pain",
            "Diabetic neuropathic pain"
        ],
        "dosage": {
            "adults": "50-100 mg orally every 4-6 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Constipation",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Severe asthma",
            "Paralytic ileus"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tuberculin purified protein derivative": {
        "definition": "A diagnostic antigen for tuberculosis skin testing (Mantoux test).",
        "mechanism": "Elicits delayed-type hypersensitivity reaction in sensitized individuals.",
        "indications": [
            "Tuberculosis screening (Mantoux test)"
        ],
        "dosage": {
            "adults": "0.1 mL (5 TU) intradermally.",
            "children": "Same as adults."
        },
        "side effects": [
            "Local irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe skin reactions",
            "Previous severe reaction to PPD"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Live vaccines (may affect results)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "CDC",
            "MedlinePlus"
        ]
    },
    "metyrapone": {
        "definition": "An adrenal steroid synthesis inhibitor for Cushing's syndrome diagnosis and treatment.",
        "mechanism": "Inhibits 11-beta-hydroxylase, reducing cortisol synthesis.",
        "indications": [
            "Cushing's syndrome",
            "Diagnosis of adrenal insufficiency"
        ],
        "dosage": {
            "adults": "250 mg orally every 4 hours (diagnosis); up to 6 g/day (treatment).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Hirsutism"
        ],
        "contraindications": [
            "Adrenal cortical insufficiency",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tetrofosmin": {
        "definition": "A technetium-99m radiopharmaceutical for myocardial perfusion imaging.",
        "mechanism": "Distributes in myocardium proportional to blood flow; emits gamma rays.",
        "indications": [
            "Myocardial perfusion imaging (SPECT)"
        ],
        "dosage": {
            "adults": "10-30 mCi IV per scan.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glucagon": {
        "definition": "A pancreatic hormone for severe hypoglycemia and as a diagnostic aid.",
        "mechanism": "Stimulates hepatic glycogenolysis, raising blood glucose.",
        "indications": [
            "Severe hypoglycemia",
            "GI motility diagnostic aid",
            "Beta-blocker overdose"
        ],
        "dosage": {
            "adults": "1 mg IM/SC/IV (hypoglycemia); 3-10 mg IV (overdose).",
            "children": "0.5 mg IM/SC/IV (hypoglycemia)."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Hypersensitivity"
        ],
        "contraindications": [
            "Pheochromocytoma",
            "Insulinoma"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "regadenoson": {
        "definition": "A selective adenosine A2A receptor agonist for myocardial perfusion imaging.",
        "mechanism": "Coronary vasodilator; increases blood flow in normal coronary arteries.",
        "indications": [
            "Pharmacologic stress agent for myocardial perfusion imaging"
        ],
        "dosage": {
            "adults": "0.4 mg IV bolus.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Flushing",
            "Dyspnea"
        ],
        "contraindications": [
            "2nd/3rd degree AV block (without pacemaker)",
            "Sinus node dysfunction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Dipyridamole",
            "Methylxanthines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iobenguane I 123": {
        "definition": "A radiopharmaceutical for imaging neuroendocrine tumors (MIBG scan).",
        "mechanism": "Taken up by adrenergic tissue; emits gamma rays for imaging.",
        "indications": [
            "Imaging of neuroblastoma, pheochromocytoma, paraganglioma"
        ],
        "dosage": {
            "adults": "10 mCi IV.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Allergic reactions",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Drugs affecting norepinephrine uptake"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methacholine": {
        "definition": "A cholinergic agonist for bronchial hyperreactivity testing (methacholine challenge).",
        "mechanism": "Stimulates muscarinic receptors, causing bronchoconstriction.",
        "indications": [
            "Diagnosis of bronchial hyperreactivity (asthma)"
        ],
        "dosage": {
            "adults": "Inhaled, dose escalated per protocol.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bronchospasm",
            "Cough",
            "Headache"
        ],
        "contraindications": [
            "Severe airflow limitation",
            "Recent MI or stroke"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diphenoxylate": {
        "definition": "An opioid antidiarrheal (usually with atropine).",
        "mechanism": "Slows intestinal motility via opioid receptors in the gut.",
        "indications": [
            "Acute diarrhea (with atropine)"
        ],
        "dosage": {
            "adults": "2.5-5 mg orally 3-4 times daily (max 20 mg/day).",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Constipation",
            "Anticholinergic effects (from atropine)"
        ],
        "contraindications": [
            "Jaundice",
            "Children <6 years",
            "C. difficile infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "saccharomyces boulardii lyo": {
        "definition": "A probiotic yeast for prevention and treatment of diarrhea.",
        "mechanism": "Restores normal gut flora; inhibits pathogenic bacteria.",
        "indications": [
            "Antibiotic-associated diarrhea",
            "C. difficile recurrence prevention",
            "Traveler's diarrhea"
        ],
        "dosage": {
            "adults": "250-500 mg orally 1-2 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Flatulence",
            "Constipation",
            "Fungemia (rare, immunocompromised)"
        ],
        "contraindications": [
            "Severe immunosuppression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antifungals"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "opium": {
        "definition": "An opioid alkaloid mixture for pain and diarrhea (tincture of opium).",
        "mechanism": "Binds opioid receptors in CNS and gut.",
        "indications": [
            "Diarrhea (tincture)",
            "Pain (historical)"
        ],
        "dosage": {
            "adults": "0.6 mL tincture orally 1-4 times daily.",
            "children": "Not recommended."
        },
        "side effects": [
            "Constipation",
            "Respiratory depression",
            "Drowsiness"
        ],
        "contraindications": [
            "Respiratory depression",
            "Severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "multivitamin": {
        "definition": "A combination of essential vitamins and minerals for nutritional supplementation.",
        "mechanism": "Provides vitamins/minerals to prevent or treat deficiencies.",
        "indications": [
            "Vitamin/mineral deficiency",
            "Supplementation"
        ],
        "dosage": {
            "adults": "1 tablet/capsule daily or as directed.",
            "children": "Pediatric formulations available."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe (prenatal formulations preferred)."
        },
        "interactions": [
            "Other vitamin/mineral supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "biotin": {
        "definition": "A water-soluble B vitamin (B7) for deficiency and hair/nail health.",
        "mechanism": "Cofactor in carboxylation reactions.",
        "indications": [
            "Biotin deficiency",
            "Hair/nail health (supplement)"
        ],
        "dosage": {
            "adults": "30-100 mcg orally daily; higher for deficiency.",
            "children": "Dose by age."
        },
        "side effects": [
            "Rare; GI upset possible"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Laboratory test interference"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "omega-3 polyunsaturated fatty acids": {
        "definition": "Essential fatty acids for cardiovascular health and hypertriglyceridemia.",
        "mechanism": "Reduces hepatic triglyceride synthesis.",
        "indications": [
            "Hypertriglyceridemia",
            "Cardiovascular risk reduction",
            "Dietary supplementation"
        ],
        "dosage": {
            "adults": "1-4 g orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Fishy aftertaste",
            "GI upset",
            "Bleeding (high doses)"
        ],
        "contraindications": [
            "Fish/shellfish allergy"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium citrate": {
        "definition": "A calcium supplement for deficiency and osteoporosis prevention.",
        "mechanism": "Provides calcium ions for bone health and physiological functions.",
        "indications": [
            "Calcium deficiency",
            "Osteoporosis prevention"
        ],
        "dosage": {
            "adults": "500-1200 mg elemental calcium daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Hypercalcemia (high doses)"
        ],
        "contraindications": [
            "Hypercalcemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ascorbic acid": {
        "definition": "Vitamin C, a water-soluble vitamin for deficiency and antioxidant support.",
        "mechanism": "Cofactor in collagen synthesis and antioxidant.",
        "indications": [
            "Vitamin C deficiency (scurvy)",
            "Dietary supplementation"
        ],
        "dosage": {
            "adults": "75-2000 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Kidney stones (high doses)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Iron (increases absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bifidobacterium infantis": {
        "definition": "A probiotic bacterium for gut health and IBS.",
        "mechanism": "Restores normal gut flora; modulates immune response.",
        "indications": [
            "IBS",
            "Gut health",
            "Prevention of antibiotic-associated diarrhea"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Flatulence",
            "Bloating"
        ],
        "contraindications": [
            "Severe immunosuppression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lactobacillus acidophilus": {
        "definition": "A probiotic bacterium for gut health and prevention of diarrhea.",
        "mechanism": "Restores normal gut flora; inhibits pathogenic bacteria.",
        "indications": [
            "Antibiotic-associated diarrhea",
            "Gut health",
            "IBS"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Flatulence",
            "Bloating"
        ],
        "contraindications": [
            "Severe immunosuppression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zolpidem": {
        "definition": "A non-benzodiazepine hypnotic for insomnia.",
        "mechanism": "Binds GABA-A receptors at the benzodiazepine site, enhancing inhibitory neurotransmission.",
        "indications": [
            "Insomnia (short-term)"
        ],
        "dosage": {
            "adults": "5-10 mg orally at bedtime (immediate-release); 6.25-12.5 mg (extended-release).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Complex sleep behaviors"
        ],
        "contraindications": [
            "History of complex sleep behaviors",
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "temazepam": {
        "definition": "A benzodiazepine hypnotic for insomnia.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Insomnia (short-term)"
        ],
        "dosage": {
            "adults": "7.5-30 mg orally at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Dependence"
        ],
        "contraindications": [
            "Pregnancy",
            "History of substance abuse"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eszopiclone": {
        "definition": "A non-benzodiazepine hypnotic for insomnia.",
        "mechanism": "Binds GABA-A receptors at the benzodiazepine site, enhancing inhibitory neurotransmission.",
        "indications": [
            "Insomnia"
        ],
        "dosage": {
            "adults": "1-3 mg orally at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dysgeusia",
            "Complex sleep behaviors"
        ],
        "contraindications": [
            "History of complex sleep behaviors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flurazepam": {
        "definition": "A benzodiazepine hypnotic for insomnia.",
        "mechanism": "Enhances GABAergic inhibition in the CNS.",
        "indications": [
            "Insomnia (short-term)"
        ],
        "dosage": {
            "adults": "15-30 mg orally at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Dependence"
        ],
        "contraindications": [
            "Pregnancy",
            "History of substance abuse"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "axicabtagene ciloleucel": {
        "definition": "An anti-CD19 CAR T-cell therapy for relapsed/refractory large B-cell lymphoma.",
        "mechanism": "Genetically modified T-cells target and kill CD19+ B-cells.",
        "indications": [
            "Relapsed/refractory large B-cell lymphoma"
        ],
        "dosage": {
            "adults": "2 x 10^6 CAR-positive T cells/kg IV once.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cytokine release syndrome",
            "Neurotoxicity",
            "Infection"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hyaluronidase": {
        "definition": "An enzyme that increases tissue permeability for drug dispersion and subcutaneous fluid absorption.",
        "mechanism": "Hydrolyzes hyaluronic acid in connective tissue.",
        "indications": [
            "Subcutaneous fluid administration",
            "Enhancing drug absorption",
            "Extravasation management"
        ],
        "dosage": {
            "adults": "150 units SC/IV per site.",
            "children": "Same as adults."
        },
        "side effects": [
            "Local reactions",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Furosemide",
            "Benzodiazepines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "polatuzumab vedotin": {
        "definition": "An anti-CD79b antibody-drug conjugate for diffuse large B-cell lymphoma.",
        "mechanism": "Delivers cytotoxic agent to CD79b+ B-cells.",
        "indications": [
            "Diffuse large B-cell lymphoma (relapsed/refractory)"
        ],
        "dosage": {
            "adults": "1.8 mg/kg IV every 21 days (6 cycles).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Peripheral neuropathy",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "digoxin immune fab": {
        "definition": "An antidote for life-threatening digoxin toxicity.",
        "mechanism": "Binds free digoxin, forming complexes excreted by kidneys.",
        "indications": [
            "Digoxin toxicity (life-threatening)"
        ],
        "dosage": {
            "adults": "Dose by amount ingested or serum digoxin level.",
            "children": "Same as adults."
        },
        "side effects": [
            "Hypokalemia",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to ovine proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diphtheria toxoid": {
        "definition": "A vaccine antigen for prevention of diphtheria.",
        "mechanism": "Induces active immunity against diphtheria toxin.",
        "indications": [
            "Prevention of diphtheria (as part of DTaP, Tdap, DT, Td vaccines)"
        ],
        "dosage": {
            "adults": "0.5 mL IM per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Tdap recommended during each pregnancy."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "pertussis, acellular": {
        "definition": "A vaccine antigen for prevention of pertussis (whooping cough).",
        "mechanism": "Induces active immunity against Bordetella pertussis.",
        "indications": [
            "Prevention of pertussis (as part of DTaP, Tdap vaccines)"
        ],
        "dosage": {
            "adults": "0.5 mL IM per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Tdap recommended during each pregnancy."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "tetanus toxoid": {
        "definition": "A vaccine antigen for prevention of tetanus.",
        "mechanism": "Induces active immunity against tetanus toxin.",
        "indications": [
            "Prevention of tetanus (as part of DTaP, Tdap, DT, Td vaccines)"
        ],
        "dosage": {
            "adults": "0.5 mL IM per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Tdap recommended during each pregnancy."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "haemophilus b conjugate (prp-t) vaccine": {
        "definition": "A vaccine for prevention of Haemophilus influenzae type b (Hib) infection.",
        "mechanism": "Induces active immunity against Hib polysaccharide antigen.",
        "indications": [
            "Prevention of Hib infection"
        ],
        "dosage": {
            "adults": "Not routinely used.",
            "children": "0.5 mL IM per schedule (infants/children)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Not routinely indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "poliovirus vaccine, inactivated": {
        "definition": "An inactivated vaccine for prevention of poliomyelitis.",
        "mechanism": "Induces active immunity against poliovirus types 1, 2, and 3.",
        "indications": [
            "Prevention of poliomyelitis"
        ],
        "dosage": {
            "adults": "0.5 mL IM or SC per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "diphtheria and tetanus toxoids": {
        "definition": "A vaccine for prevention of diphtheria and tetanus (DT, Td).",
        "mechanism": "Induces active immunity against diphtheria and tetanus toxins.",
        "indications": [
            "Prevention of diphtheria and tetanus"
        ],
        "dosage": {
            "adults": "0.5 mL IM per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Tdap recommended during each pregnancy."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "hepatitis b pediatric vaccine": {
        "definition": "A recombinant vaccine for prevention of hepatitis B in infants and children.",
        "mechanism": "Induces active immunity against hepatitis B surface antigen.",
        "indications": [
            "Prevention of hepatitis B infection"
        ],
        "dosage": {
            "adults": "Not for adults.",
            "children": "0.5 mL IM per schedule (birth, 1-2 months, 6-18 months)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose or yeast"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "haemophilus b conjugate": {
        "definition": "A vaccine for prevention of Haemophilus influenzae type b (Hib) infection.",
        "mechanism": "Induces active immunity against Hib polysaccharide antigen.",
        "indications": [
            "Prevention of Hib infection"
        ],
        "dosage": {
            "adults": "Not routinely used.",
            "children": "0.5 mL IM per schedule (infants/children)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Not routinely indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "hepatitis b vaccine": {
        "definition": "A recombinant vaccine for prevention of hepatitis B.",
        "mechanism": "Induces active immunity against hepatitis B surface antigen.",
        "indications": [
            "Prevention of hepatitis B infection"
        ],
        "dosage": {
            "adults": "1 mL IM per schedule (0, 1, 6 months).",
            "children": "0.5 mL IM per schedule."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose or yeast"
        ],
        "special populations": {
            "pregnancy": "Recommended if indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "belimumab": {
        "definition": "A monoclonal antibody for systemic lupus erythematosus (SLE).",
        "mechanism": "Inhibits B-lymphocyte stimulator (BLyS), reducing B-cell activity.",
        "indications": [
            "Systemic lupus erythematosus"
        ],
        "dosage": {
            "adults": "10 mg/kg IV every 2 weeks for 3 doses, then every 4 weeks; SC: 200 mg weekly.",
            "children": "Dose by weight (age 5+)."
        },
        "side effects": [
            "Infection",
            "Nausea",
            "Depression"
        ],
        "contraindications": [
            "Severe active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cycloserine": {
        "definition": "A second-line antitubercular agent for drug-resistant tuberculosis.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Drug-resistant tuberculosis"
        ],
        "dosage": {
            "adults": "250-500 mg orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Neurotoxicity",
            "Seizures",
            "Depression"
        ],
        "contraindications": [
            "Epilepsy",
            "Severe psychiatric disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Alcohol",
            "Isoniazid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deoxycholic acid": {
        "definition": "A bile acid for submental fat reduction (injection).",
        "mechanism": "Disrupts adipocyte membranes, causing fat cell lysis.",
        "indications": [
            "Submental fat reduction (cosmetic)"
        ],
        "dosage": {
            "adults": "0.2 mL per injection, up to 50 injections per session.",
            "children": "Not indicated."
        },
        "side effects": [
            "Swelling",
            "Bruising",
            "Numbness"
        ],
        "contraindications": [
            "Infection at injection site"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cannabidiol": {
        "definition": "A cannabinoid for seizures associated with Lennox-Gastaut, Dravet, and tuberous sclerosis syndromes.",
        "mechanism": "Modulates endocannabinoid system; exact mechanism unknown.",
        "indications": [
            "Lennox-Gastaut syndrome",
            "Dravet syndrome",
            "Tuberous sclerosis complex"
        ],
        "dosage": {
            "adults": "5-20 mg/kg/day orally in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Somnolence",
            "Elevated liver enzymes",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2C19, CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "stiripentol": {
        "definition": "An antiepileptic for Dravet syndrome (with clobazam and valproate).",
        "mechanism": "Enhances GABAergic transmission; exact mechanism unknown.",
        "indications": [
            "Dravet syndrome (with clobazam and valproate)"
        ],
        "dosage": {
            "adults": "50 mg/kg/day orally in 2-3 divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Somnolence",
            "Loss of appetite",
            "Neutropenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP450 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valsartan": {
        "definition": "An angiotensin II receptor blocker (ARB) for hypertension, heart failure, and post-MI.",
        "mechanism": "Blocks angiotensin II type 1 receptors.",
        "indications": [
            "Hypertension",
            "Heart failure",
            "Post-MI LV dysfunction"
        ],
        "dosage": {
            "adults": "80-320 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lifitegrast": {
        "definition": "A lymphocyte function-associated antigen-1 (LFA-1) antagonist for dry eye disease.",
        "mechanism": "Inhibits T-cell mediated inflammation on the ocular surface.",
        "indications": [
            "Dry eye disease"
        ],
        "dosage": {
            "adults": "1 drop in each eye twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye irritation",
            "Dysgeusia",
            "Reduced visual acuity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxypropyl methylcellulose": {
        "definition": "A synthetic polymer used as an ocular lubricant and artificial tear.",
        "mechanism": "Lubricates and moistens the ocular surface.",
        "indications": [
            "Dry eye",
            "Ocular irritation"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Blurred vision",
            "Eye irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pilocarpine": {
        "definition": "A cholinergic agonist for glaucoma and xerostomia.",
        "mechanism": "Stimulates muscarinic receptors, increasing aqueous humor outflow and salivation.",
        "indications": [
            "Glaucoma",
            "Xerostomia"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1-2 drops up to 4 times daily; Oral: 5 mg 3-4 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Sweating",
            "Nausea",
            "Eye irritation"
        ],
        "contraindications": [
            "Uncontrolled asthma",
            "Acute iritis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta blockers",
            "Anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "saliva substitutes": {
        "definition": "Artificial saliva for xerostomia (dry mouth).",
        "mechanism": "Moisturizes and lubricates oral mucosa.",
        "indications": [
            "Xerostomia"
        ],
        "dosage": {
            "adults": "Use as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Altered taste",
            "Mouth irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glycerin": {
        "definition": "A humectant and osmotic laxative for constipation and skin care.",
        "mechanism": "Draws water into the colon and skin.",
        "indications": [
            "Constipation (suppository)",
            "Skin moisturizer"
        ],
        "dosage": {
            "adults": "Suppository: 1 per rectum as needed; topical as needed.",
            "children": "Suppository: dose by age."
        },
        "side effects": [
            "Rectal irritation",
            "Diarrhea (suppository)",
            "Skin irritation (topical)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "emollients": {
        "definition": "Topical agents that moisturize and soften the skin.",
        "mechanism": "Form a protective barrier to prevent water loss.",
        "indications": [
            "Dry skin",
            "Eczema",
            "Dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deflazacort": {
        "definition": "A glucocorticoid for Duchenne muscular dystrophy.",
        "mechanism": "Reduces inflammation and immune response.",
        "indications": [
            "Duchenne muscular dystrophy"
        ],
        "dosage": {
            "adults": "0.9 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Weight gain",
            "Cushingoid features",
            "Immunosuppression"
        ],
        "contraindications": [
            "Systemic fungal infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eteplirsen": {
        "definition": "An antisense oligonucleotide for Duchenne muscular dystrophy (exon 51 skipping).",
        "mechanism": "Promotes exon 51 skipping in dystrophin gene.",
        "indications": [
            "Duchenne muscular dystrophy (exon 51 amenable)"
        ],
        "dosage": {
            "adults": "30 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Balance disorder",
            "Vomiting",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "golodirsen": {
        "definition": "An antisense oligonucleotide for Duchenne muscular dystrophy (exon 53 skipping).",
        "mechanism": "Promotes exon 53 skipping in dystrophin gene.",
        "indications": [
            "Duchenne muscular dystrophy (exon 53 amenable)"
        ],
        "dosage": {
            "adults": "30 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Headache",
            "Fever",
            "Increased creatinine"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acarbose": {
        "definition": "An alpha-glucosidase inhibitor for type 2 diabetes.",
        "mechanism": "Delays carbohydrate absorption in the intestine.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "25-100 mg orally 3 times daily with first bite of meal.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flatulence",
            "Diarrhea",
            "Abdominal pain"
        ],
        "contraindications": [
            "Inflammatory bowel disease",
            "GI obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Digestive enzyme preparations"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methscopolamine": {
        "definition": "An anticholinergic for peptic ulcer and GI disorders.",
        "mechanism": "Blocks muscarinic receptors, reducing GI secretions and motility.",
        "indications": [
            "Peptic ulcer",
            "GI spasms"
        ],
        "dosage": {
            "adults": "2.5 mg orally 4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "scopolamine": {
        "definition": "An anticholinergic for motion sickness and postoperative nausea/vomiting.",
        "mechanism": "Blocks muscarinic receptors in the CNS and vestibular system.",
        "indications": [
            "Motion sickness",
            "Postoperative nausea/vomiting"
        ],
        "dosage": {
            "adults": "Transdermal patch: 1.5 mg behind ear every 72 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Drowsiness",
            "Blurred vision"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "collagenase clostridium histolyticum": {
        "definition": "An enzyme for treatment of Dupuytren's contracture and Peyronie's disease.",
        "mechanism": "Breaks down collagen in affected tissue.",
        "indications": [
            "Dupuytren's contracture",
            "Peyronie's disease"
        ],
        "dosage": {
            "adults": "0.58 mg injected into cord/plaque per session.",
            "children": "Not indicated."
        },
        "side effects": [
            "Swelling",
            "Bruising",
            "Pain at injection site"
        ],
        "contraindications": [
            "Infection at injection site"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyridostigmine": {
        "definition": "A cholinesterase inhibitor for myasthenia gravis and reversal of neuromuscular blockade.",
        "mechanism": "Inhibits acetylcholinesterase, increasing acetylcholine at neuromuscular junction.",
        "indications": [
            "Myasthenia gravis",
            "Reversal of nondepolarizing neuromuscular blockade"
        ],
        "dosage": {
            "adults": "60-1500 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Muscle cramps",
            "Diarrhea",
            "Bradycardia"
        ],
        "contraindications": [
            "GI or urinary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pitavastatin": {
        "definition": "A statin for hypercholesterolemia and cardiovascular risk reduction.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "1-4 mg orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Myopathy",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Cyclosporine",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluvastatin": {
        "definition": "A statin for hypercholesterolemia and cardiovascular risk reduction.",
        "mechanism": "Inhibits HMG-CoA reductase, reducing cholesterol synthesis.",
        "indications": [
            "Hypercholesterolemia",
            "Cardiovascular risk reduction"
        ],
        "dosage": {
            "adults": "20-80 mg orally once daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Myopathy",
            "Liver enzyme elevation",
            "Diabetes risk"
        ],
        "contraindications": [
            "Active liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Cyclosporine",
            "Gemfibrozil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mefenamic acid": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for mild to moderate pain and dysmenorrhea.",
        "mechanism": "Inhibits prostaglandin synthesis via COX-1 and COX-2 inhibition.",
        "indications": [
            "Mild to moderate pain",
            "Dysmenorrhea"
        ],
        "dosage": {
            "adults": "500 mg orally, then 250 mg every 6 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI bleeding",
            "Renal toxicity",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment",
            "Peptic ulcer disease"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Other NSAIDs",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ketoprofen": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for pain, inflammation, and dysmenorrhea.",
        "mechanism": "Inhibits prostaglandin synthesis via COX-1 and COX-2 inhibition.",
        "indications": [
            "Mild to moderate pain",
            "Inflammatory disorders",
            "Dysmenorrhea"
        ],
        "dosage": {
            "adults": "25-75 mg orally every 6-8 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI bleeding",
            "Renal toxicity",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment",
            "Peptic ulcer disease"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Other NSAIDs",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ospemifene": {
        "definition": "A selective estrogen receptor modulator (SERM) for dyspareunia due to vulvovaginal atrophy.",
        "mechanism": "Estrogen agonist in vaginal tissue.",
        "indications": [
            "Dyspareunia due to vulvovaginal atrophy (postmenopausal women)"
        ],
        "dosage": {
            "adults": "60 mg orally once daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Hot flashes",
            "Vaginal discharge",
            "Thromboembolism"
        ],
        "contraindications": [
            "Estrogen-dependent cancer",
            "Active or past VTE"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dehydroepiandrosterone": {
        "definition": "A steroid hormone supplement for adrenal insufficiency and menopause symptoms.",
        "mechanism": "Precursor to androgens and estrogens.",
        "indications": [
            "Adrenal insufficiency",
            "Menopausal symptoms (off-label)"
        ],
        "dosage": {
            "adults": "25-50 mg orally daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Acne",
            "Hirsutism",
            "Mood changes"
        ],
        "contraindications": [
            "Hormone-sensitive cancers"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aluminum acetate": {
        "definition": "A topical astringent for skin irritation and inflammation.",
        "mechanism": "Precipitates proteins, reducing irritation and exudation.",
        "indications": [
            "Minor skin irritation",
            "Dermatitis",
            "Poison ivy/oak/sumac"
        ],
        "dosage": {
            "adults": "Apply as wet dressing or soak as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amifampridine": {
        "definition": "A potassium channel blocker for Lambert-Eaton myasthenic syndrome (LEMS).",
        "mechanism": "Increases acetylcholine release at neuromuscular junction.",
        "indications": [
            "Lambert-Eaton myasthenic syndrome (LEMS)"
        ],
        "dosage": {
            "adults": "15-30 mg orally 2-4 times daily (max 80 mg/day).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Seizures",
            "Paresthesia",
            "Abdominal pain"
        ],
        "contraindications": [
            "History of seizures"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other drugs lowering seizure threshold"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ebola zaire vaccine, live": {
        "definition": "A live attenuated vaccine for prevention of Ebola virus disease (Zaire ebolavirus).",
        "mechanism": "Induces active immunity against Zaire ebolavirus glycoprotein.",
        "indications": [
            "Prevention of Ebola virus disease (Zaire)"
        ],
        "dosage": {
            "adults": "0.5 mL IM single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Arthralgia",
            "Fever",
            "Injection site reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "CDC",
            "MedlinePlus"
        ]
    },
    "ulipristal": {
        "definition": "A selective progesterone receptor modulator for emergency contraception and uterine fibroids.",
        "mechanism": "Inhibits or delays ovulation; modulates progesterone receptors.",
        "indications": [
            "Emergency contraception",
            "Uterine fibroids"
        ],
        "dosage": {
            "adults": "30 mg orally (emergency contraception); 5-10 mg daily (fibroids).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Abdominal pain",
            "Menstrual changes"
        ],
        "contraindications": [
            "Pregnancy",
            "Unexplained vaginal bleeding"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "norgestrel": {
        "definition": "A progestin used in oral contraceptives and for emergency contraception.",
        "mechanism": "Suppresses ovulation and thickens cervical mucus.",
        "indications": [
            "Contraception",
            "Emergency contraception"
        ],
        "dosage": {
            "adults": "0.075 mg orally daily (contraception); 0.75 mg twice 12 hours apart (emergency).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Irregular bleeding",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Pregnancy",
            "Active liver disease",
            "Breast cancer"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vardenafil": {
        "definition": "A phosphodiesterase-5 inhibitor for erectile dysfunction.",
        "mechanism": "Inhibits PDE-5, increasing cGMP and causing vasodilation.",
        "indications": [
            "Erectile dysfunction"
        ],
        "dosage": {
            "adults": "5-20 mg orally as needed 60 min before sex (max once daily).",
            "children": "Not indicated."
        },
        "side effects": [
            "Headache",
            "Flushing",
            "Rhinitis"
        ],
        "contraindications": [
            "Nitrate therapy",
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Nitrates",
            "Alpha-blockers",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alprostadil": {
        "definition": "A prostaglandin E1 analog for erectile dysfunction and ductus arteriosus patency.",
        "mechanism": "Vasodilates smooth muscle; maintains ductus arteriosus.",
        "indications": [
            "Erectile dysfunction",
            "Maintaining ductus arteriosus patency (infants)"
        ],
        "dosage": {
            "adults": "Intracavernosal: 2.5-20 mcg; intraurethral: 125-1000 mcg.",
            "children": "0.05-0.1 mcg/kg/min IV (infants)."
        },
        "side effects": [
            "Penile pain",
            "Hypotension",
            "Priapism"
        ],
        "contraindications": [
            "Sickle cell disease (ED use)",
            "Anatomical penile deformities"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "avanafil": {
        "definition": "A phosphodiesterase-5 inhibitor for erectile dysfunction.",
        "mechanism": "Inhibits PDE-5, increasing cGMP and causing vasodilation.",
        "indications": [
            "Erectile dysfunction"
        ],
        "dosage": {
            "adults": "50-200 mg orally as needed 15-30 min before sex (max once daily).",
            "children": "Not indicated."
        },
        "side effects": [
            "Headache",
            "Flushing",
            "Back pain"
        ],
        "contraindications": [
            "Nitrate therapy",
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Nitrates",
            "Alpha-blockers",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ropinirole": {
        "definition": "A dopamine agonist for Parkinson's disease and restless legs syndrome.",
        "mechanism": "Stimulates dopamine D2 and D3 receptors in the brain.",
        "indications": [
            "Parkinson's disease",
            "Restless legs syndrome"
        ],
        "dosage": {
            "adults": "0.25-24 mg orally daily (titrated); RLS: 0.25-4 mg daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Somnolence"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pramipexole": {
        "definition": "A dopamine agonist for Parkinson's disease and restless legs syndrome.",
        "mechanism": "Stimulates dopamine D2 and D3 receptors in the brain.",
        "indications": [
            "Parkinson's disease",
            "Restless legs syndrome"
        ],
        "dosage": {
            "adults": "0.125-4.5 mg orally daily (titrated); RLS: 0.125-0.5 mg daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Somnolence"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cimetidine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carbidopa": {
        "definition": "A peripheral dopa decarboxylase inhibitor used with levodopa for Parkinson's disease.",
        "mechanism": "Prevents peripheral breakdown of levodopa, increasing CNS availability.",
        "indications": [
            "Parkinson's disease (with levodopa)"
        ],
        "dosage": {
            "adults": "25-200 mg daily in divided doses (with levodopa).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Dyskinesia",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levodopa": {
        "definition": "A dopamine precursor for Parkinson's disease, usually combined with carbidopa.",
        "mechanism": "Converted to dopamine in the brain.",
        "indications": [
            "Parkinson's disease"
        ],
        "dosage": {
            "adults": "Individualized; usually with carbidopa.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Dyskinesia",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Antipsychotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rotigotine": {
        "definition": "A dopamine agonist patch for Parkinson's disease and restless legs syndrome.",
        "mechanism": "Stimulates dopamine D1, D2, and D3 receptors.",
        "indications": [
            "Parkinson's disease",
            "Restless legs syndrome"
        ],
        "dosage": {
            "adults": "2-16 mg/24h transdermal patch daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Application site reactions",
            "Nausea",
            "Somnolence"
        ],
        "contraindications": [
            "Hypersensitivity to patch adhesives"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antipsychotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxacillin": {
        "definition": "A penicillinase-resistant penicillin antibiotic for staphylococcal infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Staphylococcal infections (MSSA)",
            "Skin and soft tissue infections"
        ],
        "dosage": {
            "adults": "250-2000 mg IV/IM every 4-6 hours.",
            "children": "50-100 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Penicillin allergy"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Methotrexate"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iopamidol": {
        "definition": "A non-ionic iodinated contrast agent for radiographic imaging.",
        "mechanism": "Enhances X-ray contrast by increasing absorption in blood vessels/tissues.",
        "indications": [
            "CT scans",
            "Angiography",
            "Urography"
        ],
        "dosage": {
            "adults": "Dose varies by procedure and concentration.",
            "children": "Dose by weight and procedure."
        },
        "side effects": [
            "Nausea",
            "Allergic reactions",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity to iodinated contrast agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Monitor renal function."
        },
        "interactions": [
            "Metformin (risk of lactic acidosis)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clidinium": {
        "definition": "An anticholinergic for peptic ulcer and GI disorders (usually with chlordiazepoxide).",
        "mechanism": "Blocks muscarinic receptors, reducing GI secretions and motility.",
        "indications": [
            "Peptic ulcer",
            "GI spasms (with chlordiazepoxide)"
        ],
        "dosage": {
            "adults": "2.5 mg orally 3-4 times daily (with chlordiazepoxide).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tazemetostat": {
        "definition": "An EZH2 inhibitor for epithelioid sarcoma and follicular lymphoma.",
        "mechanism": "Inhibits EZH2 methyltransferase, affecting gene expression.",
        "indications": [
            "Epithelioid sarcoma",
            "Follicular lymphoma (EZH2 mutation)"
        ],
        "dosage": {
            "adults": "800 mg orally twice daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vemurafenib": {
        "definition": "A BRAF inhibitor for BRAF V600E-mutant melanoma.",
        "mechanism": "Inhibits mutated BRAF kinase.",
        "indications": [
            "Unresectable or metastatic BRAF V600E-mutant melanoma"
        ],
        "dosage": {
            "adults": "960 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Arthralgia",
            "Rash",
            "QT prolongation"
        ],
        "contraindications": [
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diflorasone": {
        "definition": "A potent topical corticosteroid for inflammatory skin conditions.",
        "mechanism": "Suppresses inflammation and immune response in the skin.",
        "indications": [
            "Corticosteroid-responsive dermatoses"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 1-2 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Skin atrophy",
            "Burning",
            "Striae"
        ],
        "contraindications": [
            "Viral/fungal skin infections"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcipotriene": {
        "definition": "A vitamin D analog for psoriasis.",
        "mechanism": "Regulates skin cell production and differentiation.",
        "indications": [
            "Plaque psoriasis"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area 1-2 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Skin irritation",
            "Hypercalcemia (rare)"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acitretin": {
        "definition": "An oral retinoid for severe psoriasis.",
        "mechanism": "Modulates epidermal cell proliferation and differentiation.",
        "indications": [
            "Severe psoriasis"
        ],
        "dosage": {
            "adults": "25-50 mg orally once daily with food.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Teratogenicity",
            "Dry skin",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Pregnancy",
            "Severe liver/renal impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Methotrexate",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "porfimer": {
        "definition": "A photosensitizing agent for photodynamic therapy of esophageal and lung cancer.",
        "mechanism": "Generates reactive oxygen species when activated by light, causing cell death.",
        "indications": [
            "Esophageal cancer",
            "Non-small cell lung cancer (palliative)"
        ],
        "dosage": {
            "adults": "2 mg/kg IV, followed by light activation.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Photosensitivity",
            "Chest pain",
            "Esophageal edema"
        ],
        "contraindications": [
            "Porphyria",
            "Severe liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other photosensitizing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ethanolamine oleate": {
        "definition": "A sclerosing agent for esophageal varices.",
        "mechanism": "Destroys endothelial cells, causing thrombosis and sclerosis.",
        "indications": [
            "Esophageal varices (sclerotherapy)"
        ],
        "dosage": {
            "adults": "5% solution, 2-5 mL per injection.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Chest pain",
            "Fever",
            "Esophageal ulceration"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tolvaptan": {
        "definition": "A vasopressin V2 receptor antagonist for hyponatremia and polycystic kidney disease.",
        "mechanism": "Promotes free water excretion without sodium loss.",
        "indications": [
            "Hyponatremia (SIADH)",
            "Autosomal dominant polycystic kidney disease"
        ],
        "dosage": {
            "adults": "15-60 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Thirst",
            "Polyuria",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Anuria",
            "Hypovolemic hyponatremia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "conivaptan": {
        "definition": "A vasopressin V1A and V2 receptor antagonist for euvolemic and hypervolemic hyponatremia.",
        "mechanism": "Promotes free water excretion without sodium loss.",
        "indications": [
            "Euvolemic and hypervolemic hyponatremia"
        ],
        "dosage": {
            "adults": "20 mg IV loading, then 20 mg IV over 24 hours (up to 4 days).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Thirst",
            "Hypokalemia",
            "Injection site reactions"
        ],
        "contraindications": [
            "Anuria",
            "Hypovolemic hyponatremia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aluminum chloride hexahydrate": {
        "definition": "A topical antiperspirant for hyperhidrosis.",
        "mechanism": "Blocks sweat gland ducts.",
        "indications": [
            "Hyperhidrosis"
        ],
        "dosage": {
            "adults": "Apply to affected area nightly.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning"
        ],
        "contraindications": [
            "Broken or irritated skin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benztropine": {
        "definition": "An anticholinergic for Parkinson's disease and drug-induced extrapyramidal symptoms.",
        "mechanism": "Blocks central muscarinic receptors.",
        "indications": [
            "Parkinson's disease",
            "Extrapyramidal symptoms"
        ],
        "dosage": {
            "adults": "0.5-6 mg orally/IM/IV daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Constipation"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glycopyrronium": {
        "definition": "An anticholinergic for COPD and drooling (sialorrhea).",
        "mechanism": "Blocks muscarinic receptors in smooth muscle and secretory glands.",
        "indications": [
            "COPD (as glycopyrrolate inhaler)",
            "Sialorrhea"
        ],
        "dosage": {
            "adults": "COPD: 15.6-25 mcg inhaled twice daily; Sialorrhea: 1-2 mg orally 2-3 times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium gluconate": {
        "definition": "A calcium salt for hypocalcemia, hyperkalemia, and cardiac arrest.",
        "mechanism": "Provides calcium ions for physiological processes.",
        "indications": [
            "Hypocalcemia",
            "Hyperkalemia",
            "Calcium channel blocker overdose"
        ],
        "dosage": {
            "adults": "1-2 g IV over 2-5 min.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Phlebitis",
            "Hypercalcemia",
            "Arrhythmias"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Ventricular fibrillation"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Digoxin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hepatitis b immune globulin": {
        "definition": "A human immune globulin for post-exposure prophylaxis of hepatitis B.",
        "mechanism": "Provides passive immunity against hepatitis B virus.",
        "indications": [
            "Post-exposure prophylaxis of hepatitis B"
        ],
        "dosage": {
            "adults": "0.06 mL/kg IM within 24 hours of exposure.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "IgA deficiency with antibodies to IgA"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "coagulation factor viia": {
        "definition": "A recombinant clotting factor for bleeding episodes in hemophilia and factor VII deficiency.",
        "mechanism": "Activates the coagulation cascade, promoting clot formation.",
        "indications": [
            "Hemophilia A or B with inhibitors",
            "Congenital factor VII deficiency"
        ],
        "dosage": {
            "adults": "15-90 mcg/kg IV bolus every 2-6 hours as needed.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lutein": {
        "definition": "A carotenoid antioxidant for eye health and macular degeneration prevention.",
        "mechanism": "Protects retinal cells from oxidative damage.",
        "indications": [
            "Age-related macular degeneration",
            "Eye health"
        ],
        "dosage": {
            "adults": "6-20 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Yellow skin (high doses)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "natamycin": {
        "definition": "A topical polyene antifungal for fungal eye infections.",
        "mechanism": "Binds to ergosterol, increasing fungal cell membrane permeability.",
        "indications": [
            "Fungal blepharitis",
            "Conjunctivitis",
            "Keratitis"
        ],
        "dosage": {
            "adults": "1 drop in affected eye every 1-2 hours, then less often.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluorometholone": {
        "definition": "A topical corticosteroid for eye inflammation.",
        "mechanism": "Suppresses ocular inflammation.",
        "indications": [
            "Ocular inflammation",
            "Allergic conjunctivitis"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) 2-4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Increased intraocular pressure",
            "Blurred vision",
            "Burning"
        ],
        "contraindications": [
            "Viral/fungal eye infections"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naphazoline": {
        "definition": "A topical ocular decongestant for eye redness.",
        "mechanism": "Stimulates alpha-adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Ocular redness",
            "Minor eye irritation"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) up to 4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Mydriasis",
            "Rebound hyperemia"
        ],
        "contraindications": [
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tetrahydrozoline": {
        "definition": "A topical ocular decongestant for eye redness.",
        "mechanism": "Stimulates alpha-adrenergic receptors, causing vasoconstriction.",
        "indications": [
            "Ocular redness",
            "Minor eye irritation"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) up to 4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Mydriasis",
            "Rebound hyperemia"
        ],
        "contraindications": [
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pheniramine": {
        "definition": "A first-generation antihistamine for allergy symptoms and as an ocular decongestant.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic conjunctivitis",
            "Allergic rhinitis"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1-2 drops in affected eye(s) up to 4 times daily; Oral: 22.7 mg every 4-6 hours.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Eye irritation"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zinc sulfate": {
        "definition": "A zinc salt for supplementation and eye drops for conjunctivitis.",
        "mechanism": "Provides zinc for physiological functions; may reduce eye irritation.",
        "indications": [
            "Zinc deficiency",
            "Conjunctivitis (topical)"
        ],
        "dosage": {
            "adults": "220 mg orally 1-3 times daily; 0.25% eye drops as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Metallic taste",
            "Eye irritation (topical)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bimatoprost": {
        "definition": "A prostaglandin analog for glaucoma and eyelash growth.",
        "mechanism": "Increases aqueous humor outflow, lowering intraocular pressure.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension",
            "Hypotrichosis of eyelashes"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once daily (glaucoma); apply to upper eyelid (eyelash growth).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye redness",
            "Eyelash growth",
            "Iris pigmentation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "agalsidase beta": {
        "definition": "A recombinant enzyme for Fabry disease.",
        "mechanism": "Replaces alpha-galactosidase A enzyme.",
        "indications": [
            "Fabry disease"
        ],
        "dosage": {
            "adults": "1 mg/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Chills"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "migalastat": {
        "definition": "A pharmacological chaperone for Fabry disease (amenable mutations).",
        "mechanism": "Stabilizes alpha-galactosidase A enzyme.",
        "indications": [
            "Fabry disease (amenable mutations)"
        ],
        "dosage": {
            "adults": "123 mg orally every other day.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "UTI"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "poly-l-lactic acid": {
        "definition": "A biodegradable injectable filler for facial lipoatrophy and cosmetic use.",
        "mechanism": "Stimulates collagen production.",
        "indications": [
            "Facial lipoatrophy",
            "Cosmetic facial augmentation"
        ],
        "dosage": {
            "adults": "Injected into dermis/subcutis by trained provider.",
            "children": "Not indicated."
        },
        "side effects": [
            "Nodule formation",
            "Swelling",
            "Bruising"
        ],
        "contraindications": [
            "Active skin infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other dermal fillers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "coagulation factor x": {
        "definition": "A plasma-derived clotting factor for hereditary factor X deficiency.",
        "mechanism": "Replaces deficient factor X, enabling normal coagulation.",
        "indications": [
            "Hereditary factor X deficiency"
        ],
        "dosage": {
            "adults": "Dose individualized by factor X activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "factor XIII": {
        "definition": "A plasma-derived or recombinant clotting factor for factor XIII deficiency.",
        "mechanism": "Replaces deficient factor XIII, enabling normal clot formation.",
        "indications": [
            "Congenital factor XIII deficiency"
        ],
        "dosage": {
            "adults": "35 IU/kg IV every 4 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lomitapide": {
        "definition": "A microsomal triglyceride transfer protein inhibitor for homozygous familial hypercholesterolemia.",
        "mechanism": "Inhibits VLDL assembly and secretion.",
        "indications": [
            "Homozygous familial hypercholesterolemia"
        ],
        "dosage": {
            "adults": "5-60 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hepatotoxicity",
            "GI upset",
            "Steatosis"
        ],
        "contraindications": [
            "Pregnancy",
            "Liver disease"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ergocalciferol": {
        "definition": "Vitamin D2 for deficiency and hypoparathyroidism.",
        "mechanism": "Increases intestinal absorption of calcium and phosphate.",
        "indications": [
            "Vitamin D deficiency",
            "Hypoparathyroidism",
            "Rickets"
        ],
        "dosage": {
            "adults": "400-50,000 IU orally daily/weekly.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypercalcemia",
            "Hypercalciuria"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "triclabendazole": {
        "definition": "An oral anthelmintic for fascioliasis (liver fluke infection).",
        "mechanism": "Disrupts microtubule function in parasites.",
        "indications": [
            "Fascioliasis"
        ],
        "dosage": {
            "adults": "10 mg/kg orally, repeat in 12 hours.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Abdominal pain",
            "Headache",
            "Increased liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "orlistat": {
        "definition": "A pancreatic lipase inhibitor for obesity management.",
        "mechanism": "Inhibits fat absorption in the intestine.",
        "indications": [
            "Obesity",
            "Weight loss"
        ],
        "dosage": {
            "adults": "120 mg orally three times daily with meals.",
            "children": "Dose by age (12+)."
        },
        "side effects": [
            "Steatorrhea",
            "Flatulence",
            "Fat-soluble vitamin deficiency"
        ],
        "contraindications": [
            "Chronic malabsorption",
            "Cholestasis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Cyclosporine",
            "Levothyroxine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "betaine": {
        "definition": "A methyl donor for homocystinuria due to CBS deficiency.",
        "mechanism": "Converts homocysteine to methionine.",
        "indications": [
            "Homocystinuria (CBS deficiency)"
        ],
        "dosage": {
            "adults": "3-6 g orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Body odor"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rosiglitazone": {
        "definition": "A thiazolidinedione oral hypoglycemic for type 2 diabetes.",
        "mechanism": "Increases insulin sensitivity via PPAR-gamma activation.",
        "indications": [
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "4-8 mg orally once daily or in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Weight gain",
            "Edema",
            "Heart failure exacerbation"
        ],
        "contraindications": [
            "Heart failure (NYHA III/IV)",
            "Bladder cancer"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "auranofin": {
        "definition": "An oral gold compound for rheumatoid arthritis.",
        "mechanism": "Modulates immune response; exact mechanism unknown.",
        "indications": [
            "Rheumatoid arthritis (not first-line)"
        ],
        "dosage": {
            "adults": "6 mg orally once daily or in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Proteinuria"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clomiphene": {
        "definition": "A selective estrogen receptor modulator (SERM) for ovulation induction.",
        "mechanism": "Blocks estrogen receptors in hypothalamus, increasing FSH and LH.",
        "indications": [
            "Ovulatory dysfunction in infertility"
        ],
        "dosage": {
            "adults": "50 mg orally daily for 5 days (cycle days 3-7 or 5-9).",
            "children": "Not indicated."
        },
        "side effects": [
            "Hot flashes",
            "Ovarian enlargement",
            "Multiple gestation"
        ],
        "contraindications": [
            "Liver disease",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chorionic gonadotropin (hcg)": {
        "definition": "A hormone for ovulation induction, hypogonadism, and cryptorchidism.",
        "mechanism": "Stimulates ovarian follicle rupture and testosterone production.",
        "indications": [
            "Ovulation induction",
            "Male hypogonadism",
            "Cryptorchidism"
        ],
        "dosage": {
            "adults": "5000-10,000 units IM/SC per cycle.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Ovarian hyperstimulation",
            "Gynecomastia",
            "Headache"
        ],
        "contraindications": [
            "Precocious puberty",
            "Prostate cancer"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "menotropins": {
        "definition": "A mixture of FSH and LH for ovulation induction and male infertility.",
        "mechanism": "Stimulates ovarian follicle development and spermatogenesis.",
        "indications": [
            "Ovulation induction",
            "Male infertility"
        ],
        "dosage": {
            "adults": "75-450 IU IM/SC daily per protocol.",
            "children": "Not indicated."
        },
        "side effects": [
            "Ovarian hyperstimulation",
            "Multiple gestation",
            "Headache"
        ],
        "contraindications": [
            "Ovarian cysts",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other fertility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "urofollitropin": {
        "definition": "A purified FSH for ovulation induction and assisted reproduction.",
        "mechanism": "Stimulates ovarian follicle development.",
        "indications": [
            "Ovulation induction",
            "Assisted reproductive technology"
        ],
        "dosage": {
            "adults": "75-450 IU SC/IM daily per protocol.",
            "children": "Not indicated."
        },
        "side effects": [
            "Ovarian hyperstimulation",
            "Multiple gestation",
            "Headache"
        ],
        "contraindications": [
            "Ovarian cysts",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other fertility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flibanserin": {
        "definition": "A serotonin receptor agonist/antagonist for hypoactive sexual desire disorder in premenopausal women.",
        "mechanism": "Modulates serotonin and dopamine in the CNS.",
        "indications": [
            "Hypoactive sexual desire disorder (pre-menopausal women)"
        ],
        "dosage": {
            "adults": "100 mg orally at bedtime.",
            "children": "Not indicated."
        },
        "side effects": [
            "Dizziness",
            "Somnolence",
            "Hypotension"
        ],
        "contraindications": [
            "Alcohol use",
            "Liver impairment"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Alcohol"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bremelanotide": {
        "definition": "A melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women.",
        "mechanism": "Activates melanocortin receptors in the CNS.",
        "indications": [
            "Hypoactive sexual desire disorder (pre-menopausal women)"
        ],
        "dosage": {
            "adults": "1.75 mg SC as needed (max 1 dose/24h, 8/month).",
            "children": "Not indicated."
        },
        "side effects": [
            "Nausea",
            "Flushing",
            "Hypertension"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Cardiovascular disease"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Naltrexone"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aminocaproic acid": {
        "definition": "An antifibrinolytic agent for bleeding disorders.",
        "mechanism": "Inhibits plasminogen activation, preventing fibrin degradation.",
        "indications": [
            "Bleeding due to hyperfibrinolysis",
            "Surgical bleeding"
        ],
        "dosage": {
            "adults": "4-5 g IV, then 1 g/hr infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Hypotension",
            "Myopathy"
        ],
        "contraindications": [
            "Active intravascular clotting"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antifibrinolytics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nabilone": {
        "definition": "A synthetic cannabinoid for chemotherapy-induced nausea and vomiting.",
        "mechanism": "Activates cannabinoid receptors in CNS.",
        "indications": [
            "Chemotherapy-induced nausea and vomiting (refractory)"
        ],
        "dosage": {
            "adults": "1-2 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dizziness",
            "Euphoria"
        ],
        "contraindications": [
            "Psychiatric disorders",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zanamivir": {
        "definition": "An inhaled neuraminidase inhibitor for influenza A and B.",
        "mechanism": "Inhibits influenza virus neuraminidase, blocking viral release.",
        "indications": [
            "Treatment and prophylaxis of influenza A and B"
        ],
        "dosage": {
            "adults": "10 mg (2 inhalations) twice daily for 5 days.",
            "children": "Same as adults (age 7+)."
        },
        "side effects": [
            "Bronchospasm",
            "Cough",
            "Headache"
        ],
        "contraindications": [
            "Asthma",
            "COPD"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live attenuated influenza vaccine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "peramivir": {
        "definition": "An IV neuraminidase inhibitor for influenza.",
        "mechanism": "Inhibits influenza virus neuraminidase, blocking viral release.",
        "indications": [
            "Treatment of acute uncomplicated influenza"
        ],
        "dosage": {
            "adults": "600 mg IV single dose.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Diarrhea",
            "Neutropenia",
            "Neuropsychiatric events"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live attenuated influenza vaccine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "baloxavir marboxil": {
        "definition": "An oral cap-dependent endonuclease inhibitor for influenza.",
        "mechanism": "Inhibits influenza virus polymerase, blocking replication.",
        "indications": [
            "Treatment of acute uncomplicated influenza"
        ],
        "dosage": {
            "adults": "40-80 mg orally single dose (weight-based).",
            "children": "Dose by weight (age 5+)."
        },
        "side effects": [
            "Diarrhea",
            "Bronchitis",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Polyvalent cations (antacids, etc.)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "influenza virus vaccine, inactivated": {
        "definition": "An inactivated vaccine for prevention of influenza A and B.",
        "mechanism": "Induces active immunity against influenza virus antigens.",
        "indications": [
            "Prevention of influenza"
        ],
        "dosage": {
            "adults": "0.5 mL IM annually.",
            "children": "0.25-0.5 mL IM annually (dose by age)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Recommended."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "influenza virus vaccine, live, trivalent": {
        "definition": "A live attenuated intranasal vaccine for prevention of influenza.",
        "mechanism": "Induces active immunity against influenza virus antigens.",
        "indications": [
            "Prevention of influenza (ages 2-49)"
        ],
        "dosage": {
            "adults": "0.2 mL intranasal annually.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Nasal congestion",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy",
            "Asthma (age <5)"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Antiviral drugs (oseltamivir, zanamivir)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "rimantadine": {
        "definition": "An oral adamantane antiviral for influenza A (not recommended due to resistance).",
        "mechanism": "Inhibits M2 protein, blocking viral uncoating.",
        "indications": [
            "Influenza A (not recommended due to resistance)"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "CNS effects",
            "Insomnia"
        ],
        "contraindications": [
            "Severe liver or renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "follicle stimulating hormone": {
        "definition": "A recombinant or purified hormone for ovulation induction and male infertility.",
        "mechanism": "Stimulates ovarian follicle development and spermatogenesis.",
        "indications": [
            "Ovulation induction",
            "Male infertility"
        ],
        "dosage": {
            "adults": "75-450 IU SC/IM daily per protocol.",
            "children": "Not indicated."
        },
        "side effects": [
            "Ovarian hyperstimulation",
            "Multiple gestation",
            "Headache"
        ],
        "contraindications": [
            "Ovarian cysts",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other fertility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "copanlisib": {
        "definition": "A PI3K inhibitor for relapsed follicular lymphoma.",
        "mechanism": "Inhibits PI3K-alpha and PI3K-delta, blocking cell proliferation.",
        "indications": [
            "Relapsed follicular lymphoma"
        ],
        "dosage": {
            "adults": "60 mg IV on days 1, 8, 15 of a 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperglycemia",
            "Hypertension",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "duvelisib": {
        "definition": "A PI3K-delta and gamma inhibitor for CLL/SLL and follicular lymphoma.",
        "mechanism": "Inhibits PI3K-delta and gamma, blocking cell proliferation.",
        "indications": [
            "Chronic lymphocytic leukemia/small lymphocytic lymphoma",
            "Follicular lymphoma"
        ],
        "dosage": {
            "adults": "25 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Infection",
            "Pneumonitis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prabotulinumtoxinA": {
        "definition": "A botulinum toxin type A for temporary improvement of glabellar lines (cosmetic).",
        "mechanism": "Blocks acetylcholine release at neuromuscular junction.",
        "indications": [
            "Glabellar lines (cosmetic)"
        ],
        "dosage": {
            "adults": "20 units IM in 5 sites per treatment.",
            "children": "Not indicated."
        },
        "side effects": [
            "Headache",
            "Eyelid ptosis",
            "Injection site pain"
        ],
        "contraindications": [
            "Infection at injection site",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Aminoglycosides"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fenofibrate": {
        "definition": "A fibric acid derivative for hypertriglyceridemia and mixed dyslipidemia.",
        "mechanism": "Activates PPAR-alpha, increasing lipolysis of triglycerides.",
        "indications": [
            "Hypertriglyceridemia",
            "Mixed dyslipidemia"
        ],
        "dosage": {
            "adults": "48-160 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dyspepsia",
            "Gallstones",
            "Myopathy (with statins)"
        ],
        "contraindications": [
            "Severe renal or hepatic impairment",
            "Gallbladder disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Statins",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "colestipol": {
        "definition": "A bile acid sequestrant for hypercholesterolemia.",
        "mechanism": "Binds bile acids in the intestine, reducing cholesterol absorption.",
        "indications": [
            "Hypercholesterolemia"
        ],
        "dosage": {
            "adults": "5-30 g orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Bloating",
            "Increased triglycerides"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oral drugs (may reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clioquinol": {
        "definition": "A topical antifungal and antibacterial for skin infections.",
        "mechanism": "Disrupts microbial DNA and protein synthesis.",
        "indications": [
            "Dermatitis",
            "Fungal skin infections"
        ],
        "dosage": {
            "adults": "Apply to affected area 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Yellow-brown staining"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "undecylenic acid": {
        "definition": "A topical antifungal for tinea pedis and other fungal skin infections.",
        "mechanism": "Disrupts fungal cell membranes.",
        "indications": [
            "Tinea pedis",
            "Other dermatophytoses"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "efinaconazole": {
        "definition": "A topical triazole antifungal for onychomycosis.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Onychomycosis (toenails)"
        ],
        "dosage": {
            "adults": "Apply to affected toenail once daily for 48 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Ingrown toenail",
            "Application site dermatitis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tavaborole": {
        "definition": "A topical oxaborole antifungal for onychomycosis.",
        "mechanism": "Inhibits fungal protein synthesis.",
        "indications": [
            "Onychomycosis (toenails)"
        ],
        "dosage": {
            "adults": "Apply to affected toenail once daily for 48 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Ingrown toenail",
            "Application site dermatitis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chenodeoxycholic acid": {
        "definition": "A bile acid for gallstone dissolution and cerebrotendinous xanthomatosis.",
        "mechanism": "Reduces cholesterol saturation in bile.",
        "indications": [
            "Gallstone dissolution",
            "Cerebrotendinous xanthomatosis"
        ],
        "dosage": {
            "adults": "250 mg orally 2-4 times daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Diarrhea",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Obstructive biliary disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Bile acid sequestrants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tipiracil": {
        "definition": "A thymidine phosphorylase inhibitor (with trifluridine) for metastatic colorectal cancer.",
        "mechanism": "Prevents degradation of trifluridine, enhancing its effect.",
        "indications": [
            "Metastatic colorectal cancer (with trifluridine)"
        ],
        "dosage": {
            "adults": "35 mg/m² orally twice daily (with trifluridine).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Anemia",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rotavirus vaccine": {
        "definition": "A live oral vaccine for prevention of rotavirus gastroenteritis in infants.",
        "mechanism": "Induces active immunity against rotavirus.",
        "indications": [
            "Prevention of rotavirus gastroenteritis"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "2-3 oral doses (depending on product) at 2, 4, (6) months."
        },
        "side effects": [
            "Diarrhea",
            "Vomiting",
            "Intussusception (rare)"
        ],
        "contraindications": [
            "Severe combined immunodeficiency",
            "History of intussusception"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Other live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "avapritinib": {
        "definition": "A tyrosine kinase inhibitor for gastrointestinal stromal tumor (GIST) with PDGFRA exon 18 mutation.",
        "mechanism": "Inhibits mutant PDGFRA and KIT kinases.",
        "indications": [
            "GIST with PDGFRA exon 18 mutation"
        ],
        "dosage": {
            "adults": "300 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Edema",
            "Nausea",
            "Cognitive effects"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "alvimopan": {
        "definition": "A peripherally acting opioid antagonist for postoperative ileus.",
        "mechanism": "Blocks opioid receptors in the GI tract without affecting analgesia.",
        "indications": [
            "Postoperative ileus (short-term hospital use)"
        ],
        "dosage": {
            "adults": "12 mg orally pre-op, then 12 mg twice daily (max 15 doses).",
            "children": "Not indicated."
        },
        "side effects": [
            "Hypokalemia",
            "Dyspepsia",
            "Anemia"
        ],
        "contraindications": [
            "Opioid use >7 days prior to surgery"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other opioid antagonists"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "imiglucerase": {
        "definition": "A recombinant enzyme for Gaucher disease type 1.",
        "mechanism": "Replaces glucocerebrosidase enzyme.",
        "indications": [
            "Gaucher disease type 1"
        ],
        "dosage": {
            "adults": "2.5-60 units/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "miglustat": {
        "definition": "A substrate reduction therapy for Gaucher disease type 1 and Niemann-Pick type C.",
        "mechanism": "Inhibits glucosylceramide synthase.",
        "indications": [
            "Gaucher disease type 1 (mild/moderate)",
            "Niemann-Pick type C"
        ],
        "dosage": {
            "adults": "100 mg orally three times daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Diarrhea",
            "Tremor",
            "Weight loss"
        ],
        "contraindications": [
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "velaglucerase alfa": {
        "definition": "A recombinant enzyme for Gaucher disease type 1.",
        "mechanism": "Replaces glucocerebrosidase enzyme.",
        "indications": [
            "Gaucher disease type 1"
        ],
        "dosage": {
            "adults": "60 units/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eliglustat": {
        "definition": "A substrate reduction therapy for Gaucher disease type 1.",
        "mechanism": "Inhibits glucosylceramide synthase.",
        "indications": [
            "Gaucher disease type 1 (CYP2D6 metabolizer-dependent)"
        ],
        "dosage": {
            "adults": "84 mg orally once or twice daily (CYP2D6 dependent).",
            "children": "Not indicated."
        },
        "side effects": [
            "Fatigue",
            "Nausea",
            "QT prolongation"
        ],
        "contraindications": [
            "CYP2D6 poor metabolizers with CYP3A inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2D6, CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "taliglucerase alfa": {
        "definition": "A recombinant enzyme for Gaucher disease type 1.",
        "mechanism": "Replaces glucocerebrosidase enzyme.",
        "indications": [
            "Gaucher disease type 1"
        ],
        "dosage": {
            "adults": "30-60 units/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pexidartinib": {
        "definition": "A CSF1R inhibitor for tenosynovial giant cell tumor (TGCT).",
        "mechanism": "Inhibits colony-stimulating factor 1 receptor (CSF1R).",
        "indications": [
            "Tenosynovial giant cell tumor (TGCT)"
        ],
        "dosage": {
            "adults": "400 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hepatotoxicity",
            "Hair color changes",
            "Edema"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "insulin isophane": {
        "definition": "An intermediate-acting insulin (NPH) for diabetes mellitus.",
        "mechanism": "Replaces endogenous insulin, regulating glucose metabolism.",
        "indications": [
            "Type 1 diabetes",
            "Type 2 diabetes"
        ],
        "dosage": {
            "adults": "Individualized; SC once or twice daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypoglycemia",
            "Weight gain",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypoglycemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other hypoglycemics",
            "Beta blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlorhexidine": {
        "definition": "A topical antiseptic and disinfectant for skin, oral, and wound care.",
        "mechanism": "Disrupts microbial cell membranes.",
        "indications": [
            "Skin antisepsis",
            "Oral rinse",
            "Wound cleansing"
        ],
        "dosage": {
            "adults": "Apply or rinse as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Tooth staining (oral)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other topical antiseptics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "timolol": {
        "definition": "A non-selective beta-blocker for glaucoma and hypertension.",
        "mechanism": "Reduces aqueous humor production in the eye; blocks beta-adrenergic receptors.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension",
            "Hypertension (oral)"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1 drop 0.25-0.5% in affected eye(s) twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Bradycardia",
            "Bronchospasm"
        ],
        "contraindications": [
            "Asthma",
            "Severe COPD",
            "Sinus bradycardia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other beta-blockers",
            "Calcium channel blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methazolamide": {
        "definition": "A carbonic anhydrase inhibitor for glaucoma.",
        "mechanism": "Decreases aqueous humor production by inhibiting carbonic anhydrase.",
        "indications": [
            "Glaucoma"
        ],
        "dosage": {
            "adults": "50-100 mg orally 1-3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Paresthesia",
            "Fatigue",
            "Metabolic acidosis"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Severe renal/hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "apraclonidine": {
        "definition": "An alpha-2 adrenergic agonist for short-term intraocular pressure reduction.",
        "mechanism": "Reduces aqueous humor production and increases uveoscleral outflow.",
        "indications": [
            "Short-term IOP reduction (post-surgery, glaucoma)"
        ],
        "dosage": {
            "adults": "1 drop 0.5-1% in affected eye(s) 1-3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye redness",
            "Dry mouth",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carbachol": {
        "definition": "A cholinergic agonist for glaucoma and intraocular surgery.",
        "mechanism": "Stimulates muscarinic receptors, increasing aqueous humor outflow.",
        "indications": [
            "Glaucoma",
            "Miosis during surgery"
        ],
        "dosage": {
            "adults": "Ophthalmic: 1-2 drops up to 3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Headache",
            "Reduced vision (night)"
        ],
        "contraindications": [
            "Iritis",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "echothiophate iodide": {
        "definition": "A long-acting cholinesterase inhibitor for glaucoma.",
        "mechanism": "Inhibits cholinesterase, increasing acetylcholine and aqueous outflow.",
        "indications": [
            "Glaucoma",
            "Accommodative esotropia"
        ],
        "dosage": {
            "adults": "1 drop 0.03-0.25% in affected eye(s) once or twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Cataract",
            "Iritis",
            "Systemic cholinergic effects"
        ],
        "contraindications": [
            "Uveitis",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "latanoprost": {
        "definition": "A prostaglandin analog for glaucoma.",
        "mechanism": "Increases uveoscleral outflow of aqueous humor.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once daily in evening.",
            "children": "Same as adults."
        },
        "side effects": [
            "Iris pigmentation",
            "Eyelash growth",
            "Eye irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other prostaglandin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dorzolamide": {
        "definition": "A topical carbonic anhydrase inhibitor for glaucoma.",
        "mechanism": "Decreases aqueous humor production.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop 2% in affected eye(s) 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Bitter taste",
            "Allergic reactions"
        ],
        "contraindications": [
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "travoprost": {
        "definition": "A prostaglandin analog for glaucoma.",
        "mechanism": "Increases uveoscleral outflow of aqueous humor.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once daily in evening.",
            "children": "Same as adults."
        },
        "side effects": [
            "Iris pigmentation",
            "Eyelash growth",
            "Eye irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other prostaglandin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brinzolamide": {
        "definition": "A topical carbonic anhydrase inhibitor for glaucoma.",
        "mechanism": "Decreases aqueous humor production.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop 1% in affected eye(s) 2-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Blurred vision",
            "Eye irritation",
            "Bitter taste"
        ],
        "contraindications": [
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tafluprost": {
        "definition": "A preservative-free prostaglandin analog for glaucoma.",
        "mechanism": "Increases uveoscleral outflow of aqueous humor.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once daily in evening.",
            "children": "Same as adults."
        },
        "side effects": [
            "Iris pigmentation",
            "Eyelash growth",
            "Eye irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other prostaglandin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "latanoprostene bunod": {
        "definition": "A prostaglandin analog and nitric oxide donor for glaucoma.",
        "mechanism": "Increases uveoscleral and trabecular outflow of aqueous humor.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once daily in evening.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye redness",
            "Iris pigmentation",
            "Eyelash growth"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other prostaglandin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ganirelix": {
        "definition": "A GnRH antagonist for controlled ovarian stimulation in assisted reproduction.",
        "mechanism": "Blocks GnRH receptors, preventing premature LH surge.",
        "indications": [
            "Prevention of premature ovulation in IVF protocols"
        ],
        "dosage": {
            "adults": "250 mcg SC daily during ovarian stimulation.",
            "children": "Not indicated."
        },
        "side effects": [
            "Abdominal pain",
            "Headache",
            "Injection site reactions"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other fertility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefixime": {
        "definition": "A third-generation oral cephalosporin antibiotic.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "UTI",
            "Otitis media",
            "Pharyngitis",
            "Gonorrhea"
        ],
        "dosage": {
            "adults": "400 mg orally once daily or 200 mg twice daily.",
            "children": "8 mg/kg once daily."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Allergic reactions"
        ],
        "contraindications": [
            "Cephalosporin allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "febuxostat": {
        "definition": "A xanthine oxidase inhibitor for gout management.",
        "mechanism": "Inhibits xanthine oxidase, reducing uric acid production.",
        "indications": [
            "Chronic management of gout"
        ],
        "dosage": {
            "adults": "40-80 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Liver enzyme elevation",
            "Rash",
            "Cardiovascular events"
        ],
        "contraindications": [
            "Azathioprine or mercaptopurine use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Azathioprine",
            "Mercaptopurine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegloticase": {
        "definition": "A recombinant uricase enzyme for refractory chronic gout.",
        "mechanism": "Converts uric acid to allantoin, which is more soluble.",
        "indications": [
            "Chronic refractory gout"
        ],
        "dosage": {
            "adults": "8 mg IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infusion reactions",
            "Gout flares",
            "Anaphylaxis"
        ],
        "contraindications": [
            "G6PD deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other urate-lowering drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lesinurad": {
        "definition": "A uric acid reabsorption inhibitor for gout (withdrawn in some markets).",
        "mechanism": "Inhibits URAT1, increasing uric acid excretion.",
        "indications": [
            "Gout (with xanthine oxidase inhibitor)"
        ],
        "dosage": {
            "adults": "200 mg orally once daily (with food and XOI).",
            "children": "Not indicated."
        },
        "side effects": [
            "Renal failure",
            "Headache",
            "Increased creatinine"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Kidney transplant"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Xanthine oxidase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "colistimethate": {
        "definition": "A polymyxin antibiotic for multidrug-resistant Gram-negative infections.",
        "mechanism": "Disrupts bacterial cell membrane.",
        "indications": [
            "Serious Gram-negative infections (Pseudomonas, Acinetobacter)"
        ],
        "dosage": {
            "adults": "2.5-5 mg/kg/day IV in 2-4 divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Neurotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gemifloxacin": {
        "definition": "A fluoroquinolone antibiotic for respiratory tract infections.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV.",
        "indications": [
            "Community-acquired pneumonia",
            "Acute exacerbation of chronic bronchitis"
        ],
        "dosage": {
            "adults": "320 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity",
            "Tendon disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "macimorelin": {
        "definition": "An oral ghrelin receptor agonist for adult growth hormone deficiency diagnosis.",
        "mechanism": "Stimulates growth hormone secretion via ghrelin receptor activation.",
        "indications": [
            "Diagnosis of adult growth hormone deficiency"
        ],
        "dosage": {
            "adults": "0.5 mg/kg orally as a single dose.",
            "children": "Not indicated."
        },
        "side effects": [
            "Dysgeusia",
            "Headache",
            "Fatigue"
        ],
        "contraindications": [
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Drugs that prolong QT interval"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vestronidase alfa": {
        "definition": "A recombinant enzyme for mucopolysaccharidosis VII (Sly syndrome).",
        "mechanism": "Replaces beta-glucuronidase enzyme.",
        "indications": [
            "Mucopolysaccharidosis VII (Sly syndrome)"
        ],
        "dosage": {
            "adults": "4 mg/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Rash",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "C1 esterase inhibitor (human)": {
        "definition": "A plasma-derived protein for hereditary angioedema (HAE) prophylaxis and treatment.",
        "mechanism": "Replaces deficient C1 esterase inhibitor, regulating complement activation.",
        "indications": [
            "Hereditary angioedema (HAE) prophylaxis and acute attacks"
        ],
        "dosage": {
            "adults": "20 units/kg IV for acute attack; 1000 units IV every 3-4 days (prophylaxis).",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ecallantide": {
        "definition": "A kallikrein inhibitor for acute hereditary angioedema (HAE) attacks.",
        "mechanism": "Inhibits plasma kallikrein, reducing bradykinin production.",
        "indications": [
            "Acute hereditary angioedema (HAE) attacks"
        ],
        "dosage": {
            "adults": "30 mg SC (3 injections) as a single dose.",
            "children": "Same as adults."
        },
        "side effects": [
            "Anaphylaxis",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "icatibant": {
        "definition": "A bradykinin B2 receptor antagonist for acute hereditary angioedema (HAE) attacks.",
        "mechanism": "Blocks bradykinin B2 receptors, reducing angioedema.",
        "indications": [
            "Acute hereditary angioedema (HAE) attacks"
        ],
        "dosage": {
            "adults": "30 mg SC; may repeat up to 3 doses in 24 hours.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Dizziness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "conestat alfa": {
        "definition": "A recombinant C1 esterase inhibitor for hereditary angioedema (HAE) attacks.",
        "mechanism": "Replaces deficient C1 esterase inhibitor, regulating complement activation.",
        "indications": [
            "Acute hereditary angioedema (HAE) attacks"
        ],
        "dosage": {
            "adults": "50 IU/kg IV as a single dose.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lanadelumab": {
        "definition": "A monoclonal antibody for prophylaxis of hereditary angioedema (HAE).",
        "mechanism": "Inhibits plasma kallikrein, reducing bradykinin production.",
        "indications": [
            "Hereditary angioedema (HAE) prophylaxis"
        ],
        "dosage": {
            "adults": "300 mg SC every 2 weeks.",
            "children": "Dose by weight (age 12+)."
        },
        "side effects": [
            "Injection site reactions",
            "Headache",
            "Myalgia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "emapalumab": {
        "definition": "An anti-interferon gamma monoclonal antibody for primary hemophagocytic lymphohistiocytosis (HLH).",
        "mechanism": "Binds and neutralizes interferon gamma.",
        "indications": [
            "Primary hemophagocytic lymphohistiocytosis (HLH)"
        ],
        "dosage": {
            "adults": "1 mg/kg IV twice weekly, titrated.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infection",
            "Hypertension",
            "Fever"
        ],
        "contraindications": [
            "Active severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "haemophilus b conjugate (prp-omp) vaccine": {
        "definition": "A vaccine for prevention of Haemophilus influenzae type b (Hib) infection.",
        "mechanism": "Induces active immunity against Hib polysaccharide antigen.",
        "indications": [
            "Prevention of Hib infection"
        ],
        "dosage": {
            "adults": "Not routinely used.",
            "children": "0.5 mL IM per schedule (infants/children)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Not routinely indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "malathion": {
        "definition": "A topical organophosphate insecticide for head lice.",
        "mechanism": "Inhibits acetylcholinesterase in lice.",
        "indications": [
            "Head lice"
        ],
        "dosage": {
            "adults": "Apply to dry hair/scalp, leave 8-12 hours, then wash.",
            "children": "Same as adults (age 6+)."
        },
        "side effects": [
            "Skin irritation",
            "Odor",
            "Chemical burns (rare)"
        ],
        "contraindications": [
            "Infants <6 years",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "electrolyte replacement solutions": {
        "definition": "Oral or IV solutions for fluid and electrolyte replacement.",
        "mechanism": "Restore fluid and electrolyte balance.",
        "indications": [
            "Dehydration",
            "Electrolyte imbalance"
        ],
        "dosage": {
            "adults": "Dose per clinical need.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Fluid overload",
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Fluid overload states",
            "Specific electrolyte abnormalities"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dienogest": {
        "definition": "A progestin for endometriosis and contraception (in combination).",
        "mechanism": "Suppresses endometrial growth and ovulation.",
        "indications": [
            "Endometriosis",
            "Contraception (with estrogen)"
        ],
        "dosage": {
            "adults": "2 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Irregular bleeding",
            "Headache",
            "Weight gain"
        ],
        "contraindications": [
            "Pregnancy",
            "Active thromboembolic disorders"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bismuth subcitrate potassium": {
        "definition": "A bismuth salt for H. pylori eradication (with antibiotics).",
        "mechanism": "Antimicrobial and mucosal protective effects.",
        "indications": [
            "H. pylori eradication (with metronidazole and tetracycline)"
        ],
        "dosage": {
            "adults": "140 mg orally 4 times daily (with other drugs).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Black tongue/stool",
            "Nausea",
            "Salicylate toxicity"
        ],
        "contraindications": [
            "Salicylate allergy",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Tetracyclines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eculizumab": {
        "definition": "A monoclonal antibody for paroxysmal nocturnal hemoglobinuria (PNH), aHUS, and myasthenia gravis.",
        "mechanism": "Inhibits complement protein C5.",
        "indications": [
            "PNH",
            "Atypical hemolytic uremic syndrome (aHUS)",
            "Generalized myasthenia gravis"
        ],
        "dosage": {
            "adults": "600-1200 mg IV every 1-2 weeks (indication-specific).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Meningococcal infection",
            "Headache",
            "Hypertension"
        ],
        "contraindications": [
            "Active Neisseria infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ravulizumab": {
        "definition": "A long-acting monoclonal antibody for PNH and aHUS.",
        "mechanism": "Inhibits complement protein C5.",
        "indications": [
            "PNH",
            "Atypical hemolytic uremic syndrome (aHUS)"
        ],
        "dosage": {
            "adults": "2700-3000 mg IV every 8 weeks (weight-based).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Meningococcal infection",
            "Headache",
            "Hypertension"
        ],
        "contraindications": [
            "Active Neisseria infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antihemophilic factor": {
        "definition": "A recombinant or plasma-derived factor VIII for hemophilia A.",
        "mechanism": "Replaces deficient factor VIII, enabling normal coagulation.",
        "indications": [
            "Hemophilia A"
        ],
        "dosage": {
            "adults": "Dose individualized by factor VIII activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anti-inhibitor coagulant complex": {
        "definition": "A plasma-derived concentrate for hemophilia with inhibitors.",
        "mechanism": "Bypasses factor VIII/IX, promoting clot formation.",
        "indications": [
            "Hemophilia A or B with inhibitors"
        ],
        "dosage": {
            "adults": "50-100 units/kg IV every 8-12 hours.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "von willebrand factor": {
        "definition": "A plasma-derived or recombinant factor for von Willebrand disease.",
        "mechanism": "Replaces deficient von Willebrand factor, enabling normal coagulation.",
        "indications": [
            "Von Willebrand disease"
        ],
        "dosage": {
            "adults": "Dose individualized by vWF activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "emicizumab": {
        "definition": "A bispecific monoclonal antibody for hemophilia A with or without inhibitors.",
        "mechanism": "Bridges activated factor IX and X, mimicking factor VIII.",
        "indications": [
            "Hemophilia A (with or without inhibitors)"
        ],
        "dosage": {
            "adults": "3 mg/kg SC weekly for 4 weeks, then 1.5 mg/kg weekly or 3 mg/kg every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Thrombotic microangiopathy"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Activated prothrombin complex concentrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mesna": {
        "definition": "A uroprotective agent for prevention of hemorrhagic cystitis with certain chemotherapy.",
        "mechanism": "Binds and inactivates acrolein, a toxic metabolite of cyclophosphamide/ifosfamide.",
        "indications": [
            "Prevention of hemorrhagic cystitis (with ifosfamide/cyclophosphamide)"
        ],
        "dosage": {
            "adults": "20% of ifosfamide dose IV at 0, 4, 8 hours.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dibucaine": {
        "definition": "A topical local anesthetic for pain and itching.",
        "mechanism": "Blocks sodium channels, inhibiting nerve impulse conduction.",
        "indications": [
            "Hemorrhoids",
            "Minor burns",
            "Skin irritation"
        ],
        "dosage": {
            "adults": "Apply thin layer to affected area up to 3-4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thrombin": {
        "definition": "A topical hemostatic agent for surgical bleeding.",
        "mechanism": "Converts fibrinogen to fibrin, promoting clot formation.",
        "indications": [
            "Surgical hemostasis"
        ],
        "dosage": {
            "adults": "Apply topically as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Bleeding"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "protamine": {
        "definition": "A heparin antagonist for reversal of heparin anticoagulation.",
        "mechanism": "Binds heparin, forming an inactive complex.",
        "indications": [
            "Heparin overdose",
            "Reversal of heparin during surgery"
        ],
        "dosage": {
            "adults": "1 mg per 100 units heparin IV over 10 min.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Allergic reactions",
            "Bradycardia"
        ],
        "contraindications": [
            "Fish allergy (relative)",
            "Prior protamine reaction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "defibrotide": {
        "definition": "An endothelial protective agent for hepatic veno-occlusive disease (VOD).",
        "mechanism": "Reduces endothelial cell activation and inflammation.",
        "indications": [
            "Hepatic veno-occlusive disease (VOD) post stem cell transplant"
        ],
        "dosage": {
            "adults": "6.25 mg/kg IV every 6 hours for at least 21 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Hypotension",
            "Diarrhea"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hepatitis a adult vaccine": {
        "definition": "An inactivated vaccine for prevention of hepatitis A in adults.",
        "mechanism": "Induces active immunity against hepatitis A virus.",
        "indications": [
            "Prevention of hepatitis A"
        ],
        "dosage": {
            "adults": "1 mL IM at 0, 6-12 months.",
            "children": "See pediatric formulation."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "hepatitis b adult vaccine": {
        "definition": "A recombinant vaccine for prevention of hepatitis B in adults.",
        "mechanism": "Induces active immunity against hepatitis B surface antigen.",
        "indications": [
            "Prevention of hepatitis B infection"
        ],
        "dosage": {
            "adults": "1 mL IM at 0, 1, 6 months.",
            "children": "See pediatric formulation."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose or yeast"
        ],
        "special populations": {
            "pregnancy": "Recommended if indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "hepatitis a pediatric vaccine": {
        "definition": "An inactivated vaccine for prevention of hepatitis A in children.",
        "mechanism": "Induces active immunity against hepatitis A virus.",
        "indications": [
            "Prevention of hepatitis A"
        ],
        "dosage": {
            "adults": "See adult formulation.",
            "children": "0.5 mL IM at 0, 6-12 months."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "bioflavonoids": {
        "definition": "A group of plant-derived compounds with antioxidant properties.",
        "mechanism": "Scavenge free radicals and support capillary health.",
        "indications": [
            "Capillary fragility",
            "Venous insufficiency",
            "Supplementation"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitisinone": {
        "definition": "A 4-hydroxyphenylpyruvate dioxygenase inhibitor for hereditary tyrosinemia type 1.",
        "mechanism": "Blocks tyrosine degradation, reducing toxic metabolites.",
        "indications": [
            "Hereditary tyrosinemia type 1"
        ],
        "dosage": {
            "adults": "1-2 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Elevated tyrosine",
            "Eye pain",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium trisilicate": {
        "definition": "An antacid for dyspepsia and peptic ulcer disease.",
        "mechanism": "Neutralizes gastric acid.",
        "indications": [
            "Dyspepsia",
            "Peptic ulcer disease"
        ],
        "dosage": {
            "adults": "500-1000 mg orally as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "docosanol": {
        "definition": "A topical antiviral for herpes labialis (cold sores).",
        "mechanism": "Inhibits fusion of HSV envelope with cell membrane.",
        "indications": [
            "Herpes labialis (cold sores)"
        ],
        "dosage": {
            "adults": "Apply 5 times daily at first sign of outbreak.",
            "children": "Same as adults."
        },
        "side effects": [
            "Application site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "allantoin": {
        "definition": "A topical skin protectant and moisturizer.",
        "mechanism": "Promotes cell proliferation and wound healing.",
        "indications": [
            "Minor wounds",
            "Burns",
            "Dry skin"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "camphor": {
        "definition": "A topical counterirritant and cough suppressant.",
        "mechanism": "Activates TRPV1 and cold receptors, producing cooling sensation.",
        "indications": [
            "Minor pain",
            "Cough",
            "Itching"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Toxicity if ingested"
        ],
        "contraindications": [
            "Broken skin",
            "Infants"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenol": {
        "definition": "A topical antiseptic and anesthetic.",
        "mechanism": "Denatures proteins and disrupts cell membranes.",
        "indications": [
            "Sore throat (lozenges)",
            "Minor skin irritation"
        ],
        "dosage": {
            "adults": "Apply or use as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Systemic toxicity (large exposure)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zoster vaccine live": {
        "definition": "A live attenuated vaccine for prevention of herpes zoster (shingles).",
        "mechanism": "Induces active immunity against varicella-zoster virus.",
        "indications": [
            "Prevention of shingles (age 50+)"
        ],
        "dosage": {
            "adults": "0.65 mL SC single dose.",
            "children": "Not indicated."
        },
        "side effects": [
            "Injection site reactions",
            "Rash",
            "Fever"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Antivirals"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "zoster vaccine, inactivated": {
        "definition": "A recombinant subunit vaccine for prevention of herpes zoster (shingles).",
        "mechanism": "Induces active immunity against varicella-zoster virus glycoprotein E.",
        "indications": [
            "Prevention of shingles (age 50+)"
        ],
        "dosage": {
            "adults": "0.5 mL IM at 0, 2-6 months.",
            "children": "Not indicated."
        },
        "side effects": [
            "Injection site reactions",
            "Myalgia",
            "Fever"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "etidronate": {
        "definition": "A bisphosphonate for osteoporosis and Paget's disease.",
        "mechanism": "Inhibits bone resorption by osteoclasts.",
        "indications": [
            "Osteoporosis",
            "Paget's disease of bone"
        ],
        "dosage": {
            "adults": "200-400 mg orally daily for 2 weeks every 3 months (Paget's); 5 mg/kg daily (osteoporosis).",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Osteomalacia",
            "Bone pain"
        ],
        "contraindications": [
            "Hypocalcemia",
            "Esophageal abnormalities"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Calcium",
            "Antacids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prochlorperazine": {
        "definition": "A phenothiazine antiemetic and antipsychotic.",
        "mechanism": "Blocks dopamine D2 receptors in the CNS.",
        "indications": [
            "Nausea and vomiting",
            "Schizophrenia",
            "Anxiety"
        ],
        "dosage": {
            "adults": "5-10 mg orally 3-4 times daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Drowsiness",
            "Extrapyramidal symptoms",
            "Hypotension"
        ],
        "contraindications": [
            "Coma",
            "Severe CNS depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "abciximab": {
        "definition": "A glycoprotein IIb/IIIa inhibitor for percutaneous coronary intervention (PCI).",
        "mechanism": "Blocks platelet aggregation by inhibiting GP IIb/IIIa receptor.",
        "indications": [
            "PCI adjunct",
            "Unstable angina (with PCI)"
        ],
        "dosage": {
            "adults": "0.25 mg/kg IV bolus, then 0.125 mcg/kg/min IV infusion for 12 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia",
            "Hypotension"
        ],
        "contraindications": [
            "Active bleeding",
            "Severe hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "eflornithine": {
        "definition": "A topical ornithine decarboxylase inhibitor for facial hirsutism; IV for African trypanosomiasis.",
        "mechanism": "Inhibits ornithine decarboxylase, slowing hair growth or parasite proliferation.",
        "indications": [
            "Facial hirsutism (topical)",
            "African trypanosomiasis (IV)"
        ],
        "dosage": {
            "adults": "Topical: apply twice daily; IV: 400 mg/kg/day in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Skin irritation (topical)",
            "Anemia (IV)",
            "GI upset (IV)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "omalizumab": {
        "definition": "An anti-IgE monoclonal antibody for asthma and chronic urticaria.",
        "mechanism": "Binds IgE, preventing allergic inflammation.",
        "indications": [
            "Moderate-to-severe allergic asthma",
            "Chronic spontaneous urticaria"
        ],
        "dosage": {
            "adults": "150-375 mg SC every 2-4 weeks.",
            "children": "Dose by weight and IgE level (age 6+)."
        },
        "side effects": [
            "Injection site reactions",
            "Anaphylaxis",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bazedoxifene": {
        "definition": "A selective estrogen receptor modulator (SERM) for osteoporosis prevention (postmenopausal women).",
        "mechanism": "Estrogen agonist in bone; antagonist in uterus and breast.",
        "indications": [
            "Osteoporosis prevention (postmenopausal women)"
        ],
        "dosage": {
            "adults": "20 mg orally once daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Hot flashes",
            "Leg cramps",
            "Thromboembolism"
        ],
        "contraindications": [
            "Active or past VTE",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Estrogens"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "podophyllum resin": {
        "definition": "A topical cytotoxic agent for genital warts.",
        "mechanism": "Inhibits cell mitosis, causing wart necrosis.",
        "indications": [
            "External genital warts"
        ],
        "dosage": {
            "adults": "Apply to wart, wash off after 1-4 hours; repeat weekly as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Local irritation",
            "Ulceration"
        ],
        "contraindications": [
            "Pregnancy",
            "Open wounds"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "resorcinol": {
        "definition": "A topical keratolytic and antiseptic for acne, eczema, and other skin conditions.",
        "mechanism": "Promotes exfoliation and has mild antiseptic properties.",
        "indications": [
            "Acne",
            "Eczema",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-3 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Brown discoloration"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "human papillomavirus vaccine": {
        "definition": "A recombinant vaccine for prevention of HPV-related diseases.",
        "mechanism": "Induces active immunity against HPV types (varies by product).",
        "indications": [
            "Prevention of cervical, vulvar, vaginal, anal, and oropharyngeal cancers; genital warts"
        ],
        "dosage": {
            "adults": "0.5 mL IM at 0, 1-2, 6 months (age ≤26; up to 45).",
            "children": "Same as adults (age 9+)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to previous dose"
        ],
        "special populations": {
            "pregnancy": "Not recommended."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "tetrabenazine": {
        "definition": "A VMAT2 inhibitor for chorea in Huntington's disease.",
        "mechanism": "Depletes presynaptic dopamine by inhibiting VMAT2.",
        "indications": [
            "Chorea associated with Huntington's disease"
        ],
        "dosage": {
            "adults": "12.5-100 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Depression",
            "Parkinsonism",
            "Drowsiness"
        ],
        "contraindications": [
            "Suicidal ideation",
            "Hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Reserpine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deutetrabenazine": {
        "definition": "A VMAT2 inhibitor for chorea in Huntington's disease and tardive dyskinesia.",
        "mechanism": "Depletes presynaptic dopamine by inhibiting VMAT2.",
        "indications": [
            "Chorea in Huntington's disease",
            "Tardive dyskinesia"
        ],
        "dosage": {
            "adults": "6-48 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Depression",
            "Parkinsonism",
            "Drowsiness"
        ],
        "contraindications": [
            "Suicidal ideation",
            "Hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Reserpine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "laronidase": {
        "definition": "A recombinant enzyme for mucopolysaccharidosis I (Hurler, Hurler-Scheie, Scheie syndromes).",
        "mechanism": "Replaces alpha-L-iduronidase enzyme.",
        "indications": [
            "Mucopolysaccharidosis I"
        ],
        "dosage": {
            "adults": "0.58 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium benzoate": {
        "definition": "A urinary acidifier and ammonia scavenger for hyperammonemia.",
        "mechanism": "Conjugates with glycine to form hippurate, excreted in urine.",
        "indications": [
            "Hyperammonemia (urea cycle disorders)"
        ],
        "dosage": {
            "adults": "250 mg/kg IV daily in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Metabolic acidosis",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium phenylacetate": {
        "definition": "An ammonia scavenger for hyperammonemia (urea cycle disorders).",
        "mechanism": "Conjugates with glutamine to form phenylacetylglutamine, excreted in urine.",
        "indications": [
            "Hyperammonemia (urea cycle disorders)"
        ],
        "dosage": {
            "adults": "250 mg/kg IV daily in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Metabolic acidosis",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "carglumic acid": {
        "definition": "A synthetic analog of N-acetylglutamate for hyperammonemia due to NAGS deficiency.",
        "mechanism": "Activates carbamoyl phosphate synthetase I, enhancing urea cycle.",
        "indications": [
            "Hyperammonemia due to NAGS deficiency"
        ],
        "dosage": {
            "adults": "100-250 mg/kg orally daily in divided doses.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Vomiting",
            "Abdominal pain",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cinacalcet": {
        "definition": "A calcimimetic for secondary hyperparathyroidism and parathyroid carcinoma.",
        "mechanism": "Increases sensitivity of calcium-sensing receptors in parathyroid gland.",
        "indications": [
            "Secondary hyperparathyroidism (dialysis)",
            "Parathyroid carcinoma",
            "Primary hyperparathyroidism (ineligible for surgery)"
        ],
        "dosage": {
            "adults": "30-180 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Nausea",
            "Hypocalcemia",
            "Seizures"
        ],
        "contraindications": [
            "Hypocalcemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium polystyrene sulfonate": {
        "definition": "A potassium-binding resin for hyperkalemia.",
        "mechanism": "Exchanges sodium for potassium in the colon.",
        "indications": [
            "Hyperkalemia"
        ],
        "dosage": {
            "adults": "15-60 g orally or rectally once or twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Constipation",
            "Hypokalemia",
            "Intestinal necrosis (rare)"
        ],
        "contraindications": [
            "Bowel obstruction",
            "Hypokalemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids",
            "Laxatives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "patiromer": {
        "definition": "A non-absorbed potassium binder for hyperkalemia.",
        "mechanism": "Binds potassium in the colon, increasing fecal excretion.",
        "indications": [
            "Hyperkalemia"
        ],
        "dosage": {
            "adults": "8.4-25.2 g orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Hypomagnesemia",
            "GI upset"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by 3 hours)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium zirconium cyclosilicate": {
        "definition": "A non-absorbed potassium binder for hyperkalemia.",
        "mechanism": "Binds potassium in the GI tract, increasing fecal excretion.",
        "indications": [
            "Hyperkalemia"
        ],
        "dosage": {
            "adults": "10 g orally 1-3 times daily (initial); 5-15 g daily (maintenance).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Edema",
            "Hypokalemia",
            "GI upset"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by 2 hours)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dichlorphenamide": {
        "definition": "A carbonic anhydrase inhibitor for primary periodic paralysis.",
        "mechanism": "Inhibits carbonic anhydrase, reducing muscle membrane excitability.",
        "indications": [
            "Primary periodic paralysis"
        ],
        "dosage": {
            "adults": "50 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Paresthesia",
            "Fatigue",
            "Metabolic acidosis"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Severe renal/hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other carbonic anhydrase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcifediol": {
        "definition": "A vitamin D analog for secondary hyperparathyroidism in CKD.",
        "mechanism": "Increases intestinal absorption of calcium and phosphate.",
        "indications": [
            "Secondary hyperparathyroidism (CKD)"
        ],
        "dosage": {
            "adults": "30-60 mcg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypercalcemia",
            "Hyperphosphatemia"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "etelcalcetide": {
        "definition": "A calcimimetic for secondary hyperparathyroidism in dialysis patients.",
        "mechanism": "Increases sensitivity of calcium-sensing receptors in parathyroid gland.",
        "indications": [
            "Secondary hyperparathyroidism (dialysis)"
        ],
        "dosage": {
            "adults": "5-15 mg IV three times weekly (after dialysis).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Hypocalcemia",
            "Muscle spasms"
        ],
        "contraindications": [
            "Hypocalcemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other drugs causing hypocalcemia"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium acetate": {
        "definition": "A phosphate binder for hyperphosphatemia in CKD.",
        "mechanism": "Binds dietary phosphate in the gut, reducing absorption.",
        "indications": [
            "Hyperphosphatemia (CKD)"
        ],
        "dosage": {
            "adults": "1334 mg orally with each meal.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypercalcemia",
            "Constipation"
        ],
        "contraindications": [
            "Hypercalcemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sevelamer": {
        "definition": "A non-calcium phosphate binder for hyperphosphatemia in CKD.",
        "mechanism": "Binds dietary phosphate in the gut, reducing absorption.",
        "indications": [
            "Hyperphosphatemia (CKD)"
        ],
        "dosage": {
            "adults": "800-1600 mg orally 3 times daily with meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Constipation",
            "Metabolic acidosis"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by 1 hour)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lanthanum carbonate": {
        "definition": "A non-calcium phosphate binder for hyperphosphatemia in CKD.",
        "mechanism": "Binds dietary phosphate in the gut, reducing absorption.",
        "indications": [
            "Hyperphosphatemia (CKD)"
        ],
        "dosage": {
            "adults": "750-3000 mg orally in divided doses with meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Constipation",
            "Abdominal pain"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by 2 hours)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ferric citrate": {
        "definition": "An iron-based phosphate binder for hyperphosphatemia in CKD.",
        "mechanism": "Binds dietary phosphate in the gut, reducing absorption; provides iron.",
        "indications": [
            "Hyperphosphatemia (CKD)",
            "Iron deficiency anemia (CKD)"
        ],
        "dosage": {
            "adults": "2 tablets (420 mg) orally 3 times daily with meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Discolored stool",
            "Nausea"
        ],
        "contraindications": [
            "Iron overload",
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by 1 hour)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sucroferric oxyhydroxide": {
        "definition": "An iron-based phosphate binder for hyperphosphatemia in chronic kidney disease (CKD) on dialysis.",
        "mechanism": "Binds dietary phosphate in the gut, reducing absorption.",
        "indications": [
            "Hyperphosphatemia in CKD on dialysis"
        ],
        "dosage": {
            "adults": "500 mg orally three times daily with meals, titrate as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Discolored stool",
            "Nausea"
        ],
        "contraindications": [
            "Iron overload",
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral drugs (separate by at least 1 hour)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium carbonate": {
        "definition": "An antacid and magnesium supplement.",
        "mechanism": "Neutralizes gastric acid; provides magnesium ions.",
        "indications": [
            "Dyspepsia",
            "Magnesium deficiency"
        ],
        "dosage": {
            "adults": "Dose per product, typically 500-1000 mg orally as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cabergoline": {
        "definition": "A dopamine agonist for hyperprolactinemia and Parkinson's disease.",
        "mechanism": "Stimulates dopamine receptors, inhibiting prolactin secretion.",
        "indications": [
            "Hyperprolactinemia",
            "Parkinson's disease (off-label)"
        ],
        "dosage": {
            "adults": "0.25-1 mg orally twice weekly (hyperprolactinemia).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Uncontrolled hypertension",
            "Valvular heart disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other dopamine agonists"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methyldopa": {
        "definition": "A centrally acting alpha-2 agonist antihypertensive.",
        "mechanism": "Stimulates central alpha-2 receptors, reducing sympathetic outflow.",
        "indications": [
            "Hypertension (especially in pregnancy)"
        ],
        "dosage": {
            "adults": "250-2000 mg orally daily in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Sedation",
            "Dry mouth",
            "Hemolytic anemia"
        ],
        "contraindications": [
            "Active liver disease",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Preferred antihypertensive in pregnancy."
        },
        "interactions": [
            "Other antihypertensives",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diazoxide": {
        "definition": "A potassium channel opener for hypertensive emergencies and hypoglycemia.",
        "mechanism": "Relaxes arteriolar smooth muscle; inhibits insulin release.",
        "indications": [
            "Hypertensive emergency",
            "Hyperinsulinemic hypoglycemia"
        ],
        "dosage": {
            "adults": "3-6 mg/kg IV bolus (hypertensive crisis); 3-8 mg/kg orally daily (hypoglycemia).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hyperglycemia",
            "Fluid retention",
            "Hypotension"
        ],
        "contraindications": [
            "Sulfa allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antidiabetic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fenoldopam": {
        "definition": "A dopamine D1 agonist for hypertensive emergencies.",
        "mechanism": "Vasodilates renal and peripheral arteries via D1 receptor activation.",
        "indications": [
            "Hypertensive emergency"
        ],
        "dosage": {
            "adults": "0.01-0.3 mcg/kg/min IV infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "Tachycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clevidipine": {
        "definition": "A short-acting IV calcium channel blocker for hypertensive emergencies.",
        "mechanism": "Inhibits L-type calcium channels, causing arterial vasodilation.",
        "indications": [
            "Hypertensive emergency"
        ],
        "dosage": {
            "adults": "1-21 mg/hour IV infusion, titrate to BP.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypotension",
            "Reflex tachycardia",
            "Nausea"
        ],
        "contraindications": [
            "Soy/egg allergy",
            "Severe aortic stenosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methimazole": {
        "definition": "A thionamide antithyroid drug for hyperthyroidism.",
        "mechanism": "Inhibits thyroid hormone synthesis.",
        "indications": [
            "Hyperthyroidism",
            "Graves' disease"
        ],
        "dosage": {
            "adults": "5-40 mg orally daily in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Rash",
            "Agranulocytosis",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Pregnancy (1st trimester)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iodine": {
        "definition": "A thyroid blocking agent and antiseptic; used for thyroid storm and preoperative thyroid surgery.",
        "mechanism": "Inhibits thyroid hormone release; antiseptic action.",
        "indications": [
            "Thyroid storm",
            "Preoperative thyroidectomy",
            "Antiseptic"
        ],
        "dosage": {
            "adults": "5-10 drops (Lugol's solution) orally 3 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Rash",
            "GI upset",
            "Iodism"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antithyroid drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rasburicase": {
        "definition": "A recombinant uricase enzyme for hyperuricemia in tumor lysis syndrome.",
        "mechanism": "Converts uric acid to allantoin, which is more soluble.",
        "indications": [
            "Tumor lysis syndrome (hyperuricemia)"
        ],
        "dosage": {
            "adults": "0.2 mg/kg IV once daily up to 5 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypersensitivity",
            "Hemolysis (G6PD deficiency)",
            "Methemoglobinemia"
        ],
        "contraindications": [
            "G6PD deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcitriol": {
        "definition": "The active form of vitamin D for hypocalcemia and secondary hyperparathyroidism.",
        "mechanism": "Increases intestinal absorption of calcium and phosphate.",
        "indications": [
            "Hypocalcemia",
            "Secondary hyperparathyroidism (CKD)",
            "Hypoparathyroidism"
        ],
        "dosage": {
            "adults": "0.25-1 mcg orally daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Hypercalcemia",
            "Hyperphosphatemia"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "parathyroid hormone": {
        "definition": "A recombinant hormone for hypoparathyroidism (as Natpara).",
        "mechanism": "Regulates calcium and phosphate homeostasis.",
        "indications": [
            "Hypoparathyroidism"
        ],
        "dosage": {
            "adults": "50-100 mcg SC once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypocalcemia",
            "Hypercalcemia",
            "Nausea"
        ],
        "contraindications": [
            "Risk of osteosarcoma (black box)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other calcium/vitamin D products"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium lactate": {
        "definition": "A calcium supplement for hypocalcemia and dietary supplementation.",
        "mechanism": "Provides calcium ions for physiological processes.",
        "indications": [
            "Hypocalcemia",
            "Dietary supplementation"
        ],
        "dosage": {
            "adults": "325-650 mg orally 2-3 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Hypercalcemia"
        ],
        "contraindications": [
            "Hypercalcemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calcium phosphate, tribasic": {
        "definition": "A calcium and phosphate supplement for deficiency states.",
        "mechanism": "Provides calcium and phosphate for bone and metabolic needs.",
        "indications": [
            "Calcium and phosphate supplementation"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Constipation",
            "Hypercalcemia"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Hyperphosphatemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "estropipate": {
        "definition": "An oral estrogen for menopausal symptoms and osteoporosis prevention.",
        "mechanism": "Replaces endogenous estrogen.",
        "indications": [
            "Menopausal symptoms",
            "Osteoporosis prevention"
        ],
        "dosage": {
            "adults": "0.75-6 mg orally daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Nausea",
            "Breast tenderness",
            "Thromboembolism"
        ],
        "contraindications": [
            "Breast cancer",
            "Active VTE",
            "Liver disease"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium chloride": {
        "definition": "A potassium supplement for hypokalemia.",
        "mechanism": "Provides potassium ions for cellular function.",
        "indications": [
            "Hypokalemia",
            "Prevention of potassium deficiency"
        ],
        "dosage": {
            "adults": "20-100 mEq orally or IV daily (individualized).",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Hyperkalemia",
            "Phlebitis (IV)"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium-sparing diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium gluconate": {
        "definition": "A potassium supplement for hypokalemia.",
        "mechanism": "Provides potassium ions for cellular function.",
        "indications": [
            "Hypokalemia",
            "Prevention of potassium deficiency"
        ],
        "dosage": {
            "adults": "20-100 mEq orally daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Hyperkalemia"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium-sparing diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium bicarbonate": {
        "definition": "A potassium supplement and alkalinizer for hypokalemia and metabolic acidosis.",
        "mechanism": "Provides potassium and bicarbonate ions.",
        "indications": [
            "Hypokalemia",
            "Metabolic acidosis"
        ],
        "dosage": {
            "adults": "20-100 mEq orally daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Hyperkalemia",
            "Metabolic alkalosis"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "ACE inhibitors",
            "Potassium-sparing diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium chloride": {
        "definition": "A magnesium supplement for deficiency and as an electrolyte replenisher.",
        "mechanism": "Provides magnesium ions for physiological processes.",
        "indications": [
            "Magnesium deficiency"
        ],
        "dosage": {
            "adults": "200-400 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium amino acids chelate": {
        "definition": "A magnesium supplement for deficiency, chelated to amino acids for improved absorption.",
        "mechanism": "Provides magnesium ions for physiological processes.",
        "indications": [
            "Magnesium deficiency"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium gluconate": {
        "definition": "A magnesium supplement for deficiency.",
        "mechanism": "Provides magnesium ions for physiological processes.",
        "indications": [
            "Magnesium deficiency"
        ],
        "dosage": {
            "adults": "500-1000 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Diarrhea",
            "Hypermagnesemia"
        ],
        "contraindications": [
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium acetate": {
        "definition": "An alkalinizing agent and sodium supplement for metabolic acidosis.",
        "mechanism": "Provides sodium and acetate, which is metabolized to bicarbonate.",
        "indications": [
            "Metabolic acidosis",
            "Sodium supplementation"
        ],
        "dosage": {
            "adults": "Dose individualized IV.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hypernatremia",
            "Metabolic alkalosis"
        ],
        "contraindications": [
            "Hypernatremia",
            "Alkalosis"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other sodium-containing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "asfotase alfa": {
        "definition": "A recombinant enzyme for perinatal/infantile and juvenile-onset hypophosphatasia.",
        "mechanism": "Replaces tissue-nonspecific alkaline phosphatase.",
        "indications": [
            "Hypophosphatasia (perinatal/infantile/juvenile-onset)"
        ],
        "dosage": {
            "adults": "2 mg/kg SC three times weekly or 1 mg/kg six times weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Lipodystrophy",
            "Hypersensitivity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium phosphate": {
        "definition": "A phosphate and potassium supplement for deficiency states.",
        "mechanism": "Provides phosphate and potassium ions.",
        "indications": [
            "Hypophosphatemia",
            "Hypokalemia"
        ],
        "dosage": {
            "adults": "Dose individualized IV or orally.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hyperkalemia",
            "Hyperphosphatemia"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Hyperphosphatemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Calcium-containing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium phosphate": {
        "definition": "A phosphate and sodium supplement and laxative.",
        "mechanism": "Provides phosphate and sodium ions; draws water into the bowel.",
        "indications": [
            "Bowel cleansing",
            "Hypophosphatemia"
        ],
        "dosage": {
            "adults": "Dose per product and indication.",
            "children": "Dose by age."
        },
        "side effects": [
            "Electrolyte imbalance",
            "Dehydration"
        ],
        "contraindications": [
            "Renal failure",
            "Heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "ACE inhibitors",
            "Diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "albumin human": {
        "definition": "A plasma protein for volume expansion and hypoalbuminemia.",
        "mechanism": "Increases plasma oncotic pressure.",
        "indications": [
            "Hypovolemia",
            "Hypoalbuminemia",
            "Burns",
            "Shock"
        ],
        "dosage": {
            "adults": "5% or 25% IV, dose individualized.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Volume overload",
            "Allergic reactions"
        ],
        "contraindications": [
            "Severe anemia",
            "Heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phytonadione": {
        "definition": "Vitamin K1 for reversal of anticoagulation and vitamin K deficiency.",
        "mechanism": "Promotes synthesis of clotting factors II, VII, IX, X.",
        "indications": [
            "Warfarin reversal",
            "Vitamin K deficiency bleeding"
        ],
        "dosage": {
            "adults": "1-10 mg orally/IV/SC/IM.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Anaphylaxis (IV)",
            "Flushing",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "norepinephrine": {
        "definition": "A vasopressor for hypotension and shock.",
        "mechanism": "Stimulates alpha and beta-1 adrenergic receptors, increasing vascular tone and cardiac output.",
        "indications": [
            "Septic shock",
            "Acute hypotension"
        ],
        "dosage": {
            "adults": "0.01-3 mcg/kg/min IV infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Arrhythmias",
            "Hypertension",
            "Ischemia"
        ],
        "contraindications": [
            "Mesenteric or peripheral vascular thrombosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Tricyclic antidepressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "droxidopa": {
        "definition": "A norepinephrine precursor for neurogenic orthostatic hypotension.",
        "mechanism": "Converted to norepinephrine, increasing vascular tone.",
        "indications": [
            "Neurogenic orthostatic hypotension"
        ],
        "dosage": {
            "adults": "100-600 mg orally three times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Hypertension",
            "Nausea"
        ],
        "contraindications": [
            "Uncontrolled hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "liothyronine": {
        "definition": "Synthetic T3 thyroid hormone for hypothyroidism.",
        "mechanism": "Replaces deficient triiodothyronine (T3).",
        "indications": [
            "Hypothyroidism",
            "Myxedema coma"
        ],
        "dosage": {
            "adults": "25-100 mcg orally daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Arrhythmias",
            "Weight loss",
            "Anxiety"
        ],
        "contraindications": [
            "Untreated adrenal insufficiency",
            "Acute MI"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Insulin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "liotrix": {
        "definition": "A fixed combination of synthetic T4 and T3 for hypothyroidism.",
        "mechanism": "Replaces deficient thyroxine (T4) and triiodothyronine (T3).",
        "indications": [
            "Hypothyroidism"
        ],
        "dosage": {
            "adults": "Dose individualized (ratio T4:T3 = 4:1).",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Arrhythmias",
            "Weight loss",
            "Anxiety"
        ],
        "contraindications": [
            "Untreated adrenal insufficiency",
            "Acute MI"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants",
            "Insulin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxapram": {
        "definition": "A respiratory stimulant for postoperative respiratory depression.",
        "mechanism": "Stimulates chemoreceptors in carotid bodies, increasing respiratory drive.",
        "indications": [
            "Postoperative respiratory depression",
            "Drug-induced respiratory depression"
        ],
        "dosage": {
            "adults": "1-1.5 mg/kg IV, then infusion as needed.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypertension",
            "Arrhythmias",
            "Seizures"
        ],
        "contraindications": [
            "Epilepsy",
            "Severe hypertension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxyethyl starch": {
        "definition": "A synthetic colloid plasma expander for hypovolemia.",
        "mechanism": "Increases plasma oncotic pressure, expanding intravascular volume.",
        "indications": [
            "Hypovolemia (limited use due to safety concerns)"
        ],
        "dosage": {
            "adults": "Dose per product and indication.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Coagulopathy",
            "Renal failure",
            "Pruritus"
        ],
        "contraindications": [
            "Sepsis",
            "Renal failure",
            "Bleeding disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "midazolam": {
        "definition": "A short-acting benzodiazepine for sedation, anesthesia, and status epilepticus.",
        "mechanism": "Enhances GABAergic inhibition in CNS.",
        "indications": [
            "Sedation",
            "Anesthesia",
            "Status epilepticus"
        ],
        "dosage": {
            "adults": "1-5 mg IV/IM/IN as needed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Respiratory depression",
            "Hypotension",
            "Amnesia"
        ],
        "contraindications": [
            "Acute narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pirfenidone": {
        "definition": "An antifibrotic agent for idiopathic pulmonary fibrosis (IPF).",
        "mechanism": "Inhibits TGF-beta and collagen synthesis.",
        "indications": [
            "Idiopathic pulmonary fibrosis"
        ],
        "dosage": {
            "adults": "801 mg orally three times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Rash",
            "Photosensitivity"
        ],
        "contraindications": [
            "Severe hepatic or renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nintedanib": {
        "definition": "A tyrosine kinase inhibitor for idiopathic pulmonary fibrosis (IPF).",
        "mechanism": "Inhibits multiple tyrosine kinases involved in fibrosis.",
        "indications": [
            "Idiopathic pulmonary fibrosis",
            "Chronic fibrosing interstitial lung diseases"
        ],
        "dosage": {
            "adults": "150 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Liver enzyme elevation",
            "Nausea"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp and CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "romiplostim": {
        "definition": "A thrombopoietin receptor agonist for chronic immune thrombocytopenia (ITP).",
        "mechanism": "Stimulates platelet production.",
        "indications": [
            "Chronic immune thrombocytopenia (ITP)"
        ],
        "dosage": {
            "adults": "1 mcg/kg SC weekly, titrate to response.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Headache",
            "Thromboembolism",
            "Bone marrow fibrosis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rho (d) immune globulin": {
        "definition": "A human immune globulin for prevention of Rh sensitization.",
        "mechanism": "Provides anti-D antibodies to prevent Rh alloimmunization.",
        "indications": [
            "Prevention of Rh isoimmunization in Rh-negative individuals"
        ],
        "dosage": {
            "adults": "300 mcg IM within 72 hours of exposure (pregnancy, transfusion).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Rh-positive individuals"
        ],
        "special populations": {
            "pregnancy": "Recommended for Rh-negative mothers."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "retapamulin": {
        "definition": "A topical pleuromutilin antibiotic for impetigo.",
        "mechanism": "Inhibits bacterial protein synthesis.",
        "indications": [
            "Impetigo (S. aureus, S. pyogenes)"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily for 5 days.",
            "children": "Same as adults (age 9 months+)."
        },
        "side effects": [
            "Application site irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulconazole": {
        "definition": "A topical imidazole antifungal for dermatophytoses.",
        "mechanism": "Inhibits ergosterol synthesis in fungal cell membranes.",
        "indications": [
            "Tinea corporis",
            "Tinea cruris",
            "Tinea pedis"
        ],
        "dosage": {
            "adults": "Apply to affected area once or twice daily for 2-4 weeks.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical antifungals"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ozenoxacin": {
        "definition": "A topical non-fluorinated quinolone antibiotic for impetigo.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV.",
        "indications": [
            "Impetigo (S. aureus, S. pyogenes)"
        ],
        "dosage": {
            "adults": "Apply to affected area twice daily for 5 days.",
            "children": "Same as adults (age 2 months+)."
        },
        "side effects": [
            "Application site irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ammoniated mercury": {
        "definition": "A topical antiseptic and antibacterial (historical use, rarely used now).",
        "mechanism": "Denatures bacterial proteins.",
        "indications": [
            "Minor skin infections (historical)"
        ],
        "dosage": {
            "adults": "Apply to affected area as directed.",
            "children": "Not recommended."
        },
        "side effects": [
            "Skin irritation",
            "Mercury toxicity"
        ],
        "contraindications": [
            "Hypersensitivity",
            "Broken skin"
        ],
        "special populations": {
            "pregnancy": "Avoid use."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ertapenem": {
        "definition": "A broad-spectrum carbapenem antibiotic for serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Intra-abdominal infections",
            "UTI",
            "Skin/soft tissue infections",
            "Community-acquired pneumonia"
        ],
        "dosage": {
            "adults": "1 g IV/IM once daily.",
            "children": "15 mg/kg IV/IM twice daily."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Seizures (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to beta-lactams"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "magnesium salicylate": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) and magnesium supplement.",
        "mechanism": "Inhibits prostaglandin synthesis; provides magnesium.",
        "indications": [
            "Mild to moderate pain",
            "Musculoskeletal pain"
        ],
        "dosage": {
            "adults": "580 mg orally every 4 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Tinnitus",
            "Bleeding"
        ],
        "contraindications": [
            "Salicylate allergy",
            "Renal failure"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Anticoagulants",
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tolmetin": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for pain and inflammation.",
        "mechanism": "Inhibits prostaglandin synthesis.",
        "indications": [
            "Rheumatoid arthritis",
            "Osteoarthritis",
            "Juvenile arthritis"
        ],
        "dosage": {
            "adults": "400 mg orally 3 times daily.",
            "children": "20 mg/kg/day in divided doses."
        },
        "side effects": [
            "GI upset",
            "Bleeding",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Anticoagulants",
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flurbiprofen": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for pain, inflammation, and ophthalmic use.",
        "mechanism": "Inhibits prostaglandin synthesis.",
        "indications": [
            "Pain",
            "Osteoarthritis",
            "Rheumatoid arthritis",
            "Ophthalmic inflammation"
        ],
        "dosage": {
            "adults": "50-100 mg orally 2-4 times daily; 1 drop ophthalmic 4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Bleeding",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Anticoagulants",
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cilostazol": {
        "definition": "A phosphodiesterase III inhibitor for intermittent claudication.",
        "mechanism": "Inhibits platelet aggregation and causes vasodilation.",
        "indications": [
            "Intermittent claudication (peripheral arterial disease)"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Headache",
            "Diarrhea",
            "Palpitations"
        ],
        "contraindications": [
            "Heart failure"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentoxifylline": {
        "definition": "A methylxanthine derivative for intermittent claudication.",
        "mechanism": "Improves erythrocyte flexibility and reduces blood viscosity.",
        "indications": [
            "Intermittent claudication"
        ],
        "dosage": {
            "adults": "400 mg orally 2-3 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Dizziness",
            "Headache"
        ],
        "contraindications": [
            "Cerebral or retinal hemorrhage"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doripenem": {
        "definition": "A carbapenem antibiotic for serious bacterial infections.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Intra-abdominal infections",
            "UTI",
            "Pneumonia"
        ],
        "dosage": {
            "adults": "500 mg IV every 8 hours.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Rash",
            "Seizures (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to beta-lactams"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tigecycline": {
        "definition": "A glycylcycline antibiotic for complicated infections.",
        "mechanism": "Inhibits bacterial protein synthesis.",
        "indications": [
            "Complicated skin/soft tissue infections",
            "Intra-abdominal infections",
            "Community-acquired pneumonia"
        ],
        "dosage": {
            "adults": "100 mg IV loading, then 50 mg IV every 12 hours.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nausea",
            "Vomiting",
            "Increased mortality (black box)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levobunolol": {
        "definition": "A non-selective beta-blocker for glaucoma.",
        "mechanism": "Reduces aqueous humor production in the eye.",
        "indications": [
            "Open-angle glaucoma",
            "Ocular hypertension"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) once or twice daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Bradycardia",
            "Bronchospasm"
        ],
        "contraindications": [
            "Asthma",
            "Severe COPD",
            "Sinus bradycardia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other beta-blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "deferoxamine": {
        "definition": "An iron chelator for acute iron toxicity and chronic iron overload.",
        "mechanism": "Binds free iron, forming a complex excreted in urine.",
        "indications": [
            "Acute iron poisoning",
            "Chronic iron overload (transfusion)"
        ],
        "dosage": {
            "adults": "IV/IM/SC, dose by weight and indication.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Allergic reactions",
            "Ocular/ototoxicity"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Vitamin C (high dose)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "calamine": {
        "definition": "A topical skin protectant and antipruritic.",
        "mechanism": "Soothes and protects irritated skin.",
        "indications": [
            "Pruritus",
            "Minor skin irritation",
            "Poison ivy/oak"
        ],
        "dosage": {
            "adults": "Apply to affected area as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "japanese enceph vacc sa14-14-2, inactivated": {
        "definition": "An inactivated vaccine for prevention of Japanese encephalitis.",
        "mechanism": "Induces active immunity against Japanese encephalitis virus.",
        "indications": [
            "Prevention of Japanese encephalitis (travelers, endemic areas)"
        ],
        "dosage": {
            "adults": "0.5 mL IM at 0, 28 days.",
            "children": "Same as adults (age 2 months+)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "oxaprozin": {
        "definition": "A nonsteroidal anti-inflammatory drug (NSAID) for pain and inflammation.",
        "mechanism": "Inhibits prostaglandin synthesis.",
        "indications": [
            "Osteoarthritis",
            "Rheumatoid arthritis"
        ],
        "dosage": {
            "adults": "1200 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Bleeding",
            "Headache"
        ],
        "contraindications": [
            "Active GI bleeding",
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Avoid in third trimester."
        },
        "interactions": [
            "Anticoagulants",
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "abatacept": {
        "definition": "A T-cell co-stimulation modulator for rheumatoid arthritis and juvenile idiopathic arthritis.",
        "mechanism": "Inhibits T-cell activation by binding CD80/CD86.",
        "indications": [
            "Rheumatoid arthritis",
            "Juvenile idiopathic arthritis"
        ],
        "dosage": {
            "adults": "500-1000 mg IV every 4 weeks or 125 mg SC weekly.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Headache",
            "Nausea"
        ],
        "contraindications": [
            "Severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methyl aminolevulinate": {
        "definition": "A topical photosensitizer for photodynamic therapy of actinic keratosis and basal cell carcinoma.",
        "mechanism": "Converted to protoporphyrin IX, activated by light to produce cytotoxic species.",
        "indications": [
            "Actinic keratosis",
            "Basal cell carcinoma"
        ],
        "dosage": {
            "adults": "Apply to lesion, cover for 3 hours, then illuminate.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Redness",
            "Pain",
            "Swelling"
        ],
        "contraindications": [
            "Porphyria",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other photosensitizers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "oxymorphone": {
        "definition": "A semi-synthetic opioid analgesic for moderate to severe pain.",
        "mechanism": "Binds mu-opioid receptors in CNS.",
        "indications": [
            "Moderate to severe pain"
        ],
        "dosage": {
            "adults": "5-20 mg orally every 4-6 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lactase": {
        "definition": "An enzyme supplement for lactose intolerance.",
        "mechanism": "Breaks down lactose into glucose and galactose.",
        "indications": [
            "Lactose intolerance"
        ],
        "dosage": {
            "adults": "Dose per product with first bite of dairy.",
            "children": "Same as adults."
        },
        "side effects": [
            "None significant"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sirolimus": {
        "definition": "An mTOR inhibitor immunosuppressant for organ transplant and lymphangioleiomyomatosis.",
        "mechanism": "Inhibits mTOR, suppressing T-cell proliferation.",
        "indications": [
            "Organ transplant rejection prophylaxis",
            "Lymphangioleiomyomatosis"
        ],
        "dosage": {
            "adults": "2-5 mg orally once daily (target trough level).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hyperlipidemia",
            "Infection",
            "Mouth ulcers"
        ],
        "contraindications": [
            "Liver impairment (severe)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "edetate calcium disodium": {
        "definition": "A chelating agent for lead poisoning.",
        "mechanism": "Binds lead, forming a complex excreted in urine.",
        "indications": [
            "Lead poisoning"
        ],
        "dosage": {
            "adults": "1000 mg/m²/day IV/IM for 5 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Nephrotoxicity",
            "Hypocalcemia"
        ],
        "contraindications": [
            "Anuria"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "succimer": {
        "definition": "An oral chelating agent for lead poisoning.",
        "mechanism": "Binds lead, forming a complex excreted in urine.",
        "indications": [
            "Lead poisoning (blood lead >45 mcg/dL)"
        ],
        "dosage": {
            "adults": "10 mg/kg orally every 8 hours for 5 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "GI upset",
            "Rash",
            "Elevated liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other chelators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clobazam": {
        "definition": "A benzodiazepine anticonvulsant for Lennox-Gastaut syndrome.",
        "mechanism": "Enhances GABAergic inhibition in CNS.",
        "indications": [
            "Lennox-Gastaut syndrome (adjunct)"
        ],
        "dosage": {
            "adults": "5-40 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Drowsiness",
            "Ataxia",
            "Respiratory depression"
        ],
        "contraindications": [
            "Severe respiratory impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "CYP2C19 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rufinamide": {
        "definition": "An anticonvulsant for Lennox-Gastaut syndrome.",
        "mechanism": "Prolongs inactivation of sodium channels.",
        "indications": [
            "Lennox-Gastaut syndrome (adjunct)"
        ],
        "dosage": {
            "adults": "400-3200 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Drowsiness",
            "QT shortening",
            "Nausea"
        ],
        "contraindications": [
            "Familial short QT syndrome"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "felbamate": {
        "definition": "An anticonvulsant for refractory epilepsy.",
        "mechanism": "Blocks NMDA receptors and modulates GABA.",
        "indications": [
            "Refractory epilepsy",
            "Lennox-Gastaut syndrome"
        ],
        "dosage": {
            "adults": "1200-3600 mg orally daily in divided doses.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Aplastic anemia",
            "Liver failure",
            "Weight loss"
        ],
        "contraindications": [
            "History of blood dyscrasia",
            "Liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Phenytoin",
            "Carbamazepine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clofazimine": {
        "definition": "A phenazine dye antibiotic for leprosy and mycobacterial infections.",
        "mechanism": "Binds mycobacterial DNA, interfering with growth.",
        "indications": [
            "Leprosy",
            "Mycobacterium avium complex (off-label)"
        ],
        "dosage": {
            "adults": "50-100 mg orally daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Skin discoloration",
            "GI upset",
            "Ichthyosis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aloe polysaccharides": {
        "definition": "Bioactive compounds from aloe vera used for wound healing and skin care.",
        "mechanism": "Promotes wound healing and has anti-inflammatory effects.",
        "indications": [
            "Minor burns",
            "Wound healing",
            "Skin irritation"
        ],
        "dosage": {
            "adults": "Apply topically as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iodoquinol": {
        "definition": "An oral and topical amebicide for intestinal amebiasis and skin infections.",
        "mechanism": "Unknown; may chelate metals needed by protozoa.",
        "indications": [
            "Intestinal amebiasis",
            "Dermatitis herpetiformis (topical)"
        ],
        "dosage": {
            "adults": "650 mg orally three times daily for 20 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Optic neuritis (rare)"
        ],
        "contraindications": [
            "Iodine hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "meperidine": {
        "definition": "A synthetic opioid analgesic for moderate to severe pain.",
        "mechanism": "Binds mu-opioid receptors in CNS.",
        "indications": [
            "Moderate to severe pain"
        ],
        "dosage": {
            "adults": "50-150 mg orally/IM/SC every 3-4 hours as needed.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Seizures",
            "Constipation",
            "Respiratory depression"
        ],
        "contraindications": [
            "MAO inhibitor use",
            "Severe respiratory depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "secobarbital": {
        "definition": "A barbiturate sedative-hypnotic for short-term insomnia and preoperative sedation.",
        "mechanism": "Enhances GABAergic inhibition in CNS.",
        "indications": [
            "Insomnia (short-term)",
            "Preoperative sedation"
        ],
        "dosage": {
            "adults": "100 mg orally at bedtime.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Drowsiness",
            "Dependence",
            "Respiratory depression"
        ],
        "contraindications": [
            "Porphyria",
            "Severe respiratory depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "CYP inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levorphanol": {
        "definition": "A synthetic opioid analgesic for severe pain.",
        "mechanism": "Binds mu-opioid receptors in CNS.",
        "indications": [
            "Severe pain"
        ],
        "dosage": {
            "adults": "2 mg orally every 6-8 hours as needed.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Constipation",
            "Nausea",
            "Respiratory depression"
        ],
        "contraindications": [
            "Respiratory depression",
            "Severe asthma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tesamorelin": {
        "definition": "A growth hormone-releasing factor analog for HIV-associated lipodystrophy.",
        "mechanism": "Stimulates pituitary GH release, reducing visceral adiposity.",
        "indications": [
            "HIV-associated lipodystrophy"
        ],
        "dosage": {
            "adults": "2 mg SC once daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Arthralgia",
            "Peripheral edema",
            "Injection site reactions"
        ],
        "contraindications": [
            "Active malignancy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metreleptin": {
        "definition": "A recombinant human leptin analog for generalized lipodystrophy.",
        "mechanism": "Replaces deficient leptin, regulating metabolism.",
        "indications": [
            "Generalized lipodystrophy"
        ],
        "dosage": {
            "adults": "0.06-0.13 mg/kg SC daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypoglycemia",
            "Lymphoma",
            "Neutralizing antibodies"
        ],
        "contraindications": [
            "General obesity without lipodystrophy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin",
            "Antidiabetic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gadoxetate disodium": {
        "definition": "A gadolinium-based MRI contrast agent for liver imaging.",
        "mechanism": "Enhances MRI images by shortening T1 relaxation time.",
        "indications": [
            "Liver MRI contrast enhancement"
        ],
        "dosage": {
            "adults": "0.025 mmol/kg IV.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Nephrogenic systemic fibrosis (rare)"
        ],
        "contraindications": [
            "Hypersensitivity to gadolinium agents"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks.",
            "renal impairment": "Use with caution."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "floxuridine": {
        "definition": "A pyrimidine analog antimetabolite for hepatic metastases of GI cancer.",
        "mechanism": "Inhibits DNA synthesis.",
        "indications": [
            "Hepatic metastases of GI cancer (regional arterial infusion)"
        ],
        "dosage": {
            "adults": "0.1-0.6 mg/kg/day by continuous arterial infusion for 14 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "GI toxicity",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Severe bone marrow suppression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mepivacaine": {
        "definition": "An amide-type local anesthetic for infiltration and nerve block anesthesia.",
        "mechanism": "Blocks sodium channels, inhibiting nerve conduction.",
        "indications": [
            "Local anesthesia (infiltration, nerve block)"
        ],
        "dosage": {
            "adults": "Dose per procedure.",
            "children": "Dose by weight."
        },
        "side effects": [
            "CNS toxicity",
            "Cardiac arrhythmias"
        ],
        "contraindications": [
            "Hypersensitivity to amide anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cocaine": {
        "definition": "A local anesthetic and vasoconstrictor for mucous membrane anesthesia.",
        "mechanism": "Blocks sodium channels; inhibits norepinephrine reuptake.",
        "indications": [
            "Topical anesthesia of mucous membranes (ENT procedures)"
        ],
        "dosage": {
            "adults": "Dose per procedure.",
            "children": "Not routinely used."
        },
        "side effects": [
            "CNS stimulation",
            "Arrhythmias",
            "Hypertension"
        ],
        "contraindications": [
            "Cardiac disease",
            "Thyrotoxicosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Sympathomimetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "articaine": {
        "definition": "An amide-type local anesthetic for dental procedures.",
        "mechanism": "Blocks sodium channels, inhibiting nerve conduction.",
        "indications": [
            "Local anesthesia in dentistry"
        ],
        "dosage": {
            "adults": "Dose per procedure.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Paresthesia",
            "CNS toxicity"
        ],
        "contraindications": [
            "Hypersensitivity to amide anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chloroprocaine": {
        "definition": "An ester-type local anesthetic for infiltration and regional anesthesia.",
        "mechanism": "Blocks sodium channels, inhibiting nerve conduction.",
        "indications": [
            "Local anesthesia (infiltration, regional block)"
        ],
        "dosage": {
            "adults": "Dose per procedure.",
            "children": "Dose by weight."
        },
        "side effects": [
            "CNS toxicity",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity to ester anesthetics"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sebelipase alfa": {
        "definition": "A recombinant enzyme for lysosomal acid lipase deficiency (LAL-D).",
        "mechanism": "Replaces lysosomal acid lipase enzyme.",
        "indications": [
            "Lysosomal acid lipase deficiency (LAL-D)"
        ],
        "dosage": {
            "adults": "1 mg/kg IV every other week.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "verteporfin": {
        "definition": "A photosensitizing agent for photodynamic therapy of age-related macular degeneration (AMD).",
        "mechanism": "Generates reactive oxygen species when activated by light, causing local vascular occlusion.",
        "indications": [
            "Choroidal neovascularization in AMD",
            "Pathologic myopia"
        ],
        "dosage": {
            "adults": "6 mg/m² IV over 10 min, then laser activation.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Photosensitivity",
            "Visual disturbances",
            "Injection site reactions"
        ],
        "contraindications": [
            "Porphyria",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other photosensitizers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegaptanib": {
        "definition": "A VEGF inhibitor for neovascular (wet) age-related macular degeneration.",
        "mechanism": "Binds and inhibits VEGF165 isoform, reducing neovascularization.",
        "indications": [
            "Neovascular (wet) AMD"
        ],
        "dosage": {
            "adults": "0.3 mg intravitreal injection every 6 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye pain",
            "Increased intraocular pressure",
            "Endophthalmitis"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravitreal agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brolucizumab": {
        "definition": "A monoclonal antibody fragment (VEGF inhibitor) for neovascular (wet) AMD.",
        "mechanism": "Binds and inhibits all isoforms of VEGF-A.",
        "indications": [
            "Neovascular (wet) AMD"
        ],
        "dosage": {
            "adults": "6 mg intravitreal injection every 4-12 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Eye pain",
            "Retinal vasculitis",
            "Endophthalmitis"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravitreal agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "artemether": {
        "definition": "An artemisinin derivative antimalarial, usually combined with lumefantrine.",
        "mechanism": "Generates free radicals toxic to malaria parasites.",
        "indications": [
            "Acute uncomplicated malaria (with lumefantrine)"
        ],
        "dosage": {
            "adults": "20 mg artemether/120 mg lumefantrine per tablet; 4 tablets initially, then at 8, 24, 36, 48, 60 hours.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "GI upset",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lumefantrine": {
        "definition": "An antimalarial, always used in combination with artemether.",
        "mechanism": "Inhibits heme polymerization in malaria parasites.",
        "indications": [
            "Acute uncomplicated malaria (with artemether)"
        ],
        "dosage": {
            "adults": "See artemether/lumefantrine combination.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "GI upset",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mefloquine": {
        "definition": "An antimalarial for prophylaxis and treatment of malaria.",
        "mechanism": "Disrupts parasite's food vacuole function.",
        "indications": [
            "Malaria prophylaxis",
            "Treatment of malaria"
        ],
        "dosage": {
            "adults": "250 mg orally once weekly (prophylaxis); 1250 mg single dose (treatment).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Neuropsychiatric effects",
            "GI upset",
            "Dizziness"
        ],
        "contraindications": [
            "History of neuropsychiatric disorders",
            "Seizure disorder"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antimalarials"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "proguanil": {
        "definition": "A dihydrofolate reductase inhibitor antimalarial, often combined with atovaquone.",
        "mechanism": "Inhibits parasite folate synthesis.",
        "indications": [
            "Malaria prophylaxis and treatment (with atovaquone)"
        ],
        "dosage": {
            "adults": "100 mg proguanil/250 mg atovaquone daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Mouth ulcers",
            "Alopecia"
        ],
        "contraindications": [
            "Severe renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "primaquine": {
        "definition": "An antimalarial for radical cure and prevention of relapse (P. vivax, P. ovale).",
        "mechanism": "Disrupts mitochondrial electron transport in parasites.",
        "indications": [
            "Radical cure of P. vivax and P. ovale malaria",
            "Malaria prophylaxis (off-label)"
        ],
        "dosage": {
            "adults": "15-30 mg base orally daily for 14 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hemolysis (G6PD deficiency)",
            "GI upset",
            "Methemoglobinemia"
        ],
        "contraindications": [
            "G6PD deficiency",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other hemolytic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrimethamine": {
        "definition": "A dihydrofolate reductase inhibitor for malaria and toxoplasmosis.",
        "mechanism": "Inhibits parasite folate synthesis.",
        "indications": [
            "Malaria (with sulfonamides)",
            "Toxoplasmosis"
        ],
        "dosage": {
            "adults": "25-75 mg orally daily (malaria); 50-75 mg daily (toxoplasmosis).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bone marrow suppression",
            "GI upset",
            "Rash"
        ],
        "contraindications": [
            "Megaloblastic anemia due to folate deficiency"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Sulfonamides",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tafenoquine": {
        "definition": "An 8-aminoquinoline antimalarial for radical cure and prophylaxis.",
        "mechanism": "Disrupts mitochondrial electron transport in parasites.",
        "indications": [
            "Radical cure of P. vivax malaria",
            "Malaria prophylaxis"
        ],
        "dosage": {
            "adults": "200 mg orally once weekly (prophylaxis); 300 mg single dose (radical cure).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hemolysis (G6PD deficiency)",
            "GI upset",
            "Methemoglobinemia"
        ],
        "contraindications": [
            "G6PD deficiency",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other hemolytic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acalabrutinib": {
        "definition": "A Bruton tyrosine kinase (BTK) inhibitor for B-cell malignancies.",
        "mechanism": "Inhibits BTK, blocking B-cell receptor signaling.",
        "indications": [
            "Mantle cell lymphoma",
            "Chronic lymphocytic leukemia (CLL)"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Infection",
            "Bleeding"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zanubrutinib": {
        "definition": "A Bruton tyrosine kinase (BTK) inhibitor for B-cell malignancies.",
        "mechanism": "Inhibits BTK, blocking B-cell receptor signaling.",
        "indications": [
            "Mantle cell lymphoma",
            "Waldenström's macroglobulinemia",
            "CLL/SLL"
        ],
        "dosage": {
            "adults": "160 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Neutropenia",
            "Infection",
            "Bleeding"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "azacitidine": {
        "definition": "A hypomethylating agent for myelodysplastic syndromes (MDS) and AML.",
        "mechanism": "Inhibits DNA methyltransferase, restoring normal gene expression.",
        "indications": [
            "Myelodysplastic syndromes",
            "Acute myeloid leukemia (AML)"
        ],
        "dosage": {
            "adults": "75 mg/m² SC/IV daily for 7 days every 28 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "GI upset",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "measles virus vaccine": {
        "definition": "A live attenuated vaccine for prevention of measles.",
        "mechanism": "Induces active immunity against measles virus.",
        "indications": [
            "Prevention of measles (as MMR or MMRV)"
        ],
        "dosage": {
            "adults": "0.5 mL SC per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Injection site reactions"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunoglobulins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "mumps virus vaccine": {
        "definition": "A live attenuated vaccine for prevention of mumps.",
        "mechanism": "Induces active immunity against mumps virus.",
        "indications": [
            "Prevention of mumps (as MMR or MMRV)"
        ],
        "dosage": {
            "adults": "0.5 mL SC per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Fever",
            "Parotitis",
            "Injection site reactions"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunoglobulins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "rubella virus vaccine": {
        "definition": "A live attenuated vaccine for prevention of rubella.",
        "mechanism": "Induces active immunity against rubella virus.",
        "indications": [
            "Prevention of rubella (as MMR or MMRV)"
        ],
        "dosage": {
            "adults": "0.5 mL SC per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Arthralgia"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunoglobulins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "varicella virus vaccine": {
        "definition": "A live attenuated vaccine for prevention of varicella (chickenpox).",
        "mechanism": "Induces active immunity against varicella-zoster virus.",
        "indications": [
            "Prevention of varicella (chickenpox)"
        ],
        "dosage": {
            "adults": "0.5 mL SC per schedule.",
            "children": "Same as adults."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Injection site reactions"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunoglobulins"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "formaldehyde": {
        "definition": "A disinfectant and vaccine preservative.",
        "mechanism": "Cross-links proteins and nucleic acids, inactivating pathogens.",
        "indications": [
            "Disinfection",
            "Vaccine production (inactivating agent)"
        ],
        "dosage": {
            "adults": "Not applicable for direct administration.",
            "children": "Not applicable."
        },
        "side effects": [
            "Irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Avoid exposure."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "NIH"
        ]
    },
    "cobimetinib": {
        "definition": "A MEK inhibitor for BRAF V600E/K-mutant melanoma (with vemurafenib).",
        "mechanism": "Inhibits MEK1/2, blocking MAPK pathway.",
        "indications": [
            "Unresectable or metastatic BRAF V600E/K-mutant melanoma (with vemurafenib)"
        ],
        "dosage": {
            "adults": "60 mg orally once daily (21 days on, 7 days off).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rash",
            "Diarrhea",
            "Cardiomyopathy"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "meningococcal group B vaccine": {
        "definition": "A recombinant vaccine for prevention of Neisseria meningitidis serogroup B infection.",
        "mechanism": "Induces active immunity against meningococcal group B.",
        "indications": [
            "Prevention of meningococcal group B disease"
        ],
        "dosage": {
            "adults": "0.5 mL IM at 0, 1 month (Bexsero) or 0, 1-6 months (Trumenba).",
            "children": "Same as adults (age 10+)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "meningococcal conjugate vaccine": {
        "definition": "A conjugate vaccine for prevention of Neisseria meningitidis serogroups A, C, W, Y.",
        "mechanism": "Induces active immunity against meningococcal serogroups A, C, W, Y.",
        "indications": [
            "Prevention of meningococcal disease (A, C, W, Y)"
        ],
        "dosage": {
            "adults": "0.5 mL IM single dose; booster as needed.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "drospirenone": {
        "definition": "A progestin used in oral contraceptives and hormone therapy.",
        "mechanism": "Suppresses ovulation and alters cervical mucus.",
        "indications": [
            "Contraception",
            "Acne",
            "Premenstrual dysphoric disorder"
        ],
        "dosage": {
            "adults": "3 mg orally daily (with ethinyl estradiol).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hyperkalemia",
            "Irregular bleeding",
            "Headache"
        ],
        "contraindications": [
            "Renal or hepatic impairment",
            "Adrenal insufficiency"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers",
            "ACE inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levoleucovorin": {
        "definition": "An active isomer of leucovorin for methotrexate rescue and chemotherapy modulation.",
        "mechanism": "Bypasses dihydrofolate reductase blockade.",
        "indications": [
            "Methotrexate rescue",
            "Fluorouracil toxicity reduction"
        ],
        "dosage": {
            "adults": "10-25 mg/m² IV/IM every 6 hours (methotrexate rescue).",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Allergic reactions",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Methotrexate",
            "Fluorouracil"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glucarpidase": {
        "definition": "An enzyme for rapid methotrexate detoxification in renal impairment.",
        "mechanism": "Hydrolyzes methotrexate to inactive metabolites.",
        "indications": [
            "Toxic plasma methotrexate concentrations due to renal dysfunction"
        ],
        "dosage": {
            "adults": "50 units/kg IV as a single dose.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hypersensitivity",
            "Flushing",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Leucovorin (separate by 2 hours)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olmesartan": {
        "definition": "An angiotensin II receptor blocker (ARB) for hypertension.",
        "mechanism": "Blocks angiotensin II type 1 receptors.",
        "indications": [
            "Hypertension"
        ],
        "dosage": {
            "adults": "20-40 mg orally once daily.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Hyperkalemia",
            "Hypotension",
            "Dizziness"
        ],
        "contraindications": [
            "Pregnancy",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Potassium-sparing diuretics",
            "NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzoin": {
        "definition": "A topical protectant and adhesive for skin and mucous membranes.",
        "mechanism": "Forms a protective film on skin/mucosa.",
        "indications": [
            "Protecting skin",
            "Improving adhesion of bandages",
            "Mouth ulcers"
        ],
        "dosage": {
            "adults": "Apply as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "smallpox and monkeypox vaccine": {
        "definition": "A live, non-replicating vaccine for prevention of smallpox and monkeypox.",
        "mechanism": "Induces active immunity against orthopoxviruses.",
        "indications": [
            "Prevention of smallpox and monkeypox"
        ],
        "dosage": {
            "adults": "0.5 mL SC or 0.1 mL ID per schedule.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Myalgia"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "ginger": {
        "definition": "A herbal supplement for nausea, motion sickness, and GI upset.",
        "mechanism": "May affect GI motility and serotonin receptors.",
        "indications": [
            "Nausea",
            "Motion sickness",
            "GI upset"
        ],
        "dosage": {
            "adults": "250-1000 mg orally up to 4 times daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Heartburn",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe in moderate doses."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "NIH",
            "MedlinePlus"
        ]
    },
    "elosulfase alfa": {
        "definition": "A recombinant enzyme for mucopolysaccharidosis IVA (Morquio A syndrome).",
        "mechanism": "Replaces N-acetylgalactosamine-6-sulfatase enzyme.",
        "indications": [
            "Mucopolysaccharidosis IVA (Morquio A syndrome)"
        ],
        "dosage": {
            "adults": "2 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Vomiting"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dimenhydrinate": {
        "definition": "A first-generation antihistamine for motion sickness and nausea.",
        "mechanism": "Blocks histamine H1 receptors in the CNS.",
        "indications": [
            "Motion sickness",
            "Nausea",
            "Vertigo"
        ],
        "dosage": {
            "adults": "50-100 mg orally every 4-6 hours as needed.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Blurred vision"
        ],
        "contraindications": [
            "Glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glatiramer": {
        "definition": "An immunomodulator for relapsing forms of multiple sclerosis.",
        "mechanism": "Modulates immune response to myelin basic protein.",
        "indications": [
            "Relapsing-remitting multiple sclerosis"
        ],
        "dosage": {
            "adults": "20 mg SC daily or 40 mg SC three times weekly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Flushing",
            "Chest pain"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dalfampridine": {
        "definition": "A potassium channel blocker to improve walking in multiple sclerosis.",
        "mechanism": "Increases conduction in demyelinated nerves.",
        "indications": [
            "Improvement of walking in MS"
        ],
        "dosage": {
            "adults": "10 mg orally twice daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Seizures",
            "UTI",
            "Insomnia"
        ],
        "contraindications": [
            "History of seizures",
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other seizure-threshold lowering drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fingolimod": {
        "definition": "A sphingosine 1-phosphate receptor modulator for MS.",
        "mechanism": "Prevents lymphocyte egress from lymph nodes.",
        "indications": [
            "Relapsing forms of multiple sclerosis"
        ],
        "dosage": {
            "adults": "0.5 mg orally once daily.",
            "children": "Dose by weight (age 10+)."
        },
        "side effects": [
            "Bradycardia",
            "Macular edema",
            "Infection"
        ],
        "contraindications": [
            "Recent MI/stroke",
            "AV block",
            "Severe infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antiarrhythmics",
            "Ketoconazole"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "interferon beta-1a": {
        "definition": "A recombinant interferon for relapsing forms of multiple sclerosis.",
        "mechanism": "Modulates immune response, reduces inflammation.",
        "indications": [
            "Relapsing forms of multiple sclerosis"
        ],
        "dosage": {
            "adults": "30 mcg IM once weekly or 22-44 mcg SC three times weekly.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flu-like symptoms",
            "Injection site reactions",
            "Depression"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunomodulators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dimethyl fumarate": {
        "definition": "An oral immunomodulator for relapsing forms of multiple sclerosis.",
        "mechanism": "Activates Nrf2 pathway, reducing oxidative stress.",
        "indications": [
            "Relapsing forms of multiple sclerosis"
        ],
        "dosage": {
            "adults": "120 mg orally twice daily for 7 days, then 240 mg twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Flushing",
            "GI upset",
            "Lymphopenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "teriflunomide": {
        "definition": "A pyrimidine synthesis inhibitor for relapsing forms of multiple sclerosis.",
        "mechanism": "Inhibits dihydroorotate dehydrogenase, reducing lymphocyte proliferation.",
        "indications": [
            "Relapsing forms of multiple sclerosis"
        ],
        "dosage": {
            "adults": "7-14 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hepatotoxicity",
            "Alopecia",
            "Diarrhea"
        ],
        "contraindications": [
            "Pregnancy",
            "Severe liver disease"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Warfarin",
            "CYP inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "idursulfase": {
        "definition": "A recombinant enzyme for Hunter syndrome (MPS II).",
        "mechanism": "Replaces iduronate-2-sulfatase enzyme.",
        "indications": [
            "Hunter syndrome (MPS II)"
        ],
        "dosage": {
            "adults": "0.5 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "galsulfase": {
        "definition": "A recombinant enzyme for Maroteaux-Lamy syndrome (MPS VI).",
        "mechanism": "Replaces N-acetylgalactosamine-4-sulfatase enzyme.",
        "indications": [
            "Maroteaux-Lamy syndrome (MPS VI)"
        ],
        "dosage": {
            "adults": "1 mg/kg IV once weekly.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Fever",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "palifermin": {
        "definition": "A keratinocyte growth factor for prevention of oral mucositis in hematologic malignancy.",
        "mechanism": "Stimulates proliferation of epithelial cells.",
        "indications": [
            "Prevention of severe oral mucositis (stem cell transplant)"
        ],
        "dosage": {
            "adults": "60 mcg/kg IV daily for 3 days before and after conditioning therapy.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Rash",
            "Edema",
            "Taste alteration"
        ],
        "contraindications": [
            "Solid tumors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Heparin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "neostigmine": {
        "definition": "A reversible acetylcholinesterase inhibitor for myasthenia gravis and reversal of neuromuscular blockade.",
        "mechanism": "Inhibits acetylcholinesterase, increasing acetylcholine at neuromuscular junction.",
        "indications": [
            "Myasthenia gravis",
            "Reversal of nondepolarizing neuromuscular blockade",
            "Acute colonic pseudo-obstruction"
        ],
        "dosage": {
            "adults": "15-375 mg orally daily in divided doses; 0.5-2 mg IV/IM as needed.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Bradycardia",
            "GI upset",
            "Muscle cramps"
        ],
        "contraindications": [
            "GI or urinary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ethambutol": {
        "definition": "A first-line antitubercular agent.",
        "mechanism": "Inhibits arabinosyl transferase, blocking mycobacterial cell wall synthesis.",
        "indications": [
            "Tuberculosis (with other drugs)"
        ],
        "dosage": {
            "adults": "15-25 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Optic neuritis",
            "GI upset",
            "Rash"
        ],
        "contraindications": [
            "Optic neuritis",
            "Young children (risk of vision loss)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antituberculars"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rifabutin": {
        "definition": "A rifamycin antibiotic for mycobacterial infections (esp. MAC in HIV).",
        "mechanism": "Inhibits DNA-dependent RNA polymerase in mycobacteria.",
        "indications": [
            "Mycobacterium avium complex (MAC)",
            "Tuberculosis (alternative)"
        ],
        "dosage": {
            "adults": "300 mg orally once daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Uveitis",
            "Neutropenia",
            "Orange discoloration of body fluids"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "amikacin liposome": {
        "definition": "A liposomal aminoglycoside for refractory Mycobacterium avium complex (MAC) lung disease.",
        "mechanism": "Inhibits bacterial protein synthesis (30S ribosomal subunit).",
        "indications": [
            "Refractory MAC lung disease (inhaled)"
        ],
        "dosage": {
            "adults": "590 mg inhaled once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dysphonia",
            "Cough",
            "Ototoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nephrotoxic/ototoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isoniazid": {
        "definition": "A first-line antitubercular agent.",
        "mechanism": "Inhibits mycolic acid synthesis in mycobacterial cell wall.",
        "indications": [
            "Tuberculosis (treatment and prophylaxis)"
        ],
        "dosage": {
            "adults": "5 mg/kg orally once daily (max 300 mg).",
            "children": "10 mg/kg once daily."
        },
        "side effects": [
            "Hepatitis",
            "Peripheral neuropathy",
            "Rash"
        ],
        "contraindications": [
            "Acute liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Phenytoin",
            "Carbamazepine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mechlorethamine": {
        "definition": "A nitrogen mustard alkylating agent for cancer (topical for mycosis fungoides).",
        "mechanism": "Alkylates DNA, causing cell death.",
        "indications": [
            "Hodgkin lymphoma (IV)",
            "Mycosis fungoides (topical)"
        ],
        "dosage": {
            "adults": "IV: 0.4 mg/kg every 4 weeks; topical: apply once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Skin irritation (topical)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other myelosuppressive agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mogamulizumab": {
        "definition": "An anti-CCR4 monoclonal antibody for cutaneous T-cell lymphoma.",
        "mechanism": "Targets CCR4 on malignant T-cells.",
        "indications": [
            "Mycosis fungoides",
            "Sézary syndrome"
        ],
        "dosage": {
            "adults": "1 mg/kg IV weekly for 5 weeks, then every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rash",
            "Infusion reactions",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "poly-ureaurethane": {
        "definition": "A synthetic polymer used in medical devices and drug delivery systems.",
        "mechanism": "Acts as a biocompatible, durable material.",
        "indications": [
            "Medical device coatings",
            "Drug delivery systems"
        ],
        "dosage": {
            "adults": "Not applicable.",
            "children": "Not applicable."
        },
        "side effects": [
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Not applicable."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA",
            "NIH"
        ]
    },
    "aprepitant": {
        "definition": "A neurokinin-1 (NK1) receptor antagonist for chemotherapy-induced nausea and vomiting (CINV).",
        "mechanism": "Blocks substance P/NK1 receptors in CNS.",
        "indications": [
            "Prevention of acute and delayed CINV"
        ],
        "dosage": {
            "adults": "125 mg orally on day 1, then 80 mg on days 2 and 3.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Fatigue",
            "Hiccups",
            "Constipation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "granisetron": {
        "definition": "A 5-HT3 receptor antagonist for nausea and vomiting.",
        "mechanism": "Blocks serotonin 5-HT3 receptors in CNS and GI tract.",
        "indications": [
            "CINV",
            "Postoperative nausea and vomiting"
        ],
        "dosage": {
            "adults": "1-2 mg orally once daily or 1 mg IV.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "Constipation",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "palonosetron": {
        "definition": "A second-generation 5-HT3 receptor antagonist for nausea and vomiting.",
        "mechanism": "Blocks serotonin 5-HT3 receptors in CNS and GI tract.",
        "indications": [
            "CINV",
            "Postoperative nausea and vomiting"
        ],
        "dosage": {
            "adults": "0.25 mg IV as a single dose.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "Constipation",
            "QT prolongation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "droperidol": {
        "definition": "A butyrophenone antiemetic and antipsychotic for nausea and agitation.",
        "mechanism": "Blocks dopamine D2 receptors in CNS.",
        "indications": [
            "Nausea and vomiting",
            "Agitation (off-label)"
        ],
        "dosage": {
            "adults": "0.625-2.5 mg IV/IM.",
            "children": "Dose by weight."
        },
        "side effects": [
            "QT prolongation",
            "Sedation",
            "Hypotension"
        ],
        "contraindications": [
            "QT prolongation",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other QT-prolonging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dinutuximab": {
        "definition": "An anti-GD2 monoclonal antibody for high-risk neuroblastoma.",
        "mechanism": "Targets GD2 on neuroblastoma cells.",
        "indications": [
            "High-risk neuroblastoma"
        ],
        "dosage": {
            "adults": "17.5 mg/m² IV daily for 4 days per cycle.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Pain",
            "Capillary leak syndrome",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lutetium lu 177 dotatate": {
        "definition": "A radiolabeled somatostatin analog for neuroendocrine tumors.",
        "mechanism": "Binds somatostatin receptors, delivering targeted beta radiation.",
        "indications": [
            "Gastroenteropancreatic neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "7.4 GBq (200 mCi) IV every 8 weeks for 4 doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Myelosuppression",
            "Renal toxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Somatostatin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "guanidine": {
        "definition": "A rarely used drug for myasthenic syndrome (Lambert-Eaton).",
        "mechanism": "Enhances acetylcholine release at neuromuscular junction.",
        "indications": [
            "Lambert-Eaton myasthenic syndrome (off-label)"
        ],
        "dosage": {
            "adults": "15-35 mg/kg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Bone marrow suppression",
            "Nephrotoxicity"
        ],
        "contraindications": [
            "Renal impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other neuromuscular drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cenegermin": {
        "definition": "A recombinant human nerve growth factor for neurotrophic keratitis.",
        "mechanism": "Promotes corneal healing and nerve regeneration.",
        "indications": [
            "Neurotrophic keratitis"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) 6 times daily for 8 weeks.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye pain",
            "Corneal deposits",
            "Eye inflammation"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegfilgrastim": {
        "definition": "A long-acting G-CSF for neutropenia prevention in chemotherapy.",
        "mechanism": "Stimulates neutrophil production in bone marrow.",
        "indications": [
            "Prevention of chemotherapy-induced neutropenia"
        ],
        "dosage": {
            "adults": "6 mg SC once per chemotherapy cycle.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bone pain",
            "Splenic rupture",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tbo-filgrastim": {
        "definition": "A recombinant G-CSF for neutropenia prevention in chemotherapy.",
        "mechanism": "Stimulates neutrophil production in bone marrow.",
        "indications": [
            "Prevention of chemotherapy-induced neutropenia"
        ],
        "dosage": {
            "adults": "5 mcg/kg SC daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bone pain",
            "Splenic rupture",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "niacinamide": {
        "definition": "A form of vitamin B3 (nicotinamide) for deficiency and skin health.",
        "mechanism": "Precursor to NAD/NADP, supports cellular metabolism.",
        "indications": [
            "Pellagra",
            "Acne (topical)",
            "Skin health"
        ],
        "dosage": {
            "adults": "500-2000 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Flushing (less than niacin)",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tasimelteon": {
        "definition": "A melatonin receptor agonist for non-24-hour sleep-wake disorder.",
        "mechanism": "Agonist at MT1 and MT2 melatonin receptors.",
        "indications": [
            "Non-24-hour sleep-wake disorder (mainly in totally blind individuals)"
        ],
        "dosage": {
            "adults": "20 mg orally at the same time every night.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Nightmares",
            "Increased liver enzymes"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP1A2, CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dopamine": {
        "definition": "A catecholamine vasopressor and inotrope for shock and heart failure.",
        "mechanism": "Stimulates dopaminergic, beta-1, and alpha receptors (dose-dependent).",
        "indications": [
            "Shock",
            "Heart failure",
            "Bradycardia (off-label)"
        ],
        "dosage": {
            "adults": "2-20 mcg/kg/min IV infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Arrhythmias",
            "Tachycardia",
            "Ischemia"
        ],
        "contraindications": [
            "Pheochromocytoma",
            "Uncorrected tachyarrhythmia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "Phenytoin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "zidovudine": {
        "definition": "A nucleoside reverse transcriptase inhibitor (NRTI) for HIV infection.",
        "mechanism": "Inhibits HIV reverse transcriptase, blocking viral replication.",
        "indications": [
            "HIV infection",
            "HIV perinatal prophylaxis"
        ],
        "dosage": {
            "adults": "300 mg orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Anemia",
            "Neutropenia",
            "Myopathy"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Recommended for perinatal prophylaxis."
        },
        "interactions": [
            "Other myelosuppressive drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "atazanavir": {
        "definition": "A protease inhibitor for HIV infection.",
        "mechanism": "Inhibits HIV protease, blocking viral maturation.",
        "indications": [
            "HIV infection"
        ],
        "dosage": {
            "adults": "300 mg orally once daily (with ritonavir).",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hyperbilirubinemia",
            "PR prolongation",
            "Nephrolithiasis"
        ],
        "contraindications": [
            "Hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lopinavir": {
        "definition": "A protease inhibitor for HIV infection (used with ritonavir).",
        "mechanism": "Inhibits HIV protease, blocking viral maturation.",
        "indications": [
            "HIV infection"
        ],
        "dosage": {
            "adults": "400 mg lopinavir/100 mg ritonavir orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Hyperlipidemia",
            "QT/PR prolongation"
        ],
        "contraindications": [
            "Hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "parenteral nutrition solution w": {
        "definition": "A solution containing amino acids, dextrose, electrolytes, vitamins, and trace elements for IV nutrition.",
        "mechanism": "Provides essential nutrients for patients unable to eat.",
        "indications": [
            "Total parenteral nutrition (TPN)"
        ],
        "dosage": {
            "adults": "Individualized by clinical need.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Electrolyte imbalance",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Severe fluid/electrolyte abnormalities"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "electrolytes": {
        "definition": "Minerals (sodium, potassium, chloride, etc.) essential for physiological function.",
        "mechanism": "Maintain fluid balance, nerve conduction, muscle function.",
        "indications": [
            "Electrolyte imbalance",
            "IV fluid therapy"
        ],
        "dosage": {
            "adults": "Individualized by clinical need.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Electrolyte disturbances"
        ],
        "contraindications": [
            "Imbalance of specific electrolyte"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fat emulsion": {
        "definition": "An intravenous lipid emulsion for parenteral nutrition.",
        "mechanism": "Provides essential fatty acids and calories.",
        "indications": [
            "Parenteral nutrition"
        ],
        "dosage": {
            "adults": "1-2 g/kg/day IV.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Fat overload syndrome",
            "Hypertriglyceridemia"
        ],
        "contraindications": [
            "Severe hyperlipidemia",
            "Egg allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "parenteral nutrition solution": {
        "definition": "A sterile solution containing amino acids, dextrose, electrolytes, vitamins, and trace elements for IV nutrition.",
        "mechanism": "Provides essential nutrients for patients unable to eat.",
        "indications": [
            "Total parenteral nutrition (TPN)"
        ],
        "dosage": {
            "adults": "Individualized by clinical need.",
            "children": "Dose by weight and indication."
        },
        "side effects": [
            "Infection",
            "Electrolyte imbalance",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Severe fluid/electrolyte abnormalities"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chromic chloride hexahydrate": {
        "definition": "A trace element supplement for parenteral nutrition.",
        "mechanism": "Provides chromium, a cofactor for insulin action.",
        "indications": [
            "Chromium deficiency",
            "Parenteral nutrition"
        ],
        "dosage": {
            "adults": "10-15 mcg IV daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trace elements": {
        "definition": "Essential minerals (zinc, copper, manganese, etc.) for parenteral nutrition.",
        "mechanism": "Support enzymatic and metabolic functions.",
        "indications": [
            "Trace element deficiency",
            "Parenteral nutrition"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Toxicity (overdose)",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other mineral supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phentermine": {
        "definition": "A sympathomimetic appetite suppressant for obesity.",
        "mechanism": "Stimulates release of norepinephrine in CNS, reducing appetite.",
        "indications": [
            "Short-term obesity management (adjunct to diet)"
        ],
        "dosage": {
            "adults": "15-37.5 mg orally once daily before breakfast.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Insomnia",
            "Tachycardia",
            "Hypertension"
        ],
        "contraindications": [
            "Cardiovascular disease",
            "Hyperthyroidism",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phendimetrazine": {
        "definition": "A sympathomimetic appetite suppressant for obesity.",
        "mechanism": "Stimulates release of norepinephrine in CNS, reducing appetite.",
        "indications": [
            "Short-term obesity management (adjunct to diet)"
        ],
        "dosage": {
            "adults": "35 mg orally 2-3 times daily before meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Insomnia",
            "Tachycardia",
            "Hypertension"
        ],
        "contraindications": [
            "Cardiovascular disease",
            "Hyperthyroidism",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "diethylpropion": {
        "definition": "A sympathomimetic appetite suppressant for obesity.",
        "mechanism": "Stimulates release of norepinephrine in CNS, reducing appetite.",
        "indications": [
            "Short-term obesity management (adjunct to diet)"
        ],
        "dosage": {
            "adults": "25 mg orally 3 times daily before meals.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Insomnia",
            "Tachycardia",
            "Hypertension"
        ],
        "contraindications": [
            "Cardiovascular disease",
            "Hyperthyroidism",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methamphetamine": {
        "definition": "A CNS stimulant for ADHD and obesity (rarely used for obesity).",
        "mechanism": "Increases release of norepinephrine and dopamine in CNS.",
        "indications": [
            "ADHD",
            "Short-term obesity management (rare)"
        ],
        "dosage": {
            "adults": "5-25 mg orally daily in divided doses.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Insomnia",
            "Tachycardia",
            "Addiction"
        ],
        "contraindications": [
            "Cardiovascular disease",
            "Hyperthyroidism",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lorcaserin": {
        "definition": "A serotonin 2C receptor agonist for obesity (withdrawn in some markets).",
        "mechanism": "Reduces appetite via serotonin 2C receptor activation in CNS.",
        "indications": [
            "Obesity management (adjunct to diet and exercise)"
        ],
        "dosage": {
            "adults": "10 mg orally twice daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Headache",
            "Hypoglycemia",
            "Serotonin syndrome"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "SSRIs",
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "clomipramine": {
        "definition": "A tricyclic antidepressant for OCD and depression.",
        "mechanism": "Inhibits serotonin and norepinephrine reuptake.",
        "indications": [
            "Obsessive-compulsive disorder",
            "Depression"
        ],
        "dosage": {
            "adults": "25-250 mg orally daily in divided doses.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "QT prolongation"
        ],
        "contraindications": [
            "Recent MI",
            "Seizure disorder"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "SSRIs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "raltegravir": {
        "definition": "An integrase inhibitor for HIV infection.",
        "mechanism": "Inhibits HIV integrase, blocking viral DNA integration.",
        "indications": [
            "HIV infection"
        ],
        "dosage": {
            "adults": "400 mg orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Insomnia",
            "Headache",
            "Increased CPK"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antacids (aluminum, magnesium)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "moxidectin": {
        "definition": "A macrocyclic lactone anthelmintic for onchocerciasis (river blindness).",
        "mechanism": "Binds glutamate-gated chloride channels in parasites.",
        "indications": [
            "Onchocerciasis (Onchocerca volvulus)"
        ],
        "dosage": {
            "adults": "8 mg orally single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Pruritus",
            "Headache",
            "Abdominal pain"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "proparacaine": {
        "definition": "A topical ocular anesthetic for eye procedures.",
        "mechanism": "Blocks sodium channels in corneal nerves.",
        "indications": [
            "Ocular anesthesia (diagnostic/procedural)"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Eye irritation",
            "Rare corneal damage (prolonged use)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "besifloxacin": {
        "definition": "A topical fluoroquinolone antibiotic for bacterial conjunctivitis.",
        "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase IV.",
        "indications": [
            "Bacterial conjunctivitis"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) 3 times daily for 7 days.",
            "children": "Same as adults (age 1+)."
        },
        "side effects": [
            "Eye irritation",
            "Blurred vision"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ophthalmic irrigation, intraocular": {
        "definition": "Sterile solutions for rinsing and hydrating ocular tissues during surgery.",
        "mechanism": "Flushes debris and maintains hydration of ocular tissues.",
        "indications": [
            "Ophthalmic surgery",
            "Eye injury"
        ],
        "dosage": {
            "adults": "As needed during procedure.",
            "children": "Same as adults."
        },
        "side effects": [
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trypan blue": {
        "definition": "A vital dye used for staining tissues during ophthalmic surgery.",
        "mechanism": "Stains devitalized cells and tissues for visualization.",
        "indications": [
            "Ophthalmic surgery (capsulorhexis, membrane visualization)"
        ],
        "dosage": {
            "adults": "0.06% solution, applied as needed during surgery.",
            "children": "Same as adults."
        },
        "side effects": [
            "Ocular irritation",
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium chondroitin sulfate": {
        "definition": "A glycosaminoglycan used as an ophthalmic surgical aid and supplement for osteoarthritis.",
        "mechanism": "Lubricates and protects ocular tissues; supports cartilage structure.",
        "indications": [
            "Ophthalmic surgery (viscoelastic)",
            "Osteoarthritis (oral supplement)"
        ],
        "dosage": {
            "adults": "Dose per procedure or product.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Ocular irritation (ophthalmic)",
            "GI upset (oral)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants (oral)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "naloxone": {
        "definition": "An opioid antagonist for reversal of opioid overdose.",
        "mechanism": "Blocks opioid receptors, reversing opioid effects.",
        "indications": [
            "Opioid overdose",
            "Opioid-induced respiratory depression"
        ],
        "dosage": {
            "adults": "0.4-2 mg IV/IM/SC; repeat as needed.",
            "children": "0.01 mg/kg IV/IM/SC."
        },
        "side effects": [
            "Withdrawal symptoms",
            "Hypertension",
            "Nausea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Opioids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lofexidine": {
        "definition": "An alpha-2 adrenergic agonist for opioid withdrawal symptoms.",
        "mechanism": "Decreases sympathetic outflow, reducing withdrawal symptoms.",
        "indications": [
            "Opioid withdrawal symptom management"
        ],
        "dosage": {
            "adults": "0.54-2.88 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypotension",
            "Bradycardia",
            "Drowsiness"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other CNS depressants",
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "basiliximab": {
        "definition": "A monoclonal antibody immunosuppressant for renal transplant induction.",
        "mechanism": "Blocks IL-2 receptor on activated T-cells.",
        "indications": [
            "Renal transplant rejection prophylaxis"
        ],
        "dosage": {
            "adults": "20 mg IV on day 0 and 4 post-transplant.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Infection",
            "Hypersensitivity",
            "Hypertension"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "daclizumab": {
        "definition": "A monoclonal antibody formerly used for multiple sclerosis and transplant (withdrawn).",
        "mechanism": "Blocks IL-2 receptor on activated T-cells.",
        "indications": [
            "Multiple sclerosis (withdrawn)",
            "Renal transplant (withdrawn)"
        ],
        "dosage": {
            "adults": "150 mg SC monthly (MS, withdrawn).",
            "children": "Not indicated."
        },
        "side effects": [
            "Hepatitis",
            "Encephalitis",
            "Infection"
        ],
        "contraindications": [
            "Liver disease",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tropicamide": {
        "definition": "A short-acting antimuscarinic for pupil dilation (mydriasis).",
        "mechanism": "Blocks muscarinic receptors in the eye, causing mydriasis and cycloplegia.",
        "indications": [
            "Ophthalmic examination"
        ],
        "dosage": {
            "adults": "1-2 drops of 0.5-1% solution in affected eye(s).",
            "children": "Same as adults."
        },
        "side effects": [
            "Blurred vision",
            "Photophobia",
            "Increased intraocular pressure"
        ],
        "contraindications": [
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cholecalciferol": {
        "definition": "Vitamin D3 for deficiency and supplementation.",
        "mechanism": "Increases intestinal absorption of calcium and phosphate.",
        "indications": [
            "Vitamin D deficiency",
            "Osteoporosis prevention"
        ],
        "dosage": {
            "adults": "600-2000 IU orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Hypercalcemia",
            "Hypercalciuria"
        ],
        "contraindications": [
            "Hypercalcemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "genistein": {
        "definition": "A soy isoflavone with estrogenic and antioxidant effects.",
        "mechanism": "Binds estrogen receptors; antioxidant activity.",
        "indications": [
            "Menopausal symptoms",
            "Bone health (supplement)"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Not routinely used."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hormone-sensitive cancers"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Estrogens",
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "NIH",
            "MedlinePlus"
        ]
    },
    "zinc glycinate": {
        "definition": "A chelated zinc supplement for deficiency.",
        "mechanism": "Provides zinc for physiological functions.",
        "indications": [
            "Zinc deficiency",
            "Supplementation"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Tetracyclines",
            "Quinolones"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cetrorelix": {
        "definition": "A GnRH antagonist for controlled ovarian stimulation in assisted reproduction.",
        "mechanism": "Blocks GnRH receptors, preventing premature LH surge.",
        "indications": [
            "Prevention of premature ovulation in IVF protocols"
        ],
        "dosage": {
            "adults": "0.25 mg SC daily during ovarian stimulation.",
            "children": "Not indicated."
        },
        "side effects": [
            "Abdominal pain",
            "Headache",
            "Injection site reactions"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other fertility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ambrisentan": {
        "definition": "An endothelin receptor antagonist for pulmonary arterial hypertension (PAH).",
        "mechanism": "Blocks endothelin-1 type A receptors, causing vasodilation.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "5-10 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral edema",
            "Anemia",
            "Liver enzyme elevation"
        ],
        "contraindications": [
            "Pregnancy",
            "Idiopathic pulmonary fibrosis"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Cyclosporine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bosentan": {
        "definition": "A dual endothelin receptor antagonist for pulmonary arterial hypertension (PAH).",
        "mechanism": "Blocks endothelin-1 type A and B receptors.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "62.5-125 mg orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Liver enzyme elevation",
            "Anemia",
            "Edema"
        ],
        "contraindications": [
            "Pregnancy",
            "Liver impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "treprostinil": {
        "definition": "A prostacyclin analog for pulmonary arterial hypertension (PAH).",
        "mechanism": "Vasodilates pulmonary and systemic arteries; inhibits platelet aggregation.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "IV/SC: start 1.25 ng/kg/min; oral/inhaled forms available.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Flushing",
            "Jaw pain",
            "Infusion site pain"
        ],
        "contraindications": [
            "Severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "macitentan": {
        "definition": "An endothelin receptor antagonist for pulmonary arterial hypertension (PAH).",
        "mechanism": "Blocks endothelin-1 type A and B receptors.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "10 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Anemia",
            "Liver enzyme elevation",
            "Edema"
        ],
        "contraindications": [
            "Pregnancy",
            "Liver impairment"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "epoprostenol": {
        "definition": "A prostacyclin analog for pulmonary arterial hypertension (PAH).",
        "mechanism": "Vasodilates pulmonary and systemic arteries; inhibits platelet aggregation.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "2 ng/kg/min IV infusion, titrate to effect.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Flushing",
            "Jaw pain",
            "Hypotension"
        ],
        "contraindications": [
            "Heart failure (severe)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iloprost": {
        "definition": "A prostacyclin analog for pulmonary arterial hypertension (PAH).",
        "mechanism": "Vasodilates pulmonary and systemic arteries; inhibits platelet aggregation.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)"
        ],
        "dosage": {
            "adults": "Inhaled: 2.5-5 mcg 6-9 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Cough",
            "Flushing",
            "Jaw pain"
        ],
        "contraindications": [
            "Pulmonary edema"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "riociguat": {
        "definition": "A soluble guanylate cyclase stimulator for PAH and CTEPH.",
        "mechanism": "Stimulates sGC, increasing cGMP and causing vasodilation.",
        "indications": [
            "Pulmonary arterial hypertension (PAH)",
            "Chronic thromboembolic pulmonary hypertension (CTEPH)"
        ],
        "dosage": {
            "adults": "1-2.5 mg orally three times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Hypotension",
            "Headache",
            "Dyspepsia"
        ],
        "contraindications": [
            "Pregnancy",
            "PDE-5 inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "PDE-5 inhibitors",
            "Nitrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iobenguane I 131": {
        "definition": "A radiotherapeutic agent for neuroendocrine tumors (pheochromocytoma, paraganglioma).",
        "mechanism": "Taken up by adrenergic tissue, delivers targeted radiation.",
        "indications": [
            "Pheochromocytoma",
            "Paraganglioma (unresectable/metastatic)"
        ],
        "dosage": {
            "adults": "Dose by body weight and protocol.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Myelosuppression",
            "Nausea",
            "Hypothyroidism"
        ],
        "contraindications": [
            "Hypersensitivity",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Drugs affecting norepinephrine uptake"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "selegiline": {
        "definition": "A selective MAO-B inhibitor for Parkinson's disease and depression.",
        "mechanism": "Inhibits MAO-B, increasing CNS dopamine.",
        "indications": [
            "Parkinson's disease",
            "Major depressive disorder (transdermal)"
        ],
        "dosage": {
            "adults": "5-10 mg orally daily (Parkinson's); 6-12 mg/24h patch (depression).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Insomnia",
            "Nausea",
            "Orthostatic hypotension"
        ],
        "contraindications": [
            "Meperidine use",
            "Other MAO inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "SSRIs",
            "TCAs",
            "Meperidine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rasagiline": {
        "definition": "A selective MAO-B inhibitor for Parkinson's disease.",
        "mechanism": "Inhibits MAO-B, increasing CNS dopamine.",
        "indications": [
            "Parkinson's disease"
        ],
        "dosage": {
            "adults": "0.5-1 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Arthralgia",
            "Dyspepsia"
        ],
        "contraindications": [
            "Meperidine use",
            "Other MAO inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "SSRIs",
            "TCAs",
            "Meperidine"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "entacapone": {
        "definition": "A COMT inhibitor for Parkinson's disease (adjunct to levodopa/carbidopa).",
        "mechanism": "Inhibits catechol-O-methyltransferase, prolonging levodopa effect.",
        "indications": [
            "Parkinson's disease (with levodopa/carbidopa)"
        ],
        "dosage": {
            "adults": "200 mg orally with each levodopa/carbidopa dose (max 1600 mg/day).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Dyskinesia",
            "Urine discoloration"
        ],
        "contraindications": [
            "Liver disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other COMT inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pimavanserin": {
        "definition": "A selective serotonin inverse agonist/antagonist for Parkinson's disease psychosis.",
        "mechanism": "Blocks 5-HT2A receptors.",
        "indications": [
            "Parkinson's disease psychosis"
        ],
        "dosage": {
            "adults": "34 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "QT prolongation",
            "Peripheral edema",
            "Confusion"
        ],
        "contraindications": [
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "heparin flush": {
        "definition": "A low-dose heparin solution for maintaining catheter patency.",
        "mechanism": "Prevents clot formation in IV catheters.",
        "indications": [
            "Catheter patency maintenance"
        ],
        "dosage": {
            "adults": "10-100 units/mL, 1-5 mL per flush.",
            "children": "Same as adults."
        },
        "side effects": [
            "Bleeding",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Heparin-induced thrombocytopenia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "levomefolate calcium": {
        "definition": "A biologically active form of folate (L-methylfolate) for supplementation.",
        "mechanism": "Provides active folate for methylation and neurotransmitter synthesis.",
        "indications": [
            "Folate deficiency",
            "Adjunct in depression (off-label)"
        ],
        "dosage": {
            "adults": "7.5-15 mg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Methotrexate",
            "Anticonvulsants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "benzylpenicilloyl-polylysine": {
        "definition": "A skin test reagent for penicillin allergy testing.",
        "mechanism": "Detects IgE-mediated penicillin allergy.",
        "indications": [
            "Penicillin allergy skin testing"
        ],
        "dosage": {
            "adults": "0.01 mL intradermally.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Anaphylaxis (rare)"
        ],
        "contraindications": [
            "Severe penicillin allergy history"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "propantheline": {
        "definition": "An anticholinergic for peptic ulcer and GI disorders.",
        "mechanism": "Blocks muscarinic receptors, reducing GI secretions and motility.",
        "indications": [
            "Peptic ulcer",
            "GI spasms"
        ],
        "dosage": {
            "adults": "15 mg orally 3-4 times daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dry mouth",
            "Blurred vision",
            "Urinary retention"
        ],
        "contraindications": [
            "Glaucoma",
            "Myasthenia gravis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bivalirudin": {
        "definition": "A direct thrombin inhibitor anticoagulant for PCI and HIT.",
        "mechanism": "Inhibits thrombin directly.",
        "indications": [
            "Percutaneous coronary intervention (PCI)",
            "Heparin-induced thrombocytopenia (HIT, off-label)"
        ],
        "dosage": {
            "adults": "0.75 mg/kg IV bolus, then 1.75 mg/kg/h infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Back pain",
            "Nausea"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cangrelor": {
        "definition": "An IV P2Y12 inhibitor antiplatelet for PCI.",
        "mechanism": "Blocks P2Y12 ADP receptor on platelets.",
        "indications": [
            "Adjunct to PCI to reduce risk of MI, repeat revascularization, stent thrombosis"
        ],
        "dosage": {
            "adults": "30 mcg/kg IV bolus, then 4 mcg/kg/min infusion.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bleeding",
            "Dyspnea"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antiplatelets"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vorapaxar": {
        "definition": "A PAR-1 antagonist antiplatelet for reducing thrombotic CV events.",
        "mechanism": "Blocks thrombin receptor on platelets.",
        "indications": [
            "History of MI or peripheral artery disease"
        ],
        "dosage": {
            "adults": "2.08 mg orally once daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Bleeding",
            "Anemia"
        ],
        "contraindications": [
            "History of stroke, TIA, or intracranial hemorrhage"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antiplatelets",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "belinostat": {
        "definition": "A histone deacetylase inhibitor for peripheral T-cell lymphoma.",
        "mechanism": "Inhibits HDAC, altering gene expression and inducing apoptosis.",
        "indications": [
            "Peripheral T-cell lymphoma (relapsed/refractory)"
        ],
        "dosage": {
            "adults": "1000 mg/m² IV daily for 5 days every 21 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Fatigue",
            "Myelosuppression"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2C9 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "florbetapir F 18": {
        "definition": "A radiopharmaceutical PET imaging agent for beta-amyloid plaque detection.",
        "mechanism": "Binds beta-amyloid plaques in the brain.",
        "indications": [
            "PET imaging of beta-amyloid plaque density (Alzheimer's diagnosis adjunct)"
        ],
        "dosage": {
            "adults": "370 MBq (10 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gallium ga 68 dotatate": {
        "definition": "A radiopharmaceutical for PET imaging of somatostatin receptor-positive neuroendocrine tumors.",
        "mechanism": "Binds somatostatin receptors, allowing PET visualization.",
        "indications": [
            "Imaging of neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "111-148 MBq (3-4 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Somatostatin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rubidium chloride rb-82": {
        "definition": "A radiopharmaceutical for PET myocardial perfusion imaging.",
        "mechanism": "Acts as a potassium analog, taken up by myocardial cells.",
        "indications": [
            "PET myocardial perfusion imaging"
        ],
        "dosage": {
            "adults": "1110-2220 MBq (30-60 mCi) IV per scan.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Arrhythmias (rare)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "flutemetamol f-18": {
        "definition": "A radiopharmaceutical PET imaging agent for beta-amyloid plaque detection.",
        "mechanism": "Binds beta-amyloid plaques in the brain.",
        "indications": [
            "PET imaging of beta-amyloid plaque density (Alzheimer's diagnosis adjunct)"
        ],
        "dosage": {
            "adults": "185 MBq (5 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "choline c-11": {
        "definition": "A radiopharmaceutical PET imaging agent for prostate cancer recurrence.",
        "mechanism": "Taken up by prostate cancer cells.",
        "indications": [
            "PET imaging for suspected prostate cancer recurrence"
        ],
        "dosage": {
            "adults": "370-740 MBq (10-20 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "florbetaben f-18": {
        "definition": "A radiopharmaceutical PET imaging agent for beta-amyloid plaque detection.",
        "mechanism": "Binds beta-amyloid plaques in the brain.",
        "indications": [
            "PET imaging of beta-amyloid plaque density (Alzheimer's diagnosis adjunct)"
        ],
        "dosage": {
            "adults": "300 MBq (8.1 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluciclovine F 18": {
        "definition": "A radiopharmaceutical PET imaging agent for prostate cancer recurrence.",
        "mechanism": "Taken up by prostate cancer cells.",
        "indications": [
            "PET imaging for suspected prostate cancer recurrence"
        ],
        "dosage": {
            "adults": "370 MBq (10 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Rare allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "gallium ga-68 dotatoc": {
        "definition": "A radiopharmaceutical for PET imaging of somatostatin receptor-positive neuroendocrine tumors.",
        "mechanism": "Binds somatostatin receptors, allowing PET visualization.",
        "indications": [
            "Imaging of neuroendocrine tumors"
        ],
        "dosage": {
            "adults": "100-200 MBq (2.7-5.4 mCi) IV.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Somatostatin analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sapropterin": {
        "definition": "A synthetic tetrahydrobiopterin (BH4) for phenylketonuria (PKU).",
        "mechanism": "Enhances activity of phenylalanine hydroxylase.",
        "indications": [
            "Phenylketonuria (PKU)"
        ],
        "dosage": {
            "adults": "5-20 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Headache",
            "Runny nose",
            "Diarrhea"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Levodopa"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pegvaliase": {
        "definition": "A PEGylated enzyme for phenylketonuria (PKU).",
        "mechanism": "Converts phenylalanine to ammonia and trans-cinnamic acid.",
        "indications": [
            "Phenylketonuria (PKU)"
        ],
        "dosage": {
            "adults": "2.5-60 mg SC daily (titration).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Anaphylaxis",
            "Arthralgia",
            "Headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "phenoxybenzamine": {
        "definition": "A non-selective, irreversible alpha-adrenergic blocker for pheochromocytoma.",
        "mechanism": "Blocks alpha-1 and alpha-2 receptors, reducing blood pressure.",
        "indications": [
            "Pheochromocytoma (preoperative)"
        ],
        "dosage": {
            "adults": "10-40 mg orally 2-3 times daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Orthostatic hypotension",
            "Tachycardia",
            "Nasal congestion"
        ],
        "contraindications": [
            "Hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "metyrosine": {
        "definition": "A tyrosine hydroxylase inhibitor for pheochromocytoma.",
        "mechanism": "Inhibits catecholamine synthesis.",
        "indications": [
            "Pheochromocytoma (preoperative, malignant)"
        ],
        "dosage": {
            "adults": "250 mg orally 4 times daily, titrate to response.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Sedation",
            "Depression",
            "Extrapyramidal symptoms"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lactic acid": {
        "definition": "A topical keratolytic and humectant for dry, scaly skin.",
        "mechanism": "Promotes exfoliation and increases skin hydration.",
        "indications": [
            "Xerosis",
            "Ichthyosis",
            "Keratoderma"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-2 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Burning"
        ],
        "contraindications": [
            "Open wounds",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "secukinumab": {
        "definition": "An anti-IL-17A monoclonal antibody for psoriasis and spondyloarthritis.",
        "mechanism": "Blocks IL-17A-mediated inflammation.",
        "indications": [
            "Plaque psoriasis",
            "Psoriatic arthritis",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "300 mg SC at weeks 0, 1, 2, 3, 4, then monthly.",
            "children": "Dose by weight (age 6+)."
        },
        "side effects": [
            "Infection",
            "Diarrhea",
            "Neutropenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ixekizumab": {
        "definition": "An anti-IL-17A monoclonal antibody for psoriasis and spondyloarthritis.",
        "mechanism": "Blocks IL-17A-mediated inflammation.",
        "indications": [
            "Plaque psoriasis",
            "Psoriatic arthritis",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "160 mg SC initially, then 80 mg every 2-4 weeks.",
            "children": "Dose by weight (age 6+)."
        },
        "side effects": [
            "Infection",
            "Injection site reactions",
            "Neutropenia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "brodalumab": {
        "definition": "An anti-IL-17 receptor A monoclonal antibody for psoriasis.",
        "mechanism": "Blocks IL-17 receptor A, inhibiting inflammation.",
        "indications": [
            "Plaque psoriasis"
        ],
        "dosage": {
            "adults": "210 mg SC at weeks 0, 1, 2, then every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Suicidal ideation",
            "Infection",
            "Arthralgia"
        ],
        "contraindications": [
            "Crohn's disease",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sterile talc": {
        "definition": "A sclerosing agent for pleurodesis in malignant pleural effusion.",
        "mechanism": "Induces inflammation and fibrosis in pleural space.",
        "indications": [
            "Malignant pleural effusion (pleurodesis)"
        ],
        "dosage": {
            "adults": "2-10 g intrapleural as a slurry or insufflation.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fever",
            "Pain",
            "Acute respiratory distress"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrilamine": {
        "definition": "A first-generation antihistamine for allergy and insomnia (often in combination).",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic rhinitis",
            "Insomnia (OTC combinations)"
        ],
        "dosage": {
            "adults": "25-50 mg orally every 4-6 hours.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "Dry mouth",
            "Dizziness"
        ],
        "contraindications": [
            "Narrow-angle glaucoma",
            "Urinary retention"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pneumococcal 13-valent vaccine": {
        "definition": "A conjugate vaccine for prevention of Streptococcus pneumoniae infection (13 serotypes).",
        "mechanism": "Induces active immunity against 13 serotypes of S. pneumoniae.",
        "indications": [
            "Prevention of pneumococcal disease"
        ],
        "dosage": {
            "adults": "0.5 mL IM single dose (as indicated).",
            "children": "0.5 mL IM at 2, 4, 6, 12-15 months."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Irritability"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "pneumococcal 23-polyvalent vaccine": {
        "definition": "A polysaccharide vaccine for prevention of Streptococcus pneumoniae infection (23 serotypes).",
        "mechanism": "Induces active immunity against 23 serotypes of S. pneumoniae.",
        "indications": [
            "Prevention of pneumococcal disease"
        ],
        "dosage": {
            "adults": "0.5 mL IM or SC single dose.",
            "children": "Dose by age and risk factors."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Myalgia"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "alglucosidase alfa": {
        "definition": "A recombinant enzyme for Pompe disease (acid alpha-glucosidase deficiency).",
        "mechanism": "Replaces acid alpha-glucosidase enzyme.",
        "indications": [
            "Pompe disease"
        ],
        "dosage": {
            "adults": "20 mg/kg IV every 2 weeks.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Rash",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chlophedianol": {
        "definition": "A centrally acting antitussive for cough.",
        "mechanism": "Suppresses cough reflex in the CNS.",
        "indications": [
            "Cough (OTC)"
        ],
        "dosage": {
            "adults": "25 mg orally every 6 hours.",
            "children": "Dose by age."
        },
        "side effects": [
            "Drowsiness",
            "GI upset"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nepafenac": {
        "definition": "A topical NSAID for postoperative ocular pain and inflammation.",
        "mechanism": "Inhibits prostaglandin synthesis in the eye.",
        "indications": [
            "Postoperative ocular pain and inflammation"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) 3 times daily.",
            "children": "Same as adults (age 10+)."
        },
        "side effects": [
            "Eye irritation",
            "Corneal edema"
        ],
        "contraindications": [
            "NSAID allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bromfenac": {
        "definition": "A topical NSAID for postoperative ocular pain and inflammation.",
        "mechanism": "Inhibits prostaglandin synthesis in the eye.",
        "indications": [
            "Postoperative ocular pain and inflammation"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) once or twice daily.",
            "children": "Same as adults (age 18+)."
        },
        "side effects": [
            "Eye irritation",
            "Corneal edema"
        ],
        "contraindications": [
            "NSAID allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other NSAIDs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "difluprednate": {
        "definition": "A topical corticosteroid for ocular inflammation.",
        "mechanism": "Suppresses ocular inflammation.",
        "indications": [
            "Ocular inflammation",
            "Postoperative inflammation and pain"
        ],
        "dosage": {
            "adults": "1 drop in affected eye(s) 2-4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Increased intraocular pressure",
            "Cataract formation"
        ],
        "contraindications": [
            "Viral/fungal eye infections"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular corticosteroids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "methylergonovine": {
        "definition": "An ergot alkaloid for postpartum hemorrhage.",
        "mechanism": "Stimulates uterine smooth muscle contraction.",
        "indications": [
            "Prevention and treatment of postpartum hemorrhage"
        ],
        "dosage": {
            "adults": "0.2 mg IM after delivery; may repeat every 2-4 hours.",
            "children": "Not indicated."
        },
        "side effects": [
            "Hypertension",
            "Nausea",
            "Vasoconstriction"
        ],
        "contraindications": [
            "Hypertension",
            "Pre-eclampsia"
        ],
        "special populations": {
            "pregnancy": "Contraindicated (except postpartum)."
        },
        "interactions": [
            "Vasoconstrictors",
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "histrelin": {
        "definition": "A GnRH agonist for central precocious puberty and prostate cancer.",
        "mechanism": "Suppresses pituitary gonadotropin secretion.",
        "indications": [
            "Central precocious puberty",
            "Prostate cancer"
        ],
        "dosage": {
            "adults": "50 mg implant SC yearly (prostate cancer).",
            "children": "Same as adults (central precocious puberty)."
        },
        "side effects": [
            "Hot flashes",
            "Mood changes",
            "Injection site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other hormone therapies"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nafarelin": {
        "definition": "A GnRH agonist nasal spray for central precocious puberty and endometriosis.",
        "mechanism": "Suppresses pituitary gonadotropin secretion.",
        "indications": [
            "Central precocious puberty",
            "Endometriosis"
        ],
        "dosage": {
            "adults": "200 mcg (1 spray) in each nostril twice daily (endometriosis).",
            "children": "Dose by weight (central precocious puberty)."
        },
        "side effects": [
            "Hot flashes",
            "Mood changes",
            "Nasal irritation"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Other hormone therapies"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "hydroxyprogesterone": {
        "definition": "A progestin for prevention of preterm birth and amenorrhea.",
        "mechanism": "Maintains uterine quiescence and supports pregnancy.",
        "indications": [
            "Prevention of preterm birth",
            "Amenorrhea"
        ],
        "dosage": {
            "adults": "250 mg IM weekly (preterm birth).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site reactions",
            "Edema",
            "Nausea"
        ],
        "contraindications": [
            "Thromboembolic disease",
            "Breast cancer"
        ],
        "special populations": {
            "pregnancy": "Indicated for preterm birth prevention."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acebutolol": {
        "definition": "A cardioselective beta-blocker for hypertension and arrhythmias.",
        "mechanism": "Blocks beta-1 adrenergic receptors.",
        "indications": [
            "Hypertension",
            "Ventricular arrhythmias"
        ],
        "dosage": {
            "adults": "400-1200 mg orally daily in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bradycardia",
            "Fatigue",
            "Hypotension"
        ],
        "contraindications": [
            "Severe bradycardia",
            "Heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antihypertensives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluoride": {
        "definition": "A mineral for prevention of dental caries.",
        "mechanism": "Promotes remineralization and inhibits bacterial metabolism in teeth.",
        "indications": [
            "Dental caries prevention"
        ],
        "dosage": {
            "adults": "Dose per product (toothpaste, rinse, supplement).",
            "children": "Dose by age."
        },
        "side effects": [
            "Dental fluorosis (excess)",
            "GI upset"
        ],
        "contraindications": [
            "Fluorosis"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Calcium, magnesium (reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "afamelanotide": {
        "definition": "A melanocortin 1 receptor agonist for erythropoietic protoporphyria.",
        "mechanism": "Increases melanin production, reducing photosensitivity.",
        "indications": [
            "Erythropoietic protoporphyria"
        ],
        "dosage": {
            "adults": "16 mg SC implant every 2 months.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Nausea",
            "Headache",
            "Implant site reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "mecasermin": {
        "definition": "A recombinant human IGF-1 for growth failure due to IGF-1 deficiency.",
        "mechanism": "Replaces IGF-1, promoting growth.",
        "indications": [
            "Growth failure due to severe primary IGF-1 deficiency"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "0.04-0.12 mg/kg SC twice daily."
        },
        "side effects": [
            "Hypoglycemia",
            "Tonsillar hypertrophy",
            "Injection site reactions"
        ],
        "contraindications": [
            "Malignant neoplasia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "immune globulin": {
        "definition": "A preparation of human immunoglobulins for passive immunity.",
        "mechanism": "Provides passive immunity against various infections.",
        "indications": [
            "Immunodeficiency",
            "Autoimmune disorders",
            "Infection prophylaxis"
        ],
        "dosage": {
            "adults": "Dose by indication and product.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Headache",
            "Thrombosis"
        ],
        "contraindications": [
            "IgA deficiency with anti-IgA antibodies"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "acetylcholine": {
        "definition": "A parasympathomimetic agent for intraocular use during surgery.",
        "mechanism": "Stimulates muscarinic receptors, causing miosis.",
        "indications": [
            "Induction of miosis during ophthalmic surgery"
        ],
        "dosage": {
            "adults": "0.5-1% solution, intraocular instillation.",
            "children": "Same as adults."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "protein c": {
        "definition": "A recombinant or plasma-derived anticoagulant protein for severe congenital deficiency.",
        "mechanism": "Inactivates factors Va and VIIIa, inhibiting coagulation.",
        "indications": [
            "Severe congenital protein C deficiency"
        ],
        "dosage": {
            "adults": "Dose by weight and indication.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Bleeding",
            "Allergic reactions"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fluphenazine": {
        "definition": "A typical antipsychotic for schizophrenia and psychosis.",
        "mechanism": "Blocks dopamine D2 receptors in the CNS.",
        "indications": [
            "Schizophrenia",
            "Psychosis"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally daily; depot IM/SC forms available.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Extrapyramidal symptoms",
            "Sedation",
            "QT prolongation"
        ],
        "contraindications": [
            "Severe CNS depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "thiothixene": {
        "definition": "A typical antipsychotic for schizophrenia.",
        "mechanism": "Blocks dopamine D2 receptors in the CNS.",
        "indications": [
            "Schizophrenia"
        ],
        "dosage": {
            "adults": "2-60 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Extrapyramidal symptoms",
            "Sedation",
            "QT prolongation"
        ],
        "contraindications": [
            "Severe CNS depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "iloperidone": {
        "definition": "An atypical antipsychotic for schizophrenia.",
        "mechanism": "Blocks dopamine D2 and serotonin 5-HT2A receptors.",
        "indications": [
            "Schizophrenia"
        ],
        "dosage": {
            "adults": "1-12 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "QT prolongation",
            "Dizziness",
            "Weight gain"
        ],
        "contraindications": [
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP2D6, CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cyclopentolate": {
        "definition": "A short-acting antimuscarinic for pupil dilation (mydriasis) and cycloplegia.",
        "mechanism": "Blocks muscarinic receptors in the eye.",
        "indications": [
            "Ophthalmic examination"
        ],
        "dosage": {
            "adults": "1-2 drops of 0.5-2% solution in affected eye(s).",
            "children": "Same as adults."
        },
        "side effects": [
            "Blurred vision",
            "Photophobia",
            "Increased intraocular pressure"
        ],
        "contraindications": [
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticholinergics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rabies immune globulin, human": {
        "definition": "A human immune globulin for post-exposure prophylaxis of rabies.",
        "mechanism": "Provides passive immunity to rabies virus.",
        "indications": [
            "Rabies post-exposure prophylaxis"
        ],
        "dosage": {
            "adults": "20 IU/kg IM; infiltrate as much as possible around wound.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Rabies vaccine (administer at different sites)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "rabies vaccine, purified chick embryo cell": {
        "definition": "A purified inactivated rabies vaccine for pre- and post-exposure prophylaxis.",
        "mechanism": "Induces active immunity against rabies virus.",
        "indications": [
            "Rabies pre- and post-exposure prophylaxis"
        ],
        "dosage": {
            "adults": "1 mL IM on days 0, 3, 7, 14 (post-exposure); 0, 7, 21/28 (pre-exposure).",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "rabies vaccine, human diploid cell": {
        "definition": "A purified inactivated rabies vaccine for pre- and post-exposure prophylaxis.",
        "mechanism": "Induces active immunity against rabies virus.",
        "indications": [
            "Rabies pre- and post-exposure prophylaxis"
        ],
        "dosage": {
            "adults": "1 mL IM on days 0, 3, 7, 14 (post-exposure); 0, 7, 21/28 (pre-exposure).",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Fever",
            "Headache"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "pentetate calcium trisodium": {
        "definition": "A chelating agent for internal contamination with plutonium, americium, or curium.",
        "mechanism": "Binds radioactive metals, promoting urinary excretion.",
        "indications": [
            "Internal contamination with plutonium, americium, or curium"
        ],
        "dosage": {
            "adults": "1 g IV/IM once daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other chelators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prussian blue": {
        "definition": "A chelating agent for thallium and radioactive cesium poisoning.",
        "mechanism": "Binds thallium and cesium in the gut, preventing reabsorption.",
        "indications": [
            "Thallium poisoning",
            "Radioactive cesium poisoning"
        ],
        "dosage": {
            "adults": "3 g orally three times daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Constipation",
            "Blue stool"
        ],
        "contraindications": [
            "Bowel obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other oral drugs (may reduce absorption)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentetate zinc trisodium": {
        "definition": "A chelating agent for internal contamination with plutonium, americium, or curium.",
        "mechanism": "Binds radioactive metals, promoting urinary excretion.",
        "indications": [
            "Internal contamination with plutonium, americium, or curium"
        ],
        "dosage": {
            "adults": "1 g IV/IM once daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other chelators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "felodipine": {
        "definition": "A dihydropyridine calcium channel blocker for hypertension and angina.",
        "mechanism": "Inhibits L-type calcium channels, causing arterial vasodilation.",
        "indications": [
            "Hypertension",
            "Angina"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Edema",
            "Headache",
            "Flushing"
        ],
        "contraindications": [
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isradipine": {
        "definition": "A dihydropyridine calcium channel blocker for hypertension.",
        "mechanism": "Inhibits L-type calcium channels, causing arterial vasodilation.",
        "indications": [
            "Hypertension"
        ],
        "dosage": {
            "adults": "2.5-10 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Edema",
            "Headache",
            "Flushing"
        ],
        "contraindications": [
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nisoldipine": {
        "definition": "A dihydropyridine calcium channel blocker for hypertension.",
        "mechanism": "Inhibits L-type calcium channels, causing arterial vasodilation.",
        "indications": [
            "Hypertension"
        ],
        "dosage": {
            "adults": "10-40 mg orally once daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Edema",
            "Headache",
            "Flushing"
        ],
        "contraindications": [
            "Severe hypotension"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nevirapine": {
        "definition": "A non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV infection.",
        "mechanism": "Inhibits HIV-1 reverse transcriptase, blocking viral replication.",
        "indications": [
            "HIV-1 infection (in combination therapy)"
        ],
        "dosage": {
            "adults": "200 mg orally once daily for 14 days, then 200 mg twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Rash",
            "Hepatotoxicity",
            "Fever"
        ],
        "contraindications": [
            "Moderate/severe hepatic impairment"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "belatacept": {
        "definition": "A selective T-cell costimulation blocker for kidney transplant rejection prophylaxis.",
        "mechanism": "Blocks CD80/86, inhibiting T-cell activation.",
        "indications": [
            "Prophylaxis of organ rejection in kidney transplant"
        ],
        "dosage": {
            "adults": "10 mg/kg IV on days 1, 5, end of weeks 2, 4, 8, 12; then 5 mg/kg IV every 4 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Infection",
            "PTLD",
            "Anemia"
        ],
        "contraindications": [
            "EBV seronegative patients"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "muromonab-cd3": {
        "definition": "A monoclonal antibody for acute organ transplant rejection (withdrawn in US).",
        "mechanism": "Binds CD3 on T-cells, causing depletion.",
        "indications": [
            "Acute organ transplant rejection (historical use)"
        ],
        "dosage": {
            "adults": "5 mg IV daily for 10-14 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Cytokine release syndrome",
            "Infection",
            "Pulmonary edema"
        ],
        "contraindications": [
            "Heart failure",
            "Seizure disorder"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "anti-thymocyte globulin (rabbit)": {
        "definition": "A polyclonal antibody for transplant rejection and aplastic anemia.",
        "mechanism": "Depletes T-lymphocytes.",
        "indications": [
            "Acute organ transplant rejection",
            "Aplastic anemia"
        ],
        "dosage": {
            "adults": "1.5 mg/kg IV daily for 5-14 days.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Infusion reactions",
            "Leukopenia",
            "Infection"
        ],
        "contraindications": [
            "Hypersensitivity to rabbit proteins"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nitric oxide": {
        "definition": "An inhaled pulmonary vasodilator for neonatal hypoxic respiratory failure.",
        "mechanism": "Relaxes vascular smooth muscle via cGMP.",
        "indications": [
            "Persistent pulmonary hypertension of the newborn (PPHN)"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "20 ppm inhaled, titrate to effect."
        },
        "side effects": [
            "Methemoglobinemia",
            "Rebound hypoxemia"
        ],
        "contraindications": [
            "Neonates dependent on right-to-left shunt"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Other vasodilators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "voretigene neparvovec": {
        "definition": "A gene therapy for biallelic RPE65 mutation-associated retinal dystrophy.",
        "mechanism": "Delivers functional RPE65 gene via AAV vector.",
        "indications": [
            "Inherited retinal dystrophy due to RPE65 mutations"
        ],
        "dosage": {
            "adults": "1.5 x 10^11 vector genomes per eye (subretinal injection).",
            "children": "Same as adults."
        },
        "side effects": [
            "Ocular inflammation",
            "Retinal tear",
            "Cataract"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants (corticosteroids required)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "prothrombin complex": {
        "definition": "A concentrate of clotting factors II, VII, IX, X for anticoagulant reversal.",
        "mechanism": "Replaces vitamin K-dependent clotting factors.",
        "indications": [
            "Reversal of vitamin K antagonist anticoagulation",
            "Bleeding in hemophilia B (some products)"
        ],
        "dosage": {
            "adults": "Dose by INR and body weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Heparin-induced thrombocytopenia (some products)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "coagulation factor Xa": {
        "definition": "A recombinant clotting factor for hereditary factor X deficiency.",
        "mechanism": "Replaces deficient factor X, enabling coagulation.",
        "indications": [
            "Hereditary factor X deficiency"
        ],
        "dosage": {
            "adults": "Dose by factor X activity and weight.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Thrombosis",
            "Allergic reactions"
        ],
        "contraindications": [
            "DIC",
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other clotting factors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "idarucizumab": {
        "definition": "A monoclonal antibody fragment for reversal of dabigatran anticoagulation.",
        "mechanism": "Binds dabigatran, neutralizing its effect.",
        "indications": [
            "Reversal of dabigatran anticoagulation"
        ],
        "dosage": {
            "adults": "5 g IV (2 x 2.5 g doses).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Hypokalemia",
            "Fever"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Dabigatran"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sugammadex": {
        "definition": "A selective relaxant binding agent for reversal of rocuronium/vecuronium neuromuscular blockade.",
        "mechanism": "Encapsulates rocuronium/vecuronium, inactivating them.",
        "indications": [
            "Reversal of neuromuscular blockade (rocuronium, vecuronium)"
        ],
        "dosage": {
            "adults": "2-16 mg/kg IV.",
            "children": "Dose by weight (age 2+)."
        },
        "side effects": [
            "Bradycardia",
            "Anaphylaxis",
            "Bleeding"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Hormonal contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "edrophonium": {
        "definition": "A short-acting acetylcholinesterase inhibitor for myasthenia gravis diagnosis.",
        "mechanism": "Inhibits acetylcholinesterase, increasing acetylcholine.",
        "indications": [
            "Diagnosis of myasthenia gravis (Tensilon test)",
            "Reversal of nondepolarizing neuromuscular blockade"
        ],
        "dosage": {
            "adults": "2-10 mg IV.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bradycardia",
            "Bronchospasm",
            "GI upset"
        ],
        "contraindications": [
            "GI or urinary obstruction"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other cholinesterase inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sulfadiazine": {
        "definition": "A sulfonamide antibiotic for toxoplasmosis and other infections.",
        "mechanism": "Inhibits folic acid synthesis in bacteria and protozoa.",
        "indications": [
            "Toxoplasmosis (with pyrimethamine)",
            "Other susceptible infections"
        ],
        "dosage": {
            "adults": "2-4 g orally initially, then 1-2 g every 4-6 hours.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Rash",
            "Crystalluria",
            "Leukopenia"
        ],
        "contraindications": [
            "Sulfa allergy",
            "Severe liver/renal disease"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Methotrexate",
            "Warfarin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "crotamiton": {
        "definition": "A topical scabicide and antipruritic for scabies and pruritus.",
        "mechanism": "Unknown; may have antipruritic and antiparasitic effects.",
        "indications": [
            "Scabies",
            "Pruritus"
        ],
        "dosage": {
            "adults": "Apply to affected area(s) daily for 2-5 days.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Acutely inflamed skin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antivenom (centruroides scorpion)": {
        "definition": "A purified F(ab')2 antivenom for Centruroides scorpion stings.",
        "mechanism": "Binds and neutralizes scorpion venom.",
        "indications": [
            "Centruroides scorpion sting (neurotoxic symptoms)"
        ],
        "dosage": {
            "adults": "1 vial IV; repeat if needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Serum sickness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "olopatadine": {
        "definition": "A topical antihistamine for allergic conjunctivitis and rhinitis.",
        "mechanism": "Blocks histamine H1 receptors.",
        "indications": [
            "Allergic conjunctivitis",
            "Allergic rhinitis (nasal spray)"
        ],
        "dosage": {
            "adults": "1-2 drops in affected eye(s) twice daily; nasal spray: 2 sprays each nostril twice daily.",
            "children": "Same as adults (age 2+)."
        },
        "side effects": [
            "Eye irritation",
            "Headache",
            "Bitter taste"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other ocular medications"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "coal tar": {
        "definition": "A topical keratolytic for psoriasis, eczema, and seborrheic dermatitis.",
        "mechanism": "Reduces skin cell proliferation and inflammation.",
        "indications": [
            "Psoriasis",
            "Eczema",
            "Seborrheic dermatitis"
        ],
        "dosage": {
            "adults": "Apply to affected area 1-4 times daily.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Photosensitivity",
            "Staining"
        ],
        "contraindications": [
            "Acute inflamed skin"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "paricalcitol": {
        "definition": "A vitamin D analog for secondary hyperparathyroidism in CKD.",
        "mechanism": "Activates vitamin D receptors, suppressing PTH synthesis.",
        "indications": [
            "Secondary hyperparathyroidism (CKD)"
        ],
        "dosage": {
            "adults": "1-4 mcg IV 3 times/week or 1-2 mcg orally daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypercalcemia",
            "GI upset"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "doxercalciferol": {
        "definition": "A vitamin D2 analog for secondary hyperparathyroidism in CKD.",
        "mechanism": "Activates vitamin D receptors, suppressing PTH synthesis.",
        "indications": [
            "Secondary hyperparathyroidism (CKD)"
        ],
        "dosage": {
            "adults": "2.5-10 mcg IV 3 times/week or 1-3.5 mcg orally daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypercalcemia",
            "GI upset"
        ],
        "contraindications": [
            "Hypercalcemia",
            "Vitamin D toxicity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Thiazide diuretics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dexmedetomidine": {
        "definition": "A selective alpha-2 agonist sedative for ICU and procedural sedation.",
        "mechanism": "Activates central alpha-2 receptors, producing sedation and analgesia.",
        "indications": [
            "ICU sedation",
            "Procedural sedation"
        ],
        "dosage": {
            "adults": "0.2-1.5 mcg/kg/h IV infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Bradycardia",
            "Hypotension",
            "Dry mouth"
        ],
        "contraindications": [
            "Advanced heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dobutamine": {
        "definition": "A beta-1 agonist inotrope for acute heart failure and cardiogenic shock.",
        "mechanism": "Stimulates beta-1 receptors, increasing cardiac contractility.",
        "indications": [
            "Acute heart failure",
            "Cardiogenic shock"
        ],
        "dosage": {
            "adults": "2-20 mcg/kg/min IV infusion.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Arrhythmias",
            "Tachycardia",
            "Hypertension"
        ],
        "contraindications": [
            "Idiopathic hypertrophic subaortic stenosis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "teduglutide": {
        "definition": "A GLP-2 analog for short bowel syndrome.",
        "mechanism": "Enhances intestinal absorption by promoting mucosal growth.",
        "indications": [
            "Short bowel syndrome"
        ],
        "dosage": {
            "adults": "0.05 mg/kg SC once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Abdominal pain",
            "Nausea",
            "Fluid overload"
        ],
        "contraindications": [
            "GI malignancy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other GI motility drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "demeclocycline": {
        "definition": "A tetracycline antibiotic with off-label use for SIADH.",
        "mechanism": "Inhibits protein synthesis; reduces renal response to ADH.",
        "indications": [
            "Bacterial infections",
            "SIADH (off-label)"
        ],
        "dosage": {
            "adults": "600-1200 mg orally daily in divided doses.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Photosensitivity",
            "Nephrotoxicity",
            "GI upset"
        ],
        "contraindications": [
            "Pregnancy",
            "Children <8 years"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Antacids",
            "Oral contraceptives"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cevimeline": {
        "definition": "A muscarinic agonist for dry mouth in Sjögren's syndrome.",
        "mechanism": "Stimulates muscarinic receptors, increasing exocrine secretion.",
        "indications": [
            "Dry mouth (xerostomia) in Sjögren's syndrome"
        ],
        "dosage": {
            "adults": "30 mg orally three times daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Sweating",
            "Nausea",
            "Visual disturbances"
        ],
        "contraindications": [
            "Uncontrolled asthma",
            "Narrow-angle glaucoma"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Beta-blockers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tecovirimat": {
        "definition": "An antiviral for treatment of smallpox and orthopoxvirus infections.",
        "mechanism": "Inhibits viral envelope protein, preventing viral spread.",
        "indications": [
            "Smallpox",
            "Monkeypox (off-label)"
        ],
        "dosage": {
            "adults": "600 mg orally twice daily for 14 days.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Headache",
            "Nausea",
            "Abdominal pain"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "smallpox vaccine": {
        "definition": "A live vaccinia virus vaccine for prevention of smallpox.",
        "mechanism": "Induces active immunity against smallpox virus.",
        "indications": [
            "Prevention of smallpox"
        ],
        "dosage": {
            "adults": "Percutaneous (scarification) single dose.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Fever",
            "Rash",
            "Myocarditis"
        ],
        "contraindications": [
            "Immunosuppression",
            "Eczema",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "nicotine": {
        "definition": "A cholinergic agonist for smoking cessation (patch, gum, lozenge, etc.).",
        "mechanism": "Stimulates nicotinic acetylcholine receptors.",
        "indications": [
            "Smoking cessation"
        ],
        "dosage": {
            "adults": "Patch: 7-21 mg/day; Gum/lozenge: 2-4 mg as needed.",
            "children": "Not indicated."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Increased heart rate"
        ],
        "contraindications": [
            "Recent MI",
            "Arrhythmias"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other stimulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "varenicline": {
        "definition": "A partial nicotinic receptor agonist for smoking cessation.",
        "mechanism": "Partially stimulates and blocks nicotine receptors.",
        "indications": [
            "Smoking cessation"
        ],
        "dosage": {
            "adults": "0.5 mg orally daily for 3 days, then 0.5 mg twice daily for 4 days, then 1 mg twice daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "Nausea",
            "Insomnia",
            "Neuropsychiatric effects"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other smoking cessation drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "papaverine": {
        "definition": "A vasodilator for vasospasm and erectile dysfunction (off-label).",
        "mechanism": "Inhibits phosphodiesterase, increasing cAMP and cGMP.",
        "indications": [
            "Vasospasm",
            "Erectile dysfunction (intracavernosal, off-label)"
        ],
        "dosage": {
            "adults": "30-60 mg IV/IM; intracavernosal: 7.5-60 mg.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hypotension",
            "Arrhythmias",
            "Priapism"
        ],
        "contraindications": [
            "Complete AV block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other vasodilators"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "larotrectinib": {
        "definition": "A TRK inhibitor for solid tumors with NTRK gene fusion.",
        "mechanism": "Inhibits TRK fusion proteins.",
        "indications": [
            "Solid tumors with NTRK gene fusion"
        ],
        "dosage": {
            "adults": "100 mg orally twice daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Fatigue",
            "Dizziness",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "entrectinib": {
        "definition": "A TRK, ROS1, and ALK inhibitor for NTRK fusion-positive solid tumors and ROS1-positive NSCLC.",
        "mechanism": "Inhibits TRK, ROS1, and ALK fusion proteins.",
        "indications": [
            "NTRK fusion-positive solid tumors",
            "ROS1-positive NSCLC"
        ],
        "dosage": {
            "adults": "600 mg orally once daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Fatigue",
            "Dizziness",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors/inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dyclonine": {
        "definition": "A topical local anesthetic for oral and throat pain.",
        "mechanism": "Blocks sodium channels, inhibiting nerve conduction.",
        "indications": [
            "Sore throat",
            "Oral pain"
        ],
        "dosage": {
            "adults": "Lozenge: 1 every 2 hours as needed.",
            "children": "Not recommended <6 years."
        },
        "side effects": [
            "Numbness",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "butamben": {
        "definition": "A topical local anesthetic for skin and mucous membrane pain.",
        "mechanism": "Blocks sodium channels, inhibiting nerve conduction.",
        "indications": [
            "Minor skin pain",
            "Hemorrhoids",
            "Oral pain"
        ],
        "dosage": {
            "adults": "Apply as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other local anesthetics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "nusinersen": {
        "definition": "An antisense oligonucleotide for spinal muscular atrophy (SMA).",
        "mechanism": "Modifies SMN2 splicing, increasing SMN protein production.",
        "indications": [
            "Spinal muscular atrophy (SMA)"
        ],
        "dosage": {
            "adults": "12 mg intrathecal injection per protocol.",
            "children": "Same as adults."
        },
        "side effects": [
            "Respiratory infection",
            "Constipation",
            "Spinal headache"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "onasemnogene abeparvovec": {
        "definition": "A gene therapy for spinal muscular atrophy (SMA) in children <2 years.",
        "mechanism": "Delivers functional SMN1 gene via AAV9 vector.",
        "indications": [
            "SMA (children <2 years)"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "1.1 x 10^14 vector genomes/kg IV single dose."
        },
        "side effects": [
            "Elevated liver enzymes",
            "Vomiting",
            "Thrombocytopenia"
        ],
        "contraindications": [
            "Liver dysfunction"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "Immunosuppressants (corticosteroids required)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "golimumab": {
        "definition": "An anti-TNF-alpha monoclonal antibody for autoimmune diseases.",
        "mechanism": "Blocks TNF-alpha, reducing inflammation.",
        "indications": [
            "Rheumatoid arthritis",
            "Psoriatic arthritis",
            "Ulcerative colitis",
            "Ankylosing spondylitis"
        ],
        "dosage": {
            "adults": "50 mg SC monthly (RA, PsA, AS); 200 mg SC at week 0, 100 mg at week 2, then 100 mg every 4 weeks (UC).",
            "children": "Dose by weight (UC, age 2+)."
        },
        "side effects": [
            "Infection",
            "Injection site reactions",
            "Malignancy"
        ],
        "contraindications": [
            "Active infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pentobarbital": {
        "definition": "A barbiturate sedative-hypnotic for sedation, anesthesia, and status epilepticus.",
        "mechanism": "Enhances GABAergic inhibition in CNS.",
        "indications": [
            "Sedation",
            "Anesthesia",
            "Status epilepticus"
        ],
        "dosage": {
            "adults": "100-200 mg IM/IV; 1-3 mg/kg IV for status epilepticus.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Respiratory depression",
            "Hypotension",
            "Dependence"
        ],
        "contraindications": [
            "Porphyria",
            "Severe respiratory depression"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CNS depressants",
            "CYP inducers"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "fosphenytoin": {
        "definition": "A water-soluble prodrug of phenytoin for status epilepticus and seizures.",
        "mechanism": "Blocks voltage-gated sodium channels.",
        "indications": [
            "Status epilepticus",
            "Seizure prophylaxis"
        ],
        "dosage": {
            "adults": "15-20 mg PE/kg IV loading dose.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Arrhythmias",
            "Hypotension",
            "Nystagmus"
        ],
        "contraindications": [
            "Sinus bradycardia",
            "Heart block"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sacrosidase": {
        "definition": "An oral enzyme for congenital sucrase-isomaltase deficiency.",
        "mechanism": "Replaces sucrase enzyme, aiding sucrose digestion.",
        "indications": [
            "Congenital sucrase-isomaltase deficiency"
        ],
        "dosage": {
            "adults": "Not indicated.",
            "children": "1-2 mL orally with each meal/snack."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Allergic reactions"
        ],
        "contraindications": [
            "Yeast allergy"
        ],
        "special populations": {
            "pregnancy": "Not indicated."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valbenazine": {
        "definition": "A VMAT2 inhibitor for tardive dyskinesia.",
        "mechanism": "Reduces dopamine release by inhibiting VMAT2.",
        "indications": [
            "Tardive dyskinesia"
        ],
        "dosage": {
            "adults": "40 mg orally once daily, may increase to 80 mg.",
            "children": "Not indicated."
        },
        "side effects": [
            "Somnolence",
            "QT prolongation",
            "Akathisia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "apomorphine": {
        "definition": "A dopamine agonist for acute, intermittent treatment of 'off' episodes in Parkinson's disease.",
        "mechanism": "Stimulates dopamine receptors in the brain.",
        "indications": [
            "'Off' episodes in Parkinson's disease"
        ],
        "dosage": {
            "adults": "2-6 mg SC as needed (max 5 times/day).",
            "children": "Not indicated."
        },
        "side effects": [
            "Nausea",
            "Hypotension",
            "Hallucinations"
        ],
        "contraindications": [
            "5HT3 antagonist use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "5HT3 antagonists",
            "Other dopamine agonists"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "tetanus immune globulin": {
        "definition": "A human immune globulin for passive immunization against tetanus.",
        "mechanism": "Provides antibodies to neutralize tetanus toxin.",
        "indications": [
            "Tetanus prophylaxis and treatment"
        ],
        "dosage": {
            "adults": "250-500 units IM.",
            "children": "Same as adults."
        },
        "side effects": [
            "Injection site reactions",
            "Allergic reactions"
        ],
        "contraindications": [
            "IgA deficiency with anti-IgA antibodies"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Live vaccines"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "avatrombopag": {
        "definition": "A thrombopoietin receptor agonist for thrombocytopenia in chronic liver disease and ITP.",
        "mechanism": "Stimulates platelet production.",
        "indications": [
            "Thrombocytopenia in chronic liver disease",
            "Chronic immune thrombocytopenia (ITP)"
        ],
        "dosage": {
            "adults": "40-60 mg orally daily for 5 days (liver disease); 20 mg daily (ITP).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Thromboembolism",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "lusutrombopag": {
        "definition": "A thrombopoietin receptor agonist for thrombocytopenia in chronic liver disease.",
        "mechanism": "Stimulates platelet production.",
        "indications": [
            "Thrombocytopenia in chronic liver disease"
        ],
        "dosage": {
            "adults": "3 mg orally once daily for up to 7 days.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Headache",
            "Thromboembolism",
            "Fatigue"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "caplacizumab": {
        "definition": "A nanobody for acquired thrombotic thrombocytopenic purpura (aTTP).",
        "mechanism": "Inhibits vWF-platelet interaction.",
        "indications": [
            "Acquired TTP (aTTP)"
        ],
        "dosage": {
            "adults": "10 mg IV bolus, then 10 mg SC daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Bleeding",
            "Headache",
            "Fever"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "teprotumumab": {
        "definition": "An IGF-1R inhibitor for thyroid eye disease (Graves' orbitopathy).",
        "mechanism": "Blocks IGF-1 receptor, reducing inflammation and tissue expansion.",
        "indications": [
            "Thyroid eye disease"
        ],
        "dosage": {
            "adults": "10 mg/kg IV first infusion, then 20 mg/kg IV every 3 weeks (8 infusions).",
            "children": "Not routinely used."
        },
        "side effects": [
            "Muscle spasm",
            "Hyperglycemia",
            "Hearing impairment"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "cefaclor": {
        "definition": "A second-generation oral cephalosporin antibiotic.",
        "mechanism": "Inhibits bacterial cell wall synthesis.",
        "indications": [
            "Respiratory tract infections",
            "Otitis media",
            "Skin infections",
            "UTI"
        ],
        "dosage": {
            "adults": "250-500 mg orally every 8 hours.",
            "children": "20-40 mg/kg/day in divided doses."
        },
        "side effects": [
            "Rash",
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Cephalosporin allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Probenecid"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "povidone iodine": {
        "definition": "A topical antiseptic for skin, mucous membranes, and wound care.",
        "mechanism": "Releases iodine, disrupting microbial proteins and DNA.",
        "indications": [
            "Skin antisepsis",
            "Wound cleansing",
            "Mucosal antisepsis"
        ],
        "dosage": {
            "adults": "Apply as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Allergic reactions"
        ],
        "contraindications": [
            "Iodine allergy",
            "Thyroid disease (caution)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "isopropyl alcohol": {
        "definition": "A topical antiseptic and disinfectant.",
        "mechanism": "Denatures proteins and disrupts cell membranes.",
        "indications": [
            "Skin antisepsis",
            "Disinfection"
        ],
        "dosage": {
            "adults": "Apply as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Dryness"
        ],
        "contraindications": [
            "Open wounds"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium hypochlorite": {
        "definition": "A topical antiseptic and disinfectant for wound care and root canal irrigation.",
        "mechanism": "Releases chlorine, disrupting microbial proteins and DNA.",
        "indications": [
            "Wound cleansing",
            "Root canal irrigation"
        ],
        "dosage": {
            "adults": "Apply as directed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Skin irritation",
            "Chemical burns"
        ],
        "contraindications": [
            "Open wounds (concentrated solutions)"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other topical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pimozide": {
        "definition": "A typical antipsychotic for Tourette's disorder and resistant schizophrenia.",
        "mechanism": "Blocks dopamine D2 receptors in the CNS.",
        "indications": [
            "Tourette's disorder",
            "Resistant schizophrenia"
        ],
        "dosage": {
            "adults": "1-10 mg orally daily.",
            "children": "Dose by age and indication."
        },
        "side effects": [
            "QT prolongation",
            "Extrapyramidal symptoms",
            "Sedation"
        ],
        "contraindications": [
            "QT prolongation",
            "CYP3A4 inhibitors"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors",
            "Other antipsychotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pyrazinamide": {
        "definition": "A first-line antitubercular agent.",
        "mechanism": "Disrupts mycobacterial cell membrane metabolism.",
        "indications": [
            "Tuberculosis (with other drugs)"
        ],
        "dosage": {
            "adults": "15-30 mg/kg orally once daily.",
            "children": "Same as adults, dose by weight."
        },
        "side effects": [
            "Hepatotoxicity",
            "Hyperuricemia",
            "Arthralgia"
        ],
        "contraindications": [
            "Severe liver disease",
            "Gout"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other hepatotoxic drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "rifapentine": {
        "definition": "A rifamycin antibiotic for tuberculosis (with other drugs).",
        "mechanism": "Inhibits DNA-dependent RNA polymerase in mycobacteria.",
        "indications": [
            "Tuberculosis (with other drugs)"
        ],
        "dosage": {
            "adults": "600 mg orally once or twice weekly.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hepatotoxicity",
            "Rash",
            "Orange discoloration of body fluids"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 substrates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "bcg": {
        "definition": "A live attenuated Mycobacterium bovis vaccine for tuberculosis and bladder cancer immunotherapy.",
        "mechanism": "Induces immune response against mycobacteria and tumor cells.",
        "indications": [
            "Tuberculosis prevention",
            "Bladder cancer (intravesical)"
        ],
        "dosage": {
            "adults": "Vaccine: 0.1 mL ID; Bladder: 50 mg in 50 mL saline intravesical.",
            "children": "Vaccine: 0.05 mL ID (infants)."
        },
        "side effects": [
            "Local ulceration",
            "Fever",
            "Cystitis (bladder use)"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "bcg vaccine": {
        "definition": "A live attenuated Mycobacterium bovis vaccine for tuberculosis prevention.",
        "mechanism": "Induces immune response against mycobacteria.",
        "indications": [
            "Tuberculosis prevention"
        ],
        "dosage": {
            "adults": "0.1 mL ID single dose.",
            "children": "0.05 mL ID (infants)."
        },
        "side effects": [
            "Local ulceration",
            "Fever"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "bedaquiline": {
        "definition": "A diarylquinoline antitubercular for multidrug-resistant TB.",
        "mechanism": "Inhibits mycobacterial ATP synthase.",
        "indications": [
            "Multidrug-resistant tuberculosis"
        ],
        "dosage": {
            "adults": "400 mg orally daily for 2 weeks, then 200 mg three times weekly.",
            "children": "Dose by weight."
        },
        "side effects": [
            "QT prolongation",
            "Hepatotoxicity",
            "Arthralgia"
        ],
        "contraindications": [
            "QT prolongation"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "aminosalicylic acid": {
        "definition": "A second-line antitubercular agent.",
        "mechanism": "Inhibits folic acid synthesis in mycobacteria.",
        "indications": [
            "Tuberculosis (second-line)"
        ],
        "dosage": {
            "adults": "4 g orally 2-4 times daily.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Hypersensitivity",
            "Hepatitis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other antituberculars"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "pretomanid": {
        "definition": "A nitroimidazooxazine antitubercular for extensively drug-resistant TB.",
        "mechanism": "Disrupts mycobacterial cell wall synthesis.",
        "indications": [
            "Extensively drug-resistant tuberculosis (with bedaquiline and linezolid)"
        ],
        "dosage": {
            "adults": "200 mg orally once daily for 26 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral neuropathy",
            "GI upset",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inducers/inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "typhoid vaccine, live": {
        "definition": "A live oral vaccine for prevention of typhoid fever.",
        "mechanism": "Induces active immunity against Salmonella typhi.",
        "indications": [
            "Prevention of typhoid fever (travelers, endemic areas)"
        ],
        "dosage": {
            "adults": "1 capsule orally every other day for 4 doses.",
            "children": "Age 6+ same as adults."
        },
        "side effects": [
            "Fever",
            "Abdominal pain",
            "Rash"
        ],
        "contraindications": [
            "Immunosuppression",
            "Pregnancy"
        ],
        "special populations": {
            "pregnancy": "Contraindicated."
        },
        "interactions": [
            "Antibiotics"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "typhoid vaccine, inactivated": {
        "definition": "An inactivated injectable vaccine for prevention of typhoid fever.",
        "mechanism": "Induces active immunity against Salmonella typhi.",
        "indications": [
            "Prevention of typhoid fever (travelers, endemic areas)"
        ],
        "dosage": {
            "adults": "0.5 mL IM single dose.",
            "children": "Age 2+ same as adults."
        },
        "side effects": [
            "Fever",
            "Injection site reactions"
        ],
        "contraindications": [
            "Severe allergic reaction to vaccine components"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    },
    "olsalazine": {
        "definition": "A prodrug of mesalamine for ulcerative colitis.",
        "mechanism": "Converted to mesalamine in the colon, reducing inflammation.",
        "indications": [
            "Ulcerative colitis (maintenance of remission)"
        ],
        "dosage": {
            "adults": "500 mg orally twice daily.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Diarrhea",
            "Abdominal pain",
            "Headache"
        ],
        "contraindications": [
            "Salicylate allergy"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other salicylates"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium phenylbutyrate": {
        "definition": "A nitrogen-binding agent for urea cycle disorders.",
        "mechanism": "Conjugates with glutamine, promoting excretion of nitrogen.",
        "indications": [
            "Urea cycle disorders (hyperammonemia)"
        ],
        "dosage": {
            "adults": "9.9-13 g/m²/day orally in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Menstrual irregularities",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nitrogen-scavenging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "glycerol phenylbutyrate": {
        "definition": "A nitrogen-binding agent for urea cycle disorders.",
        "mechanism": "Conjugates with glutamine, promoting excretion of nitrogen.",
        "indications": [
            "Urea cycle disorders (hyperammonemia)"
        ],
        "dosage": {
            "adults": "5.7-11.2 mL/m²/day orally in divided doses.",
            "children": "Dose by weight."
        },
        "side effects": [
            "GI upset",
            "Menstrual irregularities",
            "Rash"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other nitrogen-scavenging drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "potassium acid phosphate": {
        "definition": "A phosphate and potassium supplement for deficiency states.",
        "mechanism": "Provides phosphate and potassium ions.",
        "indications": [
            "Hypophosphatemia",
            "Hypokalemia"
        ],
        "dosage": {
            "adults": "Dose individualized IV or orally.",
            "children": "Dose by weight."
        },
        "side effects": [
            "Hyperkalemia",
            "Hyperphosphatemia"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Hyperphosphatemia"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Calcium-containing drugs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "valrubicin": {
        "definition": "An anthracycline antineoplastic for bladder cancer (intravesical).",
        "mechanism": "Inhibits DNA synthesis.",
        "indications": [
            "BCG-refractory carcinoma in situ of the bladder"
        ],
        "dosage": {
            "adults": "800 mg in 75 mL saline intravesical once weekly for 6 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Dysuria",
            "Hematuria",
            "Bladder spasm"
        ],
        "contraindications": [
            "Perforated bladder"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravesical agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "durvalumab": {
        "definition": "A PD-L1 inhibitor for urothelial carcinoma and NSCLC.",
        "mechanism": "Blocks PD-L1, enhancing T-cell immune response.",
        "indications": [
            "Urothelial carcinoma",
            "Unresectable stage III NSCLC"
        ],
        "dosage": {
            "adults": "10 mg/kg IV every 2 weeks.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Immune-related adverse events",
            "Fatigue",
            "Cough"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Immunosuppressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "enfortumab vedotin": {
        "definition": "An antibody-drug conjugate for urothelial carcinoma.",
        "mechanism": "Targets Nectin-4 and delivers MMAE cytotoxin.",
        "indications": [
            "Locally advanced or metastatic urothelial carcinoma"
        ],
        "dosage": {
            "adults": "1.25 mg/kg IV on days 1, 8, 15 of 28-day cycle.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Peripheral neuropathy",
            "Rash",
            "Hyperglycemia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "CYP3A4 inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "polidocanol": {
        "definition": "A sclerosing agent for varicose veins and spider veins.",
        "mechanism": "Damages endothelium, causing vein sclerosis.",
        "indications": [
            "Varicose veins",
            "Spider veins"
        ],
        "dosage": {
            "adults": "0.5-3% solution, dose per vein and procedure.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site pain",
            "Allergic reactions"
        ],
        "contraindications": [
            "Acute thrombophlebitis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other sclerosing agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "sodium tetradecyl sulfate": {
        "definition": "A sclerosing agent for varicose veins and spider veins.",
        "mechanism": "Damages endothelium, causing vein sclerosis.",
        "indications": [
            "Varicose veins",
            "Spider veins"
        ],
        "dosage": {
            "adults": "0.1-3% solution, dose per vein and procedure.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Injection site pain",
            "Allergic reactions"
        ],
        "contraindications": [
            "Acute thrombophlebitis"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other sclerosing agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antivenin (crotalidae) polyvalent": {
        "definition": "A polyvalent antivenom for North American pit viper (rattlesnake, copperhead, cottonmouth) bites.",
        "mechanism": "Binds and neutralizes venom components.",
        "indications": [
            "Crotalidae (pit viper) envenomation"
        ],
        "dosage": {
            "adults": "10-20 vials IV initially, repeat as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Serum sickness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antivenin (micrurus fulvius)": {
        "definition": "A specific antivenom for Eastern coral snake (Micrurus fulvius) bites.",
        "mechanism": "Binds and neutralizes coral snake venom.",
        "indications": [
            "Micrurus fulvius (coral snake) envenomation"
        ],
        "dosage": {
            "adults": "3-5 vials IV initially, repeat as needed.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Serum sickness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "antivenin (black widow spider)": {
        "definition": "A specific antivenom for black widow spider (Latrodectus) bites.",
        "mechanism": "Binds and neutralizes black widow spider venom.",
        "indications": [
            "Black widow spider envenomation (severe symptoms)"
        ],
        "dosage": {
            "adults": "1 vial IV or IM.",
            "children": "Same as adults."
        },
        "side effects": [
            "Allergic reactions",
            "Serum sickness"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "None significant"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "betrixaban": {
        "definition": "An oral factor Xa inhibitor anticoagulant for VTE prophylaxis in acute medical illness.",
        "mechanism": "Inhibits factor Xa, reducing thrombin generation.",
        "indications": [
            "VTE prophylaxis in hospitalized adults"
        ],
        "dosage": {
            "adults": "160 mg orally once, then 80 mg daily for 35-42 days.",
            "children": "Not indicated."
        },
        "side effects": [
            "Bleeding",
            "Anemia"
        ],
        "contraindications": [
            "Active bleeding"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "P-gp inhibitors"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "dextran, low molecular weight": {
        "definition": "A plasma expander for hypovolemia and as an anticoagulant adjunct.",
        "mechanism": "Increases plasma oncotic pressure, inhibits platelet aggregation.",
        "indications": [
            "Hypovolemia",
            "Prevention of thromboembolism"
        ],
        "dosage": {
            "adults": "Dose per product and indication.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Anaphylaxis",
            "Bleeding",
            "Renal dysfunction"
        ],
        "contraindications": [
            "Severe heart failure",
            "Bleeding disorders"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Anticoagulants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "vitamin a": {
        "definition": "A fat-soluble vitamin for deficiency, eye health, and immune function.",
        "mechanism": "Essential for vision, immune function, and cell growth.",
        "indications": [
            "Vitamin A deficiency",
            "Measles (adjunct)",
            "Eye health"
        ],
        "dosage": {
            "adults": "700-900 mcg RAE daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Hypervitaminosis A",
            "Hepatotoxicity"
        ],
        "contraindications": [
            "Hypervitaminosis A"
        ],
        "special populations": {
            "pregnancy": "Avoid high doses."
        },
        "interactions": [
            "Retinoids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "beta-carotene": {
        "definition": "A provitamin A carotenoid antioxidant.",
        "mechanism": "Converted to vitamin A in the body.",
        "indications": [
            "Vitamin A supplementation",
            "Antioxidant"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "Carotenemia (yellow skin)"
        ],
        "contraindications": [
            "Hypervitaminosis A"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Retinoids"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "multivitamin with minerals": {
        "definition": "A dietary supplement containing multiple vitamins and minerals.",
        "mechanism": "Provides essential nutrients for health.",
        "indications": [
            "Nutritional supplementation",
            "Deficiency prevention"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Prenatal formulas preferred."
        },
        "interactions": [
            "Other supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "chromium picolinate": {
        "definition": "A trace element supplement for chromium deficiency and glycemic control (unproven).",
        "mechanism": "Cofactor for insulin action.",
        "indications": [
            "Chromium deficiency",
            "Glycemic control (supplement; evidence limited)"
        ],
        "dosage": {
            "adults": "Dose per product.",
            "children": "Dose by age."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Insulin"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "selenium": {
        "definition": "A trace element supplement for deficiency and antioxidant support.",
        "mechanism": "Cofactor for antioxidant enzymes.",
        "indications": [
            "Selenium deficiency",
            "Supplementation"
        ],
        "dosage": {
            "adults": "55 mcg orally daily.",
            "children": "Dose by age."
        },
        "side effects": [
            "Selenosis (hair loss, GI upset)"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Generally considered safe."
        },
        "interactions": [
            "Other mineral supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "multivitamin, prenatal": {
        "definition": "A dietary supplement with vitamins and minerals for pregnancy.",
        "mechanism": "Provides essential nutrients for fetal development.",
        "indications": [
            "Pregnancy supplementation"
        ],
        "dosage": {
            "adults": "1 tablet/capsule daily.",
            "children": "Not indicated."
        },
        "side effects": [
            "GI upset",
            "Allergic reactions"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Indicated."
        },
        "interactions": [
            "Other supplements"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "ocriplasmin": {
        "definition": "A recombinant protease for symptomatic vitreomacular adhesion.",
        "mechanism": "Breaks down proteins at vitreoretinal interface.",
        "indications": [
            "Symptomatic vitreomacular adhesion"
        ],
        "dosage": {
            "adults": "0.125 mg intravitreal injection.",
            "children": "Not routinely used."
        },
        "side effects": [
            "Visual disturbance",
            "Retinal tear",
            "Eye pain"
        ],
        "contraindications": [
            "Ocular infection"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Other intravitreal agents"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "desipramine": {
        "definition": "A tricyclic antidepressant (TCA) primarily used for depression and sometimes for neuropathic pain.",
        "mechanism": "Inhibits reuptake of norepinephrine and, to a lesser extent, serotonin in the CNS.",
        "indications": [
            "Major depressive disorder",
            "Off-label: neuropathic pain, ADHD"
        ],
        "dosage": {
            "adults": "100–200 mg orally daily, up to 300 mg/day; start lower and titrate.",
            "children": "1.5–5 mg/kg/day (for selected indications, specialist use)."
        },
        "side effects": [
            "Dry mouth",
            "Constipation",
            "Orthostatic hypotension",
            "Arrhythmias",
            "Weight gain"
        ],
        "contraindications": [
            "Recent MI",
            "Arrhythmias",
            "Narrow-angle glaucoma",
            "MAO inhibitor use"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "MAO inhibitors",
            "CYP2D6 inhibitors",
            "Other CNS depressants"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "trientine": {
        "definition": "A copper chelating agent for Wilson's disease.",
        "mechanism": "Binds copper, increasing its urinary excretion.",
        "indications": [
            "Wilson's disease (copper overload)"
        ],
        "dosage": {
            "adults": "750–1,500 mg orally daily in 2–4 divided doses on an empty stomach.",
            "children": "20 mg/kg/day in 2–3 divided doses."
        },
        "side effects": [
            "Iron deficiency anemia",
            "Gastritis",
            "Rash",
            "Proteinuria"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Mineral supplements (iron, zinc)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "burosumab": {
        "definition": "A monoclonal antibody for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.",
        "mechanism": "Binds and inhibits FGF23, increasing renal phosphate reabsorption and vitamin D production.",
        "indications": [
            "X-linked hypophosphatemia",
            "Tumor-induced osteomalacia"
        ],
        "dosage": {
            "adults": "1 mg/kg SC every 4 weeks (tumor-induced osteomalacia).",
            "children": "0.8 mg/kg SC every 2 weeks (XLH)."
        },
        "side effects": [
            "Injection site reactions",
            "Headache",
            "Tooth abscess",
            "Hyperphosphatemia"
        ],
        "contraindications": [
            "Severe renal impairment",
            "Hyperphosphatemia"
        ],
        "special populations": {
            "pregnancy": "Use only if benefits outweigh risks."
        },
        "interactions": [
            "Oral phosphate, active vitamin D analogs"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "FDA DailyMed",
            "DrugBank",
            "MedlinePlus"
        ]
    },
    "yellow fever vaccine": {
        "definition": "A live attenuated vaccine for prevention of yellow fever.",
        "mechanism": "Induces active immunity against yellow fever virus.",
        "indications": [
            "Prevention of yellow fever (travelers to endemic areas, outbreak control)"
        ],
        "dosage": {
            "adults": "0.5 mL SC single dose at least 10 days before exposure.",
            "children": "Same as adults (age 9 months+)."
        },
        "side effects": [
            "Fever",
            "Headache",
            "Muscle aches",
            "Hypersensitivity",
            "Rare: viscerotropic or neurologic disease"
        ],
        "contraindications": [
            "Severe allergy to egg or vaccine components",
            "Immunosuppression",
            "Infants <6 months",
            "Pregnancy (unless high risk)"
        ],
        "special populations": {
            "pregnancy": "Avoid unless risk of exposure outweighs risk."
        },
        "interactions": [
            "Immunosuppressants",
            "Other live vaccines (space by 4 weeks if not given same day)"
        ],
        "last updated": "2024-07-01",
        "official sources": [
            "CDC",
            "FDA",
            "MedlinePlus"
        ]
    }
}